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Summary 
 
P. aeruginosa is a versatile microorganism with high levels of antimicrobial resistance and a 
common contaminant of home and personal care (HPC) products. Relatively little is known 
about P. aeruginosa in industrial settings and to further investigate this, four areas were 
considered: (i) culture-dependent and –independent detection of P. aeruginosa; (ii) P. 
aeruginosa and bacterial diversity in HPC products; (iii) preservative susceptibility and 
phenotypic characterisation of industrial P. aeruginosa strains, and; (iv) P. aeruginosa 
adaptation to a preservative combination.  
A large collection of P. aeruginosa and non-P. aeruginosa industrial isolates was utilised to 
evaluate five selective agars for the detection of P. aeruginosa.  Media using negative selection 
performed best overall, but media using positive selection had potential as enrichment media. 
Culture-independent detection of P. aeruginosa and overall bacterial diversity was achieved via 
direct DNA extraction from contaminated HPC products, species specific PCRs and 16S rRNA 
gene sequencing analysis. The bacterial diversity in HPC products was low, with less than three 
contaminating genera in each product. The diversity of P. aeruginosa strains from industrial, 
clinical and environmental sources was investigated using five genotyping techniques, ranging 
from PCR-fingerprinting methods to whole genome sequencing, and phenotypic assays 
examining preservative susceptibility, growth dynamics and motility. P. aeruginosa strain 
diversity was high and there was no association between genotype, phenotype and isolation 
source. The development of adaptive resistance of P. aeruginosa to a preservative combination 
used in HPC products was modelled using planktonic growth and biofilm assays. P. aeruginosa 
PA14 grew in elevated levels of the preservatives chloromethylisothiazolinone, 
methylisothiazolinone and dimethylol dimethyl hydantoin but it was unknown whether the 
increased tolerance was stable. 
Whilst eradication of P. aeruginosa from the industrial environment is unlikely, improved 
detection methods and understanding of the species will inform industrial practices and 
preservative formulations to minimise HPC product contamination.  
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1. Introduction 
 
1.1 Microbial contamination in the home and personal care (HPC) industry 
 
1.1.1 Microbial contamination of HPC products  
 
The HPC industry manufactures a diverse range of products which are sold globally and used 
daily by consumers. Personal care products, such as cosmetics and toiletries are used to 
beautify or maintain personal hygiene (Perry 2001), whilst household care products are 
generally used to clean or freshen home surfaces and clothing.  A large variety of product 
formulations are encountered within the HPC industry and are tailored to suit the application. 
Factors such as water activity (Aw; the water content available to microbial utility) (Lundov et 
al. 2009), pH, redox potential and nutrient availability all influence a product’s propensity to 
support microbial growth (Orth et al. 2006).  HPC products with a water activity above 0.60 and 
a pH between 4.0 and 10.0 are particularly at risk of contamination (Orth et al. 2006).  
 
Although HPC products are not expected to be sterile, they are required to be ‘safe for their 
intended purpose under normal and foreseeable conditions of use’ (Orus and Leranoz 2005).  
Microbial contamination can have adverse effects which are damaging to the product, the 
manufacturer and the consumer.  Product spoilage by the presence of and/or growth of 
microorganisms renders HPC products unfit for use (Smart and Spooner 1972).  A range of 
undesirable effects can be observed including changes in odour, colour, viscosity and the 
production/utilisation of gas leading to the warping of packaging.  In addition, product 
performance may be affected such as a decrease in the effectiveness of active ingredients, a loss 
of lathering activity (Perry 2001) or the breakdown of emulsions (Smart and Spooner 1972).  
Economic losses to the manufacturer can result through loss of contaminated raw materials or 
batches of finished product, and the investigation and decontamination of production processes. 
Furthermore, contaminated products and product recalls can affect product marketability and 
consumer satisfaction (Orth et al. 2006) which impact the reputation of a company or brand 
name.   
 
More seriously, contamination represents a health risk to vulnerable consumers, and the 
presence of opportunistic pathogens in HPC products has been linked with infections in 
nosocomial settings.  These incidences include Pseudomonas aeruginosa contamination of hand 
lotion and mouthwash (Stephenson et al. 1984; Becks and Lorenzoni 1995), Burkholderia in 
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mouthwashes (Matrician et al. 2000; Molina-Cabrillana et al. 2006; Kutty et al. 2007) and 
moisturising lotion (Álvarez-Lerma et al. 2008), and Serratia marcescens in soap and detergents 
(Polilli et al. 2011).  Individual infections contracted from contaminated products outside of the 
hospital environment are less likely to be documented (Lundov, 2009) although contaminated 
products do reach the market place, as product recall data (Jimenez 2007; Lundov and 
Zachariae 2008; Sutton and Jimenez 2012) and surveys of off-the-shelf products have shown 
(Lundov et al. 2009).  
 
Contamination of HPC products may arise via two routes, through manufacture and subsequent 
storage, or through consumer use (Farrington et al. 1994).  To minimise contamination during 
manufacture, Good Manufacturing Practices (GMP) are followed by industries, stipulated by 
regulatory bodies such as the U.S. Food and Drug Administration (FDA) and within the 
European Commission (EC) Cosmetics Directive.  These guidelines cover all aspects of 
manufacture including quality control and handling of raw materials, manufacturing facilities 
and equipment, cleaning and sanitisation procedures, and personnel training. Whilst products 
may never be completely sterile, GMPs help to ensure benign levels of intrinsic contamination 
and the absence of harmful microorganisms (Perry 2001). Consumer use leads to contamination 
through repeated inoculation of the product with the skin microbiota/body fluids or with 
microorganisms from the domestic environment  (Perry 2001; Orth et al. 2006).  This 
unavoidable occurrence is counteracted by careful product formulation and the inclusion of 
preservatives to prevent microbial proliferation (Orth et al. 2006). In addition, to further 
protect the consumer, the EU has introduced ‘best used before’ and ‘period after opening’ 
guidelines which are provided on packaging to advise on product lifespan (Orus and Leranoz 
2005; Lundov et al. 2009). 
 
1.1.2 Microbiological quality assurance and detection of HPC product contamination 
 
To ensure the safety and stability of HPC products, microbiological limit testing is performed by 
manufacturers to ensure that total microbial counts are low and products are devoid of 
objectionable species.  As there are no formal regulations for microbial limits, companies 
generally follow recommendations by professional associations such as the FDA, the Personal 
Care Products Council (PCPC), the Scientific Committee on Consumer Safety (SCCS) and 
Cosmetics Europe (Table 1.1), and may even enforce stricter in-house regulations than 
suggested.  Detection is predominantly culture-dependent with total viable counts of aerobic 
mesophilic microorganisms (bacteria, yeast and mold) being achieved by traditional plate 
counts, and identification of objectionable species based on phenotypic and biochemical testing 
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(Orus and Leranoz 2005; Orth et al. 2006).  The term ‘objectionable organism’ is slightly 
ambiguous (Sutton and Jimenez 2012), and according to the PCPC definition means ‘an 
organism that can be harmful to the user based upon the nature of the product, its intended use 
and its potential hazard, or is able to compromise the physical integrity or appearance of the 
product’.  The species in Table 1.1  are specified objectionable organisms, but are certainly not 
the only problematic contaminants (Sutton and Jimenez 2012). This poses an issue for 
manufacturers who must consider which other species should be excluded from products. 
Suggestions for two further specified objectionable bacteria include Burkholderia spp. and 
Bacillus cereus (Sutton 2012). 
 
To determine whether a product formulation is adequately preserved to prevent microbial 
contamination, preservative efficacy testing (PET), also known as ‘challenge testing’, is 
performed. Evaluation of the complete formulation is required, as the concentrations of 
preservatives sufficient for growth inhibition in the laboratory may not reflect their 
performance in the product (Orth et al. 2006). The general PET method involves the inoculation 
of product samples with microorganisms, followed by the removal of aliquots at stipulated time-
points and the enumeration of survivors, in order to determine the overall reduction in viable 
cell numbers (Russell 2003). Several standardised methods of PET exist, for example those 
provided by the United States Pharmacopeia (USP), the European Pharmacopeia (EP) and the 
Japanese Pharmacopeia (JP). In addition, in-house methods adapted from the Pharmacopeia 
methods are sometimes used (Orth et al. 2006).  Variables within the methods include choice of 
microorganism, the number and frequency of sampling points after inoculation, and the limits 
determining adequate preservation (Orth et al. 2006). The microorganisms used in PET are 
those likely to contaminate products during use, such as S. aureus, P. aeruginosa, E. coli, 
Burkholderia spp., Aspergillus niger and C. albicans (Russell 2003).  Both organisms from culture 
collections and ‘in-house’ isolates which may have been isolated from contaminated products or 
the production plant are usually used (Orus and Leranoz 2005). 
 
As stated above a cultivation-based approach is routinely used in industry to detect microbial 
contaminants (Jimenez 2001a), which appears to generally provide satisfactory quality control 
for HPC products (Orth et al. 2006).  There are a number of drawbacks to culture-dependent 
methods, however, including lengthy processing times, the expense of media and reagents, and 
the difficulties associated with the detection of fastidious, ‘stressed’ or viable but not cultivable 
(VBNC) cells (Orus and Leranoz 2005).  Alternative ‘rapid’ detection methods such as ATP-
bioluminescence, impedance and flow cytometry, rely on the metabolic state of microorganisms, 
can take less than 24 hours and are more reliable for detecting stressed cells (Jimenez 2001b; 
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Orus and Leranoz 2005).  Whilst these methods confer economic benefits associated with a 
reduction in testing times, they only estimate the total bioburden, and further tests would still 
be required to identify specific groups of microorganisms (Orus & Leranoz, 2005). In addition, 
the ATP-bioluminescence method can result in false positive results through the detection of 
non-microbial ATP in the detection system, or false negatives through product ingredients 
which can limit, or ‘quench’, the reaction (Orth et al. 2006). Other molecular methods such as 
species-specific polymerase chain reaction (PCR)-based assays and immunoassays have been 
suggested for species identification in this context (Jimenez 2001b). 
 
 
 
 
 
Table 1.1 Microbial limits and specified objectionable microorganisms for personal care 
products  
 
Organism Product category 
Professional association recommendations 
PCPC (USA)1 FDA (USA)2 SCCS (EU)3 
Cosmetics4 
Europe (EU) 
Total aerobic 
mesophilic 
counts 
Product for children  
under 3 years  
< 100-500 
cfu/ml or cfu/g 
- 100 cfu/ml or 
cfu/g 
< 100-500 
cfu/ml or 
cfu/g 
Product for use in the 
eye area/on mucous 
membranes 
< 100-500 
cfu/ml or cfu/g 
500 cfu/ml or 
cfu/g 
100 cfu/ml or 
cfu/g 
< 100-500 
cfu/ml or 
cfu/g 
All other products < 1000-5000 
cfu/ml or cfu/g 
1000 cfu/ml 
or cfu/g 
1000 cfu/ml 
or cfu/g 
< 1000-5000 
cfu/ml or 
cfu/g 
Specified 
microorganisms 
Product for children  
under 3 years  
Absence of  
P. aeruginosa, 
 S. aureus and  
E. coli 
Absence of  
P. aeruginosa, 
other 
Pseudomonas 
spp., S. aureus, 
 Streptococcus 
pyogenes and 
Klebsiella 
pneumoniae 
Absence of 
 P. aeruginosa, 
S. aureus and  
C. albicans in 
1 ml or 1 g 
Absence of  
P. aeruginosa,  
S. aureus and  
C. albicans in 
0.1 ml or 0.1 g 
Product for use in the 
eye area/on mucous 
membranes 
All other products Absence of 
 P. aeruginosa, 
S. aureus and  
C. albicans in 
0.1 ml or 0.1 g 
 
Footnotes: 
1Personal Care Products Council (PCPC; formerly CFTA), Microbiology Guidelines 2007, Section 
12 Establishing Microbial Quality of Product 
2 U.S. Food and Drug Administration (FDA), Bacteriological Analytical Manual Chapter 23 Microbiological Methods for 
Cosmetics, C. Interpretation 
3Scientific Committee on Consumer Safety (SCCS) Notes of guidance for testing of cosmetic substances and their 
safety evaluation 8th Revision 
4Cosmetics Europe (formerly COLIPA), Guidelines on Microbial Quality Management, (MQM) Edition of 1997 
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1.1.3 Commonly encountered contaminants in the HPC industry 
 
As there is no requirement for industry to publish information concerning contamination 
incidents, systematic literature in this area is limited.  Product recall data, however, is collated 
by the FDA and the European Commission and made publicly available. Reports based on FDA 
data for personal care and non-sterile pharmaceutical products (Jimenez 2007; Sutton and 
Jimenez 2012) and the Rapid Alert System for non-food consumer products in the EU (RAPEX) 
(Wong et al. 2000; Lundov et al. 2009) indicate the range of microorganisms found as 
contaminants.  Figure 1.1 illustrates the different types and proportions of microorganisms 
associated with non-sterile products and was compiled with data from two published studies 
which surveyed FDA product recalls (Jimenez 2007; Sutton and Jimenez 2012), and data 
directly obtained from the EU RAPEX website 
(www.ec.europa.eu/consumers/consumers_safety/safety_products/rapex/index_en.htm) from 2005-2014 
having a microbiological risk type.  
The most common causes of product recalls were unacceptably high levels of unidentified 
aerobic mesophilic microorganisms, fungal (yeast or mold) growth, and the bacterial 
contaminants P. aeruginosa and Burkholderia spp. (see Figure 1.1).  Although the FDA and 
RAPEX reports differ in the relative proportions of groups of contaminating microorganisms, 
Gram-negative bacterial species are particularly prevalent in industry.  One report (Jimenez 
2007) documented that Gram-negative bacteria accounted for 60% of product recalls, with 
fungal and Gram-positive bacterial species accounting for approximately 25% and 5%, 
respectively.  It is speculated that this bias could be due to the association of Gram-negative 
bacterial species with water contamination, as water is one of the most common raw materials 
used in HPC manufacture (Jimenez 2007).  Whilst diverse microorganisms can contaminate HPC 
products, the majority of incidents are linked to only one species.  Reports based on FDA data 
has shown co-contamination represents about 5% of the total recalls (Jimenez 2007; Sutton and 
Jimenez 2012), and EU RAPEX data suggests slightly higher at 10-15%. In the majority of co-
contamination incidents only 2 species were reported as present, and the highest number of 
different species isolated from a single product was 5 (Jimenez 2007). 
It is not always easy to interpret the product recall data, as there is no indication of how 
thorough the identification processes have been, or whether incidents citing ‘aerobic mesophilic 
microorganisms’ as the reason for recall involve multiple species.  In addition, using only 
culture-dependent techniques for identification may exclude fastidious or uncultivable isolates 
(Orus and Leranoz 2005).  We also have very little knowledge about industrial microorganisms 
below the species level, for example whether certain strains are more prevalent in industry than 
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others.  With the exception of an incident where a contaminated mouthwash led to a multi-state 
outbreak of Burkholderia infection in the USA (Kutty et al. 2007), few studies have sought to 
apply epidemiological techniques to link strain types to contaminated products and/or 
potential sources of contamination. Dedicated studies to assess the diversity of microbial 
contamination in industry would therefore be incredibly informative.   
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Figure 1.1 Microorganisms 
associated with non-
sterile product recalls. The 
different types of micro-
organisms, and the number 
of times each group was 
linked to a contamination 
incidents is depicted 
graphically for (A) FDA data 
from 2004-2011 for 143 
product recalls (Sutton and 
Jimenez 2012), (B) FDA data 
from 1995-2006 for 134 
product recalls (Jimenez 
2007), (B) FDA data from 
1995-2006 for 134 product 
recalls, and (C) EU RAPEX 
data from 2005-2014 for 
176 product recalls with a 
microbiological risk type 
(collated in this study). 
Percentage values are given 
for groups whose prevalence 
exceeded 1%.  
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1.1.4 Preservation of HPC products 
 
Preservatives belong to a class of chemical agents known as biocides which exhibit broad 
spectrum antimicrobial activity (McDonnell and Russell 1999).  Other categories of biocides 
include antiseptics, which are used on living tissues, and disinfectants, which are used on 
inanimate objects (Orth et al. 2006). Whilst certain chemical compounds can be used for all 
three applications, those used for preservation are generally incorporated into pharmaceutical, 
cosmetic or other product types at low levels to prevent microbial spoilage (Orth et al. 2006). 
Preservatives are not added to products to compensate for inadequate manufacturing 
conditions, rather to prevent the proliferation of contaminants introduced by the consumer 
after manufacture (Hiom 2008). There are high expectations of preservatives: to demonstrate 
broad spectrum antimicrobial activity at permitted levels; to maintain activity throughout the 
lifespan of the product; to not compromise product quality or performance, and; to not pose a 
risk to consumer health (Elder and Crowley 2012).  Choosing preservatives which encompass 
all of these attributes is difficult as a number of factors affect preservative performance in 
formulation. These factors include other formulation components, product pH, product Aw, the 
intended shelf life of the product, and processing and storage conditions (Orth et al. 2006).   
 
Although there are over 50 preservatives available for use in HPC products, the most frequently 
used preservatives over the last 20-25 years have belonged to three classes: the parabens, the 
formaldehyde releasing agents, and the isothiazolinones (Lundov et al. 2009).  These classes are 
desirable as they generally have broad antimicrobial activity and are stable over a wide pH 
range (Lundov et al. 2009). Examples of commonly used preservative classes are given in 
section 1.1.5, along with examples of specific compounds in Table 1.2. Even when efficacious, a 
single preservative may be insufficient to protect complex formulations from contamination and 
spoilage (Orth et al. 2006). Combinations of preservatives, often with different modes of action, 
are therefore used to boost the spectrum of activity that can be achieved (Orus and Leranoz 
2005). Using combinations can lower the overall concentrations of individual preservatives, 
which lessens consumer exposure and minimises the emergence of resistant or tolerant 
organisms (Orth et al. 2006).  
 
In addition, certain combinations of preservatives may exhibit synergy, whereby the activity of 
the combination is greater than would be expected from the simple addition of their individual 
activities (Denyer et al. 1985).  An example of a commercially available preservative 
combination demonstrating synergistic activity is Phenonip, a mixture of phenoxyethanol and 
parabens (Parker et al. 1968). Chemical compounds, known as preservative potentiators or 
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preservative enhancers, are also incorporated into products to increase the antimicrobial 
activity of preservatives (Orth et al. 2006). These compounds are not regulated in the same way 
as preservatives and are discussed further in Section 1.1.5.7. Furthermore, other factors such as 
pH and Aw  affect the ability of a product to support microbial growth and are taken into account 
when evaluating a preservative system (Orth et al. 2006). In recent years there has been an 
increased consumer demand for ‘preservative free’ or ‘natural’ products which has challenged 
the personal care industry to use milder preservation systems or look at ‘self-preserving’ 
formulations (Orth et al. 2006; Varvaresou et al. 2009). A combination of strategies have been 
assessed, including the use of ‘Hurdle Technology’ principles and alternative or natural 
preservatives, often derived from plants, which are not under the same regulations as classical 
preservatives (Varvaresou et al. 2009). 
 
Preservatives are regulated for use in personal care products, with different regulations in 
different regions. The European Communities Cosmetic Directive, the Ministry of Health and 
Welfare and the FDA, regulate or restrict the use of preservatives in Europe, Japan and the 
United States, respectively. The legislation in Europe is outlined in the Council Directive 
76/768/EC, within which annex II to VII specify prohibited or approved preservatives, along 
with their maximum in-use concentrations (Lundov et al. 2009). Changes to the content of the 
annexes are based on recommendations from the SCCP, taking into account consumer safety 
and adhering to the microbiological quality expectations of finished products (Lundov et al. 
2009). In Japan, where the regulations are most stringent, the fewest numbers of preservatives 
are permitted for use in products (Orth et al. 2006), and lists of approved and banned 
substances are published by the Ministry of Health and Welfare under the Pharmaceutical 
Affairs Law (Chisvert and Salvador 2011). The situation is different in the United States, as there 
are no lists of approved preservatives, only a short list of substances banned or restricted by the 
FDA (Chisvert and Salvador 2011).  Due to the varying restrictions, it is very difficult for a 
company to develop a preservative system that can be implemented in product formulations 
globally (Orth et al. 2006). Regulations are in place to ensure that consumers are not at risk 
from preservative exposure, which has the potential to cause contact dermatitis if the 
preservatives are skin sensitizers or irritants. In addition, other harmful activities are assessed, 
for example the oestrogenic activity that has been associated with parabens (Harvey and 
Everett 2004; Orth et al. 2006). 
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1.1.5 Key preservatives in HPC products 
 
The following sections will introduce preservatives and preservative enhancing agents of 
importance to the home and personal care industry, highlighting which compounds were used 
in this study. A summary of preservative compounds and preservative enhancing agents is given 
in Table 1.2. 
 
1.1.5.1 Parabens 
 
Parabens are alkyl esters of para-hydroxybenzoic acid have been one of the most widely used 
groups of preservatives in the personal care industry (Soni et al. 2001). The predominant forms 
used in products include the methyl, n-propyl and the n-butyl esters (Table 1.2), which can be 
added individually or in combination, supplied by a range of manufacturers (Brannan 1997). 
Properties of parabens contributing to their utility as preservatives include a broad spectrum of 
antimicrobial activity, stability over a wide pH range and at high temperatures, sufficient 
solubility in water to achieve effective concentrations in products, and a low toxicity (Soni et al. 
2001).  The antimicrobial activity of parabens increases as the chain length of the ester group 
increases, but this also decreases the water solubility, meaning that the shorter chain length 
esters are more commonly used in products (Soni et al. 2005). Parabens have higher activity 
against fungi than bacteria and are more active against Gram-positive than Gram-negative 
bacteria (Soni et al. 2005).  They are primarily membrane active agents and disrupt the proton 
motive force of the bacterial cellular membrane, which can lead to the acidification of the 
cytoplasm (Lambert 2008). Other effects include the leakage of intracellular components and 
the inhibition of amino and oxo acid uptake (Brannan 1997; Maillard 2002). Although parabens 
are easy to formulate with and well tolerated, concerns over their safety to consumers have 
arisen in the last two decades, which had led to changes to their use in Europe. Studies have 
reported that parabens have been found in human breast tumours and may have oestrogenic 
potential (Harvey and Everett 2004). Whilst the link is still equivocal, amendments to the EU 
Cosmetics Directive have been made to prevent the use of long chain parabens 
isopropylparaben, isobutylparaben, phenylparaben, benzylparaben and pentylparaben 
(Commission regulation (EU) No 1004/2014, made on September 18th 2014), with the use of 
other parabens regulated at 0.4% (singly) or 0.8% (as a mixture). 
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1.1.5.2 Formaldehyde and formaldehyde releasing agents 
 
The use of free formaldehyde as a preservative is decreasing, instead organic compounds are 
incorporated into products which hydrolyse gradually to release low levels of formaldehyde 
(Brannan 1997).  Different formaldehyde releasing agents release varying amounts of free 
formaldehyde into products (Brannan 1997). For the agent dimethyloldimethyl hydantoin 
(DMDMH; trade name Glydant, manufactured by Lonza; Table 1.2), the rate of release of 
formaldehyde is pH dependent, with higher rates at an increased pH (9-10.5), compared to a 
lower pH (3-5) (Lambert 2008).  The broad spectrum antimicrobial activity of formaldehyde is 
attributed to the overt reactivity of the molecule. Formaldehyde targets proteins, DNA and RNA, 
reacting with several sites of importance on the biomolecules. Alkylation of amino, imino, 
amide, carboxyl and thiol groups of proteins, and the ring nitrogen atoms of purine bases may 
occur, which can result in the formation of intermolecular cross-linkages (Brannan 1997; 
Denyer and Stewart 1998). Formaldehyde has been shown to be an irritant, a moderate to 
strong allergen, and can be a potent sensitiser, with reported sensitisation rates between 1% 
and 9% (Sasseville 2004).  The concentrations of these preservatives are regulated in the EU, 
with free formaldehyde being permitted at either 0.1% (for oral hygiene) or 0.2% (except oral 
hygiene), and 0.6% for the formaldehyde releasing agent dimethylol dimethyl hydantoin 
(DMDMH). 
 
1.1.5.3 Isothiazolinones 
 
Isothiazolinones are widely used in a variety of applications including cooling water, paper and 
textiles, in addition to home and personal care products (Laopaiboon et al. 2001).  Suspensions 
of isothiazolinones, rather than pure compounds, are available commercially (Lambert 2008), 
which provide adequate preservation at low levels and have a broad spectrum of antimicrobial 
activity (Brannan 1997).  The predominant mechanism of action of the isothiazolinones is the 
oxidation of thiol groups, found on enzymes and other proteins, which are essential for function. 
Progressive loss of protein thiols disrupts pathways critical for cell metabolism and generates 
free radicals which further damage the cell (Williams 2007). Chlorinated isothiazolinones may 
also interact with non-thiol containing amino acids and interfere with DNA replication (Collier 
et al. 1990). Commercially available preservatives include methylisothiazolinone (MIT), 
chloromethylisothiazolinone (CITMIT), benzisothiazolinone (BIT), and a blend known as 
Kathon CG which is a registered trademark of the company Rohm and Haas. Kathon CG contains 
CIT and MIT in the ratio 3:1, respectively, and was first introduced used in Europe in the 
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cosmetics industry in the mid-1970s (Sasseville 2004). The isothiazolinones are known to cause 
contact dermatitis and are sensitising agents. Focussing on CITMIT, the prevalence of contact 
allergy in Europe has been found to fall between 2-2.5% (Lundov et al. 2009). In the EU only 
MIT and CITMIT are permitted for use in personal care products, at the concentrations 0.01% 
and 0.0015% respectively. 
 
1.1.5.4 Biguanides 
 
The biguanide biocide chlorhexidine (Table 1.2) is widely used in antiseptic products, as a 
disinfectant and as a preservative (McDonnell and Russell 1999). It has a broad spectrum of 
antimicrobial activity being active against both Gram-positive and Gram-negative bacteria, low 
toxicity and low irritancy (Moore and Payne 2008). The activity of biguanides is pH dependent, 
generally between pH 3-9, with the range being narrower for chlorhexidine, between pH 5-7 
(Owen 2006). Chlorhexidine is a membrane active agent and damages the cell wall, promoting 
its uptake into the cytoplasm (Maillard 2002). At lower concentrations chlorhexidine inhibits 
membrane-associated enzymes and leads to leakage of cellular components, whilst at higher 
concentrations coagulation of cytoplasmic constituents is observed (Moore and Payne 2008). 
 
1.1.5.5 Alcohols 
 
Several alcohols, including ethanol, phenethyl alcohol, benzyl alcohol and phenoxyethanol are 
used as preservatives in personal care products, with phenoxyethanol being used more 
frequently in recent times (Brannan 1997). Phenoxyethanol (Table 1.2) is compatible with most 
raw materials, is easy to formulate in the aqueous phase, can withstand temperatures up to 
85°C and has activity between PH 3 and 10 (Krowka et al. 2014). Whilst not as efficacious as 
other preservatives such as the parabens, phenoxyethanol has good activity against Gram-
negative bacterial species including P. aeruginosa, and may be used alone or in combination in 
products (Orth et al. 2006; Lambert 2008). Phenoxyethanol is a membrane active agent, 
disrupting cellular membranes and causing the leakage of intracellular components (Maillard 
2002).  In addition, some evidence has shown that phenoxyethanol inhibits enzymes involved in 
the tricarboxylic acid pathway (Gilbert et al. 1977).  The low sensitisation potential of 
phenoxyethanol has likely expanded its use in personal care products (Krowka et al. 2014) and 
it is regulated to be used at a concentration of 1% in the EU.  
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1.1.5.6 Organic acids 
 
Organic acids are becoming increasingly popular for use as preservatives in personal care 
products. The undissociated form of the acid is responsible for the antimicrobial activity which 
means that for effective preservation, the pH of the product must below 5 to prevent 
transformation of the acid into its salt (Brannan 1997).  Benzoic acid (Table 1.2) is one of the 
longest-used chemical preservatives and has been used in a variety of industries such as the 
food, cosmetics and drug industries (Chipley 1983).  Properties that make benzoic acid a useful 
preservative include a low cost, ease of incorporation in to products and low toxicity (Chipley 
1983). The mechanism of action of benzoic acid is similar to the parabens, with both being 
membrane active agents.  Benzoic acid targets the proton motive force which leads to leakage of 
intracellular contents and acidification of the cytoplasm (Maillard 2002).  
1.1.5.7 Preservative enhancing agents 
 
Preservative enhancing agents, or ‘preservative potentiators’ can increase the antimicrobial 
efficacy of the preservative without having to increase the preservative concentration, and are 
not under the same legislation as preservatives (Orth et al. 2006). Chelating agents, such as 
ethylenediamine tetracetic acid (EDTA), can potentiate the activity of many other antimicrobial 
agents, including preservatives. EDTA has greatest impact on Gram-negative bacteria and 
removes divalent cations (Mg2+ and Ca2+) from the outer membrane, increasing the permeability 
of the cell (Brannan 1997). Polar compounds which resemble the phospholipid molecules 
within the cell membrane bilayer have also been used to boost preservative activity by 
interference with the cell membrane (Papageorgiou et al. 2010). Examples of such compounds 
include caprylyl glycol, ethylhexylglycerin and sorbitan caprylate, marketed under different 
companies (Table 1.2).  This PhD evaluated two cyclohexyloxyl derivative compounds (CX3 and 
CX7; Table 1.2) and an efflux pump inhibitor (phenyl-arginine-beta-naphthylamide; PAβN) as 
novel preservative boosters (see Chapter 6).  Whilst no previous studies have reported on CX3 
and CX7, there is evidence that PAβN permeabilises the outer membrane of Gram-negative 
bacteria to certain antibiotics (Lamers et al. 2013) and therefore has potential to enhance 
preservative efficacy. 
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Table 1.2 Preservatives and preservative enhancing agents used in the HPC industry and in this study 
 
 Chemical compound(s) Structure EU regulated level1 Mechanism of action (reference) 
Trade name 
(% active ingredient) 
Manufacturer 
P
re
se
rv
at
iv
es
 
P
ar
ab
en
s 
Methyl paraben 
 
0.4% (one 
paraben) 
0.8% (paraben 
mixtures) 
Parabens are membrane active 
agents and disrupt the proton 
motive force, leading to 
acidification of the cell interior 
(Lambert 2008). 
Nipagin®M (100%) Clariant 
Propyl paraben 
 
0.4% (one 
paraben) 
0.8% (paraben 
mixtures) 
Nipasol®M (100%) Clariant 
Is
o
th
ia
zo
li
n
o
n
es
 
Methylisothiazolinone (MIT)2 
 
0.01% Isothiazolinones are oxidising 
agents and interact strongly with 
thiol groups (R-SH) which are vital 
to the function of cytoplasmic and 
membrane bound enzymes (Denyer 
and Stewart 1998). The disruption 
of cellular pathways also leads to 
the production of free radicals, and 
the inhibition of ATP synthesis and 
utilisation (Williams 2007) . 
Chlorinated forms may also interact 
with non-thiol containing amino 
acids and inhibit DNA replication 
(Collier et al. 1990) 
Neolone M10 (9.7%) Rohm & Haas 
Chloromethylisothiazolinone 
and Methylisothiazolinone 
blend in the ratio 3:1 (CITMIT)2 
 
 
0.0015% Kathon CG (1.5%) Rohm & Haas 
Benzisothiazolinone (BIT)2 
 
Not permitted in 
the EU 
Koralone B-120 (20%) Rohm & Haas 
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F
o
rm
al
d
eh
y
d
e 
re
le
as
in
g 
ag
en
ts
 
Dimethylol dimethyl hydantoin 
(DMDMH)2 
 
0.6% 
 
Formaldehyde is a highly reactive 
chemical and acts as a mutagen and 
an alkylating agent. Interaction with 
proteins and nucleic acids 
containing amino, imino, amide, 
carboxyl and thiol groups, can 
result in intermolecular 
crosslinking (Denyer and Stewart 
1998). 
 
Glydant (55%) 
 
Lonza 
B
ig
u
an
id
es
 
Chlorhexidine (CHX)2 
 
0.3% 
 
Chlorhexidine is a membrane active 
agent which disrupts the 
cytoplasmic membrane leading to 
leakage of intracellular components, 
and at high concentrations causes 
coagulation of the cytosol (Maillard 
2002) 
 
Chlorhexidine 
digluconate 
Sigma-Aldrich 
A
lc
o
h
o
ls
 
Phenoxyethanol (PHE)2 
 
1.0% 
 
Phenoxyethanol is a membrane 
active agent and causes generalised 
loss of cytoplasmic membrane 
function and changes in outer 
membrane structure, leading to 
leakage of intracellular constituents 
(Brannan 1997; Maillard 2002) 
 
Phenoxetol (100%) Clariant 
O
rg
an
ic
 a
ci
d
s 
Benzoic acid (BA)2 
 
2.5% (rinse off) 
1.7% (oral care) 
0.5% (leave-on) 
 
Organic acids are membrane active 
agents. In addition to disrupting the 
proton motive force, which leads to 
acidification of the cell interior, 
organic acids also cause the leakage 
of intracellular components 
(Maillard 2002) 
 
- Sigma-Aldrich 
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P
re
se
rv
at
iv
e 
en
h
an
ci
n
g 
ag
en
ts
 
C
h
el
at
in
g 
ag
en
ts
 
Ethylenediaminetetraacetic 
acid (EDTA) 
 
- 
 
EDTA chelates Mg2+ and Ca2+ ions 
from the Gram-negative bacterial 
outer membrane, disrupts 
membrane integrity and increases 
permeability to antimicrobial 
agents (Vaara 1992) 
 
- Sigma-Aldrich 
M
em
b
ra
n
e 
d
is
ru
p
to
rs
 
Caprylyl glycol (also known as 
1, 2-Octanediol) 
 
- 
 
These molecules have surfactant 
properties, being composed of a 
hydrophilic head region and a 
hydrophobic tail region,  and affect 
the interfacial tension at the cell 
membrane, aiding preservative 
penetration (Varvaresou et al. 2009; 
Papageorgiou et al. 2010; Pilz 2012) 
Dermosoft®Octiol Dr. Straetmans 
Ethylhexylglycerin 
 
- 
Sensiva® SC 50 
 
Schülke 
Sorbitan caprylate 
 
- Velsan SC Clariant 
E
ff
lu
x 
p
u
m
p
 
in
h
ib
it
o
rs
3
 
Phenyl-arginine-beta-
naphthylamide (PAβN)2 
 
- 
PAβN is an efflux pump inhibitor 
which inhibits multiple Gram-
negative RND-family transporters 
by competitive inhibition of 
substrate binding sites (Okandeji et 
al. 2011) 
- Sigma-Aldrich 
N
o
v
el
 c
o
m
p
o
u
n
d
s 
fo
r 
ev
al
u
at
io
n
 (
cy
cl
o
h
ex
y
lo
xy
l 
d
er
iv
at
iv
es
)3
 CX-3
2 
 
- 
Mechanism of action unknown 
CX-3 (96%) Merck 
CX-72 
 
- CX-7 (100%) Merck 
Footnotes: 1EU Cosmetics Directive 76/768/EEC maximum regulated levels of preservatives; 2Preservatives and preservative enhancing agents used in this study; 3Not currently 
used as preservative enhancers, only evaluated by this study 
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1.2 Pseudomonas aeruginosa 
 
1.2.1 P. aeruginosa as an opportunistic pathogen and industrial contaminant 
 
P. aeruginosa is an extremely versatile microorganism with the ability to survive in diverse 
habitats including soil, water, plant and animal tissues, community and hospital environments 
(Morrison and Wenzel 1984; Stover et al. 2000; Kerr and Snelling 2009).  First isolated in 1882 
by the French pharmacist Carle Gessard from an infected surgical wound (Gessard 1882), P. 
aeruginosa has subsequently been recognised as an important opportunistic pathogen in 
humans.  A broad spectrum of illness may be caused by P. aeruginosa including pneumonia, 
urinary tract infections, wound and burn infections, bacteraemia and septicaemia (Kerr and 
Snelling 2009).  The majority of these infections are encountered in healthcare settings and are 
rare in healthy individuals.  P. aeruginosa is the major pathogen in cystic fibrosis patients and is 
responsible for chronic, life-threatening pulmonary infections which are extremely difficult to 
eradicate (Gomez and Prince 2007).  Of great concern is the limited number of effective anti-
pseudomonal drugs and increasing rates of antimicrobial resistance amongst clinical isolates 
(Rossolini and Mantengoli 2005).   
Many factors contribute to the widespread prevalence of P. aeruginosa and its success as an 
opportunistic pathogen. Although considered an obligate aerobe, P. aeruginosa can exhibit 
anaerobic metabolism in the presence of nitrates or the amino acid arginine.  Anaerobic 
metabolism may enhance the survival of P. aeruginosa in the soil or in certain animal tissues 
where molecular oxygen is scarce (Vasil 1986).  P. aeruginosa also has minimal nutritional 
requirements, exemplified by its ability to grow in distilled water (Favero et al. 1971; Kayser et 
al. 1975), and displays high levels of metabolic versatility, being able to utilise over 75 organic 
compounds for growth (Stanier et al. 1966).  In addition, P. aeruginosa can withstand a wide 
temperature range of between 20C and 42C, with an optimum of 37C (Morrison and Wenzel 
1984).  Tolerance for many different antimicrobial agents (Kerr and Snelling 2009) also permits 
the persistence of P. aeruginosa in varied environments.  In the compromised host, a multitude 
of virulence factors possessed by P. aeruginosa promote successful infection.  Regulation of 
these factors is efficient and largely by means of quorum sensing, a form of cell-to-cell 
communication.  Quorum sensing pathways are also important in the formation of biofilms, 
both on living and abiotic surfaces, which offer P. aeruginosa protection from extraneous 
stresses and facilitate the sequestration of nutrients (Wagner et al. 2008).    Notably, pigment 
production is characteristic of P. aeruginosa and can be used as a means for its identification. 
Pyocyanin, the blue-green phenazine pigment (Vasil 1986), is exclusively produced by some, but 
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not all, P. aeruginosa strains (Haynes 1951) and can be considered a virulence factor as it plays a 
role in infection (Lau et al. 2004).   
To date, the focus of P. aeruginosa research has been the pathogenesis, epidemiology and 
treatment of infections caused by clinical strains. Outside of healthcare settings in the natural 
environment, P. aeruginosa populations have not been as thoroughly investigated (Lavenir et al. 
2007).  Even less is known about P. aeruginosa in industrial settings, despite it being a problem 
contaminant of raw materials, pharmaceutical and cosmetic products (Jimenez 2007)(Figure 
1.1), and other industrial products such as fuels (Edmonds and Cooney 1967; White et al. 2011). 
Contamination is a major cause of product recalls worldwide and, more seriously, represents a 
threat to the health of consumers (Jimenez 2001a). In order to begin to understand P. 
aeruginosa in an industrial context, isolates from contaminated products need to be identified, 
the diversity of strains associated with contamination surveyed, and the mechanisms which 
permit the survival of P. aeruginosa in industrial formulations elucidated.   
1.2.2 Methods for the detection and identification of P. aeruginosa 
 
The routine detection of bacterial species in medical and industrial settings is largely still via 
culture-dependent techniques (Orus and Leranoz 2005; van Belkum et al. 2013), which are 
relatively inexpensive, generally reliable and identify most of the commonly encountered 
bacteria (Woo et al. 2008; Deschaght et al. 2011).  In the case of P. aeruginosa, numerous 
selective agars and broths have been developed for its isolation, most of which exploit the 
tolerance of P. aeruginosa to antimicrobial agents and generally inhibit the growth of other 
bacteria.   Media using positive selection strategies have also been described, such as those 
containing acetamide (Hedberg 1969; Smith and Dayton 1972; Szita et al. 1998; Szita et al. 
2007) and asparagine (Favero et al. 1971) both of which P. aeruginosa can use as the sole source 
of carbon and nitrogen. More recently a chromogenic media for the detection of P. aeruginosa 
has been developed, which claims to be selective and differential for simultaneous detection and 
identification (Laine et al. 2009). A summary of selective media for P. aeruginosa is given in 
Table 1.3. Whilst production of pyocyanin can unequivocally identify P. aeruginosa, this pigment 
is not produced by all strains under different conditions (Smirnov and Kiprianova 1990). In 
these cases, and when selectivity of the medium is doubted, further diagnostic tests can be 
performed to confirm the isolation of P. aeruginosa (Phillips 1969).  In addition, commercial kits 
are available for the identification of bacteria such as the API identification schemes 
(Biomerieux, Les Halles, France) and the automated Vitec® (Biomerieux) system, which assess 
several different biochemical tests simultaneously, can also be used for bacterial identification.   
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Genotypic identification methods have a number of advantages over culture-dependent 
techniques including that they circumvent the problem of phenotypic variability under different 
growth conditions.  This is especially relevant in the case of P. aeruginosa which can display 
variable colony morphology and levels of pigment production which may confound phenotypic 
identification (Spilker et al. 2004).  In addition, selective culture media may not always have 
sufficient selectivity and have been demonstrated to misidentify non-P. aeruginosa fluorescent 
pseudomonads from environmental (river water) samples as P. aeruginosa (Pirnay et al. 2005).   
PCR and qPCR formats, including both SYBR Green-based qPCR (Jaffe et al. 2001; Qin et al. 2003; 
Motoshima et al. 2007; Choi et al. 2013) and hydrolysis probe-based qPCR (Anuj et al. 2009), 
have been developed for the detection of P. aeruginosa.  To date these formats have targeted ten 
different genes/regions, attaining species-specificity through choice of primer sequences (Table 
1.4).    As can be seen from Table 1.4, the primers pairs evaluated by multiple studies have high 
specificity (except for the fliC primer pair) and sensitivity.  These PCRs have been applied to 
DNA extracted from pure P. aeruginosa cultures in addition to clinical and environmental 
samples (Deschaght et al. 2011). There is opportunity for the design of improved PCRs for P. 
aeruginosa, however, through the utilisation of the increasing number of genome sequences 
available for the species (Choi et al. 2013). 
 
In addition to the application of species-specific PCRs to the detection of bacteria, 16S rRNA 
gene sequencing can be performed to identify bacterial species.  This type of analysis may be 
used to provide species identification for cultivated isolates (Janda and Abbott 2007; Woo et al. 
2008), or applied to DNA extracted directly from samples, also giving an idea of the total 
diversity present (Salipante et al. 2013; Dickson et al. 2014). Studies comparing 
conventional/commercial tests examining phenotypic characteristics to 16S rRNA gene 
sequence data for cultivated isolates have determined that 16S rRNA gene analysis facilitated 
the identification of an increased number of species and had identification rates between 62-
91% (Janda and Abbott 2007).  Studies utilising next-generation technologies to perform deep 
sequencing of 16S rRNA genes in clinical samples such as sputum (Salipante et al. 2013) and 
bronchoalveolar lavage fluid (Dickson et al. 2014) found that in general the results of 
conventional culture and sequencing were concordant, although sequencing facilitated the 
identification of a greater number of species than culture. There is therefore the potential for 
16S rRNA gene sequencing to be used in diagnostic microbiology but attention is needed to 
ensure correct data interpretation (Woo et al. 2008). Furthermore, the limited phylogenetic 
resolution that can be achieved with the 16S rRNA gene (Janda and Abbott 2007) and the 
limitations of DNA extraction techniques have to be considered (Deschaght et al. 2011). 
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 Table 1.3 Selective agents and media for the culture-dependent isolation of Pseudomonas aeruginosa 
Selective agents Concentration 
(g/L) 
Name of medium Comment Reference 
Individual selective agents 
Triclosan 0.025 Pseudomonas Isolation Agar (PIA) 
[Sigma-Aldrich; BD Difco™] 
Modified from Kings Medium A*  (King et al. 1954) by the addition of triclosan; 
triclosan also termed Irgasan in PIA 
- 
Cetrimide 1.0 Cetrimide agar ‘Old’ form of cetrimide in nutrient agar (Lowbury 1951) 
0.3 
Cetrimide agar 
 ‘New’ form of cetrimide (cetavlon) in nutrient agar, lower concentration required for 
sufficient selectivity than the ‘old’ form 
(Lowbury and Collins 1955) 
Cetrimide agar Cetrimide (cetavlon) in Kings medium B** (King et al. 1954) (Brown and Lowbury 1965) 
Pseudosel Agar [BD BBL™] Modified from Kings medium A (King et al. 1954) by the addition of cetrimide - 
Pseudomonas Cetrimide Agar 
[Oxoid Ltd.] 
Modified from Brown and Lowbury (1965) - 
Asparagine 3.0 Asparagine broth Developed for the isolation of P. aeruginosa from water samples (Favero et al. 1971) 
Acetamide 
10 Acetamide medium 
Modified from Christensen (1946). Peptone included as carbon source, acetamide as 
nitrogen source.  
(Bühlmann et al. 1961) 
20 
Acetamide agar Acetamide as carbon and nitrogen source (Hedberg 1969) 
Acetamide broth Modified from Hedburg (1969). Acetamide as carbon and nitrogen source (Smith and Dayton 1972) 
4.0 Z-Agar 
Developed for the isolation of P. aeruginosa from food and water (Szita et al. 1998) 
5.0 Z-broth 
Nitrofurantoin 0.05 Nitrofurantoin agar/both - (Thom et al. 1971) 
C-390 (9-chloro-9-
(4-
diethylaminophenyl)
-10-phenylacridan 
hydrochloride) 
0.03 
- C-390 in Kings Medium B (agar) (Marold et al. 1981) 
- C-390 in Brain heart Infusion broth and Mueller-Hinton agar (Fader et al. 1988) 
0.001-0.05 - 
Range of C-390 concentrations evaluated,≥0.015 g/L optimum. Different base media 
also looked at 
(Davis et al. 1983) 
0.05-0.1 - 
Range of C-390 concentrations in brain heart infusion broth evaluated, ≥0.025 g/L 
optimum. Claims to identify  P. aeruginosa within 4 hours 
(Araj 1984) 
Cadmium chloride - - - (Drake 1966) 
Combinations of selective agents 
Cetrimide (C) 
Nalidixic acid (N) 
0.2 (C) 
0.015 (N) 
Nalidixic acid cetrimide agar - (Goto and Enomoto 1970) 
0.2 (C) 
0.015 (N) 
Cetrimide-nalidixic acid agar 
Cetrimide-nalidixic acid agar (formulation of Goto and Enmoto, 1970) evaluated and 
found to be superior to cetrimide agar of Brown and Lowbury (1965) 
(Lilly and Lowbury 1972) 
0.2 (C) 
0.015(N) 
Pseudomonas Agar Base with C-N 
supplement [Oxoid Ltd] 
C-N supplement has selective agents in the same concentrations as those of Goto and 
Enmoto (1970) and Lilly and Lowbury (1972) 
- 
C-390  
Phenanthroline (P) 
0.03 (C-390) 
0.03 (P) 
PC Agar 
PC agar superior to media containing only C-390 as selective agent. Phenanthroline 
alone not selective for P. aeruginosa but in PC agar suppressed the growth of non-P. 
aeruginosa stains 
(Campbell et al. 1988) 
Kanamycin (K) 
Nalidixic acid (N) 
Sulfapyridine (S) 
0.008 (K) 
0.037 (N) 
0.176 (S) 
mPA Agar 
Developed for the isolation and enumeration of P. aeruginosa from water samples 
using a membrane filtration procedure 
(Levin and Cabelli 1972) 
mPA-B Agar (Dutka and Kwan 1977) 
0.008 (K) 
0.037 (N) 
mPA-C Agar (Brodsky and Ciebin 1978) 
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Table 1.4 Detection of Pseudomonas aeruginosa using PCR-based methods: target genes and primer pairs 
Gene Primers Primer sequence (5’→ 3’) Product size (bp) Specificity/sensitivity (%) Reference 
16S rRNA 
PA-SS-F GGGGGATCTTCGGACCTCA 
956 
100/100 (Spilker et al. 2004)a 
PA-SS-R TCCTTAGAGTGCCCACCCG 94/100 (Lavenir et al. 2007) 
16S-23S rRNA 
ITS 
PA1 TCCAAACAATCGTCGAAAGC 
181 100/100 (Lavenir et al. 2007)b 
PA2 CCGAAAATTCGCGCTTGAAC 
oprI 
OPR1 GCTCTGGCTCTGGCTGCT 
197 
99/98 (Qin et al. 2003) 
OPR2 AGGGCACGCTCGTTAGCC 80/100 (Lavenir et al. 2007) 
oprL  
PAL1 ATGGAAATGCTGAAATTCGGC 
504 
100/100 (De Vos et al. 1997)a 
86/100 (Anuj et al. 2009) 
PAL2 CTTCTTCAGCTCGACGCGACG 
100/100 (Jaffe et al. 2001) 
86/100 (Lavenir et al. 2007) 
fliC 
Fla1 GCCTGCAGATCGCCAACC 
1000/1300 13/100 (Lavenir et al. 2007)c 
Fla2 GGCAGCTGGTTGGCCTG 
ecfX 
ECF1 ATGGATGAGCGCTTCCGTG 
528 
100/100 (Lavenir et al. 2007)a 
ECF2 TCATCCTTCGCCTCCCTG 
100/0 (Choi et al. 2013) 
ecfX-F CGCATGCCTATCAGGCGTT 
63 100/100 (Anuj et al. 2009)a 
ecfX-R GAACTGCCCAGGTGCTTGC 
gyrB 
GyrPA-398 CCTGACCATCCGTCGCCACAAC 
222 
100/100 (Anuj et al. 2009) 
100/100 (Qin et al. 2003)a 
GyrPA-620 CGCAGCAGGATGCCGACGCC 
100/98 (Motoshima et al. 2007) 
100/100 (Lavenir et al. 2007) 
70 (approx.)/100 (Choi et al. 2013) 
ecfX + gyrB 
ecfX-F CGCATGCCTATCAGGCGTT 
63 
100/100 (Anuj et al. 2009) 
ecfX-R GAACTGCCCAGGTGCTTGC 
GyrPA-398 CCTGACCATCCGTCGCCACAAC 
222 
GyrPA-620 CGCAGCAGGATGCCGACGCC 
toxA 
(Exotoxin A) 
ETA1 GACAACGCCCTCAGCATCACCAGC 
396 
>95/>95 (Khan and Cerniglia 1994)a 
100/94 (Qin et al. 2003) 
ETA2 CGCTGGCCCATTCGCTCCAGCGCT 
100/95 (Lavenir et al. 2007) 
100/98 (Anuj et al. 2009) 
algD GDP 
mannose 
VIC-1 TTCCCTCGCAGAGAAAACATC 
520 
100/89 (Qin et al. 2003) 
VIC-2 CCTGGTTGATCAGGTCGATCT 100/100;100/100 
(da Silva Filho et al. 1999)a 
(da Silva Filho et al. 2004) 
O-antigen acetylase 
PA431CF 
CTGGGTCGAAAGGTGGTTGTTATC 232 100/100 (Choi et al. 2013) 
Footnotes: aFirst study to describe and evaluate particular primer pair; bPrimers first described by Tyler et al. (Tyler et al. 1995); cPrimers first described by Spangenberg et al. 
(Spangenberg et al. 1996) 
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1.2.3 P. aeruginosa genotyping, diversity and population structure  
 
DNA-based typing systems (Table 1.5) are invaluable tools in epidemiological investigations and 
many different methods have been developed for typing below the species level.  From a clinical 
perspective genetic typing is extremely useful, particularly in outbreak situations, as it allows 
questions to be answered concerning the source and route of transmission of pathogens.  In 
addition to this, typing can provide information about the clonality of a pathogen and identify 
hyper-virulent strains (Olive and Bean 1999). Strain typing also may be of use in industry when 
dealing with bacterial contamination (White et al. 2011). For example, the application of genetic 
typing techniques in industrial settings could determine whether contaminating isolates share a 
common genotype and if contamination is occurring from a common source, such as the water 
supply. With regards to P. aeruginosa, genetic typing methods have been used extensively to 
determine the epidemiology of P. aeruginosa infection, notably infections contracted by cystic 
fibrosis patients (van Mansfeld et al. 2010; Fothergill et al. 2012). Typing methods are also 
useful when applied to the broader investigation of P. aeruginosa diversity and population 
biology.   
 
The population structure of P. aeruginosa has been the subject of investigations and the current 
general consensus is that of a non-clonal epidemic structure (Pirnay et al. 2009; Dettman et al. 
2013). From these analyses, it appears that isolates from different environments are 
genotypically and functionally indistinguishable from one another (Nicas and Iglewski 1986; 
Römling et al. 1994; Rahme et al. 1995; Foght et al. 1996; Alonso et al. 1999), and different 
strains exhibit no clear selection for a particular habitat  (Pirnay et al. 2009), demonstrated by 
globally distributed clonal types such as clones C and PA14 (Tümmler et al. 2014). However,  
evidence which contends this exists, complicating the consensus model and includes the 
association of multi-drug resistant clones with the nosocomial environment (Pirnay et al. 2009), 
transmissible P. aeruginosa clones within cystic fibrosis patients (Lanotte et al. 2004; van 
Mansfeld et al. 2010), a cluster of strains associated with corneal infections (Stewart et al. 
2011),  and certain clonal complexes with river systems (Selezska et al. 2012) or the open ocean 
(Khan et al. 2008).  This suggests that the population is made up of epidemic clonal types that 
are generally ubiquitous, in addition to niche specialists (Tümmler et al. 2014). With the 
exception of a small number of studies (Pirnay et al. 2005; Khan et al. 2008; Selezska et al. 
2012) P. aeruginosa research has largely had a clinical focus.  Little is known about P. aeruginosa 
populations outside of the nosocomial environment (Lavenir et al. 2007), as even those studies 
including environmental isolates in their collections have done so in relatively small 
proportions (10-25%), and mainly considered the clinical implications of their findings 
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(Selezska et al. 2012).   The diversity of P. aeruginosa strains in industrial settings and relation 
to overall population biology of the species is as of yet unknown. 
 
 
Table 1.5 Genotyping methods which have been used for Pseudomonas aeruginosa 
 
Typing method Description of method Comments References 
Fingerprinting methods – strain-specific banding patterns resulting from the electrophoretic separation of 
DNA fragments 
Pulsed-Field Gel 
Electrophoresis 
(PFGE) 
Bacterial cells embedded within 
agarose plugs are lysed and the 
bacterial chromosome digested 
within an infrequently cutting 
restriction enzyme.  The digested 
plugs are inserted into an agarose gel 
and subjected to electrophoresis 
(PFGE). The polarity of the current in 
the PFGE apparatus is periodically 
alternated to allow the separation of 
large DNA fragments (10-800 kb).  
The resulting banding pattern can 
then be visualised.  
 
Previously widely used and 
often considered to be the ‘gold 
standard’ typing method.  
Highly discriminatory but time-
consuming, expensive and 
labour- intensive, and minor 
genetic changes (point 
mutations/insertions/deletions
) may alter results 
(Olive and Bean 
1999; Syrmis et al. 
2004; Fothergill et 
al. 2010) 
Random Amplified 
Polymorphic DNA 
(RAPD) typing 
RAPD (also known as arbitrarily 
primed-PCR) uses short primers 
(approximately 10 bp) of arbitrary 
sequence which bind, at low 
stringency conditions, to 
complementary sequences 
distributed around the bacterial 
chromosome.   If two primers anneal 
in the correction orientation and 
within a few kilobases of each other, 
PCR amplification will occur.  This 
results in DNA fragments of varying 
sizes which can be separated by 
electrophoresis and visualised.  
RAPD is very discriminatory, 
fast and inexpensive.  The RAPD 
process is sensitive to changes 
in PCR conditions (particularly 
the annealing temperature), 
however, which may affect the 
binding of the primers leading 
to variability in banding 
patterns.  In addition, RAPD 
protocols must be optimised for 
different species using different 
primers and reaction conditions 
making standardisation of this 
approach difficult.  The RAPD 
272 primers have been 
demonstrated to have high 
discriminatory power for use in 
the strain typing of P. 
aeruginosa. 
 
(Mahenthiralingam 
et al. 1996; Olive 
and Bean 1999) 
Repetitive –
element PCRs 
(BOX and ERIC-
PCR) 
Rep-PCR assays target highly 
conserved repetitive sequence 
elements distributed throughout 
bacterial genomes.  Two groups of 
these elements have been used in the 
strain typing of P. aeruginosa: 
enterobacterial repetitive intergenic 
consensus (ERIC) sequences and BOX 
elements.  Using primers which are 
complementary to either ERIC or 
BOX elements, DNA sequences of 
different lengths between the 
elements can be amplified, separated 
by electrophoresis and visualised.   
 
Rep-PCRs are inexpensive and 
fast.  They target conserved 
repetitive elements and use 
highly stringent conditions so 
are stable and relatively easily 
standardised.  Rep-PCRs are 
reported to have good 
concordance with PFGE results 
but generally have slightly less 
discriminatory power. 
(Versalovic et al. 
1991; Olive and 
Bean 1999; Syrmis 
et al. 2004) 
Sequence-based methods 
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Multilocus 
sequencing typing 
(MLST) 
MLST indexes the variation of the 
sequences of several bacterial 
housekeeping genes.  The genes 
included in an MLST scheme are 
different for different bacterial 
species.  Fragments of the 
housekeeping genes are amplified 
using PCR and sequenced.  For each 
housekeeping gene, distinct 
sequences are given an allele 
number, and the combination of 
different allele numbers defines the 
sequence type (ST) of a particular 
isolate.  STs can be compared via an 
internet database. 
 
As MLST uses sequence data it 
is an unambiguous and 
electronically portable typing 
technique.  At present the costs 
of sequencing multiple genes 
for a large isolate collection are 
still relatively high. The MLST 
scheme for P. aeruginosa 
utilises the sequences of 7 
housekeeping genes: acsA, aroE, 
guaA, mutL, nuoD, ppsA and 
trpE.  A curated MLST database 
for P. aeruginosa has been 
established. 
(Curran et al. 2004; 
Jolley et al. 2004; 
Khan et al. 2008) 
Whole genome 
sequencing and 
bioinformatic 
analysis (e.g. using 
Ribosomal 
Multilocus 
Sequencing 
Typing [rMLST]) 
Genome sequencing and subsequent 
bioinformatic analyses can allow 
phylogeny and genetic relationships 
between genomes to be inferred.  For 
example, rMLST is a recently 
described scheme which analyses the 
sequences of the 53 genes encoding 
the bacterial ribosomal protein 
subunits.  As these genes are 
distributed throughout the 
chromosome whole genome 
sequences are needed for the 
analyses.  rMLST has great potential 
for both taxonomic and typing 
analyses across all levels of bacterial 
diversity, and similarly to MLST, an 
expandable internet database has 
been established.        
A complete genome sequence is 
the ultimate means to define 
the genotype of an isolate and 
cost of genome-sequencing is 
now becoming cost effective at 
approximately £50-200 per 
isolate, dependent on genome 
size.   
(Jolley et al. 2012a) 
Micro-probe array based 
Clondiag Array 
Tube 
The Array Tube system probes both 
the core and accessory genome of P. 
aeruginosa.  Labelled DNA from 58 
targets distributed around the 
genome is generated directly from 
bacterial colonies by cycles of 
multiplex primer extension reactions.  
This DNA is then hybridised onto a 
microarray chip and detected 
colourimetrically to generate an 
electronically portable 58-binary 
marker genotype. 
 
The Clondiag Array Tube 
process is rapid, inexpensive 
and robust.  As the technique 
interrogates the accessory 
genome, in addition to the core 
genome, the presence of 
virulence markers and genomic 
islands can be identified.  This 
technique has proved useful for 
identifying isolates of the 
Liverpool Epidemic Strain (LES) 
of P. aeruginosa. 
(Wiehlmann et al. 
2007b; Mohan et al. 
2008; Fothergill et 
al. 2010)  
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1.2.4 P. aeruginosa genomics and evolution 
 
The large genome of P. aeruginosa underpins its adaptive capabilities.  Being between 5.2 and 7 
Mbp (Schmidt et al. 1996), the P. aeruginosa genome is one of the largest observed for Gram-
negative bacteria and has huge coding capacity and complexity.  From the genome of P. 
aeruginosa PAO1, the first P. aeruginosa strain to be sequenced (Stover et al. 2000), it was seen 
that a relatively high proportion of genes were involved in regulation (over 8% of the genome), 
energy metabolism and transport of small molecules reflecting ecological flexibility. The size of 
the genome indicates genetic and functional complexity rather than gene duplication, with a 
large number of paralogous gene groups being identified (Silby et al. 2011). There are still over 
2000 genes in the P. aeruginosa PAO1 genome of unknown function highlighting our limited 
insight into the full genetic repertoire of the species (Tümmler et al. 2014). 
To date, over 1000 P. aeruginosa genomes have been sequenced, with many projects ongoing 
(Rumbaugh 2014). From this we have learnt that the ‘core’ genome of P. aeruginosa comprises 
approximately 4000 genes and is generally well conserved among clonal complexes, showing 
sequence diversities of 0.5-0.7% (Klockgether et al. 2011).  The ‘accessory’ genome represents 
about 20% of the genome, is variable between strains, and is made up of ‘regions of genomic 
plasticity’ (RGP) associated with horizontal gene transfer (Klockgether et al. 2011; Tümmler et 
al. 2014). Analysis of the accessory genomes of sequenced isolates has identified many genes 
involved in metabolism, virulence and antibiotic resistance (Rumbaugh 2014), in addition to 
over 10,000 unique genes, hinting at a pan-genome that potentially exceeds 100,000 genes 
(Tümmler et al. 2014).  P. aeruginosa has access to a broad gene pool as acquisition of foreign 
DNA into the RGP can be from other P. aeruginosa strains, Pseudomonads, or Gram-negative 
species such as  Escherichia coli or Salmonella enterica (Pohl et al. 2014). 
Advances in genome sequencing have facilitated large scale studies of genome evolution in P. 
aeruginosa.  Chronic P. aeruginosa lung infections are observed in 60-70% of cystic fibrosis 
sufferers (Folkesson et al. 2012), with over 50% of cases harbouring the initially acquired clone 
long-term (Tümmler et al. 2014). This provides an opportunity to study genome evolution in 
vivo over decades.  In addition to phenotypic adaptive traits, such as variation in colony 
morphology and alginate production, motility, virulence and antimicrobial resistance (Mowat et 
al. 2011), genomic changes are now being elucidated. Whilst no two studies have reported the 
same results, trends have emerged: (1) isolates are genotypically diverse, and mutations have 
been found in a range of genes (Feliziani et al. 2014); (2) hypermutability is observed, often to 
high levels,  due to mutations in genes such as mutS and mutL involved in DNA mismatch repair 
(Marvig et al. 2013; Feliziani et al. 2014); (3) mutations in mucA are observed leading to 
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overproduction of alginate and conversion to the mucoid phenotype (Folkesson et al. 2012), 
and; (4) frequent mutation and loss of function of lasR, a transcriptional regulator of quorum 
sensing, which can decrease the expression of many virulence genes (Folkesson et al. 2012). 
Further work is required, however, to understand pathoadaptive mutations correlating with the 
evolutionary success of P. aeruginosa populations and sub-populations within the cystic fibrosis 
lung. 
 
1.3 Bacterial resistance to antimicrobial agents with reference to P. aeruginosa 
 
1.3.1 Antimicrobial agents: antibiotics and biocides 
 
The resistance of P. aeruginosa to antimicrobial agents has been widely documented, although 
considerably more literature reports on antibiotic resistance than biocide resistance.  At 
present, the antibiotic resistance of P. aeruginosa appears to be increasing and multidrug 
resistance is common in clinical settings.  It is particularly worrying that no individual antibiotic 
is active against 100% of nosocomial P. aeruginosa isolates (Rossolini and Mantengoli 2005).  
This poses significant problems for the continued successful treatment of P. aeruginosa 
infections. The modes of action of antibiotic classes and are well defined and antibiotics 
generally have specific cellular targets.  Resistance may be intrinsic, adaptive, or acquired, 
either through mutations in chromosomal genes, or via horizontal gene transfer of genes 
conferring a resistance phenotype (Tenover 2006).   
Biocides (antiseptics, disinfectants and preservatives) are chemical agents that inactivate 
microorganisms, are generally broad spectrum and have many applications in clinical, domestic 
and industrial settings (McDonnell and Russell 1999).  Table 1.6 illustrates classes of commonly 
used biocides, their uses and general mechanisms of action.  Unlike antibiotics, the mechanisms 
of action of biocides are not well elucidated and biocides appear to have multiple cellular 
targets.  The bisphenol biocide triclosan is an exception, however, and in addition to having 
generalised detrimental effects at higher concentrations (Regos and Hitz 1974; Gomez Escalada 
et al. 2005), acts on a specific cellular target (enoyl–acyl carrier protein (ACP) reductase) at 
lower concentrations (McMurry et al. 1998).  The activity of biocides is influenced by numerous 
factors including contact period and temperature of contact, presence of interfering materials 
and concentration in formulation (Russell and McDonnell 2000), further complicating our 
understanding of their mechanisms of action.   
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Bacterial resistance to biocides has been recorded as far back as the early 1950s, with the 
identification of the tolerance of P. aeruginosa to the quaternary ammonium compound (QAC) 
cetrimide (Lowbury 1951).  Subsequently P. aeruginosa has been recorded to have resistance to 
other QACs such as benzalkonium chloride (Adair et al. 1969; Langsrud et al. 2003) and didecyl 
dimethylammonium chloride (Langsrud et al. 2003), isothiazolinones (Brozel and Cloete 1994; 
Winder et al. 2000), chlorhexidine (Nakahara and Kozukue 1982), triclosan (Russell 2004), 
formaldehyde (Wollmann and Kaulfers 1991), zinc pyrithione (Abdel Malek et al. 2009) and 
heavy metal ions (Nakahara et al. 1977), amongst others.  The resistance mechanisms of P. 
aeruginosa to biocides are not well defined but it seems likely that intrinsic and adaptive 
resistance play a large role (McDonnell and Russell 1999).  
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Table 1.6 Commonly used biocides: classes, mechanisms of action and uses  
 
Footnotes: information from (McDonnell and Russell 1999; Chapman 2003a; Moore and Payne 2008; Abdel Malek et al. 2009)
 General mechanisms of action Classes Examples Uses 
B
IO
C
ID
E
S
 
E
le
ct
ro
p
h
il
e
s 
O
x
id
a
n
ts
 
Multiple cellular targets 
 
Oxidisation of organic material for a 
rapid speed of kill 
Halogen releasing compounds 
Chlorine compounds 
Antisepsis, cleaning, 
disinfection Iodine compounds 
Peroxycompounds Hydrogen peroxide Disinfection, preservation 
E
le
ct
ro
p
h
il
e
s 
Multiple cellular targets 
 
Inactivation of enzymes through 
covalent reactions with cellular 
nucleophiles  
 
Initiation of  free radical formation 
Aldehydes Formaldehyde 
Antisepsis, disinfection, 
preservation, sterilisation 
Formaldehyde releasing agents 
Hydantoins 
Antisepsis, preservation 
Oxazolidines 
Isothialzolones 
Methylisothiazolinone 
Disinfection, preservation Chloromethylisothiazolone 
Benzisothiazolinone 
- Bronopol Preservation 
Heavy metal derivatives Cu, Hg, Ag compounds 
Antisepsis, disinfection, 
preservation 
M
e
m
b
ra
n
e
 a
ct
iv
e
 
P
ro
to
n
o
p
h
o
re
s Target mainly cell membrane 
 
Disruption of proton motive force, 
rendering cell membrane unable to 
maintain pH levels.  Acidification of the 
cell interior and disruption of 
metabolism  
Parabens 
Methylparaben 
Preservation Propylparaben 
Sodium Benzoate 
Weak Acids 
Benzoic acid 
Antisepsis, preservation 
Sorbic acid 
Pyrithiones 
Sodium pyrithione 
Preservation 
Zinc pyrithione 
L
y
ti
c 
Target mainly cell membrane 
 
Destabilisation of membranes leading 
to leakage of cellular components/cell 
lysis 
Quaternary ammonium 
Compounds 
Cetrimide Antisepsis, cleaning, 
disinfection, preservation Benzethonium chloride 
Biguanides Chlorhexidine 
Antisepsis. anti-plaque agents, 
disinfection, preservation 
Phenols 
Triclosan Antisepsis, anti-plaque agents, 
preservation Hexachlorophene 
Alcohols 
Phenoxyphenol 
Antisepsis, disinfection, 
preservation 
Ethyl alcohol 
Isopropyl alcohol 
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1.3.2 Intrinsic resistance 
 
P. aeruginosa demonstrates high levels of intrinsic resistance to antibiotics and biocides of 
different classes.  Intrinsic mechanisms contribute to resistance towards antibiotics such as the 
β-lactams, older quinolones, chloramphenicol, tetracycline, macrolides, trimethoprim-
sulfamethoxazole and rifampin (Rossolini and Mantengoli 2005) and several biocides, including 
QACs, triclosan, formaldehyde and chlorhexidine (Stickler 2004).  This resistance is multi-
factorial and largely due to the concerted action of a low overall outer membrane permeability 
and efflux pumps.  In addition, a number of chromosomally encoded factors contribute 
(Hancock 1998).  
Generally, Gram-negative bacteria have higher levels of intrinsic resistance than Gram-positive 
bacteria and this is due to the composition of the cell wall (McDonnell and Russell 1999). The 
Gram-negative cell wall is a complex, multi-layered structure (Figure 1.2): the outer membrane 
acts as a semi-permeable barrier to restrict the influx of molecules such as antimicrobials, and 
the periplasmic space provides a site for the metabolism of antibiotics, and possibly biocides, 
before they reach the cytoplasmic membrane (Hancock 1998; Russell 2002).  The structure of 
the cell wall of P. aeruginosa differs slightly from other Gram-negative bacteria and is especially 
resistant to antimicrobial agents; it has been estimated that the outer membrane permeability 
of P. aeruginosa is over 100-fold less than that of Escherichia coli  (Yoshimura and Nikaido 
1982).  This increased impermeability is partially due to a high Mg2+ content in the outer 
membrane which produces strong links between lipopolysaccharide (LPS) chains (McDonnell 
and Russell 1999).  Additionally, the major nonspecific outer membrane porin OprF has a 
relatively low permeability (Nestorovich et al. 2006), and is an inefficient route for the uptake of 
antimicrobials (Hancock 1998). 
Exclusion via efflux pumps, together with high membrane impermeability, prevents 
antimicrobial agents from reaching their cellular targets and accumulating within the cell to 
toxic levels.  Efflux systems can be specific, facilitating the transport of one particular substrate, 
or general, transporting a variety of structurally unrelated compounds (Piddock 2006).   Efflux 
pumps belonging to five superfamilies have been defined, all of which have been identified in 
the genome of P. aeruginosa.  Those of the resistance-nodulation division (RND) are the most 
prevalent in P. aeruginosa with 12 RND efflux systems identified in its genome, two of which 
transport divalent metal cations (Lister et al. 2009).  Ten types of RND efflux pumps found in P. 
aeruginosa (excluding the divalent metal cation transporters) and examples of their substrates 
are detailed in (Table 1.7).  The RND family efflux systems use energy derived from the proton 
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motive force for the transport of compounds (Lister et al. 2009), and are associated with 
multidrug resistance, having the capacity to transport a large spectrum of substrates  
(Schweizer 2003).   
Chromosomally encoded resistance factors also contribute to the antimicrobial resistance of P. 
aeruginosa.  Similarly to several other Gram-negative species, P. aeruginosa possesses a 
chromosomally encoded AmpC β-lactamase.  This β-lactamase is produced at low levels and is 
also induced by certain β-lactams, conferring resistance to ampicillin and most cephems 
(Rossolini and Mantengoli 2005; Fajardo and Martinez 2008).  Resistance to formaldehyde in P. 
aeruginosa has been attributed to both outer membrane impermeability (Stickler 2004) and a 
chromosomally encoded formaldehyde dehydrogenase (Wollmann and Kaulfers 1991) which 
metabolises formaldehyde into a non-toxic metabolite (Chapman et al. 1998).  Furthermore, 
triclosan resistance in P. aeruginosa may be compounded by the production of a chromosomally 
encoded, non-susceptible enoyl-ACP reductase.  P. aeruginosa was recently demonstrated to 
possess two enoyl-ACP reductases, one which was triclosan-susceptible (FabI, encoded by fabI) 
and one which was refractory to triclosan inhibition (FabV, encoded by fabV) (Zhu et al. 2010).  
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Figure 1.2 Schematic representation of the Gram-negative cell wall.  The Gram-negative cell wall comprises a cytoplasmic (inner) membrane, a thin 
peptidoglycan layer, periplasm and an outer membrane.  The cytoplasmic membrane is a phospholipid bilayer with associated proteins, whilst the outer membrane 
is composed of phospholipid molecules, proteins, lipoproteins, porins and lipopolysaccharide (LPS) molecules.  Porins allow the entrance and egress of hydrophilic 
low-molecular weight substances and may be specific or non-specific.  An efflux pump typical of the resistance-nodulation division (RND) family (as found in P. 
aeruginosa) is illustrated in the schematic, comprising a transporter protein which is located in the cytoplasmic membrane, a periplasmic fusion protein and an 
outer membrane protein.   Adapted from (Hancock 1997; Hancock 1998; Piddock 2006; Madigan et al. 2010)  
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Table 1.7 Efflux systems of Pseudomonas aeruginosa  
 
Footnotes: *can use OprM or OpmH as the outer membrane porin component of the pump  
 
 
 
 
Efflux pump Substrates References 
MexAB-OprM Quinolones, fluoroquinolones, macrolides, 
tetracyclines, lincomycin, chloramphenicol, 
novobiocin, β-lactams (except imipenem), 
trimethoprim, sulphonamides, triclosan, ethidium 
bromide, SDS, aromatic hydrocarbons, 
thiolactomycin, cerulenin, quorum sensing molecules 
(acylated homoserine lactones) 
(Masuda et al. 2000) 
(Poole 2011) 
(Schweizer 2003) 
 
MexCD-OprJ Quinolones, fluoroquinolones, macrolides, 
tetracyclines, lincomycin, chloramphenicol, 
novobiocin, penicillins (except 
carbenicillin and sulbenicillin), cephems (except 
ceftazidime), flomoxef, meropenem, S-4661, 
trimethoprim, crystal violet, ethidium bromide, 
acriflavine, SDS, aromatic hydrocarbons, triclosan  
(Masuda et al. 2000) 
(Poole 2011) 
(Schweizer 2003) 
 
 
 
MexEF-OprN Fluoroquinolones, chloramphenicol, trimethoprim, 
tetracycline, maromatic hydrocarbons, triclosan, 
quorum sensing molecules (pseudomonas quinolone 
signal molecules) 
(Köhler et al. 2001) 
(Maseda et al. 2000) 
(Poole 2011) 
(Schweizer 2003) 
MexGHI-OpmD Vanadium, norfloxacin, ethidium bromide, 
acriflavine, rhodamine 6G, quorum sensing molecules 
(N-acylhomoserine lactone and pseudomonas 
quinolone signal molecules) 
(Aendekerk et al. 
2005) 
(Sekiya et al. 2003) 
 
MexJK* Tetracycline, erythromycin, triclosan (Chuanchuen et al. 
2001) 
MexMN-OprM Chloramphenicol, thiamphenicol (Lister et al. 2009) 
MexPQ-PomE Fluoroquinolones, tetracycline, chloramphenicol, 
erythromycin 
(Lister et al. 2009) 
MexVW* Fluoroquinolones, tetracycline, chloramphenicol, 
erythromycin 
(Li et al. 2003) 
MexXY* Aminoglycosides, quinolones, macrolides, 
tetracyclines, lincomycin, chloramphenicol, 
aminoglycosides, penicillins (except 
carbenicillin and sulbenicillin), cephems (except 
cefsulodin and ceftazidime), meropenem, S-4661 
(Masuda et al. 2000) 
(Westbrock-Wadman 
et al. 1999) 
 
TriABC-OpmH Triclosan (Lister et al. 2009) 
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1.3.3 Acquired resistance 
 
Acquired resistance can arise via mutation of chromosomal genes or via acquisition of 
resistance genes though horizontal gene transfer (Fajardo and Martinez 2008).  Mutational 
resistance to several antimicrobials has been reported for P. aeruginosa (Table 1.8).  Mutations 
leading to the de-repression of the chromosomal β-lactamase, AmpC, can confer increased or 
overt resistance to β-lactams such as penicillins, cephems and monobactams.  Not all of these 
compounds would normally induce the production of AmpC, but are sensitive to degradation by 
this enzyme (Rossolini and Mantengoli 2005).  The loss of the outer membrane porin OprL 
through mutation can result in increased resistance to the carbapenem antibiotics imipenem 
and meropenem (Livermore 2002).  In addition, the loss of OprD has been linked to resistance 
to the isothiazolone biocides benzisothiazolone, N-methylisothiazolone and 5-chloro-
Nmethylisothiazolone (Brozel and Cloete 1994; Chapman 1998; Winder et al. 2000).   
Mutations resulting in the upregulation of efflux systems can enhance resistance to multiple 
classes of antimicrobials, dependent on the substrate specificity of the pump (Table 1.8).  
Mutants overexpressing the efflux system MexEF-OprN also have increased resistance to 
imipenem, meropenem and isothiazolones due to the concomitant downregulation of OprD 
(Livermore 2002).  Resistance to fluoroquinolones may occur via upregulation of efflux pumps 
or via mutations in genes encoding topoisomerases.  Mutations in gyrA lead to the reduced 
susceptibility of topoisomerase II to fluoroquinolones, whilst mutations in parC lead to the 
reduced susceptibility of topoisomerase IV (Jalal and Wretlind 1998). Polymyxin resistance is 
believed to result from mutations which lead to changes in outer membrane structure 
(Rossolini and Mantengoli 2005; Poole 2011).  Finally, changes in LPS structure resulting from 
chromosomal mutations could be responsible for reduced aminoglycoside uptake leading to 
increased resistance (Bryan et al. 1984). 
Multiple acquired resistance genes encoding β-lactamases and aminoglycoside-modifiying 
enzymes (AMEs) have been described in P. aeruginosa (Table 1.8).  The acquired β-lactamases 
belong to three different groups: (1) Narrow spectrum β-lactamases; (2) Extended spectrum β-
lactamases (ESBLs); and (3) Metallo β-lactamases (MBLs).  Both ESBLs and MBLs have very 
broad substrate profiles with MBLs being able to degrade almost all β-lactams, with the 
exception of monobactams (Rossolini and Mantengoli 2005).  Whilst the majority of the older, 
narrow spectrum β-lactamases were plasmid-encoded, ESBLs and MBLs are typically encoded 
by genes of plasmid or transposon origin found on integrons (Poole 2011).  Acquired resistance 
to aminoglycosides in P. aeruginosa has similarly been associated with AME encoding genes 
localised on integrons.  AMEs render aminoglycosides inactive by structural modification, 
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typically though phosphorylation, acetylation or adenylation (Poole 2011).  Details of some of 
the most prevalent AMEs are listed in Table 1.8.  Worryingly, multiple resistance genes may be 
carried by integrons which can lead to multi-drug resistance, and integrons carrying genes 
encoding AMEs, ESBLs and MBLs have been observed (Fajardo and Martinez 2008).  One further 
mechanism of aminoglycoside resistance is target modification via methylation of 16S rRNA 
through acquisition of a 16S rRNA methylase-encoding gene. This mechanism has emerged 
relatively recently with the recognition of the first 16S rRNA methylase, termed RmtA, in 2003 
in a clinical isolate of P. aeruginosa.  These genes are thought to be prevalent amongst Gram-
negative pathogens, and are found on transposons within transferable plasmids (Strateva and 
Yordanov 2009).   
Plasmid-mediated biocide resistance has been noted but seems to be of more significance in 
Gram-positive than Gram-negative bacteria, where intrinsic mechanisms play the major role 
(Russell 1997).  In P. aeruginosa there have been few reports of plasmid-encoded biocide 
resistance aside from resistance to hexachlorophene (Sutton and Jacoby 1978), mercury and 
organomercurial compounds (Clark et al. 1977).  The significance of increased resistance to 
hexachlorophene is unknown, however, as this compound has a much greater effect upon Gram-
positive bacteria than Gram-negative bacteria (McDonnell and Russell 1999).   
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Table 1.8 Acquired resistance mechanisms of Pseudomonas aeruginosa 
Resistance mechanism Affected antimicrobial agents 
Mutation of chromosomal genes 
De-repression of AmpC Penicillins, cephems, monobactams 
Loss of OprD Imipenem, meropenem, 
isothiazolones 
Upregulation of efflux systems 
- MexAB-OprM 
 
- MexCD-OprJ 
 
- MexEF-OprN (concomitant OprD 
downregulation) 
- MexXY-OprM 
 
All β-lactams except imipenem, 
fluoroquinolones 
Some β-lactams (cefoperazone, 
cefpirome, cefepime, meropenem), 
fluoroquinolone 
Fluoroquinolones (imipenem, 
meropenem, isothiazolones) 
Some β-lactams (cefoperazone, 
cefpirome, cefepime, meropenem), 
fluoroquinolones, aminoglycosides 
Mutations in gyrA and/or parC Fluoroquinolones  
Mutations leading to changes in outer membrane 
structure  
Polymyxins, aminoglycosides 
Acquisition of resistance genes via horizontal gene transfer 
β-lactamases 
- Narrow spectrum 
Molecular class A (e.g. PSE-1, PSE-4, TEM-1) 
Molecular class D (e.g. OXA-3) 
- Extended spectrum 
Molecular class A (e.g. PER-1, VEB-1, GES-1, 
GES-2, TEM-42, SHV-5) 
Molecular class D (e.g. OXA-11, OXA-14, OXA-18, 
OXA-28) 
- Metallo-enzymes 
Molecular class B (e.g. IMP-, VIM-, SPM-, GIM-
type) 
 
Penicillins, cefoperazone 
 
 
Penicillins, cephems, monobactams 
 
 
 
 
All β-lactams except monobactams 
Aminoglycoside-modifying enzymes 
- AAC(3)-I 
- AAC(3)-II 
- AAC(6’)-I 
- AAC(6’)-II 
- ANT(2’)-I 
Aminoglycosides 
Gentamicin 
Gentamicin, tobramycin 
Tobramycin, netilmicin, amikacin 
Gentamicin, tobramycin, netilmicin 
Gentamicin, tobramycin 
16S rRNA methylases (e.g. RmtA) Aminoglycosides - amikacin, 
tobramycin, isepamicin, kanamycin, 
arbekacin, gentamicin 
Plasmids pMG1 and pMG2 Hexachlorophene 
Plasmids pMG1, pMG2, R26, R933, R93-1, pVS1 FP2, 
R38, R3108 and pVS2 
Mercury, organomercurial 
compounds 
 
Footnotes: information from (Clark et al. 1977; Sutton and Jacoby 1978; Livermore 2002; 
Rossolini and Mantengoli 2005; Strateva and Yordanov 2009)  
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1.3.4 Adaptive resistance 
 
Adaptive resistance is a phenomenon that is distinct from both intrinsic and acquired 
resistance, and is also less well understood.  Characterised by resistant phenotypes which are 
transient, rather than irreversible, adaptive resistance is triggered by exposure to a particular 
environmental stimulus, and may lead to increased resistance to one or more antimicrobial 
compounds.  Generally, as the stimulus subsides, so does the resistance phenotype, although 
this is not always the case.  Initially it was thought that exposure to sub-inhibitory 
concentrations of an antimicrobial acted as the stimulus for adaptive resistance.  Now it is 
known that in addition to this, a variety of other environmental cues are involved.  These can 
include pH, anaerobiosis and nutrient levels, as well as social behaviour such as biofilm 
formation (see section 1.3.5) and swarming motility.  The pathways involved in adaptive 
resistance are complex and only beginning to be understood (Fernández et al. 2011).  Adaptive 
resistance to both antibiotics and biocides has been described for P. aeruginosa and will be 
discussed. 
Environmental conditions such as anaerobiosis (Haussler et al. 1999), Mg2+ limitation (McPhee 
et al. 2006), carbon source availability (Conrad et al. 1979) and pH (Xiong et al. 1996) have been 
shown to trigger an adaptive resistance response in P. aeruginosa, increasing resistance to 
antibiotics such as aminoglycosides, polymyxins and amikacin.  In addition, exposure to sub-
inhibitory concentrations of some antibiotics has also led to adaptive resistance through a 
number of pathways.  For example, exposure to aminoglycosides has been shown not only to 
induce biofilm formation (Karatan and Watnick 2009) and upregulate MexXY (Hocquet et al. 
2003), but also to upregulate genes involved in anaerobic metabolism (Karlowsky et al. 1997).  
This may confer protection against antibiotic killing as the aerobic respiratory pathway is 
required for cytoplasmic accumulation of aminoglycosides (Fernández et al. 2011).  Exposure to 
sub-inhibitory concentrations of β-lactams causes the induction of the chromosomal AmpC β-
lactamase and has also been found to upregulate genes involved in multidrug efflux and 
antibiotic resistance (Blázquez et al. 2006).  The increased expression of the MexAB-OprM efflux 
system has been observed on exposure of P. aeruginosa to quinolone antibiotics, which would 
contribute to adaptive resistance through active efflux of antibiotics (Fernández et al. 2011).  
Quinolone exposure can also induce the SOS response (Brazas and Hancock 2005) which can 
combat DNA damage caused by the antibiotics and also lead to a transient increase in mutation 
frequency.  This transitory hypermutation state could lead to the permanent acquisition of 
resistance to one or more antibiotics, a phenomenon known as adaptive mutation (Fernández et 
al. 2011). Furthermore, sub-inhibitory concentrations of polymyxins have been demonstrated 
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to upregulate expression of the LPS modification gene operon.  The modification that is induced 
by this pathway decreases the net negative charge of the LPS rendering the outer membrane 
less able to bind positively charged antimicrobials (Fernández et al. 2011). 
The mechanisms of adaptive resistance to biocides are poorly understood and mostly believed 
to be non-specific. Multiple mechanisms of adaptive resistance have been observed during the 
sub-culturing of P. aeruginosa in media containing increasing concentrations of biocide, 
including: (i) outer membrane alterations on exposure to QACs (Loughlin et al. 2002) and zinc 
pyrithione (Abdel Malek et al. 2009); (ii) changes in the fatty acid profiles of the outer 
membrane on exposure to QACs and amphoteric surfactants (Jones et al. 1988; Loughlin et al. 
2002), and; (iii) increased active efflux on exposure to zinc pyrithione (Abdel Malek et al. 2009).  
Worryingly, adaptive resistance to biocides in P. aeruginosa has been associated with increased 
resistance to other classes of biocides and antibiotics (Adair et al. 1969; Jones et al. 1988; 
Loughlin et al. 2002; Langsrud et al. 2003; Abdel Malek et al. 2009; Abdel Malek and Badran 
2010).  Cross resistance can occur if antimicrobials use the same pathway to reach their target 
or have a similar mechanism of action (Chapman 2003b).  The resistance mechanisms triggered 
by biocide exposure are non-specific and it is likely that overall changes in membrane 
permeability or increased activity of efflux pumps (especially those with broad specificity) could 
increase resistance to multiple antimicrobial agents simultaneously.  It is therefore a possibility 
that the widespread and indiscriminatory use of biocides, sometimes at sub-inhibitory 
concentrations, is contributing to the increasing levels of antimicrobial resistance (Fernández et 
al. 2011).    
 
1.3.5 Biofilm formation 
 
Biofilms are surface-attached bacterial communities surrounded by an exopolysaccharide 
matrix (Drenkard 2003).  The occurrence of biofilms in natural, industrial and medical habitats 
is common and it has been proposed that biofilms are the preferred mode of growth of bacterial 
cells (Costerton 1999; Stickler 2004).  Cells within biofilms exhibit growth characteristics 
different to those of planktonic cells and in particular are more resistant to antibiotics and 
biocides; as mentioned previously biofilm formation is recognised as a form of adaptive 
resistance (Fernández et al. 2011).  This poses a problem to the effective treatment of infection, 
as biofilms may form on prosthetic devices (Stickler 2004) as well as living tissues, such as 
within the cystic fibrosis lung (Davies and Bilton 2009).  In industry biofilm formation on the 
surfaces of equipment and machinery can lead to product contamination and process 
inefficiency (Stickler 2004).   
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The resistance of P. aeruginosa biofilms to antibiotics has been observed, sometimes to extreme 
levels.  For example, Nickel et al. (Nickel et al. 1985) demonstrated that biofilms of P. aeruginosa 
could be up to 1000-fold more resistant to tobramycin than planktonic cells. Biofilm-mediated 
resistance to biocides has also been noted: biofilms of P. aeruginosa grown on polycarbonate 
surfaces were reported by Brown et al. (Brown et al. 1995)  to have increased resistance to 
povidone iodine.  Additionally, Cochran et al. (Cochran et al. 2000) found that biofilms of P. 
aeruginosa attached to alginate beads exhibited enhanced resistance to hydrogen peroxide and 
monochloramine in comparison to planktonic cells.  Biofilm-mediated antimicrobial resistance 
is complex, multifactorial and not completely understood. Several mechanisms for resistance 
have been postulated (Drenkard 2003): 
 Restricted antimicrobial penetration: the exopolysaccharide matrix may delay the 
penetration of some antimicrobials such as aminoglycosides into P. aeruginosa biofilms 
(Shigeta et al. 1997).    
 Cells within the biofilm have limited access to oxygen and nutrient and exhibit 
decreased metabolic activity.  This may increase antimicrobial tolerance as 
antimicrobials are more effective against metabolically active cells (Drenkard 2003). 
Growth under anaerobic conditions in P. aeruginosa biofilms has led to increased 
resistance to antibiotics such as tobramycin, ciprofloxacin, carbenicillin, ceftazidime, 
chloramphenicol and tetracycline (Borriello et al. 2004). 
 Biofilm-specific phenotype: biofilm bacteria and planktonic have different gene and 
protein expression profiles.  The physiological, metabolic and phenotypic changes 
occurring in cells in the developing biofilm may be important in the activation of 
resistance mechanisms (Drenkard 2003). 
 Persister cells and highly resistant phenotypic variants: these two types of antimicrobial 
resistant variants exist as subpopulations within the biofilm and promote biofilm 
survival on repeated exposure to antimicrobial agents (Drenkard 2003).   
 Activation of a generalised protective stress response and possible upregulation of 
multidrug efflux pumps (Drenkard 2003). 
 Interaction of the biofilm with antimicrobials: some strains of P. aeruginosa synthesise 
glucans which can be incorporated into the biofilm and bind aminoglycosides (Poole 
2011). 
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Regulation of biofilm formation is complex and mediated by numerous environmental cues 
including mechanical, metabolic and nutritional signals, the availability of inorganic ions, 
osmolarity, host-derived factors, antimicrobials (such as tobramycin which induces biofilm 
formation in P. aeruginosa) and quorum sensing (QS) signals (Karatan and Watnick 2009).  QS 
circuits are very important in virulence and biofilm formation in P. aeruginosa; it has been 
observed that mutants with defective QS components could not form biofilms of the regular 
structure and had increased susceptibility to sodium dodecyl sulphate (Davies et al. 1998; 
Stickler 2004).  Therefore, an attractive method for the control of P. aeruginosa biofilms is the 
disruption of QS signals.  Promisingly, potential targets for the disruption of QS in P. aeruginosa 
have been identified (del Pozo and Patel 2007), for example small molecule inhibitors of the 
quorum sensing receptors LasR and RhlR have been described by O’Loughlin et al. (O’Loughlin 
et al. 2013).   
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1.4 Project aims 
 
The overall aim of the PhD was to investigate P. aeruginosa as an important and common 
contaminant of home and personal care products.  The different areas that were covered are 
summarised in Figure 1.3. This PhD was funded by the Biotechnology and Biological Sciences 
Research Council (BBSRC) and being a BBSRC-CASE studentship, was also sponsored by 
Unilever Research and Development UK. Several of the questions explored during this study 
were guided by the interests of Unilever, with the goal of informing industrial practices. 
 
Specific project aims were as follows:  
 
1. Evaluate culture-dependent methods for the detection of P. aeruginosa using a 
diverse strain panel (Chapter 3). Five agars for the detection of P. aeruginosa were 
screened for sensitivity and specificity using a large strain panel originating from 
clinical, environmental and industrial sources. In addition, the utility of acetamide-based 
selective media as enrichment media for P. aeruginosa was assessed. A pre-requisite to 
these investigations was the establishment of a collection of P. aeruginosa and non-P. 
aeruginosa strains from industrial sources. As culture-dependent methods are a 
mainstay of contaminant detection in industry, this chapter informed Unilever of 
current best practices. 
 
2. The design and evaluation of novel PCRs for the detection of P. aeruginosa and 
investigation of the bacterial diversity associated with home and personal care 
products (Chapter 4). Two novel species-specific PCRs were designed to detect P. 
aeruginosa and evaluated for sensitivity and specificity using a large, genetically diverse 
strain panel.  The applicability of culture-independent techniques to contaminant 
detection from industrial products was assessed. Subsequent investigations were 
performed to examine the bacterial diversity encountered in home and personal care 
products. 
 
3. The examination of P. aeruginosa strain diversity in industry and its relation to 
the wider population biology of the species (Chapter 5). A large collection of P. 
aeruginosa strains isolated from industrial products was subjected to multiple strain-
typing techniques to determine any associations between genotype and product type, 
time or location of isolation. Relation to a broad database of other P. aeruginosa strains 
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from clinical and environmental habitats facilitated investigations into population 
structure. 
 
4. Characterisation of a P. aeruginosa strain panel originating from industrial 
sources (Chapter 6). The preservative susceptibility of a panel of P. aeruginosa strains 
from clinical, environmental and industrial sources was determined, in addition to 
growth and motility characteristics.  Putative differences between isolation source and 
phenotypic profiles were examined. In addition, the development of adaptive resistance 
to a preservative combination was examined using both planktonic growth and biofilm 
models. 
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Figure 1.3 Key focus areas of the PhD. To investigate P. aeruginosa as an industrial 
contaminant, four main areas were considered: (1) detection (Chapters 3 and 4); (2) diversity 
(Chapters 4 and 5); (3) strain characterisation (Chapter 6), and; (4) modelling of adaptive 
resistance to preservatives (Chapter 6). All of the studies were underpinned by the assembly of 
a large industrial isolate collection (Chapter 3). HPC, home and personal care.  
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2. Methods & materials 
 
2.1. Chemicals 
All chemicals were purchased from Sigma-Aldrich Company Ltd. (Dorest, UK) and Fisher 
Scientific (Loughborough, UK), unless otherwise stated. Aqueous solutions of chemicals were 
prepared in double-deionised water and sterilised either by autoclaving at 121°C for 15 
minutes, or filtration using Minisart® syringe filters (pore size 0.2 µm; Sartorius Stedim 
Biotech, UK) for small volumes. 
2.2. Media 
All media were prepared with double-deionised water and sterilised by autoclaving at 121°C for 
15 minutes.  Where applicable the media were prepared according to the manufacturer’s 
instructions. Tryptone Soya Agar (TSA; Oxoid Ltd., Basingstoke, UK) and Tryptone Soya Broth 
(TSB; Oxoid Ltd.) were routinely used growth media for bacterial isolates.  Selective media for 
the growth of P. aeruginosa included Pseudomonas CN selective agar (PCN; Oxoid Ltd.), 
Pseudomonas isolation agar (PIA; Sigma Aldrich Complany Ltd, Dorset, UK), chromID® P. 
aeruginosa (chromID Pa; bioMérieux UK Ltd, Basingstoke, UK; supplied as pre-poured plates), Z-
agar (Szita et al. 1998), and modified Z-agar (mZ-agar) which had the same formula as Z-agar 
but with the addition of 0.01% (w/v) Bacto™ Casamino acids (BD UK Ltd., Oxford, UK) and 
0.01% (w/v) yeast extract (Oxoid Ltd.). Other media used included non-cation adjusted Mueller-
Hinton (MH) broth (Oxoid Ltd.) for growth curve experiments, and modified Z-broth for 
enrichment assays. The formulation of the Z-broth was modified from the original (Szita et al. 
1998) and was as follows: acetamide 4 g/L (concentration adjusted for enrichment assays from 
1 – 50 g/L), dipotassium hydrogen phosphate (5 g/L), potassium dihydrogen phosphate (1 g/L), 
potassium sulphate (2 g/L) and magnesium sulphate heptahydrate (0.05 g/L) 
2.3.  Preparation of antimicrobial agents 
2.3.1. Preservatives and preservative enhancing agents 
 
Storage of all preservatives and preservative enhancing agents was at room temperature with 
the exception of phenyl-arginine-beta-naphthylamide (PAβN; MC-207,110; Sigma-Aldrich) 
which was stored at -20°C. Stock solutions of the preservatives: CITMIT (Kathon CG [CIT and 
MIT blend]; Dow Europe GmbH, Switzerland); BIT (Koralone B-120; Dow Europe GmbH); MIT 
(Neolone M10; Dow Europe GmbH); PHE (Phenoxetol; Clariant Produkte GmbH, Germany) and 
CHAPTER 2 – METHODS & MATERIALS 
 
44 
 
CHX (chlorhexidine digluconate; Sigma-Aldrich Company Ltd.); and preservative boosters PAβN, 
CX-3 (Merck KGaA, Germany), CX-7 (Merck KGaA) and Velsan SC (VSC; Clariant Produkte 
GmbH), were prepared in polished water. Benzoic acid (BA; Sigma-Aldrich Company Ltd.) was 
dissolved in an aqueous solution of 20% dimethylsulphoxide (DMSO). Further dilutions for 
minimum inhibitory concentration and growth assays were prepared from these solutions, 
detailed in the relevant sections. Stocks for viscous agents (Koralone B-120, CX-3, CX-7 and VSC) 
were prepared by weight, rather than volume, as they were difficult to accurately pipette; in 
these stocks the weight of the equivalent volume of water was added, and calculations 
performed in a % (v/v) manner.  Stocks of all agents were prepared on the day of use and stored 
for no longer than 2 days at 4°C (except PAβN which was kept at -20°C) before discarding and 
making fresh.   
2.4. Bacterial strains and routine growth conditions 
2.4.1. Strain panel 
Bacterial strains were drawn from the Mahenthiralingam group strain collection at Cardiff 
University and copies of the international Pseudomonas aeruginosa reference panel (De Soyza et 
al. 2013) and EuroCareCF strain panel (European Coordination Action for Research in Cystic 
Fibrosis; EC FP6 project no. LSHM-CT-2005-018932) that were held at Cardiff University. 
Challenge test strains and contamination isolates were also obtained from freezer stocks held at 
Unilever Research and Development Port Sunlight (URDPS).  Additional industrial strains were 
isolated from contaminated home and personal care products archived at URDPS (described in 
section 2.8.1). Species and strains used in experiments are detailed in the relevant sections.  
2.4.2. Growth and storage of bacterial isolates 
Bacterial isolates were routinely grown on TSA or in TSB overnight (16-18 hours) at either 30°C 
or 37°C, stated in the relevant sections. Overnight cultures were prepared by inoculating 3 ml of 
TSB with fresh (<72 hours) growth material collected using a sterile pipette tip from a pure 
streak plate, and incubated on an orbital shaker (150 rpm). Freezer stocks of individual isolates 
were prepared in TSB containing 8% (v/v) DMSO and stored at -80°C. 
2.5. Growth curve analysis in liquid media  
2.5.1. Growth in the Bioscreen C 
To examine growth dynamics of P. aeruginosa strains a Bioscreen C instrument (Labsystems, 
Finland) was used.  Each Bioscreen C microplate well contained 200 µl liquid medium 
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inoculated with approximately 105 cfu/ml from an overnight culture. The liquid medium used 
and whether the medium was supplemented with preservatives was experiment-dependent, 
and will be described in the relevant methods sections. Growth was monitored for 48 hours at 
37°C; turbidity measurements were taken at 15 minute intervals using a wide band filter (450-
580 nm) after shaking the microplates for 10 seconds at an intermediate intensity. Each 
experiment was performed twice with different starting overnight cultures and contained 4 
technical replicates; data was pooled from these cultures for analysis as stated below.  
2.5.2. Data handling and estimation of growth parameters 
The data from the Bioscreen C were exported into Microsoft Excel and the mean value of the 
broth-only control wells subtracted from all test samples. Subsequently, the optical density (OD) 
data for each sample were averaged and logarithmically transformed.  To quickly visually assess 
the data, scatterplots were constructed in Microsoft Excel. The gcFit function of the grofit 
statistical package (Matthias et al. 2010) for use in R statistical software (R-Core-Team 2013) 
was used to estimate the following growth parameters for logarithmically transformed data, i) 
length of lag phase, ii) maximum growth rate, and iii) maximum culture density reached.  
Strains producing growth curves which could not be modelled accurately by grofit (discordance 
between model and model-free-spline fits) were excluded.  
2.5.3. Comparison of growth parameters 
To examine the distribution of the growth parameter data, boxplots were generated using 
BoxPlotR (Michaela et al. 2014). The growth parameter data was analysed with non-parametric 
statistical methods. Using R statistical software, a Kruskal-Wallis test and post-hoc Wilcoxon 
tests with Benjamini-Hochberg correction were used to determine if the medians of the strain 
groups from different isolation sources were significantly different at the p=0.05 level.  
 
2.6. DNA extraction 
2.6.1. Rapid DNA extraction using Chelex®100 resin 
Material from a single colony was transferred into 50 µl 5% Chelex® 100 resin solution (Bio-
rad, Hertfordshire, UK; autoclaved prior to use) using a sterile pipette tip.  The sample was 
heated to 98ºC in a c1000™ Thermal Cycler (Bio-Rad) for 5 minutes, then placed at 4°C for 5 
minutes.  This process was repeated before centrifuging the sample at 800 g for 1 minute to 
sediment the Chelex® 100 resin and cellular debris.  Crude DNA from the supernatant was used 
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in PCR reactions.  Storage of the DNA was at 4°C and DNA was used on the same day as the 
Chelex® preparation was performed. 
2.6.2. Promega Wizard® Genomic DNA purification kit 
DNA extraction using the Wizard DNA purification kit (Promega) was performed according to 
the manufacturer’s instructions (extraction from Gram-negative bacteria) with the following 
modifications: 5 ml of an overnight bacterial culture was harvested by centrifugation, the 
supernatant discarded, and 600 µl nuclei lysis solution added to the cell pellet.  The remainder 
of the protocol was followed exactly, with the exception that the harvested DNA was re-
suspended in 100 µl low EDTA TE buffer (10mM Tris-HCI, 0.01mM EDTA, pH 8.0) rather than 
the DNA re-suspension buffer provided with the kit. Storage of the DNA was at -20°C 
2.6.3. Automated DNA extraction using the Maxwell® 16 system 
Genomic DNA extraction from pure bacterial cultures and total DNA from home and personal 
care products was achieved using the Maxwell® 16 instrument (Promega) and the Maxwell® 
16 Tissue DNA purification kit, according to the manufacturer’s instructions. For extraction 
from pure cultures a 3 ml overnight culture was centrifuged (2054g for 10 minutes) to harvest 
the cells, the pellet resuspended in 300 µl TE buffer (10 mM Tris, 1 mM EDTA, pH 8) (Sambrook 
et al. 1989) and added into the DNA purification kit cartridges. For extraction from home and 
personal care products, 0.3 g of each product was added directly into the DNA purification kit 
cartridges.  RNase A was added to eluted DNA to a final concentration of 0.5 µg/ml and the 
solution incubated at 37°C for 1 hour.  
2.6.4. Quantitation and quality assessment of extracted DNA 
 
Genomic DNA was analysed by gel electrophoresis using 1% (w/v) agarose (molecular grade 
agarose; Severn Biotech Ltd.) gels stained with SafeView stain (NBS Biologicals Ltd., 
Cambridgeshire, UK; 10 µl SafeView per 100 ml of agarose gel) and run at 80 V for 
approximately 1.5 hours.  Quantitation of genomic DNA was performed using the Quantifluor® 
dsDNA system (Promega, Wisconsin, USA) kit and the Qubit™ fluorometer (Invitrogen, 
Massachusetts, USA), following the manufacturer’s instructions. DNA quality was assessed using 
the absorbance ratio at 260 and 280 nm (A260 nm/A280 nm) using a NanoDrop Spectrophotometer 
(Thermo Fisher Scientific, Massachusetts, USA); ratios of approximately 1.8 were taken as an 
indication of good quality DNA.  Any necessary dilutions of DNA were performed using sterile 
nuclease free water (Severn Biotech Ltd.).  
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2.7. Molecular taxonomy: species-level identification of bacterial isolates and 
analysis of gene sequences 
2.7.1. Marker gene amplification, sequencing and species identification 
2.7.1.1. PCR reaction volumes and conditions  
Amplification of fragments of the 16S rRNA, rpoD, recA and gyrB genes was achieved using the 
primers described in Table 2.1. PCR reactions had a total volume of 25 µl containing 1X 
Coralload buffer, 1X Q-solution, 200 µm deoxynucleoside triphosphates (dNTPs), 1.6 µm each 
primer, 1 U Taq polymerase and 2 µl DNA template (approximately 20 ng). All reagents were 
supplied by Qiagen (Limburg, Netherlands). PCR cycles were performed on a c1000™ Thermal 
Cycler (Bio-Rad) and are shown in Table 2.2. Gel electrophoresis was performed on 1.5% (w/v) 
agarose gels stained with SafeView (10 µl SafeView per 100 ml of agarose gel). PCR products 
were visualised with a UV transilluminator and gel images captured using GeneSnap Software.  
PCR products were purified using the QIAquick PCR Purification kit (Qiagen) before submission 
for Sanger sequencing. 
Table 2.1 Primers used to amplify marker genes for species identification 
Target 
gene 
Primer 
pair 
Primer sequence 5’>3’ 
Annealing 
temp (°C) 
Target group Reference 
16S 
rRNA 
27F AGAGTTTGATCCTGGCTCAG 
52 
Bacteria 
(Universal) 
(Lane et al. 
1985) 1492R GGTTACCTTGTTACGACTT 
rpoD 
PsEG30F ATYGAAATCGCCAARCG 
54 Pseudomonas 
(Mulet et al. 
2009) PsEG790R CGGTTGATKTCCTTGA 
recA 
F AGGACGATTCATGGAAGAWAGC 
58 Burkholderia 
(Spilker et 
al. 2009) R GACGCACYGAYGMRTAGAACTT 
gyrB 
F ACCGGTCTGCAYCACCTCGT 
60 Burkholderia 
(Spilker et 
al. 2009) R YTCGTTGWARCTGTCGTTCCACTGC 
 
 
Table 2.2 PCR cycles for the amplification of marker genes for species identification 
 
 a Annealing temperatures vary for rpoD, recA and gyrB primer sets (see Table 2.1) 
 
PCR step 
16S rRNA gene rpoD, recA, and gyrB genes 
Temp 
(°C) 
Time 
(mins) 
No cycles 
Temp 
(°C) 
Time 
(mins) 
No cycles 
1  Initial DNA denaturation 95 2 1 94 5 1 
2 DNA denaturation 94 0.5  
35 
94 1 
30 3 Primer annealing 52 0.5 a 1 
4  Primer extension 72 1.5 72 1.5 
5 Final extension 72 5 1 72 10 1 
6 Indefinite hold 10 - - 10 - - 
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2.7.1.2. Gene sequencing and data processing 
Purified PCR products were submitted to the MWG Eurofins DNA Sanger sequencing service 
following the sample submission guidelines for ‘MWG Eurofins Value Read Service in Tubes’.  
The forward and reverse primers for each gene fragment were sent together with the PCR 
products in order to obtain sequences for both the forward and reverse strands.  Using BioEdit 
Sequence Alignment Editor (Hall 1999), consensus gene sequences for individual isolates were 
built from the forward and reverse sequences generated by Sanger Sequencing.  The 16S rRNA 
gene consensus sequences were compared to sequences of cultivable bacteria in the Ribosomal 
Database Project (RDP) II (Cole et al. 2009). The closest sequences matches from the RDP II 
database were used to assign isolates to a particular species.  Database searches conducted at 
the NCBI taxonomy database (Sayers et al. 2009), the Pseudomonas genome database (Winsor et 
al. 2009) and the Burkholderia genome database (Winsor et al. 2008) using the Basic Local 
Alignment Search Tool (BLAST) algorithm (Altschul et al. 1990) were used to infer species 
identities from the rpoD, recA and gyrB consensus gene sequences. 
2.7.2. Sequence alignment and phylogenetic tree construction 
Gene sequences were imported into MEGA 6 (Tamura et al. 2013), trimmed, and aligned using 
ClustalW2 (Larkin et al. 2007). A neighbour-joining tree based on 1000 bootstrap replicates was 
constructed in MEGA 6 using the Jukes-Cantor model.  Bootstrap values were calculated as 
percentages of 1000 replications.   Trees were drawn to scale and evolutionary distances 
computed using the Jukes-Cantor method, with units being the number of base substitutions per 
site. 
2.8. Culture-dependent detection methods 
2.8.1. Isolation of industrial isolates from URDPS freezer archives 
 
URDPS holds a large collection of microbial isolates from previous contamination incidents 
stored on beads within cryogenic vials at -80°C.  To obtain isolates for the RW collection at 
Cardiff, one cryogenic bead from a freezer vial was streaked over the surface of a TSA plate and 
allowed to grow for a maximum of 48 hours at 30°C.  Growth from pure streak plates was stored 
on transport swabs (M40 Transystem charcoal swabs; Copan Diagnostics Inc., CA, USA) which 
were sent back to Cardiff University. Once at Cardiff, the swabs were re-streaked onto TSA to 
ensure purity, and freezer stocks prepared in TSB containing 8% (v/v) DMSO. The complete 
industrial isolate panel is shown in Table 2.3. 
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2.8.2. Isolation of cultivable bacteria from home and personal care samples 
 
A range of contaminated home and personal care products sourced from the contaminated 
product library at URDPS were sampled for bacterial growth (Table 2.4).  To isolate cultivable 
bacteria and determine total viable counts, tenfold serial dilutions (100 to 10-7) of products were 
performed in TSB and 100 µl spread onto TSA plates.  After incubation at 30°C for a maximum of 
5 days the numbers and types of different colony morphologies were recorded, streaked to 
purify on fresh TSA plates and freezer stocks prepared in TSB containing 8% DMSO.  Total 
viable counts in cfu/ml were calculated from the number of colonies recorded. Serial dilutions 
of viscous products (dish wash liquids, liquid abrasive cleaners, fabric washes and personal care 
products) were prepared by weight, rather than volume, as they were difficult to accurately 
pipette; in these dilutions the weight of the equivalent volume of water was added, for example 
1 g product plus 9 ml diluent for a tenfold dilution.  If required, a neutralisation step was 
performed to encourage more bacterial growth; tenfold serial dilutions were performed as 
above except using an aqueous solution containing 2% (w/v) peptone and 1% (v/v) Tween 80 
as the diluent.  Each dilution was exposed to the neutralising agent for no longer than 10 
minutes before spreading on TSA plates. The complete industrial isolate panel is shown in Table 
2.3. 
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Table 2.3 Industrial isolate panel 
RW# Genus/Species ID Comment 
109 Pseudomonas aeruginosa Challenge test strain used in preservative efficacy testing 
110 Pseudomonas aeruginosa Challenge test strain used in preservative efficacy testing 
111 Pseudomonas pseudoalcaligenes Challenge test strain used in preservative efficacy testing 
112 Pseudomonas putida Challenge test strain used in preservative efficacy testing 
113 Pseudomonas aeruginosa SC; 2011 
114 Pseudomonas aeruginosa SC; 2011 
115 Pseudomonas aeruginosa SC; 2011 
116 Pseudomonas aeruginosa SC; 2011 
117 Pseudomonas aeruginosa DWL; 2010; Indonesia 
118 Pseudomonas aeruginosa DWL; 2010; Indonesia 
119 Pseudomonas aeruginosa DWL; 2010; Italy 
120 Pseudomonas aeruginosa DWL; 2010; Italy 
121 Pseudomonas aeruginosa DWL; 2010; Italy 
122 Pseudomonas aeruginosa DWL; 2009; Italy; 
123 Pseudomonas aeruginosa DWL; 2011; Malaysia 
124 Pseudomonas aeruginosa DWL; 2009; Italy 
125 Pseudomonas aeruginosa DWL; 2009; Italy 
126 Pseudomonas aeruginosa DWL; 2009; Italy 
127 Pseudomonas aeruginosa DWL; 2010; Indonesia 
128 Pseudomonas aeruginosa DWL; 2010; Italy 
129 Pseudomonas aeruginosa DWL; 2010; Italy 
130 Pseudomonas aeruginosa DWL; 2010; Italy 
131 Pseudomonas aeruginosa DWL; 2010; Italy 
132 Pseudomonas aeruginosa DWL; 2010; Italy 
133 Pseudomonas aeruginosa DWL; 2010; Thailand 
134 Pseudomonas aeruginosa DWL; 2010; Thailand 
135 Pseudomonas aeruginosa DWL; 2010; Indonesia 
136 Pseudomonas aeruginosa DWL; 2010; Indonesia 
137 Pseudomonas aeruginosa DWL; 2010; Italy 
138 Pseudomonas aeruginosa LAC; 2001 
139 Pseudomonas aeruginosa LAC; 2001 
140 Pseudomonas aeruginosa DWL 
141 Pseudomonas spp. DWL 
142 Pseudomonas spp. DWL 
143 Pseudomonas aeruginosa DWL 
144 Pseudomonas aeruginosa DWL 
145 Pseudomonas aeruginosa DWL; 2010 
146 Pseudomonas aeruginosa DWL; 2004; Italy 
147 Pseudomonas aeruginosa PC 
148 Pseudomonas aeruginosa PC 
149 Pseudomonas aeruginosa PC 
150 Pseudomonas aeruginosa PC 
151 Pseudomonas aeruginosa strain ATCC 9027 used in period after opening studies 
152 Burkholderia vietnamiensis PC; 2002 
153 Pseudomonas putida PC 
154 Pseudomonas putida PC; 2003 
155 Pseudomonas spp. PC 
156 Burkholderia cenocepacia PC 
157 Pseudomonas putida PC 
158 Pseudomonas putida DWL 
159 Pseudomonas putida DWL 
160 Ochrobactrum anthropi RM 
161 Pseudomonas putida RM; 2005 
162 Bacillus spp. RM; 2009 
163 Pseudomonas spp. RM; 2004 
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164 Pseudomonas spp. RM 
165 Pseudomonas spp. Misc 
166 Pantoea agglomerans Misc; 2002 
167 Pseudomonas spp. Misc 
168.1 Serratia marcescens FWS 
168.2 Pseudomonas aeruginosa FWS 
169 Pseudomonas spp. FWS 
170 Pseudomonas putida SC 
171 Halomonas spp. SC 
172 Pseudomonas aeruginosa DWL; 2009 
173 Pseudomonas aeruginosa DWL; 2011 
174 Pseudomonas aeruginosa DWL; 2010 
175 Pseudomonas aeruginosa DWL; 2010 
176 Pseudomonas aeruginosa DWL; 2010 
177 Pseudomonas aeruginosa DWL; 2010 
178 Pseudomonas aeruginosa DWL; 2010 
179 Pseudomonas aeruginosa DWL; 2010 
180 Pseudomonas aeruginosa DWL 
181 Pseudomonas aeruginosa DWL 
182 Pseudomonas aeruginosa DWL 
183 Pseudomonas spp. DWL 
184 Pseudomonas aeruginosa DWL 
185 Pseudomonas aeruginosa SC 
186 Burkholderia spp. SC 
187 Pseudomonas aeruginosa PC 
188 Pseudomonas aeruginosa PC 
189 Pseudomonas aeruginosa PC 
190 Pseudomonas aeruginosa SC  
191 Pseudomonas aeruginosa SC 
192 Pseudomonas aeruginosa SC 
193 Pseudomonas aeruginosa PC; 2003 
194 Pseudomonas aeruginosa DWL; 2011; Trinidad and Tobago 
195 Pseudomonas aeruginosa DWL; 2006 
196 Pseudomonas aeruginosa 
ATCC 13388; reference strain used in industrial testing (ISO 
846C); origin unknown 
197 Pseudomonas aeruginosa ATCC 10145; reference strain used in industrial testing,  
198 Pseudomonas aeruginosa 
ATCC 15442; reference strain used in industrial testing, , 
originally isolated from an animal room water bottle; ENV 
199 Pseudomonas aeruginosa MWF 
200 Pseudomonas aeruginosa TC 
202 Pseudomonas aeruginosa LAC; 2012; EU 
203 Pseudomonas spp. PC; 2012 
204 Pseudomonas aeruginosa DWL; 2012 
205 Pseudomonas putida DWL; 2012; EU 
206 Pseudomonas pseudoalcaligenes LAC; 2012; EU 
260 Pseudomonas aeruginosa FWS; 2014; Brazil 
261 Pseudomonas aeruginosa FWS; 2012; Brazil 
262 Pseudomonas aeruginosa FWS; 2012; Brazil 
263 Pseudomonas aeruginosa FWS; 2014; Brazil 
264 Pseudomonas aeruginosa FWS; 2012; Brazil 
265 Pseudomonas aeruginosa FWS; 2012; Brazil 
266 Staphylococcus succinus FWS; 2012; Brazil 
Footnotes: SC, surface cleaner; DWL, dish wash liquid; LAC, liquid abrasive cleaner; PC, personal care; RM, raw 
materials; Misc, miscellaneous; FWS, fabric wash; MWF, metal working fluid; TC, timber care; ENV, environmental 
isolation source 
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Table 2.4 Contaminated HPC-products sampled for bacterial growth 
Product Production year Location Isolate(s) 
Dish Wash Liquid   
DWL1a 2000 - RW182 
DWL2a 1997 - RW180 
DWL3a  1998 - RW181 
DWL4a 2005 - RW183 
DWL5a 2013 - * 
DWL6 2009 - RW172 
DWL7 2011 Indonesia RW173 
DWL8 2010 Italy RW174 
DWL9 2009 Malaysia RW175 
DWL10 2010 Indonesia RW176 
DWL11 2010 Indonesia RW177 
DWL12a 2010 Malaysia RW178 
DWL12b 2010 Malaysia RW179 
DWL13 2006 - RW193 
DWL14 2011 - RW195 
DWL15 2006  RW184 
Surface cleaner   
SC1a 2010 - RW192 
SC2a  - - RW185 
SC3a 2013 - * 
SC4 - - RW186 
SC5 2011 - RW190 
SC6 2011 - RW191 
SC7 2010  RW192 
Personal Care   
PC1a 2000 - RW189 
PC2a 1996 - RW188 
PC3 2002 - RW187 
PC4 2003 - RW194 
Fabric Wash   
FWS1a 2012 Brazil 
* FWS2a 2012 Brazil 
FWS3a 2013 - 
Wood Cleaner   
WC1a 2013 - * 
 
aProducts included in bacterial diversity investigations in Chapter 4; *Isolates from these products not in the 
collection, products used only in diversity investigations in Chapter 4. 
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2.8.3. Comparison of five selective media  
 
A comparison of five selective agars for the detection of P. aeruginosa was performed. The five 
agars included in the study were PCN, PIA, ChromID Pa, Z-agar and mZ-agar (further details of 
the agars are given in section 2.2). 
2.8.3.1. Strain panel for the comparative study 
A strain panel comprising 148 strains including 58 P. aeruginosa and 90 non-P. aeruginosa 
strains was assembled for the agar comparison study (full details in Table 2.5).  All P. aeruginosa 
isolates were confirmed as P. aeruginosa by the use of a species-specific PCR (oprL PCR; De Vos 
et al. 1997). Non-P. aeruginosa strains belonged to other Pseudomonas species, other Gram-
negative species and Gram-positive species. Strains originated from clinical, environmental and 
industrial sources. Ninety strains were obtained from the collection held at Cardiff University 
(including those from the EuroCareCF panel) whilst 58 strains were supplied by industry or 
recovered from industrial sources. 
2.8.3.2. Comparison of selective media 
Overnight cultures of strains were diluted to an optical density (OD) of 1 at 600 nm 
(corresponding to approximately 108 cfu/ml) and 200 µl of the diluted culture pipetted into 
separate wells of a 96 well micro-titre plate.  The cultures were replica plated, using a 48 pin 
replicator (approximately 105 cfu/ml transferred) from the 96 well plate onto TSA, PCN, PIA, 
chromID Pa, Z-agar and modified Z-agar in triplicate.  All agar plates were incubated at 37°C and 
42°C for 72 hours, except the TSA plates for the non-P. aeruginosa panel which were incubated 
at 30°C for 72 hours, and the Z-agar and modified Z-agar plates which were only incubated at 
37°C.  Results were recorded at 24 and 72 hours.  Positive results on chromID Pa were originally 
intended to be taken as growth accompanied by a red/pink/purple colouration as described 
previously (Laine et al. 2009), but this interpretation was modified to also incorporate strains 
that displayed a pink-brown colour. Pigment production (pyocyanin and pyoverdin) by P. 
aeruginosa strains on TSA, PCN and PIA was recorded at 37°C. Growth on any of the other media 
was taken as a positive result, regardless of the presence/absence of pigment production. 
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2.8.3.3. Evaluation criteria 
The sensitivity and specificity of the agars were calculated as follows. The sensitivity was taken 
as the number of P. aeruginosa strains identified as positive for growth on the media, divided by 
the total number of P. aeruginosa strains screened; the probability of a true positive.  The 
specificity was taken as the number of non-P. aeruginosa strains negative for growth on the 
media, divided by the total number of non-P. aeruginosa strains screened; the probability of a 
true negative (Lalkhen and McCluskey 2008). Positive and negative predictive values 
(PPV/NPV) were calculated to determine the proportions of true positives and negatives for the 
study population. The PPV was taken as the number of P. aeruginosa strains identified as 
positive for growth on the media, divided by the total number of strains (both P. aeruginosa and 
non-P. aeruginosa) positive for growth. The NPV was taken as the number of non-P. aeruginosa 
strains negative for growth on the media, divided by the total number of strains (both P. 
aeruginosa and non-P. aeruginosa) which were negative for growth (Lalkhen and McCluskey 
2008).   
2.8.4. Acetamide media as enrichment media for P. aeruginosa 
The Bioscreen C was used to examine the growth dynamics of P. aeruginosa and non-P. 
aeruginosa strains in Z-broth supplemented with different concentrations of acetamide, ranging 
from 1 to 50 g/L, as the selective agent (growth curve analysis was set up as described in 
section 2.5).  Two experiments were performed to investigate growth over 72 hours at 37°C, as 
described in section 3.2.3 with varying acetamide concentrations and control isolates evaluated 
in each experiment. Where applicable, to examine differences between the maximum ODs 
reached at different acetamide concentrations for different strains, a Welch’s 2-sample t-test for 
normally distributed data with unequal variances was performed in R statistical software. 
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Table 2.5 Strain collection used in the comparative agar study 
Species (strain) Isolation source and other information Supplied by 
Pseudomonas aeruginosa 
PAK-SR CLIN; Streptomycin resistant parent of Fla-/Pil- mutants of PAK Cardiff 
PAO1 CLIN; First P. aeruginosa strain to be genome sequenced Cardiff 
C3790 CLIN, CF; Melbourne epidemic strain 1 (AES-1) Cardiff 
C3803 CLIN, CF; Melbourne epidemic strain 2 (AES-2) Cardiff 
P10119 CLIN, CF; Clone C epidemic strain Cardiff 
P9245 CLIN, CF; Midlands epidemic strain 1 (Mid1) Cardiff 
LES B58 CLIN, CF; Liverpool  epidemic strain LES B58 Cardiff 
NCTC 12903; ATCC 
27853 
CLIN; Antibiotic efficacy testing reference strain Cardiff 
C3719 CF; Manchester epidemic strain (MES) Cardiff 
N19 CLIN; Urinary tract infection (catheter) isolate Cardiff 
PA5 CLIN; Chronic prostatitis isolate (2006) Cardiff 
C259 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C132 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C1138 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C158 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C2957 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C4278 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C1698 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C511 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C2846 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C3128 CLIN, CF isolate; (Speert et al. 2002) Cardiff 
PA0025 CLIN Cardiff 
RW140 IND, isolated 1998 Industry 
RW168 IND, isolated 1993 Industry 
RW172 IND, isolated 2009 Industry 
RW179 IND, isolated 2010 Industry 
RW180 IND, isolated 1997 Industry 
RW181 IND, isolated 1998 Industry 
RW184 IND, isolated 2006 Industry 
RW188 IND, isolated 1996 Industry 
RW196 IND; ATCC 13388; reference strain used in industrial testing Industry 
RW197 IND; ATCC 10145; reference strain used in industrial testing Industry 
RW198 IND; ATCC 15442; reference strain used in industrial testing Industry 
RW199 IND; date of isolation unknown Industry 
RW200 IND; date of isolation unknown Industry 
RW113 IND, isolated 2011 Industry 
RW130 IND, isolated 2010 Industry 
RW133 IND, isolated 2011 Industry 
RW135 IND, isolated 2012 Industry 
RW137 IND, isolated 2011 Industry 
RW138 IND, isolated 2001 Industry 
RW147 IND, isolated 1996 Industry 
RW149 IND, isolated 2004 Industry 
RW151 IND; ATCC 9027; reference strain used in industrial testing Industry 
RW174 IND, isolated 2010 Industry 
RW175 IND, isolated 2010 Industry 
RW187 IND, isolated 2002 Industry 
RW189 IND, isolated 2000 Industry 
RW192 IND, isolated 2011 Industry 
RW176 IND, isolated 2010 Industry 
RW109 IND; date of isolation unknown Industry 
RW110 IND; date of isolation unknown Industry 
MB2.2 ENV strain; Domestic isolate from a washing machine in Cardiff, Autumn 2011 Domestic isolates 
LM1.1 ENV strain; Domestic isolate from a kitchen sink in Cardiff, Autumn 2011 Domestic isolates 
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PA0048 Environmental isolate Cardiff 
PA0301 Environmental isolate Cardiff 
BCC0432 Environmental isolate Cardiff 
PA0003 Environmental isolate Cardiff 
Achromobacter xylosoxidans 
BCC1386 CLIN Cardiff 
LMG 1863 CLIN (EuroCareCF panel) Cardiff 
Acinetobacter species  
ESH#749 IND; date of isolation unknown Industry 
Bacillus species  
RW#162  IND; isolated 2009 Industry 
Burkholderia ambifaria  
AMMDa ENV; genome available Cardiff 
MC40-6 CLIN; genome available Cardiff 
MEX-5 ENV; genome available Cardiff 
Burkholderia cenocepacia  
AU1054a CLIN; genome available Cardiff 
HI2424a ENV; genome available Cardiff 
J2315; LMG 16656a CLIN; genome available Cardiff 
LMG 12614a CLIN (EuroCareCF panel) Cardiff 
LMG 16654a CLIN (EuroCareCF panel) Cardiff 
LMG 16656a CLIN (EuroCareCF panel) Cardiff 
LMG 18829b CLIN (EuroCareCF panel) Cardiff 
LMG 18830 CLIN (EuroCareCF panel) Cardiff 
MC0-3a ENV; genome available Cardiff 
RW#156b IND; date of isolation unknown Industry 
Burkholderia cepacia  
LMG 1222a CLIN (EuroCareCF panel) Cardiff 
Burkholderia cepacia complex  
ESH#751b IND; date of isolation unknown Industry 
ESH#750a IND; date of isolation unknown Industry 
Burkholderia contaminans  
LMG 23255a CLIN; genome available Cardiff 
Burkholderia dolosa  
LMG 18943 CLIN (EuroCareCF panel) Cardiff 
Burkholderia gladioli  
LMG 18157 CLIN (EuroCareCF panel) Cardiff 
Burkholderia lata  
383; ATCC 17660; LMG 
22485 
ENV; genome available Cardiff 
Burkholderia multivorans 
ATCC 17616 ENV; genome available Cardiff 
C1576 CLIN; genome available Cardiff 
LMG 13010 CLIN (EuroCareCF panel) Cardiff 
LMG 16660a CLIN (EuroCareCF panel) Cardiff 
LMG 16775a CLIN (EuroCareCF panel) Cardiff 
Burkholderia phymatum  
BCC1607a ENV; genome available Cardiff 
Burkholderia phytofirmans 
BCC 1604 ENV; genome available Cardiff 
Burkholderia pyrrocinia  
LMG 21824a CLIN (EuroCareCF panel) Cardiff 
Burkholderia stabilis  
LMG 14294b CLIN (EuroCareCF panel) Cardiff 
Burkholderia vietnamiensis  
G4; ATCC 53617a ENV; genome available Cardiff 
LMG 18835 CLIN (EuroCareCF panel) Cardiff 
RW#152  IND; isolated 2002 Industry 
Escherichia coli  
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NCTC 12241; ATCC 
25922 
CLIN; Antibiotic efficacy testing reference strain Cardiff 
Halomonas species 
RW#171  IND; isolated 1997 Industry 
Ochrobactrum anthropi 
RW#160  IND; isolated 1997 Industry 
Pandoraea apista 
BCC0125 CLIN Cardiff 
LMG 16407 CLIN (EuroCareCF panel) Cardiff 
Pandoraea pnomenusa  
BCC0092; C7351 CLIN Cardiff 
BCC0580; C8029 CLIN Cardiff 
LMG 18087 CLIN (EuroCareCF panel) Cardiff 
Pandoraea pulmonicola 
BCC0150; FC0330 CLIN  Cardiff 
LMG 18106 CLIN (EuroCareCF panel) Cardiff 
Pandoraea sputorum  
BCC0139 CLIN  Cardiff 
BCC0212 CLIN Cardiff 
BCC0219 CLIN Cardiff 
LMG 18819 CLIN (EuroCareCF panel) Cardiff 
Pantoea agglomerans  
RW#166  IND; isolated 2002 Industry 
Pseudomonas alcaligenes  
LMG 1224 ENV; isolated from swimming pool water Cardiff 
Pseudomonas aureofaciens 
LMG 1245b ENV; isolated from Maas River clay suspended in kerosene for three weeks Cardiff 
Pseudomonas fluorescens  
LMG 1794a ENV; isolated from water-works tanks Cardiff 
RW#85 IND; date of isolation unknown Industry 
RW#89 IND; date of isolation unknown Industry 
Pseudomonas mendocina  
LMG 1223 ENV; isolated from soil  Cardiff 
Pseudomonas oleovorans 
LMG 2229a IND; isolated from metal working fluid Cardiff 
Pseudomonas pseudoalcalienes  
RW#111 IND; date of isolation unknown Industry 
Pseudomonas putida 
LMG 2257  ENV; soil Cardiff 
RW#153b  IND; isolated 2003 Industry 
RW#154 IND; isolated 2003 Industry 
RW#157  IND; isolated 2010 Industry 
RW#158 IND; isolated 2003 Industry 
RW#159 IND; isolated 2006 Industry 
RW#161 IND; isolated 2005 Industry 
RW#205b  IND; isolated 2012 Industry 
Pseudomonas species  
RW#112 b IND; date of isolation unknown Industry 
RW#155  IND; isolated 2003 Industry 
RW#163 IND; isolated 2004 Industry 
RW#164  IND; isolated 2010 Industry 
RW#165b IND; isolated 2000 Industry 
RW#167  IND; isolated 2002 Industry 
RW#169  IND; isolated 2008 Industry 
RW#206  IND; isolated 2012 Industry 
Ralstonia insidiosa  
LMG 18101 CLIN (EuroCareCF panel) Cardiff 
Ralstonia mannitolilytica  
BCC1391 CLIN Cardiff 
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LMG 18103 CLIN (EuroCareCF panel) Cardiff 
Ralstonia picketii  
LMG 18088 CLIN (EuroCareCF panel) Cardiff 
BCC0039 CLIN Cardiff 
BCC1392 CLIN Cardiff 
Serratia marcescens 
LMG 2792 ENV Cardiff 
LMG 25713 ENV Cardiff 
ATCC 14756 Isolation source unknown; test, control and bioassay strain Cardiff 
RW#168.2 IND; date of isolation unkown Industry 
Staphylococcus aureus  
ATCC 6538 CLIN Cardiff 
NCTC 12981a CLIN Cardiff 
Staphylococcus epidermidis 
ATCC 12228 CLIN Cardiff 
Stenotrophomonas maltophilia  
BCC1394 CLIN Cardiff 
Stenotrophomonas species  
ESH#758 IND; date of isolation unknown Industry 
 
aStrains recorded as positive on chromID Pa after incubation at 37°C for 24 hours, but negative on chromID Pa after 
incubation at 42°C for 24 hours 
bStrains recorded a negative on chromID Pa after incubation at 37°C for 24 hours, but positive on chromID Pa after 
incubation at 42°C for 24 hours 
LMG, Belgian co-ordinated collections of micro-organisms, Gent; ATCC, America type culture collection; NCTC, 
National collection of type cultures, Public Health England; BCC, Cardiff strain collection; ESH#/RW#, held in 
ESH/RW collections at Cardiff, originally supplied by industry; CLIN, clinical; CLIN CF, Cystic Fibrosis; ENV, 
environmental; IND, industrial 
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2.9. Culture-independent detection methods 
2.9.1. Primer design for novel P. aeruginosa-specific PCRs 
 
2.9.1.1. Primer design for PCR amplification of the phzS gene 
 
The sequences of the phzS genes from 9 P. aeruginosa strains and phzS gene orthologs from 6 
other bacterial species were obtained from the integrated microbial genomes (IMG) database 
(Markowitz et al. 2012).  The 7 phzS orthologs from other bacterial species within the Class 
Actinobacteria were the top hits of an IMG database search using Basic Local Alignment Search 
Tool (BLAST) algorithms with the search input as the P. aeruginosa PA01 phzS gene complete 
sequence.  The phzS gene and gene ortholog sequences were aligned with Clustal W2 (Larkin et 
al. 2007) and viewed using BioEdit Sequence Alignment Editor (Hall 1999).  Two sets of primers 
(main and nested), specific for P. aeruginosa strains, were designed based on these alignments 
(Table 2.6).     
2.9.1.2. Primer design for PCR amplification of the genes within the ami operon  
 
The organisation of the ami operon of P. aeruginosa strains and orthologous operons in other 
bacterial species was viewed using the ‘gene ortholog neighbourhood’ viewer tool of the IMG 
database. The sequences of the amiL-amiE intergenic spacer region in 9 P. aeruginosa strains 
and orthologous sequences in other Pseudomonas species were obtained from the IMG database. 
In addition, the amiE gene sequences of 9 P.aeruginosa strains and amiE or orthologous genes 
from 5 strains of other Pseudomonas species were obtained from the IMG database and the 
Pseudomonas genome database (Winsor et al. 2009).  Sequences were aligned using Clustal W2 
and viewed using BioEdit Sequence Alignment Editor. One set of primers specific for P. 
aeruginosa, was designed based on these alignments (Table 2.6).  
2.9.2. PCR reaction conditions for P. aeruginosa specific PCRs 
 
PCR reactions had a total volume of 25 µl containing 1X Coralload buffer, 1X Q-solution, 200 µm 
deoxynucleoside triphosphates (dNTPs), 1.6 µm each primer, 1 U Taq polymerase and 2 µl DNA 
template (approximately 20 ng). If using DNA extracted from HPC-products, 6 µl was used as 
the template. All reagents were supplied by Qiagen.  Primer pairs and PCR cycles for the 
different target genes are shown in Tables 2.6 and 2.7, respectively. For nested PCR reactions 2 
µl of product from the first round of PCR was taken as the template for the second PCR reaction.  
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PCR cycles were performed on a c1000™ Thermal Cycler (Bio-Rad), and the annealing 
temperature optimised for specificity towards P. aeruginosa.  Gel electrophoresis was 
performed on 1.5% (w/v) agarose gels stained with SafeView (10 µl SafeView per 100 ml of 
agarose gel).  PCR products were visualised with a UV transilluminator and gel images captured 
using GeneSnap Software. 
 
2.9.3. Evaluation of phzS and ami operon PCRs 
 
The sensitivity and specificity of the phzS and ami operon PCR was evaluated using a panel 
comprising 60 P. aeruginosa and 65 non-P. aeruginosa strains (Table 2.8).  To further evaluate 
the phzS PCR, four strains from a previous study (Finnan et al. 2004) that were found to be 
negative for the phzS gene were included in the phzS PCR test panel (Table 2.8). The sensitivity 
was taken as the number of P. aeruginosa strains identified as positive for the phzS or ami 
operon PCRs, divided by the total number of P. aeruginosa strains screened; the probability of a 
true positive.  The specificity was taken as the number of non-P. aeruginosa strains negative for 
the phzS or ami operon PCRs, divided by the total number of non-P. aeruginosa strains screened; 
the probability of a true negative (Lalkhen and McCluskey 2008). 
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Table 2.6 Primers for the PCR amplification of P. aeruginosa genes 
 
 
 
Table 2.7 PCR cycles for the amplification of P. aeruginosa genes 
 a Annealing temperatures vary for different primer sets (see Table 2.6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Target gene 
Primer 
pair 
Primer sequence 5’>3’ 
Annealing 
temp (°C) 
Product 
Size (bp) 
Reference 
oprL 
PAL1 ATG GAA ATG CTG AAA TTC GGC 
61 504 
(De Vos et al. 
1997) 
PAL2 CTT CTT CAG CTC GAC GCG ACG 
PAoprL.6 GCC TTC CAG CAC TAC GCG CTG 
phzS phzS.F GGA AGC CGG CAA CGC CTA T 
65 584 
This study 
 phzS.R GCA GGA TCA ACT GGT TGC GGG T  
phzS(nested) phzSn.F CGC GGC GAA CTG CAG ATG ATC 
65 435 
This study 
 phzSn.R CTC GTT GTC GAG CTG GCC GA  
amiL-amiE 
amiE.F CAT CAG GTC RTG CGC ATC AGC 
65 588 This study 
amiE.R GCC CTT CGG CCC KTC GCT 
PCR step Temperature (°C) Time (minutes) No cycles 
1  Initial DNA denaturation 94 3 1 
2 DNA denaturation 94 0.5  
30 3 Primer annealing a 1 
4  Primer extension 72 1 
5 Final extension 72 5 1 
6 Indefinite hold 10 - - 
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Table 2.8 Strain collection used for the evaluation of the phzS and ami operon PCRs 
 
Species (strain) Isolation source and other information Supplied by 
Pseudomonas aeruginosa 
PAK-SR CLIN; Streptomycin resistant parent of Fla-/Pil- mutants of PAK Cardiff 
PAO1 CLIN; First P. aeruginosa strain to be genome sequenced Cardiff 
C3790 CLIN, CF; Melbourne epidemic strain 1 (AES-1) Cardiff 
C3803 CLIN, CF; Melbourne epidemic strain 2 (AES-2) Cardiff 
P10119 CLIN, CF; Clone C epidemic strain Cardiff 
P9245 CLIN, CF; Midlands epidemic strain 1 (Mid1) Cardiff 
LES B58 CLIN, CF; Liverpool  epidemic strain LES B58 Cardiff 
NCTC 12903; ATCC 
27853 
CLIN; Antibiotic efficacy testing reference strain Cardiff 
C3719 CF; Manchester epidemic strain (MES) Cardiff 
N19 CLIN; Urinary tract infection (catheter) isolate Cardiff 
PA5 CLIN; Chronic prostatitis isolate (2006) Cardiff 
C259 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C132 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C1138 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C158 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C2957 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C4278 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C1698 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C511 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C2846 CLIN, CF; (Mahenthiralingam et al. 1996) Cardiff 
C3128 CLIN, CF isolate; (Speert et al. 2002) Cardiff 
PA0025 CLIN Cardiff 
RW140 IND, isolated 1998 Industry 
RW168 IND, isolated 1993 Industry 
RW172 IND, isolated 2009 Industry 
RW179 IND, isolated 2010 Industry 
RW180 IND, isolated 1997 Industry 
RW181 IND, isolated 1998 Industry 
RW184 IND, isolated 2006 Industry 
RW188 IND, isolated 1996 Industry 
RW196 IND; ATCC 13388; reference strain used in industrial testing Industry 
RW197 IND; ATCC 10145; reference strain used in industrial testing Industry 
RW198 IND; ATCC 15442; reference strain used in industrial testing Industry 
RW199 IND; date of isolation unknown Industry 
RW200 IND; date of isolation unknown Industry 
RW113 IND, isolated 2011 Industry 
RW129 IND; isolated 2010 Industry 
RW130 IND, isolated 2010 Industry 
RW133 IND, isolated 2011 Industry 
RW135 IND, isolated 2012 Industry 
RW137 IND, isolated 2011 Industry 
RW138 IND, isolated 2001 Industry 
RW147 IND, isolated 1996 Industry 
RW149 IND, isolated 2004 Industry 
RW151 IND; ATCC 9027; reference strain used in industrial testing Industry 
RW174 IND, isolated 2010 Industry 
RW175 IND, isolated 2010 Industry 
RW187 IND, isolated 2002 Industry 
RW189 IND, isolated 2000 Industry 
RW192 IND, isolated 2011 Industry 
RW194 IND; isolated 2011 Industry 
RW176 IND, isolated 2010 Industry 
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RW109 IND; date of isolation unknown Industry 
RW110 IND; date of isolation unknown Industry 
MB2.2 ENV strain; Domestic isolate from a washing machine in Cardiff, Autumn 2011 Domestic isolates 
LM1.1 ENV strain; Domestic isolate from a kitchen sink in Cardiff, Autumn 2011 Domestic isolates 
PA0048 Environmental isolate Cardiff 
PA0301 Environmental isolate Cardiff 
BCC0432 Environmental isolate Cardiff 
PA0003 Environmental isolate Cardiff 
CF194* (Finnan et al. 2004) 
University College 
Cork (UCC) 
CF198* (Finnan et al. 2004) UCC 
CF242* (Finnan et al. 2004) UCC 
BR227* (Finnan et al. 2004) UCC 
Achromobacter xylosoxidans 
LMG 1863 CLIN (EuroCareCF panel) Cardiff 
Acinetobacter species  
ESH#749 IND; date of isolation unknown Industry 
Bacillus species  
RW#162  IND; isolated 2009 Industry 
Burkholderia ambifaria  
AMMDa ENV; genome available Cardiff 
Burkholderia cenocepacia  
J2315; LMG 16656a CLIN; genome available Cardiff 
RW#156b IND; date of isolation unknown Industry 
Burkholderia cepacia complex  
ESH#751b IND; date of isolation unknown Industry 
ESH#750a IND; date of isolation unknown Industry 
Burkholderia contaminans  
LMG 23255a CLIN; genome available Cardiff 
Burkholderia dolosa  
LMG 18943 CLIN (EuroCareCF panel) Cardiff 
Burkholderia gladioli  
LMG 18157 CLIN (EuroCareCF panel) Cardiff 
Burkholderia lata  
383; ATCC 17660; LMG 
22485 
ENV; genome available Cardiff 
Burkholderia multivorans 
ATCC 17616 ENV; genome available Cardiff 
Burkholderia phymatum  
BCC1607a ENV; genome available Cardiff 
Burkholderia phytofirmans 
BCC 1604 ENV; genome available Cardiff 
Burkholderia pyrrocinia  
LMG 21824a CLIN (EuroCareCF panel) Cardiff 
Burkholderia stabilis  
LMG 14294b CLIN (EuroCareCF panel) Cardiff 
Burkholderia vietnamiensis  
G4; ATCC 53617a ENV; genome available Cardiff 
RW#152  IND; isolated 2002 Industry 
Enterobacter species 
ESH#752 IND; date of isolation unknown Industry 
Enterobacter gergoviae 
ESH#753 IND; date of isolation unknown Industry 
Escherichia coli  
NCTC 12241; ATCC 
25922 
CLIN; Antibiotic efficacy testing reference strain Cardiff 
Halomonas species 
RW#171  IND; isolated 1997 Industry 
Klebsiella species 
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ESH#759 IND; date of isolation unknown Industry 
Ochrobactrum anthropi 
RW#160  IND; isolated 1997 Industry 
Pandoraea apista 
LMG 16407 CLIN (EuroCareCF panel) Cardiff 
Pandoraea pnomenusa  
LMG 18087 CLIN (EuroCareCF panel) Cardiff 
Pandoraea pulmonicola 
LMG 18106 CLIN (EuroCareCF panel) Cardiff 
Pandoraea sputorum  
LMG 18819 CLIN (EuroCareCF panel) Cardiff 
Pantoea agglomerans  
RW#166  IND; isolated 2002 Industry 
Pseudomonas alcaligenes  
LMG 1224 ENV; isolated from swimming pool water Cardiff 
Pseudomonas aureofaciens 
LMG 1245b ENV; isolated from Maas River clay suspended in kerosene for three weeks Cardiff 
Pseudomonas fluorescens  
LMG 1794a ENV; isolated from water-works tanks Cardiff 
Pseudomonas mendocina  
LMG 1223 ENV; isolated from soil  Cardiff 
Pseudomonas oleovorans 
LMG 2229a IND; isolated from metal working fluid Cardiff 
Pseudomonas pseudoalcalienes  
RW#111 IND; date of isolation unknown Industry 
Pseudomonas putida 
LMG 2257  ENV; soil Cardiff 
RW#153b  IND; isolated 2003 Industry 
RW#154 IND; isolated 2003 Industry 
RW#157  IND; isolated 2010 Industry 
RW#158 IND; isolated 2003 Industry 
RW#159 IND; isolated 2006 Industry 
RW#161 IND; isolated 2005 Industry 
RW#205b  IND; isolated 2012 Industry 
Pseudomonas species  
RW#112 b IND; date of isolation unknown Industry 
Ralstonia insidiosa  
LMG 18101 CLIN (EuroCareCF panel) Cardiff 
Ralstonia mannitolilytica 
LMG 18103 CLIN (EuroCareCF panel) Cardiff 
Ralstonia picketii  
LMG 18088 CLIN (EuroCareCF panel) Cardiff 
Staphylococcus aureus  
ATCC 6538 CLIN Cardiff 
NCTC 12981a CLIN Cardiff 
Staphylococcus epidermidis 
ATCC 12228 CLIN Cardiff 
Stenotrophomonas maltophilia  
BCC1394 CLIN Cardiff 
Stenotrophomonas species  
ESH#758 IND; date of isolation unknown Industry 
*Strains only used for the evaluation of the phzS PCR 
LMG, Belgian co-ordinated collections of micro-organisms, Gent; ATCC, America type culture collection; NCTC, 
National collection of type cultures, Public Health England; BCC, Cardiff strain collection; ESH#/RW#, held in 
ESH/RW collections at Cardiff, originally supplied by industry; CLIN, clinical; CLIN CF, Cystic Fibrosis; ENV, 
environmental; IND, industrial 
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2.10. Genotyping techniques and investigation of strain diversity 
2.10.1. PCR-fingerprinting: Random Amplified Polymorphic DNA (RAPD) typing 
RAPD typing was adapted from Mahenthiralingam et al. (Mahenthiralingam et al. 1996) and 
Fothergill et al. (Fothergill et al. 2010). PCR reaction mixtures had a total volume of 25 µl, 
comprising 1 x PCR buffer, 1 x Q-solution, 3 mM MgCl2, 200 µm dNTPs, 1.6 µM primer 272 (5′-
AGCGGGCCAA-3′), 1 U Taq DNA polymerase and 2 µl template genomic DNA (approximately 20 
ng). All PCR reagents were supplied by Qiagen and PCR reactions were carried out on a c1000™ 
Thermal Cycler with the cycles shown in Table 2.9.  1µl of RAPD-PCR product was loaded onto a 
DNA 7500 chip and analysed by microfluidics using an Agilent 2100 Bioanalyzer, according to 
the manufacturer’s instructions.  Cluster analysis of the RAPD-PCR profiles was performed using 
the Gel Compar package within Bionumerics 6.6 software (Applied Maths).  A Pearson 
correlation similarity coefficient with a UPGMA dendrogram type was used to determine 
similarity between RAPD profiles.  Isolate profiles displaying ≥80% profile similarity were 
considered as a single RAPD type (White et al. 2011). The selection of P. aeruginosa isolates 
associated with industry and subjected to RAPD typing analysis is given in Table 2.10. 
 
 
Table 2.9 RAPD-PCR cycles 
 
 
 
 
 
 
 
 
 
 
PCR step 
Temperature 
(°C) 
Time (minutes) No cycles 
1 DNA denaturation 94 5 
4 2 Primer annealing 36 5 
3 Primer extension 72 5 
4 DNA denaturation 94 1 
30 
5 Primer annealing 36 1 
6 Primer extension 72 2 
7 Final extension 72 6 
8 Indefinite hold 10 - - 
CHAPTER 2 – METHODS & MATERIALS 
 
66 
 
Table 2.10 P. aeruginosa strains associated with industry used in RAPD-PCR typing 
RW# Comment 
109 Challenge test strain used in preservative efficacy testing 
110 Challenge test strain used in preservative efficacy testing 
113 SC; 2011 
114 SC; 2011 
115 SC; 2011 
116 SC; 2011 
117 DWL; 2010; Indonesia 
118 DWL; 2010; Indonesia 
119 DWL; 2010; Italy 
120 DWL; 2010; Italy 
121 DWL; 2010; Italy 
122 DWL; 2009; Italy; 
123 DWL; 2011; Malaysia 
124 DWL; 2009; Italy 
125 DWL; 2009; Italy 
126 DWL; 2009; Italy 
127 DWL; 2010; Indonesia 
128 DWL; 2010; Italy 
129 DWL; 2010; Italy 
130 DWL; 2010; Italy 
131 DWL; 2010; Italy 
132 DWL; 2010; Italy 
133 DWL; 2010; Thailand 
134 DWL; 2010; Thailand 
135 DWL; 2010; Indonesia 
136 DWL; 2010; Indonesia 
137 DWL; 2010; Italy 
138 LAC; 2001 
139 LAC; 2001 
140 DWL 
143 DWL 
144 DWL 
145 DWL; 2010 
146 DWL; 2004; Italy 
147 PC 
148 PC 
149 PC 
150 PC 
151 strain ATCC 9027 used in period after opening studies 
168.2 FWS 
172 DWL; 2009 
173 DWL; 2011 
174 DWL; 2010 
175 DWL; 2010 
176 DWL; 2010 
177 DWL; 2010 
178 DWL; 2010 
179 DWL; 2010 
180 DWL 
181 DWL 
182 DWL 
184 DWL 
185 SC 
187 PC 
188 PC 
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189 PC 
190 SC 
191 SC 
192 SC 
193 PC; 2003 
194 DWL; 2011; Trinidad and Tobago 
195 DWL; 2006 
196 
ATCC 13388; reference strain used in industrial testing (ISO 846C); origin 
unknown 
197 ATCC 10145; reference strain used in industrial testing,  
198 
ATCC 15442; reference strain used in industrial testing, , originally isolated 
from an animal room water bottle; ENV 
199 MWF 
200 TC 
202 LAC; 2012; EU 
204 DWL; 2012 
SC, surface cleaner; DWL, dish wash liquid; LAC, liquid abrasive cleaner; PC, personal care; RM, raw materials; Misc, 
miscellaneous; FWS, fabric wash; MWF, metal working fluid; TC, timber care; ENV, environmental isolation source 
 
 
 
2.10.2. Clondiag Array-Tube typing  
The Clondiag Array Tube (AT) P. aeruginosa genotyping kit (Alere Technologies Gmbh, 
Germany) was used to genotype selected P. aeruginosa strains according to the manufacturer’s 
instructions.  This genotyping method samples the core genome (via the detection of 13 single 
nucleotide polymorphisms) and the accessory genome (via the detection of 39 variable genetic 
markers). Interpretation of the presence or absence of the SNPs representing the core genome 
results in a 16-digit binary genotype, that is expressed as a four letter hexadecimal code.   The 
hexadecimal code types can be compared to a database of previously documented strain types 
and used in population structure analyses, for example with the eBURST (enhanced version of 
based upon related sequence types) algorithm (Feil et al. 2004). The relatedness of the P. 
aeruginosa strains was determined by comparison to a 917-strong database of clinical and 
environmental strains [a subset of the database of (Cramer N. et al. 2012)] using the eBURST 
algorithm (http://eburst.mlst.net) (Feil et al. 2004). 
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2.10.3. Whole genome sequence-based methods 
2.10.3.1. Genome sequencing: DNA preparation, sequencing technology and draft genome 
assembly 
Genomic DNA extraction from pure bacterial cultures and total was achieved using the 
Maxwell® 16 instrument as described in section 2.6.3. Quantitation and quality control of the 
extracted DNA was performed as described in section 2.6.4. Genomic library preparation and 
DNA sequencing was performed at the Oxford Genomics Centre of the Welcome Trust Centre for 
Human Genetics. DNA sequencing was achieved using 100-bp paired-end Illumina HiSeq2000 
technology. De novo assembly of genomes from the paired-end sequence data was performed 
using SPAdes Genome Assembler v3.5.0 (Bankevich et al. 2012), genome assembly statistics are 
given in Table 2.11. Sequences were uploaded to the European Nucleotide Archive (ENA; 
http://www.ebi.ac.uk/ena).  
 
Table 2.11 SPAdes genome assembly statistics for the 24 P. aeruginosa genome sequenced 
strains 
Strain 
(RW#) 
Other strain 
designations 
Genome assembly information 
Number of 
contigsa 
N50a 
Fold sequence 
coverage 
Assembly 
length (Mb) a 
GC%a 
11 
NCTC 12903; 
ATCC 27853 
89 296553 25.79 6.76 66.15 
18  87 189759 26.57 6.60 66.18 
27 A128 80 302083 20.47 6.47 66.3 
30 A128a 71 340995 24.38 6.32 66.4 
99 MB2.2 84 271043 24.72 6.71 66.26 
109  201 134144 19.60 7.54 65.2 
110  52 373781 29.90 6.58 66.33 
130  187 125540 28.10 7.63 65.31 
131  182 125540 31.19 7.58 65.33 
138  140 165596 28.74 7.10 65.78 
146  204 108166 21.94 7.65 65.29 
149  161 157029 22.91 7.21 65.73 
151 ATCC 9027 139 171689 24.20 6.82 65.97 
168  65 273926 26.33 6.48 66.35 
172  152 183227 23.14 7.45 65.34 
176  167 142369 30.55 7.35 65.4 
184  259 133442 20.95 7.06 65.58 
192  113 211670 30.15 6.70 65.93 
196 
ATCC 13388; 
NCTC 8060 
125 206633 34.99 6.62 66.16 
198 ATCC 15442 86 264882 35.09 6.68 66.25 
199  218 137755 34.94 7.02 65.78 
200  89 210395 37.30 6.45 66.38 
202  59 319926 37.77 6.58 66.33 
204  79 272723 31.52 6.78 65.91 
aAll statistics are based on contigs of size >= 500 bp 
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2.10.3.2. BIGSdb for analysis of genomic data 
 
Assembled genomic data were deposited in the PubMLST database, supported by the Bacterial 
Isolate Genome Sequence Database (BIGSdb) software (Jolley and Maiden 2010). The BIGSdb 
software has the capacity not only to store sequence data (ranging from single sequence reads 
to whole genomes) but can link entries to information about isolate provenance and phenotype. 
In addition BIGSdb is a powerful tool for investigations into population genomics. The Genome 
Comparator module within BIGSdb facilitates gene-by-gene analyses through the use of existing 
genotyping schemes defined within the database, such as Multilocus Sequence Typing (MLST) 
or ribosomal MLST (rMLST), as well as schemes defined by the user.  For example, whole 
genome MLST (wgMLST) or a scheme involving genes involved in certain biochemical 
pathways, can be implemented using an annotated reference genome as the comparator for 
analysis (Jolley and Maiden 2010). BIGSdb can build up profiles of alleles at each locus for 
genotyping schemes, allowing the identification of different alleles type for the isolates under 
investigation and further analysis through MLST profile comparisons (Jolley et al. 2012b).  
 
2.10.3.3. Genome comparison 
 
Using BIGSdb investigations into the strain diversity of P. aeruginosa were conducted with: (i) 
the 7 P. aeruginosa MLST loci (Curran et al. 2004); (ii) the 53  rMLST loci (Jolley et al. 2012a); 
and (iii) wgMLST with all of the loci defined in the P. aeruginosa UCBPP-PA14 genome 
annotation. Loci were compared between P. aeruginosa strains using the Genome Comparator 
tool which outputs MLST profiles and a distance matrix based on the number of variable alleles.  
Phylogenetic networks were generated from the distance matrices using the NeighbourNet 
algorithm (Bryant and Moulton 2004) in SplitsTree v4.13.1 (Huson and Bryant 2006). This 
algorithm can produce a net-like diagram supporting multiple plausible evolutionary pathways 
between sequences, which may arise due through recombinational events such as horizontal 
gene transfer (Cody et al. 2013) 
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2.11. Microbial diversity analysis 
2.11.1. Ribosomal Intergenic Spacer Analysis (RISA) PCR and profile processing 
Bacterial diversity profiling was carried out using RISA, adapted from (Baxter et al. 2013). RISA 
PCRs reaction mixtures had a final volume of 25 µl comprising 1 x PCR buffer, 1 x Q-solution, 
200 µm deoxynucleoside triphosphates (dNTPs), 0.4 µm each RISA PCR primer (1406F: 5’-
TGYACACACCGCCCGT-3’ and 23SR: 5’-GGGTTBCCCCATTCRG-3’; (Fisher and Triplett 1999), 1 U 
Taq polymerase.   The amount of template DNA used was 2 µl for DNA extracted from pure 
cultures and 6 µl for DNA extracted from HPC-products. All PCR reagents were supplied by 
Qiagen and PCR reactions were carried out on a c1000™ Thermal Cycler with the cycles shown 
in Table 2.12.  RISA-PCR products (1µl) were loaded onto a DNA 7500 chip and analysed using 
an Agilent 2100 Bioanalyzer, according to the manufacturer’s instructions. The number of bands 
observed in each RISA-PCR profile was taken as an indicator of sample diversity. To aid the 
putative identification of contaminants, DNA from a pure bacterial culture of P. aeruginosa PAO1 
was subjected to RISA and the online In Silico PCR tool was used to predict the size of ITS 
regions from likely contaminating species. 
 
 
Table 2.12 RISA-PCR cycles  
 
 
 
 
 
 
 
PCR step Temperature (°C) Time (minutes) No cycles 
1  Initial DNA denaturation 95 5 1 
2 DNA denaturation 95 1  
35 3 Primer annealing 54 0.5 
4  Primer extension 72 1 
5 Final extension 72 5 1 
6 Indefinite hold 10 - - 
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2.11.2. Bacterial 16S rRNA gene pyrosequencing and data processing 
DNA extracted from home and personal care products (section 2.6.3) was used directly (without 
dilution) for 16S rRNA gene amplification and pyrosequencing as described by (Dowd et al. 
2008), performed commercially at Research and Testing Laboratories Inc. (Lubbock, Texas, 
USA). The universal bacterial 16S rRNA primers 530F (5’-GTGCCAGCMGCNGCGG-3’) and 1100R 
(5’-GGG TTN CGN TCG TTG-3’) were used for amplification and the V4-V6 regions of the 16S 
rRNA gene sequenced using the Roche GS-FLX platform (Roche, Nutley, New Jersey). 
A two-stage approach was used to analyse the resulting sequence data, similar to that described 
by (Bokulich et al. 2013).  Firstly, the 16S rRNA sequences were analysed using the Mothur 
software package (Schloss et al. 2009) following the 454 SOP pipeline.  Each sample data set 
was subsampled in Mothur to the lowest number of sequence reads found across the samples. 
Sequences were grouped into operational taxonomic units (OTUs) based on a 0.03 distance 
limit, which equated to 97% sequence similarity. Mothur outputs for OTU richness measured by 
observed species numbers (Sobs), the Shannon and Inverse Simpson diversity indices and 
Good’s coverage estimates for the data were noted. Secondly, the RDP MultiClassifier script 
(Wang et al. 2007) was used to determine OTU taxonomies to the genus level, with manual 
searching of the RDP-II sequence database  to corroborate assignments.  Following taxonomic 
assignment, an OTU minimum abundance threshold of 10 was applied which removed OTUs 
represented fewer than 10 times across the dataset. Relative abundances of genera were 
calculated per sample. 
2.12. Antimicrobial susceptibility profiling 
2.12.1. Minimum inhibitory concentration (MIC) determination for individual preservatives  
2.12.1.1. Broth MIC determination 
 
The susceptibility of a panel of 40 P. aeruginosa strains isolated from CF individuals (10), and 
clinical (9), environmental (5), industrial (15) and unknown (1) sources was determined for 5 
preservatives.  Aqueous stock solutions of the 5 preservatives were diluted (serial doubling 
dilutions) in TSB to produce a range of concentrations:  0 – 0.01% CITMIT; 0 – 0.01% MIT; 0 – 
0.08% BIT; 0 – 2.5% PHE; 0 – 0.1% CHX; and 0 – 0.4% BA. Dilutions of BA were prepared in TSB 
at pH 5. 
 
Overnight cultures of P. aeruginosa were adjusted to an optical density (OD) of 1 at 600 nm 
(corresponding to approximately 108 cfu/ml) and 200 µl pipetted into separate wells of a 96-
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well microplate, producing a masterplate for the panel. Using a 48-pin replicator, approximately 
105 cfu from each well of the masterplate were inoculated into fresh 96-well microplates 
containing the preservative concentrations (200 µl of preservative concentration per well). 
Microplates were incubated shaking (150 rpm) for 24 hours at 37°C. After incubation the optical 
density of each well at 600 nm was recorded using the absorbance function of a microplate 
reader (Tecan Infinite® 200 PRO; Tecan UK Ltd., Reading, UK). The MIC was taken as the 
concentration of preservative at which there was an 80% reduction in OD from growth control 
wells containing TSB. Experiments were performed twice with different starting cultures and 
preservatives stock solutions to obtain biological replicates, each experiment having two 
technical replicates. 
2.12.1.2. Statistical analysis of MIC values 
 
The MIC data were analysed as discreet data using non-parametric statistical methods. The 
median of the four replicates was recorded to obtain a final MIC value for each strain for the 
different preservatives.  Boxplots were generated using BoxPlotR to examine the distribution of 
the MIC data for each preservative.  Comparisons between strain groups from different isolation 
sources were performed using a Kruskal-Wallis test and post-hoc Wilcoxon tests with 
Benjamini-Hochberg correction.  The medians of the different groups were deemed statistically 
significantly different at the p=0.05 level. 
2.12.2. Preservative combination testing 
2.12.2.1. Checkerboard method for combination testing 
 
A checkerboard method (Berenbaum 1978) was used to assess the susceptibility of a panel of 
40 P. aeruginosa strains (detailed in Chapter 6, Table 6.1) to a combination of two preservatives 
or one preservative and one preservative enhancing agent. Each strain was exposed to dilutions 
of two agents diluted in TSB, in a 96 well plate format; one agent increased in concentration 
along the horizontal axis, the other increased along the vertical axis. The combinations that 
were tested were as follows: MIT and BIT; CITMIT and PAβN; PHE and CX3; PHE and CX7; PHE 
and VSC.  The concentrations of preservatives and preservative enhancing agents that were 
tested are given in Table 2.13. The CITMIT blend was considered as one preservative for the 
purpose of these assays. 
 
Microtitre plates containing the preservative dilutions were inoculated with approximately 105 
cfu/ml of an overnight culture of P. aeruginosa PA14 per well. Plates were incubated at 37°C for 
24 hours shaking at 150 rpm. The MIC was taken as the concentration of 
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preservative/preservative combination at which there was an 80% reduction in OD from 
growth control wells containing TSB. 
 
 
 
Table 2.13 Preservative concentrations used in combination testing 
 
Preservative/ Preservative enhancing agent concentration (%) 
MIT BIT CITMIT PAβN PHE CX3 CX7 VSC 
0 0 0 0 0 0 0 0 
0.0001 0.0025 0.0005 10 0.02 0.1 0.1 1 
0.00025 0.005 0.00075 25 0.04 0.25 0.25 2 
0.0005 0.01 0.001 50 0.08 0.5 0.5 3 
0.001 0.015 0.002 100 0.1 1 1 4 
0.0025 0.02 0.003 250 0.2 2.5 2.5 5 
0.005 0.025 0.004 500 0.4    
 0.03 0.005  0.8    
 0.04 0.01  1    
 
Footnotes: MIT, methylisothiazolinone; BIT, benzisothiazolinone; CITMIT, chloromethylisothiazolinone and 
methylisothiazolinone blend in the ratio 3:1; PAβN, L-Phe-Arg-β-napthylamide; PHE, phenoxyethanol, CX3, CX3 
preservative enhancer; CX7, CX7 preservative enhancer; VSC, Velsan SC preservative enhancer. 
 
 
 
2.12.2.2. Interpretation of checkerboard testing 
 
The checkerboard test was interpreted using the fractional inhibitory concentration (FIC) index. 
The combined activity of two agents was calculated using the following formula:  
 
FIC = FICA + FIC B = [A]/MICA + [B]/MICB 
 
In this equation [A] and [B] are the concentrations of the two agents being tested and ‘MICA’ and 
‘MICB’ are the MICs of the individual agents. The relationships between the two agents were 
described as follows: FIC <0.5, synergistic; FIC 0.5-1, additive; FIC 1-4, indifferent; FIC >4, 
antagonistic (Stanojevic et al. 2009). The lowest FIC index across the range of dilutions for both 
agents was reported. 
 
CHAPTER 2 – METHODS & MATERIALS 
 
74 
 
2.13. Motility assays 
All agar plates for motility assays were poured on an even surface and dried under laminar flow 
for 30 minutes. Agar concentrations were prepared by the addition of molecular biology grade 
agarose (Severn Biotech Ltd., UK) to either LB Broth (LB; Sigma-Aldrich Co. Ltd) or Basal Salts 
Medium (Hareland et al. 1975) supplemented with 0.4% (w/v) glucose (BSM-G). At least two 
biological replicates were performed per strain for each of the assays. Methods were modified 
from (Rashid and Kornberg 2000). 
2.13.1. Swimming 
Swimming motility was assessed by inoculating the surface of a 0.3% (w/v) LB agar plate with 
overnight culture using a sterile toothpick. Swimming plates were incubated overnight at 37°C 
for 16-18 hours, wrapped in a petri-dish bag to prevent dehydration. The diameter of the 
swimming zone was calculated by taking an average of two perpendicular measurements. 
Strains were scored as non-motile (diameter ≤ 5 mm), motile (diameter > 5 mm and ≤ 60 mm), 
or highly motile (diameter > 60 mm). 
2.13.2. Swarming 
Media used to assess swarming motility were 0.5% (w/v) LB agar and 0.5% (w/v) BSM-G agar. 
Swarming plates were surface inoculated with growth from an overnight culture using a sterile 
toothpick, and incubated overnight at 30°C for 16-18 hours, wrapped in a petri dish bag to 
prevent dehydration. The diameter of the swarming zone was calculated by taking an average of 
two perpendicular measurements. Strains were scored as non-motile (diameter ≤ 5 mm), motile 
(diameter > 5 mm and ≤ 60 mm), or highly motile (diameter > 60 mm). 
2.13.3. Twitching 
Twitching motility was assessed using 1% (w/v) LB agar plates. Using a sterile toothpick, twitch 
plates were stab inoculated to the base of the petri dish with overnight culture. Following 
overnight incubation for 16-18 hours at 37°C, zones of motility at the agar/petri dish interface 
were stained to improve visualisation, using a method modified from (McMichael 1992).  Twitch 
plates were dried under laminar flow for 30 minutes and the agar removed prior to staining the 
dish with 0.5% (w/v) Coomassie brilliant blue R250 (Sigma-Aldrich Co. Ltd.; dissolved in an 
aqueous solution of 40% methanol and 10% (v/v) acetic acid) for 2 mins. Excess stain was 
washed off with an aqueous solution of 40% (v/v) methanol and 10% (v/v) acetic acid. The 
diameter of the twitching zone was calculated by taking an average of two perpendicular 
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measurements.  Strains were scored as non-motile (diameter ≤ 5 mm), motile (diameter > 5 mm 
and ≤ 30 mm), or highly motile (diameter > 30 mm). 
2.14. Adaptation to a preservative combination 
2.14.1. Susceptibility a P. aeruginosa PA14 to a preservative combination 
 
The P. aeruginosa strain PA14 was used in all of the adaptation assays.  The preservative 
combination used was 0.0009% CITMIT, 0.22% DMDMH and 0.1% EDTA (referred to as 
CITMIT-DMDMH-EDTA). The preservatives (CITMIT and DMDMH) and preservative enhancing 
agent (EDTA) were made to these concentrations in TSB (taken as 100% CITMIT-DMDMH-
EDTA) and further dilutions made in TSB. To determine the base-level susceptibility of P. 
aeruginosa PA14 to CITMIT-DMDMH-EDTA, growth in the presence of different dilutions of the 
combination was examined using the Bioscreen C instrument (set up described in section 2.5.1) 
over 48 hours. Alongside a TSB only growth control, the following concentrations of the 
preservative combination were tested: 5%, 7.5%, 10%, 12.5%, 15%, 17.5%, 20%, 25%, 50% 
and 100%.  From this experiment, sub-inhibitory concentrations of CITMIT-DMDMH-EDTA 
were selected to start the planktonic and biofilm adaptation experiments. 
2.14.2. Experimental evolution with planktonic growth 
 
A method modified from Wong et al. (Wong et al. 2012) was followed to investigate the 
adaptation of planktonic growth of P. aeruginosa PA14 to CITMIT-DMDMH-EDTA. 
Approximately 105 cfu from an overnight culture of PA14 were inoculated into 10 tubes 
containing 3 ml of TSB, 10 tubes containing 3 ml of 2.5% strength CITMIT-DMDMH-EDTA in 
TSB, and a further 10 tubes with 3ml of 2.5% strength CITMIT-DMDMH-EDTA in TSB. One of the 
sets of replicates with the 2.5% strength CITMIT-DMDMH-EDTA was used as a growth control, 
whilst the other was a ‘test’ set where the concentration of CITMIT-DMDMH-EDTA was 
increased at each transfer during the experiment in 2.5% increments. Every 24 hours for 8 days, 
each of the 30 populations was propagated by transferring 3 µl of culture into 3 ml of fresh 
growth medium and incubated at 37°C.  The populations grown in TSB only and in the 2.5% 
strength CITMIT-DMDMH-EDTA growth control were transferred in fresh TSB and 2.5% 
strength CITMIT-DMDMH-EDTA, respectively. The ‘test’ populations initially grown in 2.5% 
CITMIT-DMDMH-EDTA, were transferred into both 2.5% and 5% CITMIT-DMDMH-EDTA. After 
24 hours, if there was growth in the 5% CITMIT-DMDMH-EDTA, the culture would be 
transferred into 5% and 7.5% CITMIT-DMDMH-EDTA, and so on. If there was not growth at 5% 
CITMIT-DMDMH-EDTA, a transfer would be made from growth from the 2.5% CITMIT-DMDMH-
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EDTA into fresh 2.5% and 5% CITMIT-DMDMH-EDTA again. This transfer strategy was 
continued throughout the experiment to ensure growth was obtained for all 10 ‘test’ 
populations. Freezer stocks were made of the 30 populations after 4 transfers and 8 transfers by 
adding 8% DMSO to the cultures and storing them at - 80°C. 
 
2.14.3. Experimental evolution in a biofilm 
 
To investigate adaptation of P. aeruginosa PA14 biofilms to CITMIT-DMDMH-EDTA, a method 
modified from Poltak and Cooper (Poltak and Cooper 2011) was used. Briefly, biofilms were 
grown on 7 mm diameter plastic beads (American Educational Products; sterilised by 
autoclaving at 121°C for 15 minutes) suspended in 5 ml growth medium exposed to gentle 
rocking (Bibby Stuart Platform Rocker STR6; 10 rev/min) at 37°C, and transferred into 5 ml of 
fresh growth medium every 48 hours for one month (14 transfers). Three conditions were 
studied: (1) A planktonic growth control with TSB as the growth medium; (2) A biofilm growth 
control with TSB as the growth medium and a bead for biofilm growth; and, (3) A biofilm test 
condition with TSB plus increasing concentrations of CITMIT-DMDMH-EDTA and a bead for 
biofilm growth.  Two biological replicates were set up for each condition, with six technical 
replicates per biological replicate to allow for planktonic growth and a bead to be sampled on 
every third transfer day (6 samples). 
 
To begin the experiment, tubes containing 5 ml TSB, 5 ml TSB plus one sterile plastic bead and 5 
ml TSB with 7.5% strength CITMIT-DMDMH-EDTA plus one sterile plastic bead were inoculated 
with 105 cfu of an overnight culture of P. aeruginosa PA14. All cultures were grown rocking at 
37°C. Every 48 hours a transfer was made: (1) Planktonic growth was diluted 1:100 into fresh 
TSB; (2) The bead from the biofilm growth control was transferred, using sterile tweezers, into 
5 ml fresh TSB and a new bead to be colonised with biofilm growth; and (3) The bead from the 
biofilm test condition was transferred into either the same strength CITMIT-DMDMH-EDTA or a 
higher CITMIT-DMDMH-EDTA concentration (every third transfer the CITMIT-DMDMH-EDTA 
concentration increased as follows: 7.5%, 10%, 12.5%, 15%, 20%) containing a new bead. All 
three conditions were sampled on the start day, on every third transfer day, and the last day of 
the experiment; freezer stocks were made of planktonic growth from all three conditions by 
adding 8% DMSO and storing frozen at -80°C. In addition, total viable counts were performed on 
planktonic growth from condition (1) and for planktonic growth and colonised beads from 
conditions (2) and (3). To obtain total viable counts for colonised beads, beads were removed 
into 2 ml PBS, vortex mixed for 1 minute to remove biofilm growth, then the remaining 
suspension used. Freezer stocks were also made from the remaining suspension by adding 8% 
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DMSO and storing frozen at -80°C. Different colony morphologies from the total viable counts 
were recorded. 
2.14.4. Preservative susceptibility profiling of ancestral and derivative isolates 
 
The preservative susceptibilities of a selection of end-point isolates from the planktonic and 
biofilm experiments (Table 2.14) were determined in relation to the ancestral P. aeruginosa 
PA14 strain.  The MICs of CITMIT, DMDMH and the preservative combination CITMIT-DMDMH-
EDTA were calculated using broth dilution assays in 96 well microplates. Stock solutions of the 
preservatives and 100% CITMIT-DMDMH-EDTA were diluted in TSB to produce the range of 
concentrations listed in Table 2.15. Microplates containing the preservative dilutions were 
inoculated with approximately 105 cfu/ml of an overnight cultures of P. aeruginosa PA14 or 
derivate isolates per well. Plates were incubated at 37°C for 24 hours shaking at 150 rpm. The 
MIC was taken as the concentration of preservative/preservative combination at which there 
was an 80% reduction in OD from growth control wells containing TSB. 
 
 
 
 Table 2.14 Isolates from the adaptation experiments chosen for preservative susceptibility 
testing  
Experimental conditions Isolate(s) Description/Comment 
Pre-experiment 
 P. aeruginosa PA14 Ancestral strain for both experiments 
Adaptation of planktonic growth to CITMIT-DMDMH-EDTA 
TSB growth control TSB.1  Pooled growth from 1 biological replicate 
2.5% CITMIT-DMDMH-EDTA control 2.5%.1  Pooled growth from 1 biological replicate 
10% CITMIT-DMDMH-EDTA 10% Pooled growth from 1 biological replicate 
12.5% CITMIT-DMDMH-EDTA 12.5%.1  Pooled growth from 1 biological replicate 
15% CITMIT-DMDMH-EDTA 15% Pooled growth from 1 biological replicate 
Adaptation of biofilm growth to CITMIT-DMDMH-EDTA 
Pooled 1 (TSB planktonic growth 
replicate 1 & 2) 
- 
Pooled growth from two populations exposed 
to the same experimental conditions 
Pooled 2 (TSB Bead replicate 1 & 2) - 
Pooled growth from two populations exposed 
to the same experimental conditions 
Pooled 3 (TSB CITMIT-DMDMH-EDTA 
Bead replicate 1 & 2) 
- 
Pooled growth from two populations exposed 
to the same experimental conditions 
 
Footnotes: CITMIT, chloromethylisothiazolinone and methylisothiazolinone blend in the ratio 3:1 
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Table 2.15 Preservative concentrations used in preservative susceptibility profiling of isolates 
from preservative adaptation experiments 
 
Preservative concentration (%) 
CITMIT DMDMH CITMIT-DMDMH-EDTA 
0 0 0 
0.000156 0.0078125 2.5 
0.00313 0.015625 5 
0.000625 0.03125 7.5 
0.00125 0.0625 10 
0.0025 0.125 12.5 
0.005 0.25 17.5 
0.01  20 
  22.5 
Footnotes: CITMIT, chloromethylisothiazolinone and methylisothiazolinone blend in the ratio 3:1; DMDMH, 
dimethylol dimethyl hydantoin; CITMIT-DMDMH-EDTA, preservative combination where 100% constituted 0.0009% 
CITMIT, 0.22% DMDMH and 0.1% EDTA dissolved in TSB. 
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3 Assembly of an industrial isolate collection and evaluation of culture-
dependent techniques for the detection of Pseudomonas aeruginosa  
 
The comparative study of five selective agars described in this chapter was published within:  
Weiser, R., Donoghue, D., Weightman, A. and Mahenthiralingam, E. (2014). Evaluation of five 
selective media for the detection of Pseudomonas aeruginosa using a strain panel from clinical, 
environmental and industrial sources. Journal of Microbiological Methods 99:8-14. 
Author contributions: RW carried out the research, analysed the data and drafted the 
manuscript; RW, DD, AJW and EM contributed to the study design; RW, DD, AJW and EM 
contributed to the writing and revision of the manuscript. 
3.1 Introduction 
Microbial contamination of industrial products is of serious concern as it can lead to product 
spoilage, product recalls and poses a health risk to vulnerable consumers (Jimenez 2007).  Non-
sterile consumer products, such as cosmetics and household products, must be manufactured to 
ensure the microbial burden is below certain threshold levels and no harmful organisms are 
present (Perry 2001; Sutton and Jimenez 2012). P. aeruginosa is one of the most common 
bacterial species causing contamination of products and is considered an ‘objectionable 
organism’ as it is an opportunistic pathogen (Sutton and Jimenez 2012).  It is not the only 
microorganism capable of causing contamination, however, with variety of other Gram-negative 
bacteria, Gram-positive bacteria, yeasts and moulds being associated with product recall 
incidents (Jimenez 2007; Sutton and Jimenez 2012).  Despite this, few studies have catalogued 
the bacterial diversity associated with contamination in the home and personal care (HPC) 
industry. Much of our knowledge is currently derived from reports detailing contamination 
incidents, such as those generated by the European Commission Rapid Alert System for non-
food products posing a serious risk (RAPEX; available at:   
http://ec.europa.eu/consumers/archive/safety/rapex/) and the U.S Food and Drug 
Administration (FDA;  available at http://www.fda.gov/Safety/Recalls/EnforcementReports/ 
default.htm), or reviews of these publicly available data (Wong et al. 2000; Jimenez 2007; 
Lundov and Zachariae 2008; Sutton and Jimenez 2012). Industrial isolates have therefore 
largely been overlooked in research and no published industrial strain collections exist.  
Industrial manufacturers may have their own isolate and contaminated product archives, but 
these are not generally accessible by research institutions.   
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The correct identification of industrial contaminants is very important, particularly when a 
number of common contaminants, including P. aeruginosa, are opportunistic pathogens (Sutton 
and Jimenez 2012). The majority of routine diagnostic tests for P. aeruginosa, including those 
used by industry, are still reliant on culture-dependent methods (Orus and Leranoz 2005; 
Deschaght et al. 2011) which require growth of the target organism. Numerous selective agars 
are available for the detection of P. aeruginosa including those that contain inhibitory selective 
agents such as antibiotics and biocides (Lilly and Lowbury 1972), those that use positive 
selection (Szita et al. 1998) and those that use chromogenic selection methods (Laine et al. 
2009).  Cetrimide-containing media are commonly used both in clinical and industrial settings 
(FDA 1998) but can lack selectivity (Kodaka et al. 2003; Laine et al. 2009).  These media are 
often also designed to enhance pigment production (Brown and Lowbury 1965) as synthesis of 
pyocyanin can unequivocally identify P. aeruginosa (Reyes et al. 1981). Only 90-95% of isolates 
produce pyocyanin (Smirnov and Kiprianova 1990), however, which can confound 
identification.  Media containing acetamide as the positive selective agent have not been 
evaluated extensively as identification media, although have been reported to have good 
selectivity and may be useful for detecting low numbers of cells from ‘stressed’ environments 
(Szita et al. 1998; Szita et al. 2007).  In these media acetamide represents the sole carbon and 
nitrogen source, which few species other than P. aeruginosa can dissociate to release ammonia 
and acetic acid (Szita et al. 1998).  Auxotrophic P. aeruginosa isolates, such as those encountered 
in respiratory infections in cystic fibrosis patients (Thomas et al. 2000), have difficulty growing 
on minimal media meaning that further modification of the acetamide media may be necessary 
to improve sensitivity. Only one study has evaluated the recently developed chromID® P. 
aeruginosa (manufactured by bioMérieux, La Balme-les-Grottes, France) showing the 
chromogenic agar to have higher selectivity than Pseudomonas CN selective agar (Oxoid, 
Basingstoke, UK).  By virtue of an unambiguous colour change the medium has demonstrated 
potential for the simultaneous isolation and identification of P. aeruginosa (Laine et al. 2009), 
warranting further assessment.    
When attempting to isolate P. aeruginosa from a diverse sample, rather than diagnostic 
identification afforded by growth on selective media, enrichment is a strategy to consider.  
Enrichment media provide conditions favourable for the growth of a particular organism and 
ideally discourage the growth of others (Madigan et al. 2010). These media have proven useful 
in detecting low numbers of bacterial cells (Jasson et al. 2009) and can aid the recovery of sub-
lethally injured cells (Nexmann Jacobsen 1999; Wu 2008), a particular concern for cosmetic 
microbiologists (Orus and Leranoz 2005). Whilst the incorporation of inhibitory selective 
agents can prevent the growth of undesirable organisms, it can also compromise the recovery of 
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injured cells (Nexmann Jacobsen 1999). To circumvent this, an enrichment broth with low 
inhibitory selective pressure can be used to promote recovery, followed by a selective detection 
step to isolate the target organism (Jasson et al. 2009).  Enrichment media which have been 
used for the isolation of P. aeruginosa include acetamide broth, asparagine broth and malachite 
green broth (Geuenich and Muller 1982).  Acetamide broths containing varying concentrations 
of acetamide (from 2 to 20 g/L) and different overall formulations have been explored to enrich 
and isolate P. aeruginosa from clinical samples (Smith and Dayton 1972; Kelly et al. 1983), 
sewage water (Geuenich and Muller 1982), soil and vegetable samples (Green et al. 1974) and 
water and milk samples (Szita et al. 1998; Szita et al. 2007).  These studies have found that 
acetamide media facilitate the detection of low numbers of P. aeruginosa cells, although may 
allow the growth of other species with can deaminate acetamide (Oberhofer and Rowen 1974).  
Potentially, modification of the acetamide concentration and the overall composition of the 
media could optimise selectivity without inhibiting the growth of P. aeruginosa strains.  
3.1.1 Aims 
The aims of this chapter were as follows: 
1) To assemble a collection of industrial isolates (P. aeruginosa and non-P. aeruginosa) 
originating from contaminated HPC products and identify these to the species level. 
 
2) To perform a comparison of five selective agars for the detection of P. aeruginosa and 
determine their specificity and sensitivity, using a systematically assembled strain panel 
of P. aeruginosa and non-P. aeruginosa strains from diverse sources.  
 
3) To investigate the potential of acetamide media (Z-media) as enrichment media for P. 
aeruginosa, using growth dynamics of P. aeruginosa and non-P. aeruginosa strains to 
assess selectivity. 
 
Hypothesis 1: All five selective agars in the comparative study will perform equally well in 
terms of specificity and sensitivity. 
Hypothesis 2: Acetamide media can act as enrichment media for P. aeruginosa, permitting the 
growth of P. aeruginosa strains and inhibiting the growth of non-P. aeruginosa strains. 
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3.2 Results  
 
3.2.1 Assembly of an HPC-industrial isolate collection  
 
3.2.1.1 Sourcing of industrial isolates for the collection 
 
The collection was initially established during a 4 week placement at URDPS (April/May 2012); 
further isolates were added throughout the PhD.  Industrial isolates were drawn from both 
freezer stocks of isolates from previous contamination incidents and also isolated from 
products held in the product contamination library at URDPS.  Both P. aeruginosa and non-P. 
aeruginosa isolates from a variety of different home and personal care product (HPC) types 
were included, in addition to reference strains used in industrial testing. Further isolates and 
product samples were sent from URDPS to Cardiff after the placement had finished.  Overall 105 
industrial isolates were obtained from URDPS freezer stocks and 24 different product samples 
(Table 2.3 and Table 2.4).  There was a bias towards P. aeruginosa isolates (n=75) as this species 
was the primary focus of the PhD. As much information as possible was noted about each 
isolate, including product source and date and location of isolation. 
3.2.1.2 Identification of industrial isolates to the species level  
Although preliminary identification of many of the industrial isolates had been performed at 
URDPS, these were verified either by the application of a species-specific PCR or sequencing and 
analysis of marker genes (Section 2.7). The isolates, their species identities and isolation 
sources are shown in Table 2.3. 
3.2.2 Comparison of five selective agars for the detection of P. aeruginosa 
To further investigate culture-dependent detection methods for P. aeruginosa, a comparative 
study of five selective agars was performed.  Unlike previous studies, which in general have 
considered four or fewer selective agars with similar selection strategies (Kodaka et al. 2003), 
five selective media were evaluated in parallel and including those using inhibitory selection 
(PCN and PIA), positive selection (Z-agar, mZ-agar) and chromogenic detection (ChromID). The 
mZ-agar (acetamide agar) differed from the original Z-agar (Szita et al. 1998) by the addition of 
sufficient nutrient supplementation to facilitate growth of auxotrophic P. aeruginosa isolates 
that are commonly encountered in CF (Thomas et al. 2000). The efficacy of these isolation agars 
across strains, commonly mistaken species and accounting for strain source was considered. 
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3.2.2.1 Selection of a strain panel  
Rather than measuring the performance of these agars as part of prospective surveillance for P. 
aeruginosa in environmental or clinical samples, a bacterial test panel was systematically 
assembled to include genetically distinct P. aeruginosa strains validated by molecular 
identification and strains from commonly mistaken non-P. aeruginosa species (Spilker et al. 
2004) and Gram-negative pathogens encountered in CF patients (Hauser et al. 2011). This was 
the first media comparison study to include strains originating from clinical, environmental and 
industrial sources. The strain panel comprised 58 P. aeruginosa and 90 non-P. aeruginosa 
strains Table 2.5. 
3.2.2.2 Sensitivity of the five media 
PCN, PIA and mZ-agar demonstrated 100% sensitivity as all 58 P. aeruginosa strains grew on 
these agars after 24 hours incubation at 37°C (Table 3.1).  The sensitivity of the chromogenic 
agar did not reach this level due to the variable colours produced by certain P. aeruginosa 
strains (Figure 3.1). Overall, 47 out of 58 strains of P. aeruginosa strains were correctly 
identified after 24 hours (81% sensitivity), with 5 strains not displaying adequate growth and 6 
giving the wrong colour (yellow, orange, light brown, green and black), which may have 
reflected a deficiency in β-alanyl aminopeptidase activity. After 72 hours the sensitivity of 
chromID Pa increased to 95%. Growth on the Z-agars was much weaker than on the other agars 
(Figure 3.2) and 1 auxotrophic P. aeruginosa strain LESB58 (Winstanley et al. 2009) did not 
grow at all on the unmodified Z-agar.   The modified Z-agar had nutrient supplementation 
sufficient for the cultivation of the LESB58 strain although growth was still very weak.  There 
did not appear to be any major differences in growth characteristics between clinical, 
environmental and industrial strains apart from after 72 hours incubation on chromID Pa, the 3 
strains which gave negative results were all from industrial sources. The P. aeruginosa panel 
was also screened for growth on PCN, PIA and chromID Pa at 42°C. Whilst there were no 
changes in the sensitivity of PCN or PIA at this increased temperature, slight improvements in 
strain colouration on chromID Pa were observed which led to an increased number of strains 
recorded as positive: after 24 and 72 hours the sensitivity of chromID Pa was 81% and 95%, 
respectively.  
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Table 3.1 Growth of Pseudomonas aeruginosa strains on selective media at 37°C 
 
Species Source 
No 
Strains 
No strains exhibiting growth  
PCNa PIAb chromID Pac Z-agar mZ-agard 
24 
hours 
72 
hours 
24 
hours 
72 
hours 
24 
hours 
72 
hours 
24 
hours 
72 
hours 
24 
hours 
72 
hours 
P. aeruginosa 
CLIN 22 22 22 22 22 18 22 21 21 22 22 
ENV 6 6 6 6 6 5 6 6 6 6 6 
IND 30 30 30 30 30 24 27 30 30 30 30 
Total  58 58 58 58 58 47 55 
57 
(3+/-)e 
57 
(1+/-) 
58 
(2+/-) 
58 
(1+/-) 
Sensitivity (%) 100 100 100 100 81 95 98 98 100 100 
a PCN, Pseudomonas CN selective agar; b PIA, Pseudomonas isolation agar; c chromID Pa, chromID® P. aeruginosa; a 
positive result on chromID Pa was taken as growth accompanied by a red/pink/pink-brown/purple colouration; d 
mZ-agar, modified Z-agar; eWeakly growing strains (+/-) were recorded as an overall positive but are highlighted in 
the tables; CLIN, clinical; ENV, environmental; IND, industrial 
 
 
 
Figure 3.1 Variable colony morphology of Pseudomonas aeruginosa strains on chromID® P. 
aeruginosa. Results for 27 P. aeruginosa strains are shown after 24 hours (1a, 1b and 1c) and 72 hours 
(2a, 2b and 2c) incubation at 37°C.  Growth accompanied by a red, pink, pink-brown or purple colour was 
recorded as a positive result for P. aeruginosa.  Strains grew to produce a range of other colours including 
yellow (1a top row right), orange (1a top row middle), brown (not shown in photos), green (1c top row 
middle) and black (1c middle row middle).  The sensitivity of chromID® P. aeruginosa increased after 72 
hours incubation. 
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3.2.2.3 Pigment production 
Pigment production on TSA, PCN and PIA was variable (Table 3.2).  On TSA pyocyanin 
production was easily identified but as it was often difficult to distinguish between pyocyanin 
and pyoverdin on PCN and PIA, strains were scored as positive or negative for production of 
either/both pigments (Figure 3.2).  Over 90% of strains produced pigment on all three agars 
after 24 hours incubation.  PIA was the most successful at enhancing pigment production; 100% 
of strains were observed to produce pigment after 72 hours incubation. The majority of strains 
produced a light green/yellow pigment on PIA indicative of pyoverdin rather than pyocyanin 
production.  
 
Table 3.2 Pigment production by Pseudomonas aeruginosa strains at 37°C 
Selective agar 
No strains producing pigmenta (%) 
24 hours 72 hours 
Tryptone Soya Agar 53/58 (91) 56/58 (97) 
Pseudomonas CN selective agar 41/58 (71) 57/58 (98) 
Pseudomonas isolation agar 47/58 (81) 58/58 (100) 
aStrains producing pyocyanin, pyoverdin or both pigments 
 
 
 
 
Figure 3.2 Pigment production by Pseudomonas aeruginosa strains.Panels show growth of 
8 P. aeruginosa strains after 24 hours incubation at 37°C on (1) Tryptone soya agar (TSA), (2) 
Pseudomonas CN selective agar (PCN) and, (3) Pseudomonas isolation agar (PIA). Black arrows 
indicate a strain negative for pigment production on PCN and PIA.  
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3.2.2.4 Selectivity of the five media 
 The most selective of the 5 media was chromID Pa (Table 3.3), which after 72 hours incubation 
at 37°C had a specificity of 70%. Strains of Burkholderia (n=15), other Pseudomonas (n=12) and 
Ochrobactrum (n=1) species exhibited growth on chromID Pa that had a similar colouration to 
strains of P. aeruginosa. Although at 24 hours Z-agar had the second highest specificity of 42%, 
this dropped to 26% after 72 hours.  It was also very difficult to determine if true growth had 
occurred on both of the Z-agars (Figure 3.3) which resulted in a high proportion of positive 
results being recorded as weak (+/-) rather than true positive.  The additional nutrient 
supplementation in the modified Z-agar led to an increase in non-P. aeruginosa strains that 
could grow, and overall this agar was the least selective of the 5, having a specificity of 6% after 
72 hours incubation.  The two agars containing inhibitory selective agents, PCN and PIA, 
performed very similarly having specificities of 30% and 23%, respectively, after 72 hours 
incubation.  In general, strains of Achromobacter (n=2), Burkholderia (n=28) and Pseudomonas 
(PIA n=23; PCN n=22) species were most likely to give false positives on PCN and PIA. 
Incubation at 42°C for 72 hours increased the specificities of PCN and PIA to 61% and 47%, 
respectively.  These incubation conditions, however, also elevated the number of false positives 
recorded for chromID Pa, which decreased its specificity from 80% to 69% at 24 hours and 70% 
to 68% at 72 hours. Of the 28 strains positive for growth at 37°C on chromID after 24 hours 
incubation, 9 of these could not grow at 42°C, but 19 ‘new’ false positives were observed.  The 
effect of increased temperature on the selectivity of Z-agar and modified Z-agar was not 
investigated due to the weak growth already seen at 37°C.  Finally, it was observed that strains 
from different sources grew equally well on the 5 media tested in this study. 
 
 
 
 
 
 
 
CHAPTER 3 – ASSEMBLY OF AN INDUSTRIAL ISOLATE COLLECTION AND EVALUATION OF CULTURE-DEPENDENT TECHNIQUES FOR THE DETECTION OF 
PSEUDOMONAS AERUGINOSA 
 
87 
 
Table 3.3 Growth of non-Pseudomonas aeruginosa strains on selective media at 37°C 
Species   Source 
No 
Strains 
No strains exhibiting growth 
PCNa PIAb ChromID Pac Z-agar mZ-agard 
24 hours 72 hours 24 hours 72 hours 24 hours 72 hours 24 hours 72 hours 24 hours 72 hours 
Achromobacter xylosoxidans CLIN 2 2 2 2 2 0 0 1 (1 +/-) 2 2 (1 +/-) 2 
Acinetobacter species IND 1 0 0 0 0 0 0 1 (1 +/-) 1 1 (1 +/-) 1 
Bacillus species IND 1 0 0 0 0 0 0 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
Burkholderia ambifaria CLIN 1 1 1 1 1 0 0 0 0 0 1 (1 +/-) 
ENV 2 2 (1 +/-) 2 2 2 1 1 0 1 (1 +/-) 1 (1 +/-) 2 (1 +/-) 
Burkholderia cenocepacia CLIN 7 6 6 7 7 2 6 5 (5 +/-) 6 (6 +/-) 3 (3 +/-) 7 (6 +/-) 
ENV 2 2 2 2 2 0 1 0 2 0 2 (2 +/-) 
IND 1 0 1 1 1 1 1 1 1 1 1 
Burkholderia cepacia CLIN 1 1 1 1 1 0 0 1 1 1 1 
Burkholderia cepacia complex IND 2 1 2 (1+/-) 1 1 1 1 2 (1 +/-) 2 2 2 
Burkholderia contaminans CLIN 1 1 (1 +/-) 1 1 1 0 0 0 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
Burkholderia dolosa CLIN 1 1 1 1 1 0 0 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
Burkholderia gladioli CLIN 1 0 0 0 0 0 0 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
Burkholderia lata ENV 1 1 1 1 1 1 1 1 1 1 1 
Burkholderia multivorans CLIN 4 4 4 4 4 2 2 3 (3 +/-) 3 (3 +/-) 3 (3 +/-) 4 (4 +/-) 
ENV 1 1 1 1 1 1 1 0 0 1 (1 +/-) 1 (1 +/-) 
Burkholderia phymatum ENV 1 0 0 0 0 0 0 0 0 0 1 (1 +/-) 
Burkholderia phytofirmans ENV 1 0 0 0 0 0 0 0 0 0 1 (1 +/-) 
Burkholderia pyrrocinia CLIN 1 1 1 1 1 0 0 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
Burkholderia stabilis CLIN 1 1 (1 +/-) 1 1 1 1 1 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
Burkholderia vietnamiensis CLIN 1 1 1 1 1 0 0 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
ENV 1 1 (1 +/-) 1 1 1 0 0 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
IND 1 1 (1 +/-) 1 1 1 0 0 1 (1 +/-) 1 1 (1 +/-) 1 
Escherichia coli CLIN 1 0 0 0 0 0 0 0 0 1 (1 +/-) 1 (1 +/-) 
Halomonas species IND 1 0 0 0 1 0 0 0 1 (1 +/-) 1 (1 +/-) 1 
Ochrobactrum anthropi IND 1 0 0 0 0 1 1 1 (1 +/-) 1 1 (1 +/-) 1 
Pandoraea apsita CLIN 2 2 2 2 2 0 0 2 (2 +/-) 2 (1 +/-) 2 (2 +/-) 2 (1 +/-) 
Pandoraea pnomenusa CLIN 3 3 (3 +/-) 3 (3 +/-) 3 3 0 0 3 (3 +/-) 3 3 (2 +/-) 3 
Pandoraea pulmonicola CLIN 2 2 2 2 2 0 0 2 (2 +/-) 2 ( 1 +/-) 2 (2 +/-) 2 (1 +/-) 
Pandoraea sputorum CLIN 4 3 3 4 4 0 0 4 (4 +/-) 4 (1 +/-) 4 (4 +/-) 4 (1 +/-) 
Pantoea agglomerans IND 1 0 0 0 0 0 0 0 0 1 (1 +/-) 1 (1 +/-) 
Pseudomonas alcaligenes ENV 1 1 1 0 1 0 0 0 0 1 (1 +/-) 1 (1 +/-) 
Pseudomonas aureofaciens ENV 1 1 1 1 1 1 1 0 0 1 (1 +/-) 1 (1 +/-) 
Pseudomonas fluorescens ENV 1 0 0 1 (1 +/-) 1  (1+/-) 0 0 0 0 0 0 
IND 2 2 2 2 2 0 2 0 0 0 0 
Pseudomonas mendocina ENV 1 1 1 1 (1 +/-) 1 1 1 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
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Pseudomonas oleovorans IND 1 1 (1 +/-) 1 0 0 0 0 1 (1 +/-) 1 1 (1 +/-) 1 
Pseudomonas pseudoalcaligenes IND 1 1 (1 +/-) 1 0 1 0 0 0 1 (1 +/-) 1 (1 +/-) 1 
Pseudomonas putida ENV 1 1 (1 +/-) 1 1 1 0 0 0 0 0 0 
IND 7 6 (1 +/-) 7 (1 +/-) 7 7 3 4 6 (6 +/-) 6 (3 +/-) 7 (7 +/-) 7 (4 +/-) 
Pseudomonas species IND 8 7 (1 +/-) 8 (2 +/-) 6 7 2 3 1 (1 +/-) 5 (5 +/-) 6 (6 +/-) 7 (6 +/-) 
Ralstonia insidiosa CLIN 1 0 0 0 0 0 0 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
Ralstonia mannitolytica CLIN 2 0 0 0 0 0 0 2 (2 +/-) 2 (2 +/-) 2 (2 +/-) 2 (2 +/-) 
Ralstonia pickettii CLIN 3 0 0 0 0 0 0 3 (3 +/-) 3 (3 +/-) 3 (3 +/-) 3 (1 +/-) 
Serraria marcescens ENV 2 0 0 2 2 0 0 - - - - 
IND 1 0 0 1 1 0 0 - - - - 
NA 1 0 0 1 1 0 0 - - - - 
Staphylococcus aureus CLIN 2 0 0 0 0 0 0 0 0 1 (1 +/-) 2 (2 +/-) 
Staphylococcus epidermidis CLIN 1 0 0 0 0 0 0 0 0 1 (1 +/-) 1 (1 +/-) 
Stenotrophomonas maltophila CLIN 1 0 0 0 1 0 0 0 1 (1 +/-) 1 (1 +/-) 1 (1 +/-) 
Stenotrophomonas species IND 1 0 0 1 1 0 0 0 1 (1 +/-) 1 (1 +/-) 1 
Total 
 
59/90 
(13 +/-)e 
63/90 
(7 +/-) 
65/90 
(2 +/-) 
69/90 
(1 +/-) 
18/90 27/90 50/86 
(46 +/-) 
64/86 
(39 +/-) 
68/86 
(61 +/-) 
81/86 
(51 +/-) 
Specificity (%) 34 30 28 23 80 70 42 28 26 6 
 
a PCN, Pseudomonas CN selective agar 
b PIA, Pseudomonas isolation agar 
c chromID Pa, chromID® P. aeruginosa; a positive result on chromID Pa was taken as growth accompanied by a red/pink/pink-brown/purple colouration 
d mZ-agar, modified Z-agar 
eWeakly growing strains (+/-) were recorded as an overall positive but are highlighted in the tables 
CLIN, clinical; ENV, environmental; IND, industrial; NA, source unknown 
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Figure 3.3 Growth of Pseudomonas aeruginosa and non-P. aeruginosa strains on Z-agar 
and modified Z-agar. Results are shown for 9 P. aeruginosa strains (1a and 1b) and 21 non-P. 
aeruginosa strains (2a and 2b) after 72 hours incubation at 37°C. Z-agar plates are marked with 
red and are shown in panels 1a and 2a.  Modified Z-agar plates are marked with blue and shown 
in panels 1b and 2b. Growth was weak for both P. aeruginosa and non-P. aeruginosa strains on 
the Z-agars and it was difficult to determine whether true growth had occurred in many cases 
(for example 1a middle row middle). The addition of extra nutrient supplementation in the 
modified Z-agar encouraged the growth of P. aeruginosa strains (compare 1a to 1b) but also led 
to an increase in the number of non-P. aeruginosa strains that could grow on the agar (compare 
2a to 2b).  
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3.2.2.5 Presumptive identification of P. aeruginosa 
The PPV and NPV values for the agars at 37°C and 42°C are given in Table 3.4.  For this strain 
panel chromID Pa had the highest PPV at 37°C (72% and 67% at 24 and 72 hours, respectively) 
and at 42°C after incubation for 72 hours (62%).  Due to the increased numbers of chromID Pa 
false positives at 42°C, PCN was the agar with the highest PPV at this increased temperature 
after 24 hours incubation (68%). ChromID Pa and Z-agar were the only agars with a NPV less 
than 100% as not all P. aeruginosa strains were correctly identified on these media.  The lowest 
NPV was for chromID after 24 hours incubation at 37°C (87%), although this increased to 95% 
after 72 hours incubation and 98% at 42°C regardless of incubation duration. 
 
Table 3.4 Positive and negative predictive values for the selective agars  
Agar 
PPV (%) NPV (%) 
37°C 42°C 37°C 42°C 
24 hrs 72 hrs 24 hrs 72 hrs 24 hrs 72 hrs 24 hrs 72 hrs 
PCN 50 48 68 62 100 100 100 100 
PIA 47 46 62 55 100 100 100 100 
chromID 
Pa 
72 67 67 67 87 95 98 98 
Zagar 53 47     97 96     
mZagar 46 42     100 100     
 
PPV, Positive predictive value; NPV, negative predictive value 
PCN, Pseudomonas CN selective agar; PIA, Pseudomonas isolation agar; chromID Pa, chromID™ 
P. aeruginosa; mZ-agar, modified Z-agar 
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3.2.3 Acetamide media as enrichment media for P. aeruginosa 
 
To investigate the suitability of acetamide media as enrichment media for P. aeruginosa, the 
growth dynamics of P. aeruginosa and non-P. aeruginosa strains in Z-broth (Szita et al. 1998) 
containing different concentrations of acetamide were examined.  Data detailing 72 hours 
growth in acetamide broths was generated using the Bioscreen C instrument and analysed using 
a combination of Microsoft Excel, the groFit package for R and Boxplot R.   Of particular interest 
was whether increasing the concentration of acetamide would inhibit the growth of non-P. 
aeruginosa strains, whilst permitting, or even encouraging, the growth of P. aeruginosa strains. 
3.2.3.1 Effect of increasing the acetamide concentration: growth in Z-broth containing up to 
20 g/L acetamide 
The growth curves of the P. aeruginosa strains PAO1, RW109, RW110, LESB58 and RW113 and 
the non-P. aeruginosa strains P. putida RW112, B. lata 383 and B. dolosa LMG 18943 in the 
presence of 1, 4, 10 and 20 g/L acetamide are shown in Figure 3.4. The strains split into three 
broad groups: 1) those demonstrating ‘typical’ growth curves, exiting exponential phase at 
approximately 20-24 hours (P. aeruginosa PAO1, RW109 and RW110), 2) those with ‘atypical’ 
growth curves lacking a well-defined exponential phase and whose OD increased gradually, 
reaching their maximum after 40 hours (P. aeruginosa RW113 and B. lata 383), and 3) those 
whose OD never reached above 0.03 (P. aeruginosa LESB58, P. putida RW112 and B. dolosa LMG 
18943) (Figure 3.4).   
To more comprehensively model the growth curve parameters (length of lag phase, maximum 
growth rate and maximum culture density reached) the groFit package for R statistical software 
was used. The P. aeruginosa strains LESB58 and RW113 and the non-P. aeruginosa strains P. 
putida RW112, B. lata 383 and B. dolosa LMG 18943 were excluded from the complete analysis 
as they produced ‘atypical’ growth curves that could not be modelled accurately by groFit, 
possibly because of their long lag phase and/or poorly defined exponential phase.  The growth 
parameters lag, phase, growth rate and maximum culture density reached are illustrated for the 
three prototrophic P. aeruginosa strains in Figure 3.5.  Only the maximum OD reached (spline fit 
data), taken directly from the OD measurements, were analysed for the other P. aeruginosa and 
non-P. aeruginosa strains.  These data are shown alongside the maximum OD data for the 
prototrophic P. aeruginosa strains in Figure 3.6.  Although responses were strain specific, in 
general, increasing the acetamide concentration to 20 g/L did not inhibit the growth of 
prototrophic strains to below the levels seen at 1 g/L acetamide, with the exception of 
increasing the length of the lag phase for PAO1 and RW109. In addition the maximum ODs 
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reached for PAO1, RW109 and RW110 were determined to be significantly increased at 20 g/L 
compared to 1 g/L acetamide (p<0.05; Welch 2-sample t-test performed in R statistical 
software). There was very little change in the maximum OD reached for P. aeruginosa LESB58, P. 
putida RW112 or B. dolosa LMG 18943.  There was, however, a slight increase in the maximum 
OD obtained for the weakly growing P. aeruginosa strain RW113, suggesting that elevated 
concentration of acetamide actually encouraged the growth of this strain.  The largest effect was 
observed for B. lata 383, whose maximum OD dropped from 0.38 at 4 g/L to 0.07 at 20 g/L 
acetamide. 
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Figure 3.4 Effect of acetamide concentrations on bacterial growth. Growth curves of P. aeruginosa and non-P. aeruginosa strains in Z-broth 
containing 1, 4, 10 and 20 g/L acetamide over 35 hours are shown.  
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Figure 3.5 Effect of acetamide concentration on length of lag phase, growth rate and 
maximum culture density reached for P. aeruginosa strains. The growth parameters of the 
P. aeruginosa strains PAO1, RW109 and RW110 for growth in Z-broth containing 1, 4, 10 or 20 
g/L acetamide over 72 hours are shown. Data points are displayed as open circles and the 
corresponding concentrations (g/L) of acetamide in the Z-broth are indicated directly to the 
right of each boxplot.  
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Figure 3.6 Effect of acetamide concentration on maximum culture density. The maximum 
culture densities reached at different acetamide concentrations for P. aeruginosa (PAO1, 
RW109, RW110, LESB58 and RW113) and non-P. aeruginosa strains in Z-broth over 72 hours 
are shown.  Data points are displayed as open ovals and the corresponding concentrations (g/L) 
of acetamide in the Z-broth are indicated directly to the right of each boxplot.  
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3.2.3.2 Effect of elevated acetamide concentration: growth in Z-broth containing up to 50 g/L 
acetamide 
As increasing acetamide concentrations up to 20 g/L did not have an inhibitory effect on 
prototrophic, auxotrophic or weakly growing P. aeruginosa strains, did not enhance the growth 
of P. putida RW112 or B. dolosa LMG 18943, and considerably reduced the maximum OD of B. 
lata 383, the consequences of increasing the acetamide concentration further were investigated.  
One prototrophic P. aeruginosa strain (PAO1), the weakly growing P. aeruginosa strain (RW113) 
and B. lata 383 were grown in Z-broth containing 4, 20, 30, 40 and 50 g/L acetamide (Figure 
3.7) and growth dynamics monitored over 72 hours.  Using groFit for R statistical software, 
growth curve parameters could only be estimated for P. aeruginosa PAO1 at 20, 30 and 40 g/L 
acetamide, and for P. aeruginosa RW113 at 4 g/L acetamide.  The maximum OD (spline fit) data, 
however, were used in analysis to investigate culture density reached over 72 hours for all three 
strains (Figure 3.8).   
Increasing the acetamide concentration from 20 g/L to 30 g/L inhibited the growth of P. 
aeruginosa PAO1 strain, increasing the lag phase from 7.7 to 17.8 hours, decreasing the growth 
rate from 0.04 to 0.02 h-1 and decreasing the maximum culture density from 0.52 to 0.33.  The 
maximum OD continued to decrease when the acetamide concentration increased, with a value 
of less than at 0.02 50 g/L.  Increasing the concentration above 30 g/L decreased the maximum 
OD for all three strains (figure 3.8), and overall 20 and 30 g/L acetamide achieved the highest 
OD values for P. aeruginosa PAO1 and RW113 respectively.  The greatest inhibitory effect on B. 
lata 383 was exerted between 4 and 20 g/L acetamide, demonstrated by a decrease in 
maximum OD from 0.26 to 0.013. Above 20 g/L there was a much smaller decrease in the 
maximum OD of B. lata 383, to 0.05 at 50 g/L. 
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Figure 3.7 Effect of elevated acetamide concentrations on selected strains. The growth 
curves of P. aeruginosa PAO1 and RW113 and B. lata 383 Z-broth containing 4, 20, 30, 40 and 50 
g/L acetamide over 72 hours are shown.  
 
CHAPTER 3 – ASSEMBLY OF AN INDUSTRIAL ISOLATE COLLECTION AND EVALUATION OF CULTURE-
DEPENDENT TECHNIQUES FOR THE DETECTION OF PSEUDOMONAS AERUGINOSA 
 
98 
 
 
 
Figure 3.8 Effect of elevated acetamide concentrations on maximum culture density. The 
maximum culture densities at different acetamide concentrations for P. aeruginosa PAO1 and 
Pa113 and B. lata 383 in Z-broth over 72 hours.  Data points are displayed as open circles and 
the corresponding concentrations (g/L) of acetamide in the Z-broth are indicated directly to the 
right of each boxplot.  
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3.3  Discussion 
A large collection of isolates contaminating HPC products was assembled and identified to the 
species level using a combination of species-specific PCRs and the sequencing and analysis of 
marker genes. Marker genes other than the 16S rRNA gene were chosen to identify certain 
isolates  within the collection as the 16S rRNA gene lacks resolution for some species (Janda and 
Abbott 2007).  In the case of suspected Pseudomonas and Burkholderia species a combination of 
16S rRNA gene and rpoD (Mulet et al. 2010) or recA/gyrB (Spilker et al. 2009) gene sequencing 
and analysis was used, as these genes have been found to be more discriminatory. In many 
cases it was not possible to obtain a species ID for isolates of the genus Pseudomonas, even with 
the use of the rpoD gene sequence; these isolates were deposited in the collection as 
Pseudomonas spp. Although the collection was biased towards P. aeruginosa isolates as the 
study focus organism, other contaminating species were sampled to populate the collection for 
culture-dependent and –independent studies. These were chosen to include species that are 
commonly misidentified as P. aeruginosa by culture-dependent methods, such as other 
Pseudomonas species.  Whilst the majority of the non-P. aeruginosa isolates in the collection 
were also considered common contaminants of HPC products, Pseudomonas and Burkholderia 
species in particular, (Sutton and Jimenez 2012), they did not represent the entire range of 
different species encountered in industry.  Using this collection, a comparative study of five 
selective agars for the detection of P. aeruginosa was performed and additional investigations 
into acetamide media as enrichment broths for P. aeruginosa were carried out. 
3.3.1 Comparison of five selective agars for the detection of P. aeruginosa 
There have been many selective media developed for the isolation of P. aeruginosa from clinical 
and environmental samples. The majority of media currently available for the isolation of P. 
aeruginosa were developed some decades ago and routinely used media, such as those 
containing cetrimide, lack selectivity (Kodaka et al. 2003). In addition, even though the majority 
of diagnostics are still based on culture-dependent methods, few novel media have been 
recently developed and few studies have systematically evaluated the performance of available 
media.    
The strain collection used in this comparative study was drawn from clinical and environmental 
sources, in addition to including strains from industrial contamination incidents.  It was the first 
study to include industrial strains, which represented just under half of the P. aeruginosa and 
approximately a third of the non-P. aeruginosa sub-panels.  No major differences were observed, 
however, in the growth characteristics of the industrial strains compared to the rest of the 
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panel.  The choice of panel strains perhaps reflected the low levels of specificity and PPV values 
observed with the PCN and PIA agars as strains of Achromobacter, Burkholderia and 
Pseudomonas species are known to have broad antimicrobial resistance (Hogardt et al. 2009; Li 
and Nikaido 2009; Rose et al. 2009; Bador et al. 2011), and have previously been shown to grow 
on PCN (Kodaka et al. 2003), although no studies have evaluated PIA.  PCN and PIA are currently 
widely available commercially and performed very similarly both in terms of sensitivity and 
specificity.  Both are also formulated to encourage pigment production, being based on King’s A 
medium (King et al. 1954).  
Although on TSA the primary pigment being produced appeared to be pyocyanin, with 97% of 
strains being pigmented, growth on PCN and PIA was largely accompanied by the production of 
a light green/yellow pigment more indicative of pyoverdin.  This pigment alone cannot 
positively identify P. aeruginosa as all other fluorescent pseudomonads are capable of pyoverdin 
production (Leisinger and Margraff 1979). In addition, non-pigmented strains of P. aeruginosa 
may resemble other species that can grow on PCN and PIA.  This highlights that although 
pigment production can guide identification, subsequent diagnostic tests are required to obtain 
conclusive results. In clinical and industrial settings, growth at 42°C is often used to 
differentiate P. aeruginosa from other bacterial species, although this growth characteristic is 
not exclusive to P. aeruginosa. Incubation at 42°C was considered in the current study and was 
found to increase the specificity and PPV of PCN and PIA. A variety of chromogenic media have 
been designed for the detection of pathogens including P. aeruginosa. Through inclusion of 
chromogenic substrates for  an enzyme produced by the target species, chromogenic media aim 
to simplify the isolation and identification process by linking an unambiguous colour change 
with growth of a target organism (Perry and Freydière 2007).  chromID® P. aeruginosa was 
developed by bioMérieux for the detection of P. aeruginosa and has been evaluated by one study 
(Laine et al. 2009) which found the medium to have higher selectivity than PCN.  The present 
study also determined chromID Pa to have superior selectivity but the lowest overall sensitivity.  
If results for chromID Pa were read after 24 hours incubation at 37°C, as suggested by the 
manufacturer, there was a considerable risk of false negatives, although after 72 hours 
incubation the sensitivity was greatly improved.   This corroborates what was found by (Laine 
et al. 2009) who observed the sensitivity to be only 58% after 24 hours, increasing to 95% after 
72 hours.   
One of the main issues with chromID Pa was the interpretation of the colony colourings, which 
were very variable.  The spectrum of colours considered a positive result was expanded in this 
study to include pink-brown as at 37°C this increased the sensitivity (11% increase at 24 hours 
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incubation) without greatly compromising specificity (3% decrease at 24 hours incubation).  
Interpretation of colony colouration needs to be re-considered in future studies to ensure that 
maximum sensitivity is achieved.  At the higher incubation temperature of 42°C more P. 
aeruginosa strains grew producing a colour considered positive.  Although the change was only 
slight in most cases, from a brown to a pink-brown colour, this led to an increase in the 
sensitivity of the medium (81% and 95% after 24 and 72 hours, respectively).  A decrease in the 
specificity and PPV of the medium was also observed, however, as more non-P. aeruginosa 
strains recorded as false positives. Overall, the results for this medium were more reliable when 
an incubation temperature of 37°C was applied. 
Media containing acetamide as the positive selective agent (Z-agar/Z-broth) have been reported 
to have specificity comparable to that of nitrofurantoin broth  (Szita et al. 1998), although their 
sensitivity has not been evaluated.   The modification of Z-agar to include additional nutrient 
supplementation permitted the growth of all of the P. aeruginosa strains, including one 
auxotrophic CF strain.  This modification, however, also decreased the selectivity of the agar 
resulting in mZ-agar having the lowest specificity in the study.  After 72 hours the specificity of 
the unmodified Z-agar was also relatively low and growth of P. aeruginosa and non-P. 
aeruginosa strains was weak on both acetamide agars making interpretation of results very 
difficult. In addition, as the Z-agars have to be made up in-house they would perhaps not be a 
very attractive choice for use in clinical or industrial settings. 
In summary, chromID Pa outperformed the other agars in terms of specificity but incubation 
time, temperature and interpretation of colony colour needs to be further considered in order to 
increase sensitivity.  Chromogenic media are expensive, but if chromID Pa affords presumptive 
identification of P. aeruginosa, the costs of further biochemical tests may be off-set, as 
previously suggested (Laine et al. 2009). PCN and PIA are currently widely used general 
selective media and have high sensitivity, but may permit the growth of other species commonly 
encountered in CF and from industrial settings. Even though increasing the incubation 
temperature to 42°C may improve specificity and PPV values, further biochemical tests and/or 
genotypic methods are required for accurate species identification when using these media.  Z-
agar had lower specificity than previously reported (Szita et al. 1998; Szita et al. 2007) and is 
likely to be unsuitable for application in clinical or industrial environments without further 
modification. 
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3.3.2 Acetamide media as enrichment media for P. aeruginosa 
Enrichment media are valuable when trying to isolate an organism from a complex sample 
which may be present in low numbers, or sub-lethally injured.  The enrichment step aims to 
increase the number of cells of the target organism, whilst simultaneously discouraging the 
growth of undesirable species. Acetamide-based media have been used for the enrichment of P. 
aeruginosa but different studies report different formulations with individual formulations not 
being evaluated extensively.  In addition, growth in these studies was assessed only by looking 
at broth turbidity as an end result. To further investigate acetamide broths as enrichment 
media, growth dynamics were scrutinised over 72 hours. The effect of previously reported 
acetamide concentrations (2 to 20 g/L) were assessed, in addition to lower (1 g/L) and higher 
(up to 50 g/L) concentrations. Three groups of strains were investigated: 1) prototrophic P. 
aeruginosa strains (PAO1, RW109 and RW110), 2) auxotrophic strains (LESB58) and P. 
aeruginosa strains displaying weak growth on solid acetamide media (RW113), and 3) non-P. 
aeruginosa strains which grew weakly on solid acetamide media (P. putida RW112, B. lata 383 
and B. dolosa LMG 18943). The base formulation for the acetamide broth (Z-broth) was taken 
from (Szita et al. 1998) as the most recent publication investigating acetamide media, and its 
solid counterpart (Z-agar) was used in the comparative agar study. 
Overall increasing the acetamide concentration from 1 to 20 g/L did not inhibit the growth of P. 
aeruginosa strains and did not change the overall growth patterns of non-P. aeruginosa strains, 
with the exception of B. lata 383 whose maximum culture density reached dropped from 0.37 at 
1 g/L to 0.07 at 20 g/L acetamide.  This suggests that the response to increasing the acetamide 
concentration is species (and potentially even strain) specific, as B. dolosa LMG 18943 behaved 
very differently to B. lata 383.  Both of these species, in addition to P. putida RW112, grew 
weakly on acetamide agar and were positive for the ami operon PCR (methods section 2.9.1.2).  
It is not known, however, if the operon in these strains is capable of producing and transporting 
a fully functional amidase enzyme to metabolise acetamide. Increasing the acetamide 
concentration from 20 to 50 g/L did have an inhibitory effect on all three strains tested, 
decreasing the maximum OD reached to the lowest levels observed during the experiment. 
When looking at maximum OD reached by all strains over 72 hours, 20 g/L acetamide is the 
least inhibitory toward P. aeruginosa strains and yet had the biggest knock down effect on B. 
lata 383, the only non-P. aeruginosa strain which reached an OD similar to the prototrophic P. 
aeruginosa strains at 4 g/L acetamide. The results of this study indicate that acetamide 
selectivity for P. aeruginosa is improved at 20 g/L compared to the 4 g/L used by (Szita et al. 
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1998), although investigation into the growth dynamics of a larger strain panel is needed to 
confirm this.  
Auxotrophic P. aeruginosa strains have difficulty growing when acetamide is the sole carbon 
and nitrogen source, and previous studies have reported low numbers of P. aeruginosa strains 
unable to grow in acetamide-based enrichment media (Oberhofer and Rowen 1974).  P. 
aeruginosa strains growing weakly on acetamide media have also previously been identified 
and this trait attributed to the production of a defective amidase or problems with regulation of 
amidase production (Clarke and Tata 1973).  In the present study, very low levels of growth 
were observed for the known auxotroph P. aeruginosa LESB58 (Winstanley et al. 2009), and the 
weakly growing industrial strain P. aeruginosa RW113, in all acetamide concentrations.  
Increasing the concentration of acetamide from 4 to 20 g/L, however, marginally improved the 
growth of P. aeruginosa RW113, as measured by an increase in maximum OD from 0.12 to 0.14.  
This increase would probably not be sufficient to distinguish it from a non-P. aeruginosa, but 
increased cell numbers could improve the chance of detection if a further selection step is 
performed.   
One of the main problems encountered with the solid acetamide media was that it was difficult 
to distinguish between weakly growing P. aeruginosa strains and non-P. aeruginosa strains. It 
was thought that the growth dynamics in broth may set these groups apart. Growth in Z-broth 
containing 20 g/L acetamide revealed that whilst certain non-P. aeruginosa strains (P. putida 
RW112 and B. dolosa LMG 18943) exhibited similar growth patterns to the auxotrophic P. 
aeruginosa strain LESB58, others, such as B. lata 383, could be similar to weakly growing P. 
aeruginosa strains, such as P. aeruginosa RW113. It would therefore be difficult to use growth 
curves to differentiate between P. aeruginosa and non-P. aeruginosa strains,  and it is highly 
likely that auxotrophic P. aeruginosa strains would be missed altogether. Prototrophic P. 
aeruginosa strains could potentially be distinguished from non-P. aeruginosa strains by growth 
dynamics at 20 g/L acetamide but a larger strain panel would be needed to assess this 
comprehensively.  Whether in solid or broth form, acetamide-based media may not be suitable 
for straightforward identification, but the growth curve work has indicated that with 
modification they could still be of use for enrichment. 
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3.4 Conclusions 
 
The main conclusions from the work in this chapter were as follows: 
1) An industrial collection comprising 105 isolates was successfully assembled and isolates 
were identified to the species level where possible. This collection was invaluable as a 
well characterised resource for the PhD and industrial microbiology. 
 
2) The comparative agar study revealed that although chromID P. aeruginosa was the agar 
with the highest specificity, it lacked sensitivity.  Overall PCN was found to be the most 
robust selective agar, re-enforcing that the current industry practice of using a 
cetrimide-based medium was suitable for the identification of P. aeruginosa.  
 
3) Although acetamide-based media demonstrated low specificity in the comparative agar 
study, they showed promise as enrichment media. It is likely that auxotrophic P. 
aeruginosa strains will not be isolated with acetamide media but using a higher 
concentration of acetamide than (Szita et al. 1998) could enhance the growth of weakly 
growing P. aeruginosa strains and reduce the growth of non-P. aeruginosa strains.   
 
The hypotheses proposed at the beginning of the chapter were rejected (hypothesis 1) 
and accepted (hypothesis 2): 
 
Hypothesis 1: All five selective agars in the comparative study will perform equally well in 
terms of specificity and sensitivity. 
 
Hypothesis 2: Acetamide media will permit the growth of P. aeruginosa strains and inhibit the 
growth of non-P. aeruginosa strains. The findings are not as straightforward as this, 
however, with concentrations of acetamide above 20 g/L having an inhibitory effect on P. 
aeruginosa strains, and the growth of non-P. aeruginosa strains being inhibited to 
different extents. Further work with the acetamide media is required. 
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4 Culture-independent analysis of contaminated industrial products: 
detection of P. aeruginosa and bacterial diversity 
 
4.1 Introduction 
 
Traditionally, detection, identification and characterisation of bacteria have been via culture-
dependent methods which assess phenotype.  These methods can include the observation of 
cellular morphology, growth characteristics on selective and differential media, (Jimenez et al. 
1999b) antibiotic susceptibility and the subjection of the micro-organism to various 
biochemical assays (Johnsen et al. 1996). Often culture-based identification is time-consuming, 
labour intensive and expensive, requiring large volumes of media and reagents.  Despite this, 
and probably owing partially to their ease of use, culture-dependent methods are still routinely 
used in diagnostics in medical and industrial settings (Orus and Leranoz 2005; van Belkum et al. 
2013).  An increasing number of culture-independent detection methods are being developed 
and are starting to be implemented in industry, including ATP-bioluminescence, impedance, 
flow cytometry and PCR-based assays (Jimenez 2001b) although this has mainly been limited to 
food microbiology (Maukonen et al. 2003; Postollec et al. 2011; van Belkum et al. 2013).   
4.1.1 Culture-independent detection of P. aeruginosa 
As an opportunistic pathogen and ‘objectionable’ organism within industrial products, the 
detection of P. aeruginosa is very important. Numerous techniques have been published for the 
culture-independent detection of P. aeruginosa including end-point PCR and qPCR; both SYBR 
Green-based qPCR (Jaffe et al. 2001; Qin et al. 2003; Motoshima et al. 2007; Choi et al. 2013) and 
hydrolysis probe based qPCR (Anuj et al. 2009) formats have been evaluated. To date, ten 
different genes/regions including 16S rRNA, 16S-23S spacer region rRNA, oprL, fliC, ecfX, gyrB, 
toxA, algD and the O-antigen acetylase gene (Table 1.4) have been targeted.  The oprL gene 
encodes an outer membrane lipoprotein and primers designed for the amplification of this gene 
by (De Vos et al. 1997) have been the most widely evaluated; the oprL-PCR has been applied to a 
range of samples, including pure culture (De Vos et al. 1997; Anuj et al. 2009), clinical (De Vos et 
al. 1997; Pirnay et al. 2000; Xu et al. 2004; Deschaght et al. 2011), environmental (Schwartz et 
al. 2006; Lavenir et al. 2007), and industrial samples (Jimenez et al. 1999b; Jimenez et al. 2000b; 
Jimenez 2001c; Farajnia et al. 2009).  With the exception of the 16S-23S spacer region rRNA 
gene and the O-acetylase gene PCR (Choi et al. 2013) which have each only been evaluated by 
one study, none of the afore mentioned  P. aeruginosa-specific PCRs have both 100% sensitivity 
and specificity. The continued increase in the number of available genome sequences and tools 
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for comparative genomic analyses provide the opportunity to enhance target gene identification 
and guide PCR primer design for the culture-independent detection of bacteria (Choi et al. 
2013).  This chapter used genetic information to develop two novel species-specific PCRs for P. 
aeruginosa, and assess their application to the detection of P. aeruginosa in HPC products 
4.1.2 Culture-independent techniques to detect contamination of HPC products 
Detection of bacterial contamination in HPC-products is routinely culture-based, but culture-
independent PCR-based methods for the specific detection of low levels of microorganisms, 
including ‘objectionable’ bacterial (Salmonella spp., Escherichia coli, Pseudomonas aeruginosa, 
Burkholderia cepacia and Staphylococcus aureus) and fungal (Aspergillus niger) species have also 
been described (Jimenez et al. 1998; Jimenez et al. 1999a; Jimenez et al. 1999b; Jimenez et al. 
2000a; Jimenez et al. 2000b; Jimenez et al. 2000c; Merker et al. 2000; Jimenez 2001c; Jimenez et 
al. 2001; ŠKof et al. 2004; Karanam et al. 2008; Farajnia et al. 2009).  All of these studies 
included a culture-dependent, broth enrichment step prior to DNA extraction with the purpose 
of increasing bacterial cell numbers to detectable levels (Jimenez 2011).  Whilst this step may be 
useful for the detection of non-fastidious species present as low level contaminants, enrichment 
may introduce a culture bias (Dunbar et al. 1997) and neglects the detection of viable but non-
cultivable (VBNC) (Oliver 2005) cells. Additionally, these studies all used nutrient rich 
enrichment media which could miss fastidious or sub-lethally injured cells (Orus and Leranoz 
2005) having more specialised nutritional requirements for revival. Direct nucleic acid 
extraction from products would circumvent these issues but presents a number of challenges.   
HPC and pharmaceutical product formulations are complex, including raw materials such as 
surfactants, oils, waxes, cream bases, emulsifiers, humectants, plasticisers and preservatives, 
and vary depending on product application (Williams and Schmitt 1996).  It is generally 
unknown whether certain product components can interfere with DNA extraction or inhibit 
PCR, as there is only evidence of two studies which have attempted this (Samadi et al. 2007; 
Farajnia et al. 2009).  In these cases, DNA was extracted via treatment of the samples with a 
lysis buffer, followed by either a boiling step (Samadi et al. 2007) or phenol-chloroform 
extraction and ethanol precipitation (Farajnia et al. 2009).  Universal bacterial and species-
specific end-point PCRs were successfully applied to the DNA extracted from a pharmaceutical 
topical lotion (Samadi et al. 2007) and diluted expectorant syrup (Farajnia et al. 2009) with 
detection levels of approximately 102 cfu/ml and <10 cfu/ml, respectively.  These studies 
suggest that an enrichment step may not be necessary if DNA extraction procedures are 
optimised. Much further work needs to be done, however, to determine whether different HPC 
products are also amenable to culture-independent analysis. 
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4.1.3 Bacterial diversity in industry  
Currently we have an idea of the range of bacterial and fungal species encountered as 
contaminants in HPC-products through published reports of publicly available data (Wong et al. 
2000; Jimenez 2007; Lundov and Zachariae 2008; Sutton and Jimenez 2012).  These reports 
illustrate that although numerous species are found as contaminants, individual incidents are 
usually reported as caused by one or two species.  Not all incidents detail which species are 
responsible, instead reporting generally as ‘microbial or bacterial contamination’.  To date, our 
knowledge of microbial diversity in HPC products has been solely based on culture-dependent 
techniques.  It is widely regarded that total microbial diversity cannot be comprehensively 
assessed with culture, as the majority of microorganisms cannot be isolated on media (Ward et 
al. 1990; Armougom and Raoult 2009).  Smaller scale culture-based diversity studies have been 
attempted in an industrial setting, such as that of La Duc et al. (La Duc et al. 2007) who assessed 
microbial contamination in a clean-room.  In this study growth conditions were tailored for the 
isolation of physiologically diverse microbial populations, and molecular identification of the 
isolates was performed to the species level.  Even robustly designed, broad culture studies are 
subject to growth biases and limitations and would be enhanced by simultaneous culture-
independent analyses (Maukonen et al. 2003). 
Culture-independent techniques that are commonly used in microbial community analysis 
include PCR-denaturing gradient gel electrophoresis (DGGE), length heterogeneity PCR (LH-
PCR), ribosomal intergenic spacer analysis (RISA), sequencing of 16S rRNA gene fragments, and 
metagenomics (Maukonen et al. 2003; Rastogi and Sani 2011).  As one of the main concerns in 
industry is the detection of specific problematic species, few studies have applied these 
community sampling techniques to investigate industrial microbial contamination   (Maukonen 
et al. 2003).   There have been diversity surveys of manufacturing environments, including 
water systems used in pharmaceutical manufacturing processes (Kawai et al. 1999; Kulakov et 
al. 2002; Kawai et al. 2004) and in the food and beverage industry, where food products (Rudi et 
al. 2004; Juste et al. 2008a) and factories (Timke et al. 2005) have been investigated (Juste et al. 
2008b). In these applications, culture-independent techniques have provided a more in-depth 
analysis of the microbial complement of the environments (Rudi et al. 2004), identified 
differences in bacterial populations following treatment/production and storage (Kawai et al. 
2004), uncovered genera likely to be in high abundance but which are considered uncultivable 
(Timke et al. 2005), and given an idea of the functionality of the contaminants by identifying 
genes associated with enzymatic activities (Kulakov et al. 2002).  These findings could 
potentially inform industrial practices such as the design of manufacturing processes, the 
monitoring of process hygiene, decontamination operations, and provide information about 
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potential sources of microbial contamination (Maukonen et al. 2003; Juste et al. 2008b). As of 
yet, there have been no studies dedicated to the investigation of the bacterial diversity in HPC-
products. Within this chapter, both culture-dependent and independent techniques were used 
to examine a panel of contaminated HPC-products belonging to five different product categories 
to further knowledge in this area. 
 
4.1.4 Aims 
The aims of this chapter were as follows: 
1) To design and evaluate novel species-specific PCRs for the culture-independent 
detection of P. aeruginosa, and apply these to nucleic acids extracted from HPC-products 
 
2) To assess the bacterial diversity associated with contaminated HPC-products, 
comparing both culture-dependent and –independent techniques 
 
Hypothesis 1: Direct DNA extraction and detection of P. aeruginosa can be achieved from HPC 
products 
Hypothesis 2: The bacterial diversity associated with HPC products is low 
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4.2 Results 
 
4.2.1 Design and evaluation of species-specific PCRs for P. aeruginosa 
 
4.2.1.1 phzS gene PCR 
The gene phzS encodes a flavin containing mono-oxygenase enzyme involved in the 
biosynthesis of pyocyanin, a pigment produced only by P. aeruginosa (Haynes 1951). 
Phylogenetic trees constructed from alignments of phzS genes 9 P. aeruginosa strains and phzS 
gene orthologs from 7 species within the Class Actinobacteria revealed the phzS gene to be well 
conserved among P. aeruginosa strains (Figure 4.1).  Based on phzS and ortholog gene 
alignment, two sets of primers were designed (Figure 4.2). The first set of primers (phzS.F, 5’-
GGAAGCCGGCAACGCCTA T-3’ and phzS.R, 5’-GCAGGATCAACTGGTTGCGGGT-3’) amplified a 584 
bp fragment of the phzS gene, whilst the second set of primers (phzSN.F, 5’-
CGCGGCGAACTGCAGATGATC-3’ and phzSN.R, 5’-CTCGTTGTCGAGCTGGCCGA-3’) were nested 
within the boundaries of the first set and amplified a 435 bp fragment. 
4.2.1.2 ami operon PCR 
In P. aeruginosa genes within the ami operon are involved in the biosynthesis and transport of 
an acylamidase enzyme. Both intergenic regions and genes within the operon were considered 
when designing P. aeruginosa-specific PCR primers.  The amiL-amiE intergenic region was 
chosen as a target sequence for forward primer design as it was present in all 9 P. aeruginosa 
strains on the IMG database and orthologous regions were only present in one Pseudomonas 
species (2 strains of P. putida; Figure 4.3). The amiE gene was chosen for reverse primer design, 
being well conserved in P. aeruginosa strains (Figure 4.1) and having orthologs with sufficient 
sequence variability in other Pseudomonas species (Figure 4.3). The primers, amiE.F (5’-
CATCAGGTCRTGCGCATCAGC-3’) and amiE.R (5’-GCCCTTCGGCCCKTCGCT-3’), amplified a 588 
bp fragment spanning the amiL-amiE intergenic spacer region and the amiE gene. 
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Figure 4.1 Sequence diversity of P. aeruginosa phzS and amiE genes and orthologous genes of 
other bacterial species.(A) phzS and phzS ortholog gene sequences, (B) amiE and amiE ortholog 
sequences. Gene sequences were aligned using ClustalW2 and a neighbour-joining phylogenetic tree 
based on 1000 bootstrap replicates constructed using the Jukes-Cantor model in MEGA6. Bootstrap 
values are shown at the nodes as percentages of 1000 replications. The trees are drawn to scale with 
genetic distances given as the number of base substitutions per site. 
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(A)
(B)
phzS start codon Forward primer Forward nested primer Reverse nested primer Reverse primer
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Figure 4.2 Sequence alignments for phzS gene primer design.Sequences of the phzS gene from 9 P. aeruginosa strains and phzS gene orthologs from 7 non-P. aeruginosa species 
were aligned using ClustalW and viewed in BioEdit to facilitate primer design. The coloured boxes (see key) indicate the following: the phzS start codon, forward and nested forward 
primer locations (A), and the reverse and nested reverse primer locations within the phzS gene (B).  
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Figure 4.3 Sequence alignments for ami operon primer design.Sequences of the amiL-amiE intergenic region (A) and the amiE structural gene (B) from P. aeruginosa and 
orthologous regions from other Pseudomonas species were aligned using ClustalW and viewed in BioEdit to facilitate primer design. The location of the amiE start codon, forward and 
reverse primers are shown by the coloured boxes corresponding to the key.  
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4.2.1.3 Sensitivity and specificity of single round phzS and ami operon PCRs 
The phzS and ami PCRs were evaluated using DNA extracted by the Chelex® method (section 
2.6.1) from pure cultures of 60 P. aeruginosa and 65 non-P. aeruginosa strains (Table 2.6).  Four 
further strains from a previous study (Finnan et al. 2004) that were found to be negative for 
phzS were also included in the panel for the new phzS PCR (Table 2.8).  All P. aeruginosa strains 
were also confirmed as positive for the oprL PCR as to have confidence in species identity. Both 
PCRs demonstrated 100% sensitivity as positive results were observed for all of the P. 
aeruginosa strains screened.  The specificity of the phzS and ami PCRs were 100% and 82%, 
respectively.  The ami PCR gave an amplification product of the correct size (recorded as a false 
positive) for strains of B. ambifaria (n=1), B. cepacia complex (n=1), B. contaminans (n=1), B. 
dolosa (n=1), B. lata (n=1), B. multivorans (n=1), B. pyrrocinia (n=1), P. mendocina (n=1), P. 
oleovorans (n=1), P. pseudoalcaligenes (n=1), P. putida (n=1) and Pseudomonas spp. (n=1) (Table 
4.1).  For this reason, only the phzS PCR was investigated further. 
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Table 4.1 Specificity of species-specific PCRs for P. aeruginosa 
Species and strains 
Number of positive PCR reactions 
phzS PCR ami PCR 
Achromobacter xylosoxidans  
LMG 1863 0 0 
Acinetobacter species  
UL-1L 0 0 
Bacillus species  
RW#162 0 0 
Burkholderia ambifaria  
AMMD 0 1 
Burkholderia cenocepacia  
RW#156 0 0 
J2315 0 0 
Burkholderia cepacia complex  
UL-2P 0 1 
UL-3P 0 0 
Burkholderia contaminans  
LMG 23255 0 1 
Burkholderia dolosa  
LMG 18943 0 1 
Burkholderia gladioli  
 BCC238 0 0 
Burkholderia lata  
383 0 1 
Burkholderia multivorans  
ATCC 17616 0 1* 
Burkholderia phymatum  
BCC1607 0 0 
Burkholderia phytofirmans  
BCC 1604 0 0 
Burkholderia pyrrocinia  
LMG 21824 0 1 
Burkholderia stabilis  
LMG 14294 0 0 
Burkholderia thailandensis  
E264 0 0 
Burkholderia vietnamiensis  
RW#152 0 0 
G4 0 0 
Enterobacter gergoviae  
UL-5P 0 0 
Enterobacter species  
UL-4L 0 0 
Escherichia coli  
NCTC 12241 0 0 
Halomonas species  
RW#171 0 0 
Klebsiella species  
UL-13 0 0 
Ochrobactrum anthropi  
RW#160 0 0 
Pandoraea apista  
 LMG 16407 0 0 
Pandoraea pnomenusa  
 LMG 18087 0 0 
Pandoraea pulmonicola  
LMG 18106 0 0 
Pandoraea sputorum  
LMG 18819 0 0 
Pantoea agglomerans  
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RW#166 0 0 
Pseudomonas alcaligenes  
LMG 1224 0 0 
Pseudomonas aureofaciens  
 LMG 1245 0 0 
Pseudomonas fluorescens  
RW#85 0 0 
LMG 1794 0 0 
Pseudomonas mendocina  
LMG 1223 0 1* 
Pseudomonas oleovorans  
LMG 2229 0 1 
Pseudomonas pseudoalcaligenes  
UL-9L; RW#112 0 1 
Pseudomonas putida  
RW#153 0 0 
RW#154 0 0 
RW#157 0 0 
RW#158 0 0 
RW#159 0 0 
RW#161 0 0 
RW#205 0 0 
LMG 2257 0 1* 
Pseudomonas resinovorans  
LMG 2274 0 0 
Pseudomonas species  
RW#155 0 0 
RW#163 0 0 
RW#164 0 0 
RW#165 0 0 
RW#167 0 0 
RW#169 0 0 
RW#206 0 1 
UL-10L; RW#111 0 0 
Pseudomonas stutzeri  
LMG 11199 0 0 
Ralstonia insidiosa  
LMG 18101 0 0 
Ralstonia mannitolytica  
LMG 18103 0 0 
Ralstonia picketii  
LMG 18088 0 0 
Ralstonia respiraculi  
LMG 21510 0 0 
Staphylococcus aureus  
ATCC 6538 0 0 
NCTC 12981 0 0 
Staphylococcus epidemidis  
 ATCC 12228 0 0 
Stenotrophomonas maltophilia  
 LMG 958 0 0 
Stenotrophomonas species  
UL-12 0 0 
Total number of positive PCR 
reactions/total number of strains 
0/65 12/65 
Specificity (%) 100% 82% 
*A weak positive PCR result was observed 
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4.2.2 Culture-independent detection of P. aeruginosa in HPC-products 
 
4.2.2.1 DNA extraction from HPC-products 
An automated nucleic acid extraction robot, the Maxwell® 16 system, was investigated as a 
standardised kit-based system for DNA extraction from HPC products. A product sample input 
of either 0.3 ml (liquid product) or 0.3 g (viscous product) yielded between 0.077 and 8.41 
ng/µl of DNA for 10 of the contaminated HPC products tested (Table 4.2).  The DNA yield for the 
remaining 4 products, SC1, SC3, PC2 and WC1, was too low to quantify (less than 0.01 ng/µl).  
No correlation between DNA yield and the total viable counts obtained from the products 
(correlation coefficient = 0,153, p-value=0.574; Goodman and Kruskal’s gamma rank correlation 
test for non-parametric data including ‘tied’ observations) (Goodman and Kruskal 1979).   
To determine whether PCR inhibitors were carried over from HPC-products during the DNA 
extraction process a 16S rRNA gene PCR using universal bacterial primers was performed 
(section 2.7.1).  As the concentrations of DNA obtained were low, undiluted DNA was used and 
the amount of template DNA in the PCR was increased to 6 µl (rather than 2 µl of 10 ng/µl DNA 
as used in a standard 16S rRNA PCR; section 2.7.1.1).  Only three of the product samples (DWL4, 
SC1 and FWS3) did not yield a PCR amplification product (Table 4.2).  Both DWL4 and FWS3 
had sufficient concentrations of total DNA to yield a positive PCR result, 0.689 and 0.586 ng/µl 
respectively, suggesting the presence of PCR inhibitors, an absence of bacterial DNA or 
amplification below the level visible conventional agarose gel electrophoresis. The negative 
result for SC1, may have been due to insufficient DNA for the PCR reaction (<0.01 ng/µl).  
Overall, the Maxwell® 16 system was effective in extracting DNA from a range of different HPC 
product formulations which was of high enough quality and quantity for use in PCR 
applications.   
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4.2.2.2 Application of species-specific PCRs for P. aeruginosa 
To identify the presence of P. aeruginosa in contaminated HPC-products, two P. aeruginosa-
specific PCRs were applied to DNA extracted from products.  Both the previously published oprL 
PCR (De Vos et al. 1997) and the phzS PCR detected P. aeruginosa in 9 out of 14 HPC-products, 8 
of which were culture positive for P. aeruginosa (Table 4.2).  The surface cleaner SC2 was 
culture-negative but yielded a positive result for the 16S rRNA gene, oprL and phzS PCRs, 
suggesting either preservative neutralisation issues or the presence of viable but non-cultivable 
or dead cells. Since the phzS PCR gave the same results as the well-established oprL PCR, it was 
was further validated as a novel PCR for the detection of P. aeruginosa.  
To examine the detection limits of a single round phzS PCR and a nested phzS PCR, the PCRs 
were applied to DNA extracted from Neat, 10-1 and 10-2 dilutions of DWL1 and Neat and 10-1 
dilutions of PC1. The viable counts and DNA concentrations (obtained from 0.3 g of product) are 
shown in Table 4.3, and the PCR results shown in Figure 4.4.  The lower detection limit for a 
single round phzS PCR was approximately 102 viable cells for DWL1 (10-1 product dilution), and 
approximately 103 viable cells for PC1 (undiluted product). The application of the second round 
nested phzS PCR improved the detection limits for both products to approximately 101 viable 
cells for DWL1 and between 101 and 102 for PC1, which corresponded to the 10-2 and 10-1 
product dilutions respectively.  By cultivation (see section 4.2.3) DWL1 was contaminated with 
only P. aeruginosa, but PC1 contaminated with more than one species, with P. aeruginosa the 
dominant contaminant. The viable counts recorded for PC1 were for total cells and therefore 
may overestimate the number of P. aeruginosa cells and the amount of P. aeruginosa DNA 
present.  However, the efficacy of the nested phzS PCR for the detection of at least 1000 viable P. 
aeruginosa cells was validated. 
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Table 4.2 Culture-dependent and –independent analysis of contaminated HPC-products 
 
 
aIncluded in the RISA and culture-dependent 16S rRNA analysis; bViable counts performed on TSA medium; cDNA concentration in 300 µl or 0.3 g of product; dA band of 
approximately 753 bp was taken as indicative of the presence of P. aeruginosa; eP. aeruginosa colony types were the same RAPD type and putatively considered same-strain; fA 
positive PCR result (+) was taken as a visible band on a gel as indicated in Figure 4.1;  g16S rRNA gene amplification and pyrosequencing carried out by Research and Testing 
Laboratory
Product 
Culture-dependent analysis Culture-independent analysis 
CFU/gb 
No 
colony 
types 
16S rRNA Species ID 
from colony types 
DNA 
concentrationc 
(ng/µl) 
16S rDNA 
PCR 
oprL/ phzS 
PCRf 
RISA profile 
Culture-independent 16S 
rDNAg Genus ID 
Dish Wash Liquid  
DWL1a 103 1 P. aeruginosa 0.993 + +/+ 1 dominant band (Pad) Pseudomonas 
DWL2a 102 1 P. aeruginosa 0.103 + +/+ Multiple bands (Pac) 
Pseudomonas 
Enterobacter 
Herbaspirillum 
DWL3a 103 2 
P. aeruginosa 
Enterobacter spp. 
0.623 + +/+ Multiple bands 
Enterobacter 
Pseudomonas 
DWL4a 103 2 Pseudomonas spp. 0.689 - -/- No bands 
Pseudomonas 
Herbaspirillum 
DWL5a 104 1 P. aeruginosa 0.077 + +/+ 1 dominant band (Pad) Pseudomonas 
Surface Cleaner  
SC1 103 1 P. aeruginosa <0.01 - -/-   
SC2a - - - 0.245 + +/+ 1 dominant band (Pad) 
Pseudomonas 
Herbaspirillum 
SC3 103 1 Acinetobacter spp. <0.01 + -/-   
Personal Care   
PC1a  103 2 
P. aeruginosa 
Enterobacter cloacae 
0.06 + +/+ Multiple bands 
Enterobacter 
Pseudomonas 
Herbaspirillum 
PC2a 104 1 P. aeruginosa <0.01 + +/+ 1 dominant band (Pad) 
Pseudomonas 
Herbaspirillum 
Fabric Wash  
FWS1a 104 2 P. aeruginosae 1.53 + +/+ 1 dominant band (Pad) Pseudomonas 
FWS2a 106 1 P. aeruginosa 8.41 + +/+ 1 dominant band (Pad) Pseudomonas 
FWS3 104 1 Pseudomonas spp. 0.586 - -/-   
Wood Cleaner  
WC1 104 1 Burkholderia spp. <0.01 + -/-   
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Table 4.3 Viable counts and DNA yield for the HPC-products DWL1 and PC1 
 
Product dilution CFU/0.3 g DNA concentration in 0.3 g (ng/µl) 
DWL1 
Neat 103 0.993 
10-1 102 0.209 
10-2 101 <0.01 (Too low to detect) 
PC1 
Neat 103 0.06 
10-1 101 - 102 <0.01 (Too low to detect) 
 
 
 
 
 
Figure 4.4 Detection limits of the phzS PCR. Lanes: M, molecular ladder (relevant marker size 
indicated in kb); (+), P. aeruginosa PAO1 positive control; DWL1/PC1 dilutions, DNA extracted 
from Neat, 10-1 or 10-2 product dilutions; (-), negative water controls.  The PCR1 bracket 
indicates the results from a single round phzS PCR and the PCR2 bracket indicates the results 
from a nested phzS PCR, which takes the DNA template as the products from PCR1.  
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4.2.3 Bacterial diversity associated with HPC-products 
 
4.2.3.1 Identification of cultivable bacteria  
 
After growth on TSA, 15 different colony morphologies were isolated from 13 HPC-products, 
with SC2 failing to yield any bacterial growth (Table 4.2). Identification of each colony type was 
performed using 16S rRNA gene sequencing and analysis (Table 4.2).  For 9 of the products, 
only 1 colony type was isolated.  In these cases the contaminating organisms were P. aeruginosa 
(DWL1, DWL2, DWL5, PC2, and FWS2), Pseudomonas spp. (FWS3), Acinetobacter spp. (SC3) and 
Burkholderia spp. (WC1). For 4 of the remaining products, 2 different colony morphotypes were 
identified from each.  In the case of DWL3 and PC1, the colony types were determined to be P. 
aeruginosa and an Enterobacter spp.. The two different colony morphologies were isolated from 
DWL4 were both Pseudomonas spp., but could not be identified below the genus level.  FWS1 
was contaminated with two P. aeruginosa isolates displaying different colony morphologies.  
RAPD PCR genotyping showed that these colony types shared the same RAPD fingerprint and 
were therefore putatively considered as the same strain. Although the surface cleaner, SC2, 
failed to yield any bacterial growth, cultivation-independent analysis with the oprL and phzS 
PCRs identified that P. aeruginosa DNA was present in the sample (Table 4.2). 
4.2.3.2 Bacterial diversity profiling by RISA 
The genetic fingerprinting technique RISA was applied directly to DNA extracted from 10 of the 
14 HPC product samples.  Of the 10 products, 6 had a single dominant band (DWL1, DWL5, SC2, 
PC2, FWS1 and FWS2), three had multiple bands (DWL2, DWL3 and PC1), and 1 had no profile 
(DWL4) (Figure 4.2). To aid the putative identification of contaminants, DNA from a pure 
culture of P. aeruginosa PAO1 was subjected to RISA PCR.  The 753 bp product obtained from 
the P. aeruginosa RISA PCR correlated with the in Silico PCR tool predictions of the size of ITS 
regions from this species.  The dominant band observed for DWL1, DWL5, SC2, PC2, FWS1, 
FWS2, and DWL2 also correlated to the ITS amplicon size for P. aeruginosa.  The P. aeruginosa 
ITS band was missing from the PC1 and DWL3 profiles, in which the dominant band correlated 
to ITS sizes predictive of Enterobacter (625-640 bp). A weaker band of approximately 625-640 
bp was also observed for DWL2. As the In Silico PCR tool predicted multiple ITS amplicons of 
different sizes for Enterobacter species, however, and multiple bands in a similar size range for 
other closely related species (e.g. Pantoea spp.), RISA profiles could not be definitively linked to 
the presence of Enterobacter within PCR1, DWL2 and DWL3.  Overall though, it was clear that 
there was greater species diversity in the products PC1, DWL3 and DWL2 than the other 
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products, reflected by their more complex RISA profiles composed of at least 3 amplified ITS 
fragments (Figure 4.2).   
 
 
 
 
Figure 4.5 RISA profiles from contaminated HPC-products. The RISA profiles of 10 HPC-
products are shown alongside the ITS region amplicon (753 bp) for a pure culture of P. 
aeruginosa strain PAO1 and a molecular ladder to aid band sizing (size indicated in bp).  
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4.2.3.3 Bacterial diversity by 16S rRNA gene pyrosequencing and analysis 
 
16S rRNA gene amplification, pyrosequencing and analysis using the software package 
MOTHUR was used to comprehensively assess the bacterial diversity in 10 contaminated HPC-
products. Amplification of the 16S rRNA gene for pyrosequencing was successful for all 
products including DWL4, suggesting that the process carried out by Research and Testing 
Laboratory was more sensitive.  The number of sequence reads per sample ranged from 1763 
(PC1) to 9301 (FWS2). Sub-sampling to the lowest number of sequence reads (1763) was 
performed. Throughout the analyses operational taxonomic units (OTUs) were grouped based 
on 97% sequence similarity. 
 
From the primary analysis of sequences using MOTHUR and the 454 SOP pipeline (Table 4.4) 
the OTU richness was found to be low, with number of observed species (Sobs) at the 97% 
sequence similarity level ranging from a minimum of 6 (PC2) to a maximum of 15 (DWL1, SC2 
and PC1). Both the Shannon and Inverse Simpson (InvSimpson) indices take into account the 
richness and evenness of OTUs to give an indication of how the diversity within a sample is 
spread.  Across the 10 samples the Shannon diversity ranged from 0.055 (DWL5) to 0.723 
(DWL3), and the InvSimpson diversity values ranged from 1.01 (FWS1, FWS2 and DWL5) and 
1.650 (DWL3). These values are very low, with the Shannon diversity values being close to 0 
and the InvSimpson diversity values close to 1, suggesting that most of the abundance was 
concentrated within one or a few OTUs for each sample. The Good’s coverage estimates, which 
indicate the probability that a randomly selected sequenced from a sample has already been 
sequenced, were above 99% for all of the HPC product samples indicating that coverage was 
high and sufficient to detect the genera present. 
 
Taxonomic assignments to the genus level were made using a combination of the RDP Classifier 
script and manual analysis using the RDP II seqmatch function. As stipulated in Methods 
(section 2.12.2), an OTU threshold was implemented and OTUs excluded if they were 
represented less than 10 times across all of the 10 HPC-product samples. Initially, 86 OTUs 
representing 30 genera were identified which were filtered to a final total of 6 OTUs belonging 
to the genera Pseudomonas, Enterobacter and Herbaspirillum.  All of the products had either 
Pseudomonas (DWL1, DWL2, DWL4, DWL5, SC2, PC2, FWS1 and FWS2) or Enterobacter (DWL3 
and PC1) as the dominant contaminating genus, where the proportion of total reads for that 
genus was over 80%. Herbaspirillum sequence reads never comprised more than 0.5% of total 
sequence reads for a product (Table 4.5 and Figure 4.3). 
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Table 4.4 Sequence and OTU diversity of the 16S rRNA gene 454 pyrosequencing datasets from 
the 10 contaminated HPC-products.  
 
 *Outputs from analysis using the software package MOTHUR and the 454 SOP pipeline at 97% similarity 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Product 
Total 
reads 
Subsampled 
reads 
OTU richness* Diversity indices 
Good’s 
Coverage (%) 
Observed species 
numbers (Sobs) 
Shannon InvSimpson 
Dish Wash Liquid  
DWL1 5567 1763 15 0.112 1.017 99.3 
DWL2 2841 1763 13 0.195 1.058 99.5 
DWL3 4456 1763 7 0.723 1.650 99.8 
DWL4 2131 1763 14 0.239 1.082 99.5 
DWL5 2576 1763 7 0.055 1.010 99.7 
Surface Cleaner  
SC2 7397 1763 15 0.164 1.04 99.5 
Personal Care  
PC1  1763 1763 15 0.516 1.265 99.5 
PC2 3224 1763 6 0.075 1.020 99.8 
Fabric Wash  
FWS1 4725 1763 11 0.078 1.01 99.4 
FWS2 9301 1763 9 0.063 1.01 99.5 
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Table 4.5 Genus distributions of 16S rRNA sequence reads recovered from ten contaminated HPC-
product samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 Genus distributions of 16S rRNA sequence reads recovered from ten contaminated HPC-
product samples depicted graphically. 
Product 
Number of sequence reads (% total) 
Pseudomonas Enterobacter Herbaspirillum 
Dish Wash Liquid 
DWL1 1750 (100) - - 
DWL2 1720 (98.1) 29 (1.7) 3 (0.2) 
DWL3 316 (18) 1443 (82) - 
DWL4 1746 (99.8) - 4 (0.2) 
DWL5 1758 (100) - - 
Surface Cleaner 
SC2 1746 (99.94) - 1 (0.06) 
Personal Care 
PC1 177 (10.1) 1562 (89.4) 8 (0.5) 
PC2 1759 (100) - - 
Fabric Wash 
FWS1 1754 (100) - - 
FWS2 1756 (100) - - 
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4.2.3.4 Comparison of culture-dependent and -independent methods for identifying species 
diversity  
The results from the culture-dependent and culture-independent assessments of diversity in 
contaminated products are shown side-by-side in Table 4.2.  Comparisons could be made for the 
products DWL1, DWL2, DWL3, DWL4, DWL5, SC3, PC1, PC2, FWS1 and FWS2, as these had 
results for both culture-dependent and -independent analyses.  All of the contaminated 
products which were culture positive for P. aeruginosa were also positive for the P. aeruginosa-
specific oprL and phzS PCRs.  The RISA profiles for all but two of these products, DWL3 and PC1, 
had a dominant band of approximately 753 bp corresponding to the predicted P. aeruginosa ITS 
amplicon. The RISA PCR may have not produced an amplicon for DWL3 and PC1 as the total 
number of 16S rRNA pyrosequencing reads corresponding to P. aeruginosa was low in these 
products, 18% and 10.1%, respectively. The culture-independent 16S rRNA genus IDs were in 
concordance with the culture-dependent work, corroborating contamination with Pseudomonas.  
DWL2, DWL3, DWL4 and PC1 were contaminated with species other than P. aeruginosa. DWL4 
was found to be contaminated with non-P. aeruginosa Pseudomonas spp. by both culture 
dependent methods and 16S rRNA gene pyrosequencing and analysis. DWL2, DWL3 and PC1 
had multiple bands in their RISA profiles and were found to be contaminated by Enterobacter 
spp., in addition to P. aeruginosa, by culture-independent methods.   In the case of DWL2, 
Enterobacter was missed by culture dependent techniques; 16S rRNA gene pyrosequencing and 
analysis indicated that the proportion of sequence reads for Enterobacter in DWL2 was only 
1.7%.  Herbaspirillum was found in DWL1, DWL2, DWL4 and PC1 by 16S rRNA gene analysis 
(less than 0.5% of total pyrosequencing reads) but not identified by RISA or in culture 
dependent investigations.  With these last two exceptions, and the absence of the P. aeruginosa 
ITS amplicon in the DWL3 and PC1 RISA-PCR profiles, the culture-dependent and –independent 
investigations yielded concordant results for bacterial contaminant identification. 
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4.3 Discussion 
4.3.1 Novel species-specific PCRs for the culture-independent detection of P. aeruginosa 
 
Culture-independent methods for the detection of P. aeruginosa have been widely detailed and 
10 different genes commonly targeted for PCR-based identification (Table 1.4). Amongst these, 
the oprL gene PCR has been extensively evaluated and applied to the detection of P. aeruginosa 
from varied environments.  Despite this widespread use, the oprL PCR does not have 100% 
specificity, and increasing numbers of P. aeruginosa genome sequences determined there was 
an opportunity for improved PCR primer design. Two novel PCRs were designed which targeted 
the phzS gene and genes within the ami operon. Primer design was informed by the alignment of 
multiple gene sequences from P. aeruginosa strains and closely related species. The phzS gene is 
involved in the biosynthesis of pyocyanin, a pigment produced exclusively by P. aeruginosa.  As 
the phzS gene is highly conserved amongst P. aeruginosa strains and few orthologs exist in other 
species it was considered a suitable PCR gene target. There are no published species-specific 
PCRs for the detection of P. aeruginosa, although PCRs have been designed for the amplification 
of phzS as a ‘virulence’ gene (Finnan et al. 2004; Bradbury et al. 2010).  Both studies used the 
primers designed by (Finnan et al. 2004) which amplify a 1752 bp fragment of the phzS gene 
and determined that a number of P. aeruginosa isolates were PCR negative for this gene; 5/17 
(Finnan et al. 2004) and 4/184 (Bradbury et al. 2010).  If a proportion of P. aeruginosa isolates 
do not have the phzS gene, this would have implications for the sensitivity of any PCRs targeting 
this region. The newly designed phzS PCR described in this chapter had different primer 
sequence targets designed from systematic alignment of available P. aeruginosa gene sequences 
and amplified a smaller region of the gene (584 bp), than those designed to detect phzS as a 
virulence gene (Finnan et al. 2004).  
 
Screening against a panel of 60 P. aeruginosa isolates and 65 non-P. aeruginosa isolates 
determined the phzS PCR to have 100% sensitivity and specificity.  This panel was 
systematically selected to include genetically distinct P. aeruginosa strains and strains of 
Pseudomonas and non-Pseudomonas species often misidentified as P. aeruginosa or commonly 
encountered in cystic fibrosis microbiology (Spilker et al. 2004; Hauser et al. 2011). The phzS 
PCR showed a significant advantage over the ami PCR in not producing false postives with 
certain Burkholderia and other Pseudomonas species. The 5 P. aeruginosa isolates previously 
found by (Finnan et al. 2004) to be negative for phzS were also tested. Of the 5 isolates, one was 
oprL and phzS PCR negative (strain BR220), therefore potentially a non-P. aeruginosa species, 
whilst the remaining 4 (strains CF194, CF198, CF242 and BR227) were positive for the newly 
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designed phzS PCR.  Thus far, the phzS gene appears to be a reliable target for a species-specific 
PCR to identify P. aeruginosa and the newly designed primers have excellent sensitivity and 
specificity in a single round PCR.  
 
Genes within the ami operon were also targeted for novel PCR design, and primers were 
designed to amplify a 588 bp fragment of the operon spanning the amiL-amiE intergenic region 
and the structural amiE gene. This operon encodes the AmiE aliphatic amidase enzyme which is 
well conserved in P. aeruginosa strains and is responsible for the hydrolysis of acetamide 
(Brammar and Clarke 1964). The ami PCR displayed 100% sensitivity, but a much lower 
specificity (82%) with strains of 5 Pseudomonas and 7 Burkholderia species giving a positive 
PCR result.  Other species, such as Pseudomonas and Burkholderia, are known to possess 
amidase enzymes which can metabolise acetamide (Szita et al. 1998).  The results of Chapter 3 
also illustrated that acetamide-based media have low selectivity and may permit the growth of 
species other than P. aeruginosa.  The ami primers in this study were designed based on 
alignments of the P. aeruginosa intergenic spacer region, the amiE gene and orthologous 
regions/genes from other species, but unfortunately lacked specificity.  Other PCRs designed 
specifically for the amplification of the amiE gene of P. aeruginosa have also been reported to 
amplify an amidase gene from B. cepacia (Novo et al. 2003).  This suggests that there may not be 
enough variability between the amidase genes of different species to design a highly specific 
PCR.   
4.3.2 Application of culture-independent techniques to industrial microbiology 
Direct bacterial DNA extraction from cosmetics and HPC-products has only been described by 
two studies (Samadi et al. 2007; Farajnia et al. 2009), where two different product types and 
two different DNA extraction methodologies were used. The majority of PCR-based analysis of 
products has previously been achieved through a broth enrichment step from which DNA was 
extracted (Jimenez 2011).  Whilst this was successful, it is not a completely culture-independent 
approach.  In this chapter a method for extracting DNA directly from a variety of HPC-product 
formulations was described. The DNA yields were relatively low (<0.01 to 8.41 ng/µl), but 
sufficient for a positive in-house 16S rRNA gene PCR for 11 out of the 14 products (Table 4.2). 
The remaining three products (DWL4, SC1 and FWS3) belonged to different HPC product 
categories indicating a potentially sample specific issue, rather than a problem with a certain 
product technology. A lack of correlation between the total viable counts and the amount of 
DNA extracted was also observed, and could have been influenced by either culture dependent 
(insufficient product neutralisation) or culture-independent (DNA extraction inhibitors, PCR 
inhibitors, detection of dead cells) limitations.  To accurately assess DNA recovery yields from 
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products, experiments would need to be conducted with sterile products spiked with known 
numbers of viable cells, as has been described previously (Farajnia et al. 2009). Although 
further work is required to optimise DNA recovery from certain HPC product types, the Maxwell 
16® system successfully handled a variety of product types, offering a straightforward, fast, 
standardised protocol for DNA extraction. 
The application of species-specific PCRs to DNA extracted from products facilitates rapid 
detection of problematic species or opportunistic pathogens, which HPC products must be 
devoid of.  The option of a multiplex PCR, such as that described by (Farajnia et al. 2009) would 
allow the simultaneous detection of more than one species, further improving on reporting 
times.  In this chapter, both the oprL PCR and the newly designed phzS PCR were used to detect 
P. aeruginosa in contaminated HPC samples. In almost all of the products where P. aeruginosa 
was found using culture-dependent techniques (DWL1, DWL2, DWL3, DWL5, PC1, PC2, FWS1 
and FWS2), the oprL and phzS PCRs also gave a positive result. The exceptions were SC2, where 
no results were obtained for culture but a PCR positive was obtained, and SC1 where P. 
aeruginosa was found by culture but culture-independent analysis was unsuccessful.  
The phzS PCR and a nested phzS PCR was also applied to DNA extracted from serial dilutions of 
two products, DWL1 and PC1. Correlation to the viable counts from the serial dilutions 
indicated that a single round PCR could detect 102 viable cells in DWL1 and 103 cells in PC1, 
improving to 101 and 101-102, respectively, after the nested PCR.  It is not known, however, if 
the DNA extracted from the products is representative of viable cells, or a mixture of viable and 
dead cells, which could lead to a lower-than-actual detection limit being recorded.  Conversely, 
PC1 was contaminated with P. aeruginosa (as the dominant species), in addition to Enterobacter 
which may have given a slightly higher-than-actual detection limit, as the total DNA and colony 
counts would have been representative of the two species.  Further work with samples 
artificially spiked with known numbers of P. aeruginosa cells could give more accurate detection 
limits for the phzS PCRs. 
Whilst having numerous advantages over culture-dependent methods, culture-independent 
methods are not without their drawbacks. The detection of dead cells or free DNA in the 
product may over-estimate the level of contamination, and components within the product may 
inhibit either DNA extraction or PCR.  (Maukonen et al. 2003; Juste et al. 2008b).  Although the 
latter problem may be dealt with via the optimisation of protocols, other culture-independent 
techniques offer solutions to assessing viability.  The inclusion of certain chemicals into PCR 
reactions, including ethidium monoazide which binds to DNA within dead cells, can facilitate the 
amplification of DNA from only viable cells (Rudi et al. 2005). It is also possible to target RNA, 
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rather than DNA, as an indicator of viability, as demonstrated by (Brown et al. 2009).  Here, 
reverse transcriptase PCR was used to detect the presence of Mycoplasma in biopharmaceutical 
products.  As RNA is more sensitive to degradation than DNA, the feasibility of extracting RNA 
from HPC-samples would need to be assessed; the Maxwell® 16 system has kits for total RNA 
extraction which could be tested in future.  Overall, it is likely that a combination of both 
culture-dependent and –independent approaches would be the most practical and beneficial to 
industry for the acquisition of  reliable and comprehensive results (Juste et al. 2008b). 
4.3.3 Bacterial diversity in HPC-products 
 
The microbial diversity found in HPC products has not yet been systematically investigated.  
Reports of publicly available product recall data are the only source of information in this area 
(Jimenez 2007; Lundov and Zachariae 2008; Sutton and Jimenez 2012).  To date, our knowledge 
of contaminants derives from isolation of species by culture-dependent techniques, and may 
therefore overlook VBNC and other uncultivable cells.  In this chapter a combination of culture-
dependent and -independent methods was employed to assess the bacterial diversity associated 
with a panel of HPC products belonging to five different product categories. 
These investigations have corroborated previous culture-based findings that bacterial diversity 
is low in HPC products, with no more than a few species being found together in the same 
product. For the 10 products where both culture-dependent and –independent approaches 
could be applied, the consensus result was contamination with one dominant bacterial genus, 
where this genus represented at least 80% of the pyrosequencing reads.  For the products 
DWL1, DWL2, DWL4, DWL5, SC2, FWS1 and FWS2, Pseudomonas was dominant, and for DWL3 
and PC1, Enterobacter was dominant. DWL2 also contained Enterobacter, and products DWL3 
and PC1 had Pseudomonas as lower level contaminants (less than 20% total pyrosequencing 
reads).  In the case of DWL1, DWL2, DWL3, DWL4, SC1, PC1, PC2, FWS1 and FWS2 the 
Pseudomonas species was likely to be P. aeruginosa, whilst for DWL5 it was likely to be a non-P. 
aeruginosa Pseudomonas species. Only in the case of PC1 was the Enterobacter species 
putatively identified as E. cloacae. Four products (DWL2, DWL4, SC1 and PC1) also contained 
the genus Herbaspirillum, but this was only identified by pyrosequencing and was present at 
less than 0.5% of the total sequence reads for each product. Whereas P. aeruginosa, 
Pseudomonas spp., and Enterobacter are commonly encountered contaminants of non-sterile 
products, there is no evidence in the FDA or EU RAPEX reports of Herbaspirillum being detected. 
It is possible that Herbaspirillum has been previously overlooked as a non-cultivable species 
present in products, or that it a contaminant in another capacity in the DNA extraction and 
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pyrosequencing processes.  Herbaspirillum, in addition to numerous other species, can 
contaminate molecular biology grade water, PCR reagents and DNA extraction kits (Salter et al. 
2014), indicating that the inclusion of a negative control samples would be useful and caution 
should be exercised when analysing sequence data from diversity studies. Ascertaining whether 
the low level of Herbaspirillum 16S rRNA gene reads (<0.05%) was the result of genuine HPC 
contamination or reagent contamination will be difficult to prove; since water is a major raw 
material in HPC manufacturing processes the presence of Herbaspirillum DNA is plausible. From 
the four remaining products P. aeruginosa (SC1), Acinetobacter spp.  (SC3), Pseudomonas spp. 
(FWS3) and Burkholderia spp. (WC1) were isolated, all of which are previously reported 
contaminants, but further culture-independent analysis would be needed to confirm their 
identities.  
Overall the results of both the culture-dependent and –independent investigations were very 
similar, with three notable exceptions: 1) DWL2 was found to contain Enterobacter by culture-
independent techniques but not by culture; 2) Herbaspirillum was detected by pyrosequencing 
in DWL1, DWL2, DWL4 and PC1 but not found by culture or RISA, and; 3) DWL3 and PC1 were 
found to be contaminated with P. aeruginosa by culture, but no P. aeruginosa ITS band was 
observed in their RISA profiles. Where genera were missed by culture, the contaminants were 
likely to be at low levels, as reflected by low numbers of pyrosequencing reads, and may have 
been VBNC or sub-lethally injured, or simply process contaminants as discussed above. 
Potentially, the inclusion of more than one medium in the study could have increased the chance 
of isolation; for example, the low nutrient medium R2A has been reported to enhance the 
growth of slow growing or stressed bacteria (Reasoner and Geldreich 1985), yielding higher 
viable cell counts than other nutritionally rich media (Means et al. 1981; van der Linde et al. 
1999). The discrepancies encountered with the RISA profiles could be indicative of low DNA 
concentrations for the less-dominant species and potentially linked to a PCR-amplification bias 
(Polz and Cavanaugh 1998). Whilst RISA can provide an overall idea of diversity through the 
generation of a community profile, it cannot unequivocally identify individual species and may 
over- or under-estimate richness; unrelated species can possess similar size ITS regions and 
individual species can generate multiple ITS amplicons of different sizes (Kovacs et al. 2010).   
In this chapter the products contaminated with 3 genera (DWL3 and PC1) did have the most 
complex RISA profiles correctly indicating more diversity than the other samples.  
Pyrosequencing gave valuable insight into the ratios of genera present in the samples, although 
could only identify contaminants to the genus level due to the lack of resolution of the 16S rRNA 
gene (Armougom and Raoult 2009).  Other methods utilised in this chapter, such as the species-
specific PCRs and the isolation and identification of contaminants, provided additional 
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information which aided further taxonomic assignments.  As both culture-independent and –
independent techniques have advantages and limitations, a combination of both, in addition to 
careful interpretation, facilitates the most comprehensive and accurate results. 
It should be mentioned that 8 out of the 14 products were initially selected for investigation as 
they were thought to be contaminated with P. aeruginosa (DWL1, DWL2, DWL3, DWL4, SC1, 
SC2, PC1 and PC2).   Therefore, the products are not representative of the HPC industry as a 
whole, and neither are the overall ratios of contaminants.  For example, in this study P. 
aeruginosa, Pseudomonas spp., Enterobacter and Herbaspirillum were found in 64%, 14%, 21% 
and 29% of the products, respectively, whilst in reality the respective incidences are 7-27%, 8%, 
3-6%, 0% (Sutton and Jimenez 2012)(EU RAPEX reports 2005-2014). In addition Burkholderia 
spp., found in one out of the 14 products, is one of the most common contaminants of non-
sterile products, with an incidence rate of between 5-34% (Sutton and Jimenez 2012)(EU 
RAPEX reports 2005-2014). A prospective survey of HPC contamination incidents is required to 
fully understand microbial diversity associated with this manufacturing industry. 
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4.4 Conclusions 
 
The main conclusions from the work in this chapter were as follows: 
1) Two novel species specific PCRs were designed for the detection of P. aeruginosa. The 
phzS PCR demonstrated 100% specificity and sensitivity, and has potential as a new 
molecular diagnostic tool for P. aeruginosa. 
 
2) Direct DNA extraction from HPC products was achieved using the Maxwell 16® system, 
yielding DNA of high enough quality and quantity for use in PCR for 11 out of the 14 
products.  This technology represents a straightforward, fast, standardised method for 
DNA extraction from complex samples such as HPC products. 
 
3) The bacterial diversity associated with HPC products is low, with few species co-
contaminating products. There was general concordance between the findings of the 
culture-dependent and –independent investigations, but a combination of both was 
necessary to obtain the most comprehensive view of diversity and accurate species 
identification. 
 
The hypotheses proposed at the beginning of the chapter were accepted: 
Hypothesis 1: Direct DNA extraction and detection of P. aeruginosa can be achieved from HPC 
products. 
Hypothesis 2: The bacterial diversity associated with HPC products is low. 
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5. Genetic diversity of P. aeruginosa in industry 
5.1. Introduction  
 
Bacterial populations vary in genetic diversity and population structures are complex, ranging 
from highly clonal to non-clonal. The evolutionary driving forces of the population structures 
differ, with clonal populations generally evolving through de novo mutation, whilst genetic 
change in non-clonal populations results largely from recombination (Spratt and Maiden 1999). 
Populations may also take an intermediate structure, as has been suggested for P. aeruginosa, 
which is predominantly non-clonal but with evidence of prevalent clonal types (Pirnay et al. 
2009). Overall, the majority of studies have shown that P. aeruginosa isolates are diverse and 
the population is freely-recombining but globally distributed major clone types have been 
identified, including Clone C and PA14 (Lomholt et al. 2001; Wiehlmann et al. 2007b; Pirnay et 
al. 2009; Maatallah et al. 2011; Dettman et al. 2013; Tümmler et al. 2014). In addition, in 
general, it appears that many P. aeruginosa strains exhibit little habitat selection and are 
genotypically, chemo-taxonomically and functionally highly similar (Nicas and Iglewski 1986; 
Römling et al. 1994; Rahme et al. 1995; Foght et al. 1996; Alonso et al. 1999).    There are 
exceptions, however, indicating potential niche specialists within the population (Tümmler et al. 
2014).  These exceptions include the association of certain serotypes with the nosocomial 
settings (Pirnay et al. 2009), genotypes with keratitis (Stewart et al. 2011), clones with cystic 
fibrosis patient groups (Lanotte et al. 2004; van Mansfeld et al. 2010), and clonal complexes 
within aquatic environments (Khan et al. 2008; Selezska et al. 2012) (Table 5.1). 
 
The genome of P. aeruginosa strains varies between 5.2 and 7 Mbp and displays extensive 
genetic diversity (Schmidt et al. 1996). The genome has been described as a mosaic structure, 
composed of the core genome, which is conserved (0.5-0.7% sequence diversity) and estimated 
to comprise approximately 4000 genes, and the variable accessory genome (Klockgether et al. 
2011). The accessory genome accounts for up to 20% of the total genome content and is 
associated with horizontal gene transfer, harbouring many genes involved in mobility, 
metabolism, virulence and antibiotic resistance (Rumbaugh 2014).  It is the accessory genome 
which accounts for the majority of the diversity between P. aeruginosa strains, and is found in 
regions of genomic plasticity interspersed throughout the chromosome (Klockgether et al. 
2011). 
 
Genotyping schemes utilise genetic information to investigate strain diversity and population 
biology. A variety of typing schemes have been used for P. aeruginosa (see Table 1.5), which 
CHAPTER 5 - GENETIC DIVERSITY OF P. AERUGINOSA IN INDUSTRY   
 
135 
 
have sampled different proportions and parts of the genome. Examples of these schemes 
include genome fingerprinting techniques such as PFGE (Morales et al. 2004) or RAPD-PCR (van 
Mansfeld et al. 2010), sequence based methods such as MLST (Maatallah et al. 2011; Kidd et al. 
2012) and the micro-probe array based method Clondiag Array Tube (AT) typing (Wiehlmann 
et al. 2007b; Cramer N. et al. 2012). Other studies have assembled polyphasic profiles of 
genotypic and phenotypic characteristics, which were interrogated by biological data analysis 
software (Pirnay et al. 2002; Pirnay et al. 2005) or minimum spanning tree analysis (Pirnay et 
al. 2009). More recently, whole genome sequencing (WGS) has also been used as a means to 
examine P. aeruginosa population biology (Dettman et al. 2013). Whilst the different typing 
techniques have advantages and disadvantages, the general consensus from all of the studies 
has been that P. aeruginosa has a non-clonal epidemic population structure (Table 5.1). 
 
The majority of studies using genotyping techniques to assess P. aeruginosa population biology 
have focussed on isolates from clinical settings, with only a few looking specifically at 
environmental isolates (Pirnay et al. 2005; Khan et al. 2008; Selezska et al. 2012). Studies 
investigating a  variety of sources have also only included environmental isolates in small 
proportions, representing between 10-25% of the isolate collection (Selezska et al. 2012). Such 
a bias towards clinical isolates could potentially give an unrealistic view of the population 
structure (Spratt and Maiden 1999). Furthermore, the genotypes of P. aeruginosa isolates 
associated with industry have not yet been surveyed. In addition to gaining further insight into 
population biology, genotyping of isolates associated with contamination incidents may be 
useful to industrial practices (White et al. 2011). It is currently unknown whether certain 
strains are more likely to associate with different product types and it would be advantageous 
to uncover potential sources of contamination and identify strains causing recurrent 
contamination problems. Few studies have typed bacterial contaminants of HPC products, 
however a study by Kutty et al.  successfully linked human infection with strains of B. 
cenocepacia to contaminated mouthwash (Kutty et al. 2007). As at present P. aeruginosa strains 
are largely considered to be ubiquitous, it would be interesting to determine whether industrial 
isolates have distinct genotypes, share the same genotypes as those linked with infection or are 
associated with multiple habitats. 
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Table 5.1 Studies investigating the population structure of P. aeruginosa and their major findings
Genotyping technique  Study collection Population structure/comments Reference 
Clondiag Array Tube (AT)-typing  
 
 
 
 
 
 
240 isolates of cystic fibrosis, clinical and environmental 
origin 
Non-clonal epidemic population structure. The majority of strains belonged to 
a few dominant clone types widespread in disease and environmental habitats 
The most common genotype was PA14. 
(Wiehlmann et al. 
2007b) 
134 isolates from patients with chronic obstructive 
pulmonary disease (COPD) and the isolates from 
Wiehlmann et al. (Wiehlmann et al. 2007b) 
No P. aeruginosa clone types were found to be associated with COPD. The most 
prevalent global clone types were also found as the most abundant within the 
COPD population 
(Rakhimova et al. 
2009) 
63 isolates from patients with keratitis and a database of 
strains from three previous studies (Wiehlmann et al. 
2007a; Mainz et al. 2009; Rakhimova et al. 2009)  
Association of a subgroup of P. aeruginosa isolates with keratitis (Stewart et al. 2011) 
381 environmental strains from river systems in North 
Germany 
Certain clonal complexes were found to be associated with different water 
qualities in the river systems 
(Selezska et al. 
2012) 
454 strains from cystic fibrosis patients from 51 centres 
in Europe and Australia, 501 strains of clinical and  
environmental origin (955 strains in total) 
Non-clonal epidemic population structure. No link between clone types and 
environmental and little evidence for a widespread transmissible cystic fibrosis 
clone. The most common clone types were clone C and PA14. 
(Cramer N. et al. 
2012) 
Multi-Locus Sequence Typing (MLST)  
143 isolates of clinical and environmental origin Non-clonal epidemic population structure (Curran et al. 2004) 
34 isolates of clinical and environmental origin. 
Environmental isolates from the open ocean, coastal areas 
and freshwater environments in Japan. 
Certain genotypes were found to be associated with the open ocean (Khan et al. 2008) 
110 strains from 5 Mediterranean countries  and from 
clinical and environmental sources 
Non-clonal epidemic population structure 
(Maatallah et al. 
2011) 
501 isolates of cystic fibrosis, clinical, animal and 
environmental origin 
Non-clonal epidemic population structure. Limited association between 
genotype and ecological setting 
(Kidd et al. 2012) 
Multi-Locus Variable-number tandem-repeat analysis 
(MLVA) 
363 isolates of cystic fibrosis and clinical origin 
Population structure was found to be highly diverse and population specific. 
Clones from non-CF patients were distinct from clones from CF patients. 
Transmission of clones between different groups is rare. 
(van Mansfeld et al. 
2010) 
Random Amplified Polymorphic DNA (RAPD)-PCR typing 162 isolates of cystic fibrosis and clinical origin Associations were found between RAPD-PCR groups and CF or non-CF isolates (Lanotte et al. 2004) 
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Nucleotide sequences of three outer membrane protein 
genes i) oprI, ii) oprL, iii) oprD, iv) Amplified-Fragment 
Length Polymorphism (AFLP), v) serotype, vi) pyoverdine 
type [Bionumerics biological data analysis software used] 
73 clinical and environmental isolates collected mainly in 
the late 1980s and 1990s globally 
Non-clonal epidemic population structure (Pirnay et al. 2002) 
i) oprL gene sequence, ii) ALFP, iii) serotype, iv) 
pyoverdine type, v) antibiogram including 21 MICs of 
clinically relevant antibiotics [Bionumerics biological data 
analysis software used] 
100 isolates from the River Woluwe, Brussels, from water 
samples taken over 1 year 
Non-clonal epidemic population structure (Pirnay et al. 2005) 
i) O serotype, ii) Fluorescent Amplified-Fragment Length 
Polymorphism (FALFP) pattern, nucleotide sequences of 
three outer membrane protein genes, iii) oprI, iv) oprL, 
v) oprD, vi) pyoverdine receptor gene profile (fpvA type 
and fpvB prevalence), and prevalence of vii) exoenzyme 
genes exoS and exoU and viii) group I pilin 
glycosyltransferase gene tfpO [minimum spanning tree 
analysis used] 
328 isolates collected over 125 years from 69 localities in 
30 countries, of human, animal and environmental origin 
Non-clonal epidemic population structure. A core lineage was predominant in 
both disease and environmental habitats globally. Although no evidence was 
found for a widespread transmissible cystic fibrosis clone, the study found the 
multi-drug resistant serotype O12 clone was associated with the nosocomial 
environment   
(Pirnay et al. 2009) 
The presence of the virulence factors lasA, lasB, exoS, 
exoT, exoU and ctx, and zymography of staphylolysin, 
elastase and alkaline protease 
69 isolates from patients with different eye infections, 76 
of clinical and environmental origin (145 in total) 
Non-clonal epidemic population structure 
(Lomholt et al. 
2001) 
Whole genome sequencing 32 isolates from cystic fibrosis patients 
Non-clonal epidemic population structure. The population is composed of 
many unique recombining genotypes with the occurrence of successful 
epidemic clone types that can spread to a higher prevalence 
(Dettman et al. 
2013) 
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5.1.1. Aims 
The aims of this chapter were as follows: 
1) Investigate P. aeruginosa strain diversity associated with HPC products using RAPD-PCR 
typing 
 
2) Examine the population biology of P. aeruginosa by the application of Clondiag AT 
genotyping and multi-locus sequencing typing (MLST)-based methods to a sub-panel of 
industrial strains 
 
3) Determine whether P. aeruginosa genotypes display habitat selection  
 
Hypothesis: P. aeruginosa has a non-clonal epidemic population structure and strains isolated 
from industrial settings share genotypes with strains of cystic fibrosis, clinical and 
environmental origin. 
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5.2. Results 
 
5.2.1. RAPD-PCR genotyping of an industrial P. aeruginosa isolate collection 
 
A collection of 69 P. aeruginosa isolates associated with industry was assembled (Table 2.10) 
and genotyped using RAPD typing (section 2.10.1.1).  Within this collection were isolates from 
contaminated home and personal care products (n=65), along with reference strains used in 
industrial testing (n=4).  Of the reference strains used in industrial testing, 1 was of clinical 
origin (RW151), 1 was of environmental origin (RW198) and 2 were of unknown origin 
(RW196 and RW197).  A dendrogram illustrating the similarities between RAPD-PCR profiles 
the isolates is shown in Figure 5.1.  Using a cut off of 80% profile similarity, above which isolates 
were considered same strain, 26 different strain types were identified by RAPD, indicated by the 
different branch colours on the dendrogram (Figure 5.1).   
Three factors made it difficult to draw robust conclusions regarding any links between strain 
and isolation location or product type: 1) the collection comprised sequential isolates from the 
same location and same product type, as demonstrated by the large number of dish wash liquid 
isolates from Italy sharing the same RAPD type; 2) there was a bias toward isolates from dish 
wash liquid (DWL; n=41), with other product types being underrepresented, for example fabric 
wash (FWS; n=1) and liquid abrasive cleaner (LAC; n=3), and; 3) not all isolates had 
comprehensive background information (isolation date/isolation location/product type), with 
different amounts of information being available for each isolate.   
Despite these limitations, the following traits were noted from the RAPD genotyping (Figure 
5.1). Four different strain types were associated with products from Italy, RW130 (DWL isolate; 
Italy RAPD type 1), the cluster encompassing RW120, RW151, RW121, RW122, RW131, RW132, 
RW119, RW128, RW124, RW126, RW137, RW145, RW146, RW125 and RW174 RW129 (All 
DWL isolates except RW151; Italy RAPD type 2), RW138 (LAC isolate; Italy RAPD type 3) and 
RW129 (DWL isolate; Italy RAPD type 4).  Within the ‘Italy RAPD type 2’ cluster, all of the 
isolates from Italy were isolated in 2010 except RW#146, which was isolated in 2004, 
suggesting a recurrent contaminating strain.  One strain type was detected in DWL products 
from Indonesia, one from Thailand and three from Malaysia, and there were no overlaps  
between DWL strain types isolated from different geographic locations.  In contrast, there was 
profile similarity between RW138 isolated from an LAC in Italy, and RW133 and RW144 which 
were both isolated from DWL products in Thailand. The same RAPD strain type was also 
observed to be associated with more than one product type, for the cluster containing RW138 
(LAC product), RW144, RW133 and RW134 (DWL products), and RW115 (SC product). 
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However, the main trend from the RAPD analysis was to show that more than one strain type 
can be associated with the same product type.  Interestingly, RW151 (a reference strain isolated 
from clinical settings) has the same profile as a strain type associated with DWL contamination 
in Italy (RW#131 and RW#146), demonstrating overlap between clinical and industrial RAPD 
types (Figure 5.1). 
Using this dendrogram, 19 isolates were chosen for further analysis (see Figure 5.1, strains with 
black box outlines around the RW IDs).  These isolates were chosen to be representative of the 
RAPD profile diversity of the industrial isolate collection.  In general each selected isolate 
belonged to a different RAPD dendrogram cluster, with the exception of RW151 (reference 
strain, isolated from clinical settings), RW131 (DWL strain type, isolated from Italy in 2010) and 
RW146 (DWL strain type, isolated from Italy in 2004) in order to observe differences between 
isolates of the same stain which had been isolated from different sources and dates.  Along with 
five other strains recovered from clinical and environmental sources (RW11, RW18, RW27, 
RW30 and RW99; see Table 5.2), the 19 isolates associated with industrial settings were 
subjected to AT genotyping and WGS, to gain further insight into the population biology of P. 
aeruginosa in industry.   
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Figure 5.1 Clustered RAPD-PCR profiles of 69 industrial P. aeruginosa isolates. A Pearson correlation similarity coefficient was 
used to construct a UPGMA dendrogram of the RAPD-PCR profiles.  The PCR fingerprint profile of each isolate is shown to the right 
of the dendrogram, along with the isolate number in the RW collection (ID#) and coloured coded information about isolate 
provenance. Percentage similarities are indicated by the scale bar and on the branches of the dendrogram.  Profiles sharing ≥80% 
similarity were putatively considered same strain and different strain types are indicated by different coloured branches. Black 
boxes around ID numbers indicate isolates selected for Clondiag AT typing and genome sequencing. Preservative efficacy testing 
(PET) strains (IDs #109 and 110) and reference strains (IDs #151, 196, 197 and 198) are those used in antimicrobial efficacy testing 
in industry. Product type codes are follows: TC, timber care; MWF, metal working fluid; DWL, dish wash liquid; SC, surface cleaner; 
PC, personal care product; LAC, liquid abrasive cleaner; FWS, fabric wash.  
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5.2.2. Clondiag AT genotyping of a P. aeruginosa strain panel 
 
A collection of 24 strains was genotyped using the AT genotyping system (Table 5.2; see section 
2.10.2 for method). The strains originated from clinical (n=5), environmental (n=2), industrial 
(n=16) and unknown (n=1) sources.  AT-genotypes were obtained for 23 out of the 24 strains, 
with no AT-genotype being recorded for the industrial strain RW168.2. The strains belonged to 
18 different AT-genotypes as shown in Table 5.2.  The 16 strains isolated from contaminated 
industrial products belonged to 11 different AT-genotypes.  The AT-genotypes of the 23 strains 
were compared to a database containing 917 P. aeruginosa strains from diverse sources.  This 
collection was a sub-set of the 955-strong panel used by Cramer et al. to investigate the 
diversity of cystic fibrosis P. aeruginosa isolates (Cramer N. et al. 2012); only strains from the 
panel which had complete 16-digit binary codes were used in the present analysis.  Comparison 
with the database revealed that of the 18 different AT-genotypes, 5 were novel, with 4 of the 
novel genotypes belonging to industrial strains.  The other AT-genotypes were shared with 
previously recognised clones or genotypes associated with different environments as 
elaborated in Table 6.   
The eBURST algorithm grouped the 240 genotypes found from the collection of 940 strains into 
8 small clonal complexes, one very large clonal complex and 45 singletons (Figure 5.2; only the 
14 genotypes of industrial testing reference strains and strains from contaminated products are 
highlighted in the eBURST diagram).  740 (79% of the collection) strains belonging to 170 
genotypes made up the one very large clonal complex with 10 out of the 11 genotypes of strains 
isolated from industrial products being found within this group.  The overall P. aeruginosa 
eBURST population structure was similar to that of Cramer et al. (Cramer N. et al. 2012), 
depicting a population where recombination, rather than point mutation, is the major force 
driving evolution (Turner et al. 2007).  The eBURST analysis also illustrated that the population 
was represented by a few dominant abundant clones (shown by the larger circles in Figure 5.2), 
and multiple rarer genotypes.  There were overlaps between genotypes isolated from different 
environments (Cramer N. et al. 2012), although this is not shown on Figure 5.2 as the isolation 
sources are not elaborated.  This diverse spread of strains was also the case for strains isolated 
from industrial products, as 1) 4/11 (36%) of the genotypes were novel, and 2) the remaining 7 
industrial genotypes had been associated previously with varied habitats, for example cystic 
fibrosis patients, clinical settings and the natural environment, and previously documented P. 
aeruginosa clone types (Clones Y, D, B and X) (Table 5.2). 
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Table 5.2 ArrayTube (AT) genotypes of Pseudomonas aeruginosa strains 
Strain 
(RW#) 
Other strain 
designations 
Isolation source/comment 16 digit code Hexadecimal code 
(AT-genotype) 
Database match and comments 
11 NCTC 12903; 
ATCC 27853 
CLIN; Antibiotic efficacy testing reference strain; originally 
isolated from blood 
0001-1011-1010-1010 1BAA Novel type 
18  CLIN; Chronic prostatitis isolate  1101-0100-0010-0001 D421 Clone A (PA14), previously associated with CF,CLIN, COPD, 
KER, ENV 
27 A128 CF; (Mahenthiralingam et al. 1996)  1110-1000-0100-1010 E84A Clone A12, previously associated with CF, CLIN 
30 A128a CF; (Mahenthiralingam et al. 1996)  1110-1000-0100-1010 E84A Clone A12, previously associated with CF, CLIN 
99 MB2.2 ENV; Domestic isolate, washing machine drawer biofilm 1110-1010-0000-1010 EA0A Clone A3, previously associated with CF, CLIN, COPD, KER, 
ENV 
109*  IND; Strain used in preservative efficacy testing 0110-1100-0010-0010 6C22 Clone Y, previously associated with CF, ENV 
110*  IND; Strain used in preservative efficacy testing 1111-0100-0110-1001 F469 Clone D,  previously associated with CF, CLIN, COPD, KER, 
ENV 
130*  IND; DWL; Italy; isolated 2010 (Italy RAPD type 1) 1010 -1111-1010-1010 AFAA Novel type 
131*  IND; DWL; Italy; isolated 2010 (Italy RAPD type 2) 1010 -1111-1010-1010 AFAA Novel type 
138*  IND; LAC; Italy; isolated 2001(Italy RAPD type 3) 0110-1101-1001-0010 6D92 Clone H, previously associated with CF, CLIN, COPD, ENV 
146*  IND; DWL; Italy; isolated 2004 (Italy RAPD type 2) 1010 -1111-1010-1010 AFAA Novel type 
149*  IND; PC; origin location unknown; isolated 2003   0010-1100-0101-0010 2C52 Novel type 
151* ATCC 9027 CLIN; reference strain used in industrial testing; originally 
isolated from an outer ear infection (Italy RAPD type 2) 
0101-1100-0001-1010 5C1A Novel type  
168.2*  IND; FWS029; typing unsuccessful - - - 
172*  IND; DWL; suspected origin is Thailand; isolated 2009 1110-0100-0010-1001 E429 Clone B, previously associated with CF, CLIN, COPD, KER, 
ENV 
176*  IND; DWL; Indonesia; isolated 2010 0010-1100-0101-0010 2C52 Novel type 
184*  IND; DWL; UK; isolated 2006 0001-1011-1010-1010 1BAA Novel type 
192*  IND; SC; isolated from a contaminated product whilst on 
placement at Unilever 2012   
0110-1100-0010-0010 6C22 Clone Y, previously associated with CF, ENV 
196* ATCC 13388; 
NCTC 8060 
Origin unknown; reference strain used in industrial testing (ISO 
846C) 
0000-1011-1001-0010 0B92 Clone X, previously associated with ENV 
198* ATCC 15442 ENV; reference strain used in industrial testing, originally 
isolated from an animal room water bottle 
0000-0101-1001-1010 059A Genotype associated with CF 
199*  IND; MWF 0010-1111-1010-1010 2FAA Genotype associated with CF and ENV 
200*  IND; TC 0010-1011-1001-0010 2B92 Novel type 
202*  IND; LAC; EU; isolated 2012 1011-0100-0110-1001 B469 Genotype associated with KER 
204*  IND; DWL; isolated 2012 0010-1100-1001-1010 2C9A Genotype associated with ENV 
Abbreviations: CLIN, clinical; CF, cystic fibrosis; COPD, chronic obstructive pulmonary disease; KER, keratitis; ENV, environmental; IND, industrial; DWL, dish wash liquid; LAC, liquid abrasive cleaner; PC, personal care product; FWS, 
fabric wash; SC, surface cleaner; MWF, metal working fluid; TC, timber care; RAPD, random amplified polymorphic DNA typing. Genotypes highlighted in blue are strains isolated from the same geographic location at different dates, 
with the exception of RW#151 which is a reference strain used in ‘period after opening’ studies at Unilever. The RAPD types of these 5 strains have been detailed in order to investigate concordance between RAPD and AT genotyping 
methods. 
*AT-genotypes for these strains (as strains associated with industry) are highlighted in Figure 5.2 
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Figure 5.2 Distribution of industrial strains in the P. aeruginosa population. The clonal complex structures of 940 strains from individuals with cystic fibrosis, other human 
infections, environmental sources and industry (n=15) are shown, in addition to reference strains used in industrial testing but initially isolated from clinical (n=1; 5C1A), 
environmental (n=1; 059A) and unknown sources (n=1; 0B92) .  Clonal complexes were calculated from the 16-marker AT genotype of the core genome by the eBURST algorithm. 
AT-genotypes are indicated by the black, blue and yellow circles, with the diameter of the circle being proportional to the number of isolates with this genotype. Founding AT-
genotypes are shown in blue, subfounders in yellow and prevalent clones are marked with light blue letters next to their corresponding AT-genotype.  The AT-genotypes that the 18 
industry-associated strains belong to are marked with closed (previously reported AT-genotypes) and broken (novel AT-genotypes) red circular outlines. Four letter AT-genotypes 
are indicated in black next to the red circular outlines.  
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5.2.3. Genomic diversity of P. aeruginosa strains 
 
To define the population biology of the 24 selected RW strains (Table 5.2) at high resolution, 
WGS and analysis was performed (see methods section 2.10.3). Using the BIGSdb software 
platform 44 P. aeruginosa strains (Table 5.3), including the 24 genome sequenced strains from 
the RW collection and a selection of P. aeruginosa strains from the PubMLST database, were 
subjected to MLST,  rMLST and wgMLST to investigate overall genomic diversity (Maiden et al. 
2013).  
5.2.3.1. MLST 
 
MLST profiles, based on the scheme of Curran et al. (Curran et al. 2004), were generated for all 
44 P. aeruginosa strains, resulting in a total of 32 seven-locus sequence types (STs), of which 6 
were novel (strains 2192, C3719, MTB-1, RW110/RW202, RW130/RW131/RW146, and 
RW168.2)(Table 5.3). New alleles were found at the gua (strains 2192 and C3719) and mut loci 
(strains 2192 and 168.2). Only 3 strains were assigned to clonal complexes by the BIGSdb 
analysis, PAO1 (PAO1 clonal complex), UCBPP-PA14 and RW18 (both PA14 clonal complex). 
The industrial isolates were represented by 10 STs, which were a mixture of previously found 
(7 STs) and novel STs (3 STs).  Searches of the PubMLST databases indicated that STs of the 
majority of strains, including those of industrial origin, have been associated with multiple 
environments (Table 5.3). Two exceptions were found, both of which were strains of cystic 
fibrosis origin (LESB58 and LES431), and members of the Liverpool epidemic strain type 
(Fothergill et al. 2012). The phylogenetic network produced from the 44 MLST profiles shown 
in Figure 5.3 illustrates the diversity of the P. aeruginosa strains that were investigated.  Aside 
from the clustering of LESB58 and LES431, strains of diverse origin were distributed fairly 
evenly throughout the network, suggesting no association between ST and isolation source 
(Figure 5.3). 
 
5.2.3.2. rMLST 
 
All 53 ribosome protein subunits (rps genes) were identified in 42 out of the 44 P. aeruginosa 
strains allowing rMLST analysis (Jolley et al. 2012a) to be performed. The strains 2192 and 
C3719 were excluded from further analysis as they had multiple missing or truncated rps loci 
within their rMLST profiles. A total of 7 new rps alleles (strain VRFPA04 at the BACT000020, 
BACT000053 and BACT000057 loci; RW168.2 at the BACT000001  and BACT000007 loci; 
RW204 at the BACT000040 locus, and; NCGM_1984 and NCGM_1900 at the BACT000012 locus) 
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and 36 unique ribosomal MLST profiles (rSTs) were identified from the 42 complete rMLST 
profiles. Strains sharing the same rST were RW130/RW131/R146, RW110/RW202, 
RW109/RW192, RW27/RW30 and NCGM_1984/NCGM_1900. A greater number of unique STs 
was observed for rMLST (n=36), which profiles 53 loci, than MLST (n=32), which profiles only 7 
loci (Curran et al. 2004). The NeighbourNet phylogeny based on the complete rMLST profiles of 
the 42 P. aeruginosa strains (Figure 5.4), however, showed good congruence with the MLST 
NeighbourNet phylogeny (Figure 5.3).  Strains were grouped into the same clusters with both 
approaches, although resolution at the nodes was improved for the rMLST profiles. Clusters 
included: RW130, RW131 and RW 146; ATCC 12903 and RW184; RW27 and RW30; LESB58 and 
LES431; RW109, RW138 and RW192; RW149 and RW176; RW18 and UCBPP-PA14; RW110 
and RW202, and; NCGM_1984, NCGM_1900 and NCGM2.S1.  
5.2.3.3. wgMLST 
 
wgMLST (Maiden et al. 2013)was performed with the 44 P. aeruginosa strains using the genome 
sequence of P. aeruginosa UCBPP-PA14 as a comparator for analysis. Out of the 5883 loci 
identified in the P. aeruginosa UCBPP-PA14 reference genome, 4579 were shared between all P. 
aeruginosa strains.  A NeighbourNet phylogeny generated by pairwise comparisons of the 4579 
shared loci is shown in Figure 5.5. The degree of reticulation seen in the wgMLST NeighbourNet 
plot (Figure 5.5) is greatly reduced compared to the MLST and rMLST NeighbourNet plots 
(Figures 5.3 and 5.4, respectively), illustrating the increased resolution afforded by including a 
higher number of loci in the analysis.  Although each strain was identified as a unique ST by 
wgMLST (n=44 STs), there was concordance between the clusters of strains found by all three 
MLST-based methods. The same strain groupings were found as those outlined in section 5.3.3.2 
for the rMLST scheme.  The NeighbourNet plot topology suggested the divergence of a lineage 
containing RW110, RW202, NCGM_1984, NCGM_1900, NCGM2.S1, RW172, MTB-1, UCBPP-PA14, 
RW18, VRFPA04, B136-33 and PA7 from the larger strain subgroup. To clarify this, more strains 
would need to be included in the analysis. 
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Table 5.3 MLST allele and Sequence Type (ST) designations for the 44 P. aeruginosa strains 
P. aeruginosa  
strain 
Isolation 
source 
MLST loci 
ST ST isolation sourcesa 
clonal complexa 
(AT-type clone)b acs aro gua mut nuo pps trp 
LESB58 CF 6 5 11 3 4 23 1 146 CF (Clone T) 
PAO1 CLIN 7 5 12 3 4 1 7 549 * PA01 (Clone W)  
UCBPP-PA14 CLIN 4 4 16 12 1 6 3 253 CF, CLIN, ENV, OTHER PA14 (Clone A) 
PA7 CLIN 87 34 43 37 53 107 126 1195 OTHER 
 
2192 CF 6 6 - - 3 4 7 Novel 1   
C3719 CF 28 5 - 18 4 13 3 Novel 2  (Clone O) 
PACS2 CF 11 5 6 3 74 13 7 1394 * 
 
B136-33 CLIN 2 4 24 3 1 6 25 1024 * 
 
DK2 CF 17 5 11 18 4 10 3 386 CF, SPUTUM (Clone A2) 
LES431 CF 6 5 11 3 4 23 1 146 CF (Clone T) 
M18 ENV 16 5 1 3 4 15 7 1239 OTHER 
 
MTB-1 ENV 5 8 3 5 1 11 3 Novel 3   
NCGM2.S1 CLIN 38 11 3 13 1 2 4 235 CF, CLIN, ENV, OTHER 
 
PA1 ENV 15 3 3 11 1 15 1 782 CF, OTHER 
 
RP73 CF 11 5 11 11 3 27 7 198 CF, CLIN 
 
SCV20265 CF 17 5 36 3 3 7 3 299 CF, OTHER 
 
VRFPA04 CLIN 32 13 24 13 1 6 25 823 * 
 
F22031 CLIN 11 76 5 3 61 14 3 485 CF  
NCGM_1984 CLIN 38 11 3 13 1 2 4 235 CF, CLIN, ENV, OTHER  
NCGM_1900 CLIN 38 11 3 13 1 2 4 235 CF, CLIN, ENV, OTHER  
RW 11; NCTC_12903 CLIN 28 5 36 3 3 13 7 155 CF, ENV, OTHER  
RW18 CLIN 4 4 16 12 1 6 3 253 CF, CLIN, ENV, OTHER PA14 (Clone A) 
RW27 CF 6 5 6 34 27 3 7 162 CF, CLIN (Clone A12) 
RW30 CF 6 5 6 34 27 3 7 162 CF, CLIN (Clone A12) 
RW99 ENV 6 5 6 7 4 6 7 27 CF, CLIN, ENV, OTHER (Clone A3) 
RW109 IND 17 5 5 4 4 4 3 111 CF, CLIN, ENV, OTHER (Clone Y) 
RW110 IND 5 141 65 151 1 33 50 Novel 4  (Clone D) 
RW130 IND 15 48 20 142 4 7 7 Novel 5   
RW131 IND 15 48 20 142 4 7 7 Novel 5   
RW138 IND 17 5 5 4 4 4 3 111 CF, CLIN, ENV, OTHER  
RW146 IND 15 48 20 142 4 7 7 Novel 5   
RW149 IND 1 5 26 3 1 10 3 1342 OTHER  
RW151; ATCC 9027 CLIN 23 5 12 30 1 4 7 1105 CF 
 
RW168.2 IND 40 5 3 - 73 75 2 Novel 6   
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RW172 IND 13 8 9 3 1 6 9 316 CF, CLIN, ENV, OTHER (Clone B) 
RW176 IND 1 5 26 3 1 10 3 1342 OTHER  
RW184 IND 28 5 36 3 3 13 7 155 CF, ENV, OTHER  
RW192 IND 17 5 5 4 4 4 3 111 CF, CLIN, ENV, OTHER (Clone Y) 
RW196; ATCC 13388 UNKNOWN 17 5 12 3 14 4 7 244 CF, CLIN, ENV, OTHER (Clone X) 
RW198; ATCC 15442 ENV 6 28 4 3 3 4 7 252 CF, CLIN, ENV, OTHER  
RW199 IND 17 22 11 3 3 15 3 800 CF  
RW200 IND 6 5 6 5 4 4 7 641 CLIN  
RW202 IND 5 141 65 151 1 33 50 Novel 4   
RW204 IND 6 5 5 3 3 13 1 645 CF, CLIN,ENV  
 
CLIN, clinical; CF, cystic fibrosis; ENV, environmental; IND, industrial; ‘ – ’ designates a new allele type or ST not within the PubMLST database; aIsolation source and clonal complex 
from PubMLST database; bclone type from AT-genotyping and database searches; ‘*’ no information available on PubMLST database for this ST; Cells within the ST column shaded in 
the same colour correspond to the same MLST profile 
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Figure 5.3 Multilocus sequence 
typing (MLST)-based analysis of P. 
aeruginosa whole genome 
sequence data. The diversity of the 
44 P. aeruginosa strains based on the 
allelic diversity at 7 MLST loci is 
illustrated. Analyses were carried out 
using the Genome Comparator tool of 
the BIGSdb and phylogenetic 
networks generated using the 
NeighbourNet algorithm in SplitsTree 
v4.13.1. Strain names are colour 
coded to indicate isolate source: 
purple strains are of cystic fibrosis 
origin; orange strains are of clinical 
origin; green strains are of 
environmental origin; blue strains are 
of industrial origin, and; black strains 
are of unknown origin. Sequence 
types are shown in grey next to strain 
names on the phylogenetic network. 
The scale bar represents distances 
calculated from the number of loci.  
ST-162
ST-198
ST-1394
ST-155
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ST-244
ST-549
ST-1239
Novel ST
Novel ST
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Figure 5.4 Ribosomal multilocus sequence typing (rMLST)-based analysis of P. aeruginosa whole genome sequence data. The diversity of 42 P. aeruginosa strains based on 
the allelic diversity at 53 rMLST loci is illustrated. P. aeruginosa strains with incomplete rMLST profiles (2192 and C3719) were excluded.  Analyses were carried out using the 
Genome Comparator tool of the BIGSdb and phylogenetic networks generated using the NeighbourNet algorithm in SplitsTree v4.13.1. Strain names are colour coded to indicate 
isolate source: purple strains are of cystic fibrosis origin; orange strains are of clinical origin; green strains are of environmental origin; blue strains are of industrial origin, and; black 
strains are of unknown origin. The scale bar represents distances calculated from the number of loci.  
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Figure 5.5 Whole genome 
multilocus sequence typing 
(wgMLST)-based analysis of P. 
aeruginosa whole genome 
sequence data. The diversity of 
the 44 P. aeruginosa strains 
based on the allelic diversity at 
4579 loci of a reference genome 
sequence (P. aeruginosa UCBPP-
PA14) is illustrated. Analyses 
were carried out using the 
Genome Comparator tool of the 
BIGSdb and phylogenetic 
networks generated using the 
NeighbourNet algorithm in 
SplitsTree v4.13.1. Strain names 
are colour coded to indicate 
isolate source: purple strains are 
of cystic fibrosis origin; orange 
strains are of clinical origin; 
green strains are of 
environmental origin; blue 
strains are of industrial origin, 
and; black strains are of 
unknown origin. The scale bar 
represents distances calculated 
from the number of loci.  
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5.2.4. Congruence between genotyping methods 
 
Broadly, where genotypes were shared between multiple strains there was agreement between 
the AT-genotypes and the MLST STs (Table 5.4). Exceptions to this were the strains RW109, 
RW192 and RW138 which shared the MLST genotype ST-111, but were represented by two 
different AT-genotypes (RW109 and RW192 were 6C22, whilst RW138 was 6D92), and RW110 
and RW202 which were both classed as Novel ST-4 by  MLST but had different AT-genotypes, 
F469 and B469 respectively. Between the AT-genotypes 6C22 and 6D92 there were differences 
in 4/16 single nucleotide polymorphisms (SNPs) of the core genome (C → D, 1 SNP change; 2 → 
9, 3 SNP changes), whilst between F469 and B469 there was 1 SNP difference (F → B). As little 
as 1 SNP change can lead to a change in AT genotype, but it is unknown how many SNP changes 
correspond to a change in ST as defined by MLST.      
 
There was less congruence between RAPD-PCR types and the AT genotypes or MLST STs. Of the 
genotype clusters observed for AT-genotyping or MLST (Table 5.4) only two strains within one 
cluster shared the same RAPD profile (RW131 and RW146). There were also examples where a 
strain within a cluster had a different RAPD profile to others of the same AT genotype or ST 
(RW130 within the RW130, RW131 and RW146 cluster, and strains of the RW109, RW192 and 
RW138 cluster), and where a strain had the same RAPD profile as strains within a cluster, but 
did not share the AT genotype or ST (RW151 had the same RAPD profile as both RW131 and 
RW146). RAPD-typing was used only as a preliminary genotyping method aimed at removing 
multiple highly clonal strains obtained from single sources (e.g. sequential isolates from the 
same contamination incident), however, and was not used to inform population structure 
investigations.    
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Table 5.4 Genotypes associated with the clusters of P. aeruginosa strains identified by MLST. 
Strain Isolation source/comment AT-genotype MLST* 
RW130 IND; DWL; Italy; isolated 2010 (Italy RAPD type 1) 
AFAA Novel ST-5 RW131 IND; DWL; Italy; isolated 2010 (Italy RAPD type 2) 
RW146 IND; DWL; Italy; isolated 2004 (Italy RAPD type 2) 
ATCC 12903 
CLIN; Antibiotic efficacy testing reference strain; originally 
isolated from blood 1BAA ST-155 
RW184 IND; DWL; UK; isolated 2006 
RW27 CF; (Mahenthiralingam et al. 1996)  
E84A ST-162 
RW30 CF; (Mahenthiralingam et al. 1996)  
LESB58 CF 
4C12 ST-146 
LES431 CF 
RW109 IND; Strain used in preservative efficacy testing 
6C22 
ST-111 RW192 
IND; SC; isolated from a contaminated product whilst on 
placement at Unilever 2012   
RW138 IND; LAC; Italy; isolated 2001(Italy RAPD type 3) 6D92 
RW149 IND; PC; origin location unknown; isolated 2003   
2C52 ST-1342 
RW176 IND; DWL; Indonesia; isolated 2010 
RW18 CLIN; Chronic prostatitis isolate  
D421 ST-253 
UCBPP-PA14 CLIN 
RW110 IND; Strain used in preservative efficacy testing F469 
Novel ST-4 
RW202 IND; LAC; EU; isolated 2012 B469 
NCGM_1984 CLIN 
- ST-235 NCGM_1900 CLIN 
NCGM2.S1 CLIN 
 
Abbreviations: MLST, multi-locus sequence typing; AT-typing, Array-Tube typing; CLIN, clinical; CF, cystic fibrosis; 
IND, industrial; DWL, dish wash liquid; LAC, liquid abrasive cleaner; PC, personal care product; RAPD, random 
amplified polymorphic DNA typing. Genotypes highlighted in blue are strains isolated from the same geographic 
location at different dates  
 
*only STs for the 7-loci MLST scheme are given as clustering of strains within NeighbourNet phylogenies for MLST, 
rMLST and wgMLST resulted in the same strain groups; ‘–’ AT-genotype unknown 
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5.3. Discussion 
 
Strain typing techniques are not routinely applied to industrial contaminants, and as such the 
diversity of bacterial strains in industrial settings is unknown.  In addition, no population 
biology studies of P. aeruginosa have included isolates of industrial origin, having mainly 
focussed on clinically relevant strains and, to a lesser extent, environmental strains. The 
population structure of P. aeruginosa is thought to be non-clonal epidemic, with clinical isolates 
being indistinguishable from environmental isolates in terms of genotypic, taxonomic and 
metabolic characteristics (Morales et al. 2004; Pirnay et al. 2009; Cramer N. et al. 2012).   This 
chapter genotyped a collection of clinical, environmental and industrial P. aeruginosa isolates to 
determine if specific strains/dominant clones were associated with industrial contamination, 
and if these strains were genetically different to those encountered in clinical and natural 
environments.   
 
5.3.1. Strain diversity and population biology of P. aeruginosa in industry  
 
To gain insight into the strain diversity associated with contaminated HPC products, a collection 
of 69 industrial P. aeruginosa isolates were subjected to RAPD-PCR typing, leading to the 
identification of 26 different strain types.  No firm conclusions could be drawn linking strain 
type to product type or isolation location due to limitations with the dataset, but there was 
overlap between strain types and product types suggesting no selection for habitat; when 
overlaps in RAPD strain type were observed these were primarily linked to isolates from the 
same contamination incident.  RAPD typing facilitated the selection of industrial P. aeruginosa 
strains for further genotypic analyses; 19 isolates from the industrial collection were chosen on 
the basis of the RAPD typing.  
To investigate P. aeruginosa population biology at greater resolution more robust strain typing 
techniques were used.  Twenty-four P. aeruginosa strains, 19 of which were associated with 
industry, were subjected to AT-typing and WGS for MLST-based analyses.  AT types were 
obtained for 23 strains and compared to 917 other P. aeruginosa strains held within a 
previously established database (Cramer N. et al. 2012). This revealed that 4/11 of the 
genotypes were novel, with the remaining types being previously found and linked to diverse 
environments. The AT genotypes were also mainly spread throughout the largest clonal 
complex of the eBURST diagram suggesting that they were more related to each other than they 
were to genotypes isolated from other environments.  Even though the industrial strain panel 
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was small (<5% total strains within the AT-typing database), the genotype distribution 
corroborated the current hypothesis that isolates from different environments are genotypically 
highly similar to each other.  Due to the limited numbers of the industrial strain panel, the 
topology of the eBURST diagram was not dramatically changed from that of Cramer et al. 
(Cramer N. et al. 2012) and indicated a non-clonal epidemic population structure. To 
comprehensively assess P. aeruginosa population structure, future investigations need large 
numbers of similar proportions of strains from different environments, including industry. 
The sequence-based typing techniques MLST, rMLST and wgMLST (Maiden et al. 2013) were 
also used to genotype the 24 strains from the AT-typing investigations, in addition to a further 
20 P. aeruginosa strains from the PubMLST database representing diverse isolation sources. The 
results of the seven-locus MLST indicated that, similarly to the AT-typing analysis, industrial 
strains belonged to a mixture of previously documented (7/10) and novel STs (3/10), with the 
previously found STs being associated with multiple habitats. In addition, all of the previously 
found STs from the panel (Table 5.3) had been found in a variety of environments with the 
exception of the two cystic fibrosis-linked strains LESB58 and LES431. There is other evidence, 
however, to suggest these strains are not restricted to cystic fibrosis patients; the LES has 
caused respiratory infections in parents of a non-CF patient (McCallum et al. 2002), and has also 
been associated with transmission to a pet cat (Mohan et al. 2008), although for both of these 
studies the primary source of the infecting strain was a CF individual.  
The NeighbourNet plots of the MLST, rMLST and wgMLST data illustrated that the novel 
industrial STs did not cluster together, but were diverse. In addition, whilst the resolution was 
improved as an increasing number of loci were incorporated in the MLST schemes, the same 
strain clusters were identified for all three typing techniques. The clustering of certain strains 
was expected, for example for RW130, RW131 and RW146 (DWL strains from Italy, two of 
which shared the same RAPD profile), but not expected for others. For example, although other 
industrial strains did cluster together, the strains were of different industrial origins 
(RW109/RW192/RW138, RW149/RW176 and RW110/RW202) and one cluster comprised 
strains of clinical and industrial origin (ATCC 12903 and RW184). Overall there was no clear 
link between genotype and isolation source.   
An interesting observation from the NeighbourNet plot of the wgMLST comparison was the 
divergence of a subgroup of strains from a larger ‘core’ group (Figure 5.5), which was not 
apparent from the MLST or rMLST analysis. A recent paper by Stewart et al. (Stewart et al. 
2014) used core genome SNP analysis to compare the genomes of 55 P. aeruginosa strains, and 
had similar findings.  The analysis identified two major subgroups and a third smaller outlier 
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group containing only two isolates, which included PA7.  Strains shared between Stewart et al. 
and this PhD study fell into the same subgroups: Group 1 shared strains included PACS2, PAO1, 
C3719, DK2, M18 and LESB58; Group 2 shared strains included B136-33, NCGM2S1 and PA14. 
In this chapter, P. aeruginosa PA7, RW202 and RW110 fell outside of the two major groups. As 
concluded by Stewart et al., it is unknown whether strains from Group 1 are actually more 
abundant than those from Group 2. It is a possibility that a bias in strain selection could have 
resulted in the NeighbourNet plot topology, and the inclusion of more strains would populate 
the branches. 
5.3.2. Genotyping methods for the investigation of P. aeruginosa population biology 
 
Five genotyping methods were investigated during this chapter to assess strain diversity, 
belonging to three categories: 1) PCR fingerprinting-based methods; 2) micro probe array-
based methods, and; 3) sequence-based methods. For P. aeruginosa, RAPD-typing, AT-typing 
and seven-locus MLST have previously been used, with AT-typing and MLST being used most 
extensively in population biology investigations (Table 5.1). These methods either sample the 
whole genome (RAPD) or variation within the core genome (AT-typing, seven-locus MLST). 
Whilst AT-typing and MLST have previously been shown to demonstrate good concordance for 
P. aeruginosa, RAPD typing has higher discriminatory power and is sensitive to genomic 
rearrangements, which may decrease its utility (Hall et al. 2013). In this chapter, RAPD typing 
was used as a preliminary screen to select strains for further investigations. It was found that, 
similarly to Hall et al. (Hall et al. 2013), there was not complete congruence between RAPD and 
the other typing methods, but AT-typing and seven-locus MLST genotypes were generally 
concordant. 
With the advent of rapid, high-throughput sequencing methods which are becoming 
increasingly cost effective, it is possible to generate accurate WGS data for bacterial isolates 
(Maiden et al. 2013). Genotyping schemes can take advantage of this data to provide high 
resolution typing of isolates. The gene-by-gene approach to typing, which is an extension of the 
MLST scheme, is as a versatile means of examining variation between genome sequences 
(Maiden et al. 2013). MLST analyses are scalable to include few or many genes and may be 
tailored to the species under investigation. In this chapter, WGS data of P. aeruginosa strains 
was used for MLST, rMLST and wgMLST using BIGSdb (Jolley and Maiden 2010). Increasing the 
number of loci from 7 (MLST), to 53 (rMLST), to 4579 (wgMLST) resulted in the same strains 
clustering together in the NeighbourNet plots, but greatly increased the resolution of typing 
though an increasingly genome-wide analysis.  Although only performed for AT-typing in this 
chapter, eBURST analysis can be applied to other MLST datasets to identify clonal complexes or 
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lineages and investigate population structure (Feil et al. 2004). Extended MLST typing schemes 
utilising the gene-by-gene approach could therefore be analysed using eBURST. 
There are limitations to the gene-by-gene approach however, including that only loci which 
have been defined will be identified and that loci split over more than one contig of the genome 
assemblies will not be found by BIGSdb (Sheppard et al. 2012). These problems may be negated 
as assembly and annotation of genomes improves. One further issue with wgMLST is that a 
reference sequence is required; this will dictate the genes that are included in the analysis and 
potentially divide the comparator population into groups which are similar or dissimilar to the 
reference sequence (Sheppard et al. 2012). Whilst less user-friendly than BIGSdb, other 
computational methods are available to compare the full genetic content of bacterial genomes. 
One such method is the large-scale blast score ratio (LS-BSR) pipeline, which does not use a 
reference sequence and can identify and compare coding sequences in a set of bacterial 
genomes (Sahl et al. 2014). Further investigations with software such as the LS-BSR pipeline 
could be performed to gain insight into the pangenome of the P. aeruginosa strains examined in 
this study and potentially identify any industrial-isolate specific genes that were absent in the 
core genome. 
5.3.3. The utility of strain typing methods in industry 
 
Bacterial strain typing techniques are very important in epidemiological investigations, having 
the ability to link strain types to an outbreak of disease locally or globally, trace sources of 
infection and monitor the success of treatment for a bacterial infection (Spratt and Maiden 
1999).  In industry the use of strain typing techniques is rare, but has been applied to bacterial 
contaminants of HPC products; repetitive element PCR and PFGE were employed to link B. 
cenocepacia strains from a contaminated mouthwash to human infection (Kutty et al. 2007). 
Another industry-related case, involving human infection from the consumption of 
contaminated turkey products, used PFGE to link a strain of Listeria monocytogenes from a food-
processing plant to the outbreak (Olsen et al. 2005). The outbreak strain also shared the same 
PFGE profile as a L. monocytogenes strain identified in the plant 12 years earlier, suggesting 
persistence of the strain leading to recurrent product contamination (Olsen et al. 2005).  
 
In this chapter, three strains, which were known DWL contaminants from Italy but collected 6 
years apart (RW130/131 and RW146), clustered together as the same AT-type and ST. It is 
therefore likely that a persistent strain is present in the manufacturing environment in Italy. 
This information could be useful for informing industry if cleaning and decontamination 
practices have been successful and identify problematic strains.  In addition, sampling of factory 
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pipes and other surfaces, as well as product samples, would allow the identification of potential 
sources of contamination. Furthermore, as P. aeruginosa is hypothesised to be a predominantly 
aquatic microorganism (Selezska et al. 2012) and water is an important raw material in HPC 
products (Jimenez 2007), factory water supplies should also be monitored. 
 
5.4. Conclusions 
 
The main conclusions from the work in this chapter were as follows: 
 
1) The P. aeruginosa strains associated with HPC products were found, by RAPD-PCR, to be 
a diverse group and there were no links between strain type and product type or 
location of isolation. 
 
2) Industrial strains belonged to a mixture of previously found and novel AT-types and STs.  
The previously found genotypes were associated with a plethora of different 
environments suggesting P. aeruginosa displays no selection for habitat. 
 
3) Incorporation of the industrial strains into a large database of P. aeruginosa AT-types, 
followed by eBURST analysis, confirmed the non-clonal epidemic population structure 
of P. aeruginosa. 
 
 
The hypothesis proposed at the beginning of this chapter was accepted: 
Hypothesis: P. aeruginosa has a non-clonal epidemic population structure and strains isolated 
from industrial settings share genotypes with strains of cystic fibrosis, clinical and 
environmental origin. 
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6 Preservative susceptibility and phenotypic characterisation of an 
industrial P. aeruginosa strain panel 
 
The growth dynamics and motility data for strains belonging to the international Pseudomonas 
aeruginosa reference panel (De Soyza et al. 2013) were part of the following manuscript: 
 
Cullen, L., Weiser, R., Olszak, T., Maldonado, R., Moreira, A. S. et al. (2015). Phenotypic 
characterisation of an international P. aeruginosa reference panel: Strains of cystic fibrosis 
origin show less in vivo virulence than non-CF strains. Microbiology 161(10):1961-1977. 
 
6.1 Introduction 
 
The resistance of P. aeruginosa to antibiotics is very well documented, and contributes to its 
success as an opportunistic pathogen (Poole 2011). Treatment of P. aeruginosa is hampered by 
high levels of antibiotic resistance conferred via intrinsic, adaptive, or acquired mechanisms, 
many of which we have a good understanding of (Tenover 2006). In comparison, relatively little 
is known about the susceptibility of P. aeruginosa to biocides. Similarly, the modes of action of 
biocides and the mechanisms involved in resistance are poorly understood, complicated by the 
multitude of cellular targets that are affected (Maillard 2002).  
In general, antimicrobial activity differs greatly between different groups of micro-organisms 
and even between strains of the same species (Maillard 2002). This has been demonstrated in 
recent publications looking at the biocide susceptibilities of another group of problematic 
industrial contaminants, the Burkholderia cepacia complex bacteria (Rose et al. 2009; Rushton 
et al. 2013). In these studies large and diverse strain collections representing multiple species 
were investigated and found to be highly variable in their susceptibilities to biocides and 
preservatives.  Another recent study examined Enterobacter gergoviae as an industrial 
contaminant (Périamé et al. 2014) and found that across a panel of 12 strains, susceptibilities 
were both variable and non-variable for the different preservatives tested; for four out of the 
eight agents tested the minimum inhibitory concentrations were the same across the strain 
panel. For P. aeruginosa, analyses of both antibiotic and biocide susceptibility have found 
variable levels of antimicrobial tolerance (Van Eldere 2003; Lambert 2004).  These analyses did 
not consider strains isolated from industry, however, and did not investigate commonly used 
HPC preservatives such as parabens, formaldehyde releasing agents, isothiazolinones and 
phenoxyethanol.  Of the two studies which have included industrial strains of P. aeruginosa, one 
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was performed over a decade ago and did not report absolute minimum inhibitory 
concentration values for the preservatives tested (Chapman et al. 1998), and the other 
investigated only quaternary ammonium compounds as biocides, finding that clinical strains 
were the most tolerant and industrial strains were the most sensitive (Lambert et al. 2001). 
Further surveys of the biocide susceptibility of P. aeruginosa would be useful to understand the 
presence of P. aeruginosa in environments of frequent biocide exposure.  As a common 
contaminant of HPC products, it would be interesting to determine whether P. aeruginosa has a 
high tolerance for preservatives used in industry. 
Preservatives are used in industry to prevent spoilage of products, and preservation strategies 
are complex (Orth et al. 2006)(see section 1.1.4).  Preservative enhancing agents are often 
incorporated into formulations to improve preservative efficacy.  These compounds are not 
classed as preservatives, nor regulated under the same legislation, and alone do not necessarily 
have an antimicrobial effect (Varvaresou et al. 2009). Examples include the chelating agent 
EDTA and the surfactant-like substances caprylyl glycol and ethylhexylglycerin (Varvaresou et 
al. 2009). Combinations of preservatives and enhancers can extend the spectrum of 
antimicrobial activity, lower the levels of individual preservatives and therefore risks of toxicity 
to the consumer, and may exhibit an additive or synergistic effect (Orth et al. 2006).  
In the context of preservatives, synergy is a greater than expected combined antimicrobial effect 
than would be observed from the simple addition of the activities of the individual agents 
(Denyer et al. 1985). Incidences where synergy has been observed between preservatives and 
exploited in industry include phenoxyethanol and parabens (Phenonip) and monolaurate and 
sorbic acid (Lauribic) (Denyer et al. 1985).  As the majority of in-use preservatives belong to 
three classes (parabens, formaldehyde-releasing agents and isothiazolinones) and very few new 
preservatives have been approved in recent years (Lundov et al. 2009), the discovery of novel 
additive or synergistic combinations of available preservatives, or effective preservative 
enhancers is of great interest to industry.  In addition, the use of lower concentrations of 
preservatives and milder preservation systems has become increasingly important to the 
consumer (Varvaresou et al. 2009). Microorganisms that overcome preservation strategies to 
cause contamination must possess a variety of resistance mechanisms and be capable of 
adapting to the harsh conditions created by the different preservatives and preservative 
enhancing agents used in HPC product formulations. 
At present, there is no published literature on the phenotypic characterisation of P. aeruginosa 
strains isolated from industrial sources such as HPC products. Previous studies including both 
clinical and environmental settings have determined P. aeruginosa populations to be freely 
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recombining but punctuated with epidemic clones, and that there is little association between 
genotype and habitat (Kidd et al. 2012).   In general, it is also thought that strains from varying 
environments are functionally indistinguishable from one another (Römling et al. 1994; Rahme 
et al. 1995; Foght et al. 1996; Alonso et al. 1999), but as mentioned previously, these studies 
have not considered industry as a source.  Chapter 5 examined a collection of P. aeruginosa 
isolates from HPC contamination incidents, in addition to reference isolates used in industrial 
testing, to gain insight into the diversity present. The findings of these investigations largely 
corroborated the consensus model of P. aeruginosa population structure, but gave no indication 
of the phenotypic characteristics of the isolates. 
 In this chapter, a panel of 40 P. aeruginosa strains, including a selection from the genetically 
characterised industrial collection, and from the recently published international P. aeruginosa 
reference panel (De Soyza et al. 2013) were examined.  The 40 strains derived from industrial, 
cystic fibrosis, clinical, environmental and unknown sources and were subjected to preservative 
susceptibility assays for a number of commonly used HPC preservatives, in addition to 
preservative-preservative and preservative-preservative enhancer combinations of industrial 
interest. Growth curve and motility assays were also performed to elucidate any other 
phenotypic differences between the strains across isolation source. Furthermore, the 
development of adaptive resistance to a preservative combination was examined using 
planktonic growth and biofilm experimental evolution models. 
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6.1.1 Aims 
 
The aims of this chapter were as follows: 
1) Determine the susceptibility of a panel of 40 P. aeruginosa strains to preservatives 
commonly used in the HPC industry 
 
2) Evaluate the efficacy of novel preservative-preservative and preservative-preservative 
enhancing agent combinations using a sub-set of the P. aeruginosa panel strains, in an 
attempt to identify combinations with elevated anti-P. aeruginosa activity 
 
3) Investigate the growth dynamics in liquid media and the swimming, swarming and 
twitching motilities of the panel of 40 P. aeruginosa strains  
 
4) Determine whether differences in preservative susceptibility profiles or other 
phenotypic characteristics were linked to a clinical, environmental or industrial 
isolation source 
 
5) Examine the evolution of P. aeruginosa preservative resistance using both planktonic 
growth and biofilm growth models 
 
Hypothesis 1: The phenotypic characteristics of P. aeruginosa strains are highly variable and 
unlinked to habitat 
Hypothesis 2: Adaptive resistance can be developed to a preservative combination in 
planktonic and biofilm growth models, where P. aeruginosa can grow in preservative 
concentrations above the MIC level of the ancestral strain. 
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6.2 Results 
6.2.1 Preservative susceptibility 
 
6.2.1.1 Individual preservatives 
 
A broth dilution assay was used to determine the MICs of 6 preservatives for a collection of 40 P. 
aeruginosa strains from cystic fibrosis (CF; n=10), clinical (CLIN; n=9), environmental (ENV; 
n=5), industrial (IND; n=15) and unknown (n=1) sources.  The preservatives that were tested 
belonged to four different classes: isothiazolinones (methylisothiazolinone, MIT; 
chloromethylisothiazolinone and methylisothiazolinone blend in the ratio 3:1, CITMIT; 
benzisothiazolinone, BIT); alcohols (phenoxyethanol, PHE); biguanides (chlorhexidine, CHX), 
and; organic acids (benzoic acid, BA). For each strain, 4 replicates were recorded and the 
median and range of the data recorded in Table 6.1 (MIT, CITMIT and BIT) and Table 6.2 (PHE, 
CHX and BA). The susceptibility of P. aeruginosa for each preservative varied considerably 
across the strain panel, illustrated in Figure 6.1.  
The MIC data for MIT, CITMIT, BIT and CHX were more widely distributed than for PHE and BA, 
where the growth of the majority of strains was inhibited at one MIC value, 0.46875% (25/40 
strains) and 0.05% (35/40 strains) respectively (Table 6.1).  Strains were identified which had 
high MIC values for more than one preservative. For example RW138 had the highest recorded 
MIC for MIT (0.005%), BIT (0.04%) and PHE (1.25%), RW176 had the highest recorded MIC for 
MIT (0.005%), CITMIT (0.005%) and the second highest MIC for BIT (0.02%), and RW192 had 
the highest recorded MIC for BIT (0.04%) and the second highest recorded MIC for MIT 
(0.00375%). Strains were also identified with low MICs for multiple preservatives, for example 
Pa#1, Pa#4, Pa#7 and Pa#8 were all inhibited by the minimum MIC concentrations tested for at 
least two preservatives. High or low MIC values for one preservative, however, did not predict 
high MIC values for other preservatives, even when dealing with those of the same class. For 
example, RW138, which had the highest recorded MICs for MIT, BIT and PHE, was inhibited by a 
relatively low concentration of CITMIT (0.0009375%) and the lowest concentration of CHX 
tested (0.0005875%). In addition, the preservative susceptibility profiles were different for 
isolates of the same strain.  For example strains sharing the AT-genotypes (section 5.2.2.) F460 
(Pa#26 and RW110), 62CC (RW109 and RW192) and AFAA (RW130, RW131 and RW146) had 
varying responses to preservatives. 
When relating the results to in-use concentrations of preservatives the CITMIT MIC values for 
17 strains were above the EU cosmetics directive maximum permitted levels in personal care 
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products (0.0015%). The majority of these strains were from IND sources (n=11), fewer were of 
CF (n=2), CLIN (n=3) and ENV (n=1) origin. The CITMIT MIC for one IND strain, RW176 
(MIC=0.005), was approximately 3 times higher than the permitted level. The PHE regulated 
level (1%) was only exceeded by the PHE MIC value for the IND strain RW138 (1.25%). Growth 
of the remaining strains was inhibited at levels below the EU maximum permitted 
concentrations. 
The relationship between preservative susceptibility and isolation source was examined. The 
maximum preservative MIC values were observed for strains of IND origin across all of the 
preservatives (Figure 6.1), although in some cases, strains from other isolation sources shared 
these values; Pa#33 for CHX and Pa#19, Pa#26 and Pa#38 for BA.  In addition, the higher 
isothiazolinone MIC values (≥0.00375% MIT, ≥ 0.001875% CITMIT and ≥ 0.02% BIT) were 
predominantly linked with IND strains.   The lower isothiazolinone and PHE MIC values (≤ 
0.000625% MIT, 0.0007815% CITMIT, 0.0015625% BIT and 0.234375% PHE) were 
predominantly linked with CF strains. Statistical analyses were performed to determine if the 
median preservative MICs of the groups (Table 6.3) from different isolation sources were 
significantly different from one another.  The analyses included 39 strains; the 1 strain of 
unknown origin (RW198) was excluded. A Kruskal-Wallis test and post-hoc Wilcoxon tests with 
Benjamini Hochberg correction for non-parametric data were carried out for each preservative 
class using R statistical software.  P. aeruginosa strains from IND sources were found to have 
significantly higher (P < 0.05) median preservative MICs than strains from CF sources for the 
preservatives MIT (0.0025 compared to 0.001875), CITMIT (0.0015626 compared to 
0.0007815), BIT (0.01 compared to 0.005) and PHE (0.4688 compared to 0.2734). Furthermore, 
significant differences were found between the medians of CLIN and CF isolates, and ENV and 
CF isolates for PHE (0.4688 for CLIN and ENV isolates, compared to 0.2734 for CF isolates.  
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Table 6.1 Median and range MIC values of the isothiazolinone preservatives MIT, CITMIT and BIT 
Strain 
Other 
designations 
Isolation 
source 
MIC values (%) 
MIT CITMIT BIT 
Median Rangea Median Range Median Range 
Pa#1 LESB58 CF 0.0000781 - 0.0002345 0.000156-0.000313 0.000313 - 
Pa#4 C3719 CF 0.000313 - 0.0007815 0.00313-0,00125 0.000625 - 
Pa#5 DK2 CF 0.001875 0.00125-0.0025 0.0009375 0.000625-0.000125 0.005 - 
Pa#6 AES-1R CF 0.0025 - 0.0007815 0.00313-0.00125 0.005 - 
Pa#7 AUS23 CF 0.000313 - 0.0007815 0.00313-0.00125 0.00375 0.0025-0.005 
Pa#8 AUS52 CF 0.000625 - 0.000313 - 0.0015625 0.000625-0.0025 
Pa#17 PAO1 CLIN 0.001875 0.00125-0.005 0.0009375 0.000625-0.000125 0.0075 0.005-0.01 
Pa#18 UCBPP-PA14 CLIN 0.00125 - 0.0009375 0.000625-0.000125 0.005 - 
Pa#19 PAK CLIN 0.00125 0.00125-0.0025 0.0007815 0.000625-0.000125 0.00375 0.0025-0.005 
Pa#20 CHA CF 0.0025 - 0.0009375 0.000625-0.000125 0.005 - 
Pa#21 NN2 CF 0.001875 0.00125-0.005 0.0007815 0.000625-0.00025 0.005 - 
Pa#26 39016 CLIN 0.0025 - 0.0009375 0.00313-0.00125 0.01 - 
Pa#29 1709-12 CF 0.0025 0.0025-0.005 0.0007815 0.00313-0.00125 0.01 - 
Pa#30 Mi 162 CLIN 0.00125 - 0.0007815 0.00313-0.00125 0.005 0.005-0.01 
Pa#31 Jpn 1563 ENV 0.00375 0.0025-0.005 0.0015625 0.000625-0.00025 0.01 - 
Pa#32 LMG 14084 ENV 0.0025 - 0.0009375 0.000625-0.00025 0.005 - 
Pa#33 Pr335 ENV 0.001875 0.00125-0.0025 0.0009375 0.000625-0.00025 0.00375 0.0025-0.005 
Pa#35 CPHL 9433 ENV 0.00375 0.0025-0.005 0.0009375 0.000625-0.00025 0.01 0.005-0.01 
Pa#36 RP1 CF 0.00375 0.0025-0.005 0.0015625 0.000625-0.00025 0.005 - 
Pa#38 57P31PA CLIN 0.0025 - 0.0015625 0.000625-0.000125 0.01 - 
Pa#40 39177 CLIN 0.001875 0.00125-0.0025 0.0009375 0.000625-0.000125 0.005 - 
RW11 
NCTC 12903; 
ATCC 27853 
CLIN 0.00375 0.0025-0.005 0.0015625 0.000625-0.00025 0.01 0.005-0.01 
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RW109   IND 0.0025 0.0025-0.005 0.001875 0.00125-0.0025 0.01 - 
RW110   IND 0.0025 0.0025-0.005 0.0015625 0.000625-0.00025 0.005 0.005-0.01 
RW130   IND; DWL 0.00375 0.0025-0.005 0.0015625 0.000625-0.00025 0.02 - 
RW131   IND; DWL 0.00375 0.0025-0.005 0.001875 0.00125-0.0025 0.02 - 
RW138   IND; LAC 0.005 - 0.0009375 0.000625-0.000125 0.04 - 
RW146   IND; DWL 0.005 - 0.0015625 0.000625-0.00025 0.02 - 
RW149   IND; PC 0.00375 0.0025-0.005 0.0009375 0.000625-0.000125 0.01 - 
RW151 ATCC 9027 CLIN 0.0025 - 0.0015625 0.000625-0.00025 0.01 - 
RW172   IND; DWL 0.0025 - 0.001875 0.00125-0.0025 0.005 - 
RW176   IND; DWL 0.005 - 0.005 - 0.02 - 
RW184   IND; DWL 0.00125 0.00125-0.0025 0.0009375 0.000625-0.00025 0.005 0.0025-0.005 
RW192   IND; SC 0.00375 0.0025-0.005 0.0015625 0.000625-0.00025 0.04 - 
RW196 
ATCC 13388; 
NCTC 8060 
UNKNOWN 0.001875 0.00125-0.0025 0.00125 0.000625-0.000125 0.00375 0.0025-0.005 
RW198 ATCC 15442 ENV 0.0025 0.0025-0.005 0.0015625 0.000625-0.00025 0.005 - 
RW199   IND; MWF 0.00125 - 0.0009375 0.000625-0.000125 0.005 - 
RW200   IND; TC 0.0025 0.00125-0.0025 0.0015625 0.000625-0.00025 0.005 - 
RW202   IND; LAC 0.0025 - 0.0015625 0.000625-0.00025 0.01 - 
RW204   IND; DWL 0.001875 0.00125-0.0025 0.0015625 0.000625-0.0025 0.01 0.005-0.01 
Median MIC (%) 0.0025 0.0009375 0.005 
MIC range (%) 0.0000781-0.005 0.0002345-0.005 0.000313-0.04 
Maximum EU regulated levels (%)b 0.01 0.0015 0.2c 
 
Footnotes: MIC, minimum inhibitory concentration; MIT, methylisothiazolinone; CITMIT, chloromethylisothiazolinone and methylisothiazolinone blend in the ratio 3:1; BIT, 
benzisothiazolinone; CF, cystic fibrosis; CLIN, clinical; ENV, environmental; IND, industrial; DWL, dish wash liquid; LAC, liquid abrasive cleaner; PC, personal care; SC, Surface cleaner; 
MWF, metal working fluid; TC, timber care. Pa# strains were from the P. aeruginosa international reference panel collection held at Cardiff University, RW strains were from the RW 
collection held at Cardiff University. Median values are colour coded with darker shades reflecting an increase in MIC.  
aThe range is not reported where the replicate values were the same for a strain; b EU cosmetics directive 76/768/EEC, annex VI; cNot permitted in the EU, manufacturer’s 
recommended level 
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Table 6.2 Median and range MIC values of the preservatives phenoxyethanol, chlorhexidine and benzoic acid  
Strain 
Other 
designations 
Isolation 
source 
MIC values (%) 
PHE CHX BA 
Median Range Median Range Median Range 
Pa#1 LESB58 CF 0.1171875 0.078125-0.15625 0.0046875 0.001563-0.00625 0.0125  
Pa#4 C3719 CF 0.234375 0.15625-0.3125 0.002344 0.000781-0.003125 0.0125  
Pa#5 DK2 CF 0.46875 0.3125-0.625 0.002344 0.001563-0.003125 0.05  
Pa#6 AES-1R CF 0.234375 0.15625-0.3125 0.002344 0.000781-0.003125 0.05  
Pa#7 AUS23 CF 0.15625 0.15625-0.3125 0.001172 0.000781-0.001563 0.025  
Pa#8 AUS52 CF 0.234375 0.15625-0.3125 0.000781 
 
0.05  
Pa#17 PAO1 CLIN 0.46875 0.3125-0.625 0.0046875 0.003125-0.00625 0.05  
Pa#18 UCBPP-PA14 CLIN 0.390625 0.015625-0.625 0.001953 0.000781-0.00625 0.05  
Pa#19 PAK CLIN 0.46875 0.3125-0.625 0.002344 0.001563-0.003125 0.05  
Pa#20 CHA CF 0.46875 0.3125-0.625 0.003125 0.001563-0.003125 0.05  
Pa#21 NN2 CF 0.3125 0.15625-0.3125 0.0046875 0.003125-0.00625 0.05  
Pa#26 39016 CLIN 0.46875 0.3125-0.625 0.0046875 0.003125-0.00625 0.05  
Pa#29 1709-12 CF 0.46875 0.3125-0.625 0.0046875 0.003125-0.00625 0.05  
Pa#30 Mi 162 CLIN 0.46875 0.3125-0.625 0.002344 0.001563-0.003125 0.05  
Pa#31 Jpn 1563 ENV 0.46875 0.3125-0.625 0.0046875 0.001563-0.00625 0.075 0.1 - 0.05 
Pa#32 LMG 14084 ENV 0.625 0.3125-0.625 0.0039065 0.001563-0.00625 0.05  
Pa#33 Pr335 ENV 0.625 0.3125-0.625 0.00625  0.05  
Pa#35 CPHL 9433 ENV 0.46875 0.3125-0.625 0.003125  0.05  
Pa#36 RP1 CF 0.46875 0.3125-0.625 0.0046875 0.003125-0.00625 0.05  
Pa#38 57P31PA CLIN 0.46875 0.3125-0.625 0.0046875 0.003125-0.00625 0.05  
Pa#40 39177 CLIN 0.625 0.3125-0.625 0.0046875 0.003125-0.0125 0.05  
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RW11 
NCTC 12903; 
ATCC 27853 
CLIN 0.46875 0.3125-0.625 0.002344 0.001563-0.00625 0.075 0.1-0.05 
RW109   IND 0.46875 0.3125-0.625 0.0046875 0.001563-0.00625 0.05 
 
RW110   IND 0.46875 0.3125-0.625 0.00625 
 
0.05 0.1-0.05 
RW130   IND; DWL 0.625 - 0.002344 0.001563-0.003125 0.05 0.05 
RW131   IND; DWL 0.46875 0.3125-0.625 0.002344 0.001563-0.003125 0.05 0.05 
RW138   IND; LAC 1.25 1.25-2.5 0.00058575 0.000391- 0.001563 0.05 0.05 
RW146   IND; DWL 0.46875 0.3125-0.625 0.002344 0.001563-0.003125 0.05 0.1-0.05 
RW149   IND; PC 0.625 0.625 0.002344 0.001563-0.003125 0.05 0.05 
RW151 ATCC 9027 CLIN 0.46875 0.3125-0.625 0.0046875 0.003125-0.00625 0.05 0.05 
RW172   IND; DWL 0.46875 0.3125-0.625 0.0046875 0.003125-0.00625 0.05 0.05 
RW176   IND; DWL 0.46875 0.3125-0.625 0.002344 0.001563-0.003125 0.05 0.05 
RW184   IND; DWL 0.234375 0.15625-0.625 0.000781 
 
0.05 0.05 
RW192   IND; SC 0.46875 0.3125-0.625 0.0046875 0.003125-0.00625 0.05 0.05 
RW196 
ATCC 13388; 
NCTC 8060 
UNKNOWN 0.46875 0.3125-0.625 0.001172 0.000781-0.001563 0.05 0.05 
RW198 ATCC 15442 ENV 0.46875 0.3125-0.625 0.00625 0.003125-0.0125 0.05 0.05 
RW199   IND; MWF 0.625 0.625 0.001172 0.000781-0.003125 0.05 0.05 
RW200   IND; TC 0.46875 0.3125-0.625 0.0046875 0.003125-0.00625 0.05 0.05 
RW202   IND; LAC 0.46875 0.3125-0.625 0.00625 
 
0.05 0.05 
RW204   IND; DWL 0.46875 0.3125-0.625 0.0046875 0.003125-0.0125 0.05 0.05 
Median MIC (%) 0.46875 0.00351575 0.05 
MIC range (%) 0.1171875-1.25 0.00058575-0.00625 0.0125-0.075 
Maximum EU regulated levels (%)b 1 0.3 0.5 
Footnotes: MIC, minimum inhibitory concentration; PHE, phenoxyethanol; CHX, chlorhexidine; BA, benzoic acid at pH5; CF, cystic fibrosis; CLIN, clinical; ENV, environmental; IND, industrial; DWL, dish 
wash liquid; LAC, liquid abrasive cleaner; PC, personal care; SC, Surface cleaner; MWF, metal working fluid; TC, timber care. Pa# strains were from the P. aeruginosa international reference panel collection 
held at Cardiff University, RW strains were from the RW collection held at Cardiff University. Median values are colour coded with darker shades reflecting an increase in MIC.  
aThe range is not reported where the replicate values were the same for a strain; b EU cosmetics directive 76/768/EEC, annex VI 
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Figure 6.1 Minimum inhibitory concentrations (MICs) of preservatives for a panel of 40 P. aeruginosa strains. The distribution of the MIC data was visualised using boxplots which display the 
median, upper quartile, lower quartile, maximum and minimum values. Data points are shown by open circles, with outliers indicated outside of the boxplots. The strain names of outliers and those with 
the minimum and maximum MIC values are given to the right of the data points. In cases where more than one strain had the same MIC, all of the strains are listed. MIT, methylisothiazolinone; CITMIT, 
chloromethylisothiazolinone and methylisothiazolinone blend in the ratio 3:1; BIT, benzisothiazolinone; PHE, phenoxyethanol; CHX, chlorhexidine; BA, benzoic acid.  
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Table 6.3 Median preservative MICs of preservatives for strains from different isolation sources 
 
 
 
 
 
 
 
 
 
Footnotes:  
MIC, minimum inhibitory concentration; PHE, phenoxyethanol; CHX, chlorhexidine; BA, benzoic acid at pH 5; CF, 
cystic fibrosis; CLIN, clinical; ENV, environmental; IND, industrial 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Isolation 
source 
Median preservative MIC (%) 
MIT CITMIT BIT PHE CHX BA 
CF 0.001875 0.0007815 0.005 0.2734 0.002734 0.05 
CLIN 0.001875 0.0009375 0.0075 0.4688 0.004687 0.05 
ENV 0.0025 0.0009375 0.005 0.4688 0.004687 0.05 
IND 0.0025 0.0015625 0.01 0.4688 0.002344 0.05 
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6.2.1.2 Preservative combination testing 
 
The efficacy of an isothiazolinone combination was investigated using two P. aeruginosa strains 
from IND sources; RW109, a strain used in preservative efficacy testing, and RW176, a strain 
that possessed the highest MIC value for both MIT and BIT (section 6.2.1.1).  The relationship 
between the preservatives MIT and BIT was determined using checkerboard testing and 
interpreted using the FIC index (sections 2.12.2.1 and 2.12.2.2), the results of which are shown 
in Table 6.4.  For both RW109 and RW138 the ΣFIC was 1 suggesting a relationship where 
neither preservative agent influenced the MIC when in combination. 
 
6.2.1.2 Evaluation of preservative enhancing agents 
 
The antimicrobial activity of combinations of preservatives and preservative enhancing agents 
was investigated using checkerboard testing, and interpreted using the FIC index. The 
combinations investigated were: (1) the isothiazolinone preservative CITMIT and the efflux 
pump inhibitor phenyl-arginine-beta-naphthylamide (PAβN), and; (2) the preservative PHE 
against the preservative enhancers CX3, CX7 and Velsan SC (VSC). The CITMIT and PAβN 
combination was evaluated using 10 P. aeruginosa strains (Pa#17, Pa#18, RW11, RW109, 
RW110, RW131, RW176, RW192, RW196, and RW198) including the strain with the highest 
MIC value for CITMIT (RW176). The PHE and preservative enhancer combinations were 
evaluated using two strains, the preservative efficacy testing strain RW109 and the strain with 
the highest PHE MIC value, RW138. The relationships between CITMIT and PAβN and PHE and 
CX7 are shown in Table 6.5 and Table 6.6, respectively.  The combination of PHE and PAβN 
yielded ΣFIC results of between 0.5 and 1 for 6 strains (RW109, Pa#17, Pa#18, RW110, RW192 
and RW198) suggesting an additive relationship between the two agents in these cases. For 3 
other strains (RW176, RW11 and RW131) the combination of PHE and PAβN was more 
efficacious, yielding ΣFIC values of less than 0.5, indicating a synergistic relationship.  For the 
strain RW196 the PHE and PAβN combination was less efficacious and had a ΣFIC of 2.  The 
activity of the PHE and CX7 combination was additive, with both strains having a ΣFIC of 0.54. 
The relationships between PHE and the two other preservative enhancers, CX3 and VSC, were 
likely to be antagonistic as follows; the addition of CX3 (0 to 2.5%) doubled the MIC of PHE (0.4 
to 0.8%), and the addition of VSC (0 to 4%) increased the MIC of PHE to above the range tested 
(>1%). 
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Table 6.4 Activity of an isothiazolinone combination against P. aeruginosa 
Strain 
Preservative agents in combination 
ΣFIC Relationship MIT (%) BIT (%) 
MIC (MIT+BIT)/ 
MIC (MIT) 
FIC 
MIC (BIT+MIT)/ 
MIC (BIT) 
FIC 
RW109 0.005/0.01 0.5 0.005/0.01 0.5 1 Indifferent 
RW138 0.0025/0.005 0.5 0.005/0.01 0.5 1 Indifferent 
 
Footnotes: MIT, methylisothiazolinone; BIT, benzisothiazolinone; MIC, minimum inhibitory concentration; FIC, 
fractional inhibitory concentration; ΣFIC, fractional inhibitory concentration index. 
 
 
Table 6.5 Activity of CITMIT and PAβN combinations against P. aeruginosa 
Strain 
Preservative agents in combination 
ΣFIC Relationship CITMIT (%) PABN (mg/ml) 
MIC (CITMIT + PAβN)/ 
MIC (PAβN) 
FIC 
MIC (PAβN + CITMIT)/ 
MIC (PAβN) 
FIC 
RW109 0.0005/0.001 0.5 50/250 0.2 0.7 Additive 
RW176 0.0005/0.0003 0.167 50/250 0.2 0.367 Synergistic 
Pa#17 0.0002/0.0003 0.667 25/500 0.05 0.717 Additive 
Pa#18 0.0002/0.0004 0.5 25/500 0.05 0.55 Additive 
RW11 0.0002/0.0005 0.4 25/500 0.05 0.45 Synergistic 
RW110 0.0002/0.0004 0.5 25/500 0.05 0.55 Additive 
RW131 0.0001/0.0004 0.25 50/500 0.1 0.35 Synergistic 
RW192 0.0002/0.0004 0.5 50/500 0.1 0.6 Additive 
RW196 0.0004/0.0004 1 25/25 1 2 Indifferent 
RW198 0.0002/0.0005 0.4 50/500 0.1 0.5 Additive 
 
Footnotes: CITMIT, chloromethylisothiazolinone and methylisothiazolinone blend in the ratio 3:1; PAβN, L-Phe-Arg-
β-napthylamide; MIC, minimum inhibitory concentration; FIC, fractional inhibitory concentration; ΣFIC, fractional 
inhibitory concentration index. 
 
 
Table 6.6 Activity of the PHE and CX7 combination against P. aeruginosa 
Strain 
Preservative agents in combination 
ΣFIC Relationship PHE (%) CX7 (%) 
MIC (PHE+CX7)/ 
MIC (PHE) 
FIC 
MIC (CX7+PHE)/ 
MIC (CX7) 
FIC 
RW109 0.2/0.4 0.5 0.1/2.5 0.04 0.54 Additive 
RW138 0.2/0.4 0.5 0.1/2.5 0.04 0.54 Additive 
 
Footnotes: PHE, phenoxyethanol, CX7, CX7 preservative enhancer; MIC, minimum inhibitory concentration; FIC, 
fractional inhibitory concentration; ΣFIC, fractional inhibitory concentration index. 
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6.2.2 Phenotypic characterisation 
 
6.2.2.1 Growth curve analysis 
 
The growth dynamics of the panel strains in MH broth at 37°C over 24 hours were determined 
using a Bioscreen C microbial growth analyser. The growth curves (Figure 6.2) illustrated 
considerable variability in growth dynamics between strains.  Under these conditions the 
majority of the P. aeruginosa strains reached their maximum culture density by 15 hours and 
split largely into two groups; those reaching a higher culture density (>0.20) and those reaching 
a lower culture density (<0.20). This has been illustrated in greater detail in the boxplot in 
Figure 6.3, which resolved the maximum culture density data for the 40 panel strains into two 
broad groups. From this boxplot it appears that the majority of IND strains (13/15), CLIN 
strains (7/9), and all ENV strains (5/5) reached an OD greater than 0.20 after 15 hours. The OD 
values CF strains were distributed fairly evenly throughout the boxplot in Figure 6.3. 
To more comprehensively model the growth curve parameters (length of lag phase, maximum 
growth rate and maximum culture density reached) the grofit package for R statistical software 
was used, with data from up to 24 hours growth.  The P. aeruginosa strains Pa#1, RW130, 
RW131, RW138, RW146, RW149 and RW196 were excluded from the analysis as they produced 
growth curves that could not be modelled accurately by grofit, possibly because of their long lag 
phase and/or poorly defined exponential phase. Growth parameters for the remaining 33 
strains are displayed in Table 6.7 and the spread of data summarised by boxplots (Figure 6.4).  
Outliers in terms of growth kinetics were as follows (Figure 6.4): strain RW172 had a longer lag 
phase (8.1 hours) than the maximum value for all strains (upper whisker = 7.1 hours); strain 
RW184 had a lower growth rate (0.02 h-1) than the minimum value for IND strains (lower 
whisker = 0.06); strains Pa#4, Pa#7 and Pa#8 reached a lower culture density (log10 Max OD 
values 0.19, 0.19 and 0.16 respectively) than the minimum value for all strains (lower whisker = 
0.24), and RW184 had a lower culture density (log10 Max OD = 0.24) than the minimum value 
for IND strains (lower whisker = 0.31). To examine the relationship between growth dynamics 
and isolation source statistical analyses were performed; a Kruskal-Wallis test and post-hoc 
Wilcoxon tests with Benjamini-Hochberg correction for non-parametric data were carried out 
for each growth parameter class using R statistical software. There were no significant 
differences at the p=0.05 level between any of the group medians for lag phase, growth rate or 
maximal OD. 
CHAPTER 6 - PRESERVATIVE SUSCEPTIBILITY AND PHENOTYPIC CHARACTERISATION OF AN INDUSTRIAL P. AERUGINOSA STRAIN PANEL 
 
173 
 
 
Figure 6.2 Growth curves of the 40 P. aeruginosa panel strains. The growth of the strains in MH broth at 37°C was monitored by culture optical density over 24 hours.  
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Figure 6.3 Maximum culture density reached at 15 hours growth by the 40 P. aeruginosa panel 
strains. The distribution of the maximum culture density data at 15 hours growth was visualised using a 
boxplot displaying the median, upper quartile, lower quartile, maximum and minimum values.  Data 
points for each of the strains are included on the plot. The blue brackets illustrate three broad strain 
groupings (high, intermediate and low culture density) and the strain names are listed in order (highest 
to lowest Max OD) to the right of the boxplot, along with isolation source (CF, cystic fibrosis; CLIN, 
clinical; ENV environmental; IND, industrial; UNK, unknown).  
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Table 6.7 Growth parameters of 33 P. aeruginosa strains after 24 hours growth 
Strain Other designations Source Lag phase 
(hrs) 
Growth rate 
(hrs-1) 
Log10 Max OD 
(420-580) 
Pa#4 C3719 CF 4.45 0.02 0.19 
Pa#5 DK2 CF 4.99 0.07 0.36 
Pa#6 AES-1R CF 6.65 0.02 0.30 
Pa#7 AUS23 CF 3.92 0.02 0.19 
Pa#8 AUS52 CF 5.51 0.01 0.16 
Pa#17 PAO1 CLIN 5.14 0.07 0.37 
Pa#18 UCBPP-PA14 CLIN 3.62 0.02 0.25 
Pa#19 PAK CLIN 3.69 0.03 0.35 
Pa#20 CHA CF 4.84 0.04 0.34 
Pa#21 NN2 CF 5.68 0.12 0.38 
Pa#26 39016 CLIN 6.79 0.06 0.37 
Pa#29 1709-12 CF 5.87 0.07 0.38 
Pa#30 Mil 162 CLIN 2.61 0.02 0.24 
Pa#31 Jpn 1563 ENV 6.20 0.05 0.35 
Pa#32 LMG 14084 ENV 5.76 0.09 0.35 
Pa#33 Pr335 ENV 4.88 0.10 0.34 
Pa#35 CPHL 9433 ENV 5.53 0.13 0.37 
Pa#36 RP1 CF 4.67 0.08 0.37 
Pa#38 57P31PA CLIN 4.83 0.05 0.39 
Pa#40 39177 CLIN 4.98 0.10 0.34 
RW11 NCTC 12903;         
ATCC 27853 
CLIN 5.18 0.11 0.32 
RW109  IND 5.24 0.06 0.38 
RW110  IND 5.21 0.08 0.36 
RW151 ATCC 9027 CLIN 4.11 0.08 0.39 
RW172  IND; DWL 8.06 0.07 0.34 
RW176  IND; DWL 6.66 0.08 0.31 
RW184  IND; DWL 2.95 0.02 0.24 
RW192  IND; SC 7.12 0.07 0.37 
RW198 ATCC 15442 ENV 4.94 0.12 0.40 
RW199  IND; MWF 6.65 0.08 0.37 
RW200  IND; TC 5.74 0.08 0.36 
RW202  IND; DWL 5.33 0.07 0.35 
RW204  IND; DWL 6.89 0.08 0.37 
 
    
 
 
Footnotes: CF, cystic fibrosis; CLIN, clinical, ENV, environmental; IND, industrial; DWL, dish wash 
liquid; LAC, liquid abrasive cleaner; SC, surface cleaner; MWF, metal working fluid; TC, timber care
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Figure 6.4 Growth parameters of 33 P. aeruginosa strains at 24 hours growth. The distribution of 
the data (length of lag phase, growth rate and maximum culture density reached) was visualised using 
boxplots which display the median, upper quartile, lower quartile, maximum and minimum values. 
Outliers are indicated by open circles.  Strains included in the analysis have either been grouped together 
(All strains) or by isolation source (CF, cystic fibrosis; CLIN, clinical; ENV environmental; IND, industrial).  
Strain names have been included next to outliers.  
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6.2.2.2 6.2.2.2 Motility assays 
 
The 40 P. aeruginosa panel strains were assayed for swimming, swarming and twitching 
motilities.  The diameters of the zones of motility are shown in Table 6.8, and representative 
photographs given in Figure 6.5.  Motility was variable across the panel with the majority of 
strains (n=37) displaying at least one form. The three strains that were non-motile were of CF 
(n=2) and IND (n=1) origin. Across the rest of the panel, one did not display swarming motility 
(Pa#7), seven were deficient in swarming on at least one type of agar and twitching (Pa#1, 
Pa#6, Pa#29, Pa#30, Pa#32, RW196 and RW198), and four did not display twitching motility 
(RW121, RW138, RW149 and RW151). These strains were from CF, CLIN, ENV and IND sources; 
there did not appear to be a link between isolation source and motility. Only one strain 
(RW200) demonstrated ‘true’ swarming, indicated by the formation of finger-like projections 
radiating from the inoculation point, observed only on the minimal medium BSM-G 0.5% agar 
(Figure 6.5). Three strains of IND origin (RW130, RW131 and RW146), determined in the 
previous chapter to have the same AT-genotype (AFAA) and isolated from DWL products in 
Italy, displayed similar unusual swimming motilities. Rather than a uniform swim zone 
radiating from the inoculation point the, swimming pattern consisted of a central zone with an 
uneven growth boundary (Figure 6.6).  
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Table 6.8 Swimming, swarming and twitching motilities of the P. aeruginosa panel 
Strain  Other designations Source 
Swimming 
diameter 
(mm) 
Swarming diameter (mm) Twitching 
diameter 
(mm) LB 
0.5% agar 
BSM-G 0.5% 
agar 
Pa#1 LESB58 CF 17.5 - - - 
Pa#4 C3719 CF - - - - 
Pa#5 DK2 CF 53.5 19 12.5 12 
Pa#6 AES-1R CF 51 - - - 
Pa#7 AUS23 CF 52.5 - - 9 
Pa#8 AUS52 CF - - - - 
Pa#17 PAO1 CLIN 60.5 28 18.5 23.5 
Pa#18 UCBPP-PA14 CLIN 62.5 24 16.5 11 
Pa#19 PAK CLIN 60 12.5 10 17 
Pa#20 CHA CF 80 25.5 18 19.5 
Pa#21 NN2 CF 61 12 10 20.5 
Pa#26 39016 CLIN 75 22.5 11 30.5 
Pa#29 1709-12 CF 29.5 7.5 - - 
Pa#30 Mi 162 CLIN 62.5 - - - 
Pa#31 Jpn 1563 ENV 25 16.5 15 38 
Pa#32 LMG 14084 ENV 58.5 14.5 - - 
Pa#33 Pr335 ENV 53.5 16 11.5 18.5 
Pa#35 CPHL 9433 ENV 66 13.5 7.5 11.5 
Pa#36 RP1 CF 65 26 8.5 15.5 
Pa#38 57P31PA CLIN 68.5 31 14 14 
Pa#40 39177 CLIN 48.5 15.5 8 19.5 
RW11 NCTC 12903; ATCC 27853 CLIN 79 15.5 10 16 
RW109   IND 55 17 14 8 
RW110   IND 80 22 14.5 31.5 
RW130   IND; DWL 27.5a 8 7 - 
RW131   IND; DWL 27.6a 8.5 7.5 - 
RW138   IND; LAC 23.5 11.5 12.5 8.75 
RW146   IND; DWL 25.5a 9.5 9 - 
RW149   IND; PC 61.5 8 7 - 
RW151 ATCC 9027 CLIN 71.5 31 22.5 15.5 
RW172   IND; DWL 58 16 8 18 
RW176   IND; DWL 63.5 40 15 24.5 
RW184   IND; DWL - - - - 
RW192   IND; SC 32.5 18 9.5 16.5 
RW196 ATCC 13388; NCTC 8060 UNKNOWN 64 9.5 - - 
RW198 ATCC 15442 ENV 71.5 8.5 - - 
RW199   IND; MWF 35.5 8.5 8 13 
RW200   IND; TC 75 24 60b 39.5 
RW202   IND; LAC 76 25 16 36 
RW204   IND; DWL 76.5 32 35 38 
 
Footnotes: CF, cystic fibrosis; CLIN, clinical; ENV, environmental; IND, industrial; DWL, dish wash liquid; 
LAC, liquid abrasive cleaner; PC, personal care; SC, Surface cleaner; MWF, metal working fluid; TC, timber 
care, ‘-‘ designates non motile, and light blue shading indicates highly motile. 
aStrains exhibited an atypical swimming motility shown in Figure 6.6 
bStrain exhibited typical swarming with a diameter of approximately 60 mm shown in Figure 6.5 
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Figure 6.5 Swimming, swarming and twitching motilities of the P. aeruginosa panel strains. 
Representative images of the levels of swimming (0.3% LB agar), swarming (0.5% LB and BSM-G agar) 
and twitching (1% LB agar) motility exhibited by panel strains. Results were recorded after 16-18 hours 
incubation at 30°C (swarming) or 37°C (swimming and twitching) High level swarming motility was not 
observed for any panel strains on LB.  
 
 
 
CHAPTER 6 - PRESERVATIVE SUSCEPTIBILITY AND PHENOTYPIC CHARACTERISATION OF AN 
INDUSTRIAL P. AERUGINOSA STRAIN PANEL 
 
180 
 
 
Figure 6.6 Atypical swimming motilities of the industrial strains RW130, 131 and 146. Results were 
recorded after 16-18h growth on 0.3% LB agar at 37°C.  
 
 
6.2.3 Evolution of preservative resistance using planktonic growth and biofilm models 
 
P. aeruginosa is a highly adaptable bacterial species as shown by the diversity of environments 
it can be isolated from and its phenotypic variability. The absence of genetic lineages associated 
with industrial contamination (Chapter 5), and the fact that the highest MIC values observed for 
the preservatives MIT, CITMIT, BIT and PHE were for IND strains, suggested that P. aeruginosa 
is a diverse species able to adapt to preservatives. The development of adaptive resistance to 
preservatives by P. aeruginosa was examined using planktonic (Wong et al. 2012), and biofilm 
(Poltak and Cooper 2011) growth models. The experiments were performed with the strain 
PA14 as a well-studied P. aeruginosa reference isolate and one of the most widely distributed P. 
aeruginosa clone types (Tümmler et al. 2014). 
 
6.2.3.1 Susceptibility of P. aeruginosa PA14 to a preservative combination 
 
The preservative susceptibility of P. aeruginosa PA14 to the preservative combination CITMIT-
DMDMH-EDTA (100% strength constituted 0.0009% CITMIT, 0.22% DMDMH and 0.1% EDTA) 
was examined to establish sub-inhibitory starting concentrations for both the planktonic and 
biofilm growth experiments. Using the Bioscreen C instrument to monitor the growth dynamics 
of P. aeruginosa PA14 for 48 hours at 37°C it was determined that growth of the strain was 
inhibited by concentrations of ≥10% of CITMIT-DMDMH-EDTA (Figure 6.7).   A lower 
concentration of 7.5% CITMIT-DMDMH-EDTA inhibited growth until approximately 35 hours, 
indicating that this concentration greatly extended lag phase.  At 5% CITMIT-DMDMH-EDTA the 
growth curve resembled that of the TSB growth control, but had a lag phase of approximately 5 
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hours longer (Figure 6.7). From these results a concentration of 2.5% CITMIT-DMDMH-EDTA 
was selected to start the planktonic growth experiment where transfers were made every 24 
hours.  A concentration of 7.5% CITMIT-DMDMH-EDTA was selected to start the biofilm growth 
experiment as transfers were made every 48 hours, allowing more time for growth in the 
preservative combination. 
 
 
 
Figure 6.7 Preservative susceptibility of P. aeruginosa PA14 to the preservative combination CITMIT-
DMDMH-EDTA. The growth of PA14 at 37°C in TSB and different concentrations of the preservative combination 
CITMIT-DMDMH-EDTA (5-100%) was monitored by culture optical density over 48 hours. The 100% strength 
preservative combination constituted 0.0009% CITMIT, 0.22% DMDMH and 0.1% EDTA.  
 
6.2.3.2 Adaptation of planktonic cultures to a preservative combination 
 
Using a selection experiment similar to that of Wong et al. (Wong et al. 2012)(section 2.15.2) 
planktonic populations of P. aeruginosa PA14 were evolved under three different conditions; (1) 
TSB; (2) TSB with 2.5% preservative combination, and; (3) TSB with increasing amounts of the 
preservative combination CITMIT-DMDMH-EDTA. Every 24 hours for 8 days, populations were 
propagated by being transferred into fresh growth medium, with ten replicate cultures for each 
condition (see section 2.15.2 for full details). Growth was observed after every transfer for all of 
the replicates grown in TSB and TSB-2.5% preservative combination conditions. For the TSB-
increasing preservative concentration condition, not all replicates adapted at the same rate 
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yielding populations with varying tolerances; the highest concentrations that the replicates 
grew in were 10% (1 replicate), 12.5% (8 replicates), and 15% (1 replicate). A selection of end-
point isolates were chosen for further preservative susceptibility testing (section 6.2.3.4), to 
determine stability of phenotype. 
 
6.2.3.3 Adaptation of biofilm growth to a preservative combination 
 
A month-long experiment examined the adaptation of P. aeruginosa PA14 biofilms to a 
preservative combination, using a model adapted from Poltack and Cooper (Poltak and Cooper 
2011)(Section 2.15.3). Biofilm populations grown on plastic beads were transferred into either 
fresh TSB or TSB with increasing increments of the preservative combination every 48 hours.  
The starting concentration was 7.5% CITMIT-DMDMH-EDTA and the end concentration was 
20% CITMIT-DMDMH-EDTA. A planktonic growth control in TSB was also performed alongside 
the biofilm model. The starting inoculum for the experiment was approximately 105 cfu/ml and 
approximately 107 cfu/ml were recovered from the end sample planktonic growth from the TSB 
control and TSB of the biofilm growth populations.  The number of viable cells recovered from 
the end sample bead-grown biofilms (TSB and TSB plus preservative combination conditions) 
was also approximately 107.   Due to problems encountered in obtaining viable counts from 
samples taken during the experiment, no extra viable count data was recorded.  
 
Six days after the start of the experiment a small colony variant was observed in all populations, 
in addition to the original spreading colonies of the wild-type P. aeruginosa PA14. The small 
colony variant occurred in high numbers in all conditions, frequently equivalent to or greater 
than the ancestral PA14 morphology, although exact proportions were not recorded at this 
sample point.  Furthermore, one more colony morphotype was observed in the TSB biofilm 
population; a spreading colony with a ruffled surface (Figure 6.8). This ruffled spreading colony 
type was observed at low frequency and not seen in the TSB plus CITMIT-DMDMH-EDTA 
biofilm populations. At the end of the experiment a mixture of different colony morphologies 
were observed suggesting adaptation to the different conditions, but there was no specific 
adaptation of a single morphotype to one condition (Table 6.9). A selection of end-point isolates 
were chosen for preservative susceptibility testing (section 6.2.3.4).  To obtain populations 
representative of the three experimental conditions the two biological replicates were pooled 
for end-point samples of planktonic growth, biofilm growth from the beads of the TSB growth 
conditions and biofilm growth from the beads of the TSB plus CITMIT-DMDMH-EDTA growth 
condition.  These pooled samples were also included the preservative susceptibility testing. 
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Figure 6.8 P. aeruginosa PA14 colony morphotypes observed during the biofilm adaptation experiment. 
Representative images of the three different colony morphotypes that emerged after day six of the experiment are 
shown: (A) the spreading colony morphology of the ancestral P. aeruginosa PA14, seen for all three conditions; (B) a 
small colony variant, also observed for all three conditions, and; (C) a spreading ruffled colony type, seen in only the 
TSB biofilm population. The black scale bar represents 10 mm.  
 
 
Table 6.9 P. aeruginosa PA14 colony morphotypes isolated at the end of the biofilm experiment 
Experimental conditions Description Total viable count 
TSB planktonic growth replicate 1  Small 2.2 x 107 cfu/ml 
Spreading 2 x 105 cfu/ml 
TSB planktonic growth replicate 2  Small 1.6 x 107 cfu/ml 
Spreading 8 x 105 cfu/ml 
TSB Bead replicate 1  Small 1.8 x 107 
Spreading ruffled 1 x 105 
TSB Bead replicate 2  Small ruffled 3.5 x 107 
TSB Bead planktonic growth replicate 1  Small 4.1 x 107 cfu/ml 
Spreading 2 x 105 cfu/ml 
Spreading ruffled 1 x 105 cfu/ml 
TSB Bead planktonic growth replicate 2  Small ruffled 3.6 x 107 cfu/ml 
TSB 20 % CITMIT-DMDMH-EDTA  
Bead replicate 1 
Small 2.5 x 107 
Small ruffled 
TSB 20 % CITMIT-DMDMH-EDTA  
Bead replicate 2  
Small 3 x 106 
Spreading 1.4 x 107 
TSB 20 % CITMIT-DMDMH-EDTA 
Bead planktonic growth replicate 1  
Small  3.5 x 107 cfu/ml 
Small ruffled 
TSB 20 % CITMIT-DMDMH-EDTA 
Bead planktonic growth replicate 2 
Small 2 x 105 cfu/ml 
Spreading 1.6 x 107 cfu/ml 
 
Footnotes: 20% CITMIT-DMDMH-EDTA constituted 0.00018% CITMIT, 0.044% DMDMH and 0.02% 
EDTA) 
 
 
 
10 mm
A B C
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6.2.3.4 Preservative susceptibility of experimentally adapted isolates 
 
The ancestral P. aeruginosa strain PA14 and adapted end-point populations from the planktonic 
and biofilm growth experiments were subjected to preservative susceptibility testing to 
determine the stability of phenotype. The isolates were assayed against CITMIT, DMDMH and 
the preservative combination CITMIT-DMDMH-EDTA. The MIC of CITMIT was the same for the 
ancestral P. aeruginosa PA14 and all of the end-point isolates, whilst the MIC for DMDMH and 
the CITMIT-DMDMH-EDTA combination was increased for the planktonic end-point populations 
that grew in 12.5% and 15% CITMIT-DMDMH-EDTA, and the biofilm end-point pooled growth 
from the TSB-only condition (Table 6.10). 
 
 
Table 6.10 Preservative susceptibility of ancestral P. aeruginosa PA14 and derivative 
preservative combination-adapted populations. 
 
Experimental conditions Isolate/population 
MIC (%) 
CITMIT DMDMH 
CITMIT-
DMDMH-
EDTA 
Ancestral strain P. aeruginosa PA14 0.000625 
0.0313-
0.0625 
7.5 
Planktonic growth – end-point populations (one biological replicate tested) 
TSB only TSB  0.000625 0.0313 7.5 
TSB and 2.5% CITMIT-
DMDMH-EDTA 
2.5% CITMIT-DMDMH-EDTA  0.000625 0.0313 7.5 
TSB and increasing CITMIT-
DMDMH-EDTA 
10% CITMIT-DMDMH-EDTA  0.000625 0.0625 7.5 
12.5% CITMIT-DMDMH-EDTA 0.000625 0.125 10-12.5 
15% CITMIT-DMDMH-EDTA 0.000625 0.125 10-12.5 
Biofilm growth – end point populations (two biological replicates pooled and tested) 
TSB TSB   0.000625 0.0625 7.5 
TSB plus bead TSB plus bead  0.000625 
0.0313-
0.125 
7.5-10 
TSB and increasing CITMIT-
DMDMH-EDTA plus bead 
20% CITMIT-DMDMH-EDTA  0.000625 0.0625 7.5 
 
Footnotes: 100% strength CITMIT-DMDMH-EDTA constituted 0.0009% CITMIT, 0.22% DMDMH and 
0.1% EDTA 
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6.3 Discussion 
 
6.3.1 Preservative susceptibility of a diverse P. aeruginosa panel 
 
Few studies have investigated the preservative susceptibility of P. aeruginosa.  To further 
knowledge in this area, this chapter investigated a panel of P. aeruginosa strains for their 
susceptibilities to preservatives commonly used in HPC products.  The strain panel comprised 
diverse strains from varied isolation sources including CF, CLIN, ENV and IND settings, with one 
strain also being of unknown origin. The MICs of six preservatives were determined against a 
panel of 40 strains and found to be highly variable, even between strains sharing the same AT-
genotype, with the broadest variation in susceptibility observed for MIT, CITMIT, BIT and CHX. 
This was perhaps to be expected as biocide susceptibilities vary between microorganisms and 
strains of the same species (Maillard 2002; Rose et al. 2009; Rushton et al. 2013; Périamé et al. 
2014) and the antibiotic and biocide susceptibility of P. aeruginosa strains has shown 
considerable variation (Chapman et al. 1998; Lambert et al. 2001; Van Eldere 2003; Lambert 
2004).  
 
None of the P. aeruginosa panel strains had a high tolerance for all of the preservatives that 
were investigated. Strains were identified that had high MIC values for the two preservatives of 
the same class (RW#138 for MIT and BIT, and RW#176 for MIT and CITMIT), with one of these 
strains also being highly tolerant to an unrelated preservative (RW#138 had the highest 
observed MIC for PHE). Interestingly, an elevated tolerance for one or two isothiazolinones did 
not correlate with a high tolerance to all three isothiazolinone preservatives; RW#176 had a 
slightly lower MIC for BIT, RW#138 had a low MIC for CITMIT, and RW#192 only had a high 
MIC for BIT. No strains were identified that had increased MICs for two or more preservative 
classes including CHX or BA.  Overall, this suggests that different modes of entry/action and the 
resistance mechanisms are in operation for both different classes of preservatives and for 
preservatives within the same class.  General resistance mechanisms for biocides are thought to 
include changes in outer membrane permeability and active efflux (Lambert et al. 2001), which 
could explain resistance to different compounds. 
 
Whilst there are no recent systematic studies of biocide susceptibility for P. aeruginosa strain 
panels, the MIC ranges observed in this chapter are similar to previously published studies 
investigating P. aeruginosa susceptibility to MIT (0.0019%) (Winder et al. 2000), CITMIT 
(0.0003%) (Chapman et al. 1998),  BIT (0.0056%; 0.0032%) (Winder et al. 2000; Abdel Malek 
and Badran 2010), PHE (0.25%) (Beveridge et al. 1980) and CHX (0.005%-0.02%; 0.0006%) 
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(Nakahara and Kozukue 1982; Abdel Malek and Badran 2010). Other studies have found MICs of 
preservatives approximately tenfold higher for CITMIT (Brozel and Cloete 1994) and BA 
(Borawska et al. 2008).  In comparison to other species, the maximum preservative MICs for the 
panel of P. aeruginosa strains were slightly higher than those observed for Burkholderia species 
for MIT (0.00437%), CITMIT (0.000674%), BIT (0.008%) and PHE (0.25%) (Rushton et al. 
2013) but lower than the highest MICs of CHX recorded (0.0039%; 0,01%) (Lambert et al. 2001; 
Rose et al. 2009). Maximum MICs previously documented for E. gergoviae strains were higher 
than the maximum recorded MICs for the P. aeruginosa panel for MIT (0.01%), but lower for 
CITMIT (0.000375%) and PHE (0.45%) (Périamé et al. 2014). Without the guarantee of 
standardised methods for MIC testing and statistical analyses, however, it is difficult to directly 
compare the results from other studies to the results in this chapter. 
 
MIC values are clinically relevant as they are an important factor involved in deciding antibiotic 
treatment regimens (Lambert and Lambert 2006), and are obtained using standardised 
methods in clinical settings (Andrews 2001). The context of an MIC for preservatives can be 
debated, but in essence needs to fall below the maximal in use concentrations (see Table 1.2), 
and be proven effective in combination with other formulation components in HPC products. 
This chapter recorded MIC values using broth micro-dilution experiments involving planktonic 
growth in broth. MIC values will vary depending on whether solid or liquid media are used and 
whether planktonic or biofilm growth is investigated. These variables could be explored to 
further characterise the strain panel, in addition to performing minimum bactericidal 
concentration (MBC) experiments. Whereas MICs are the lowest concentration of an agent to 
inhibit visible overnight growth of a microorganism, the MBC of an agent represents the 
minimum concentration that will inhibit growth of an organism after subculture onto an 
antibiotic free medium (Andrews 2001), and the two frequently do not correlate (Langsrud and 
Sundheim 1997). Further investigations could also explore the susceptibilities of the P. 
aeruginosa strain panel to antibiotics, to determine if there is any correlation between antibiotic 
and preservative MIC values. Previous studies have been inconclusive, indicating both that 
highly antibiotic resistance Gram-negative bacteria also have a higher tolerance to disinfectants 
(Russell et al. 1986), and also that antibiotic resistance does not impact disinfectant resistance 
(Rutala et al. 1997). Potential cross-resistance of strains to antibiotics and biocides, and the 
emergence of antibiotic and biocide resistance, exacerbated by widespread biocide use, is a 
controversial topic still under investigation (Fraise 2002; Lambert 2004). 
 
It should also be noted then when analysing MIC values, there appears to be no robust 
consensus method. The nature of MIC data is such that ‘true’ MIC values for strains within a 
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population lie on a continuum, but the recorded MIC values are discrete concentration 
increments (Lambert and Lambert 2006).  Inherent problems in the documentation of MIC data 
include that the experimental methods and analyses may not be standardised between 
laboratories, that the discrete MIC data may not fit a normal distribution, and that small changes 
in the ‘true’ MIC could lead to a large change in the recorded MIC, depending on the 
concentration increments being used (Lambert 2004). It is therefore difficult to know whether 
statistical analyses should be performed for continuous (parametric) or discrete data (non-
parametric). Frequently studies have used parametric methods which may not reflect the ‘true’ 
underlying mean and standard deviation values (Lambert and Lambert 2006). In an attempt to 
improve the interpretation MIC data, models have been proposed based on both cumulative 
frequency distributions (Lambert and Lambert 2006) and on survival analysis for interval 
censored data (van de Kassteele et al. 2012). Whilst these models better fit the nature of the MIC 
data, they are complex and not straightforward to implement (van de Kassteele et al. 2012). In 
this chapter, MIC data were analysed as discrete data with non-parametric statistics. The 
rationale behind this was that as the data were collected as discrete data, they should be 
analysed as such (Kowalski et al. 2005). Overall, this approach is less arbitrary than assigning 
mean values to discrete data categories and using parametric statistics, but less robust than 
using a statistical model. 
 
6.3.2 Preservative susceptibility of industrial P. aeruginosa strains: potential impact on HPC 
products and industrial practices 
 
The preservative susceptibilities of IND P. aeruginosa strains were compared to the 
susceptibilities of strains from CF, CLIN and ENV sources. For the isothiazolinone preservatives 
and PHE, the strains with the highest MIC values were from IND sources, posing the question 
whether stable adaptation to preservatives occurs in the industrial environment. This was also 
the case for CHX and BA, although maximum MIC values were shared between IND, CLIN and 
ENV strains. Whilst it appeared that overall, preservative susceptibilities of the IND strains were 
lower than all of the other strain groups, the median MIC value for IND strains was only 
determined to be significantly higher than the median MIC of the CF group for the preservatives 
MIT, CITMIT, BIT, PHE and BA.  In addition the CLIN and ENV strains had significantly higher 
median MIC values than the CF strains for PHE. Although previous studies have found CF 
isolates to have high levels of antibiotic resistance (Breidenstein et al. 2011), little is known 
about their biocide resistance, and a number of strains in this chapter grew very slowly to low 
optical densities (5 strains grew to less than OD < 0.2 after 24 hours; Table 6.7) which would 
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have impacted the overall results. A larger strain panel would be needed to draw more 
meaningful conclusions about any link between isolation source and preservative susceptibility. 
 
Preservative usage must be carefully balanced to prevent over-preservation, which can pose a 
risk of contact dermatitis to consumers, and under-preservation, which may result in product 
spoilage through microbial growth (Lundov et al. 2009). The maximum preservative 
concentrations permitted in HPC products are regulated in different regions to inform product 
formulation (Orth et al. 2006). In Europe, the EC Cosmetics Directive provides information 
concerning the type and quantity of preservatives that can be incorporated into different 
products (see Table 1.2).  In this chapter five preservatives permitted for use in Europe were 
evaluated: MIT, CITMIT, PHE, CHX and BA.  No preservative MICs above the maximum permitted 
levels were reported for the P. aeruginosa strain panel for MIT, CHX or BA.   Seventeen of the 
panel strains, however, had MIC values for CITMIT that were above the EC maximum levels 
(0.0015%), in addition to one strain that exceeded the permitted level for PHE (1%). Whilst it is 
worrying that certain strains can grow in the presence of high levels of preservatives, MIC 
values in broth do not always reflect the performance of a preservative in product (Orth et al. 
2006). In addition, a preservative system is typically composed of more than one preservative, 
preservative enhancing agents and other formulation components which  interact to inhibit the 
proliferation of microorganisms (Orth et al. 2006). Therefore, to comprehensively evaluate the 
performance of a preservative, challenge testing with relevant strains should be carried out for 
the final product formulation. 
 
Preservative efficacy testing or ‘challenge testing’ is performed by manufacturers to determine 
whether a product is adequately preserved to prevent microbial contamination. It involves the 
inoculation of product samples with indicator microorganisms, followed by the enumeration of 
survivors after stipulated time points in order to determine the reduction in viable cell numbers  
(Russell 2003).  The microorganisms used in challenge testing can be from culture collections or 
are ‘in-house’ contaminants, and are chosen as likely product contaminants (Orus and Leranoz 
2005). The P. aeruginosa panel investigated in this chapter included five strains which have 
been used in preservative efficacy testing (RW109, RW110, RW151, RW196 and RW198). These 
strains varied in their preservative susceptibilities, but did not have the highest observed 
preservative MICs for the panel, with the exception of RW110 for CHX.  Based on the findings 
from the panel, the inclusion of strains with the highest tolerances for preservative agents (for 
example: RW138, RW146 and RW176 for the isothiazolinones; RW138 for PHE; RW110 for 
CHX; RW11 for BA) in challenge testing may be useful.  It would have to be determined, 
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however, that strains with elevated MICs for individual preservatives had the same levels of 
resilience in complete products for the results to be valuable.  
6.3.3 Anti-P. aeruginosa activity of preservative and preservative enhancer combinations 
 
Combinations of preservatives are frequently used in HPC products to extend the spectrum of 
antimicrobial activity, and, if the combination exhibits additive or synergistic activity, boost the 
efficacy of microbial killing (Lundov et al. 2011).  In addition, using preservative combinations 
often allows the levels of individual preservatives to be lowered, which decreases the risk of 
dose-dependent contact dermatitis (Lundov et al. 2011). Isothiazolinones are known contact 
sensitisers, with the chlorinated forms having higher potential for sensitisation (Alexander 
2002), therefore a reduction in the concentrations used in products would be highly beneficial.  
This chapter looked at both the combination of two isothiazolinone preservatives (MIT and BIT) 
and an isothiazolinone preservative (CITMIT) with a potential preservative enhancer, the efflux 
pump inhibitor PAβN. This broad spectrum efflux pump inhibitor has been well documented 
and shown to reduce the MICs of several β-lactam antibiotics for Gram-negative bacteria 
including P. aeruginosa, allowing antibiotic accumulation within the cell (Mahamoud et al. 
2007).  Whilst the combination of MIT and BIT did not display enhanced antimicrobial activity 
for the 2 P. aeruginosa strains evaluated, the CITMIT and PAβN combination exhibited additive 
or synergistic activity for 9 out of the 10 P. aeruginosa strains tested.  From these results it could 
be speculated that efflux of CITMIT plays a role in the tolerance of P. aeruginosa for this 
compound. Whether PAβN would be useful in industrial practices would need to be investigated 
further; the compound may not be stable in formulation and is relatively expensive, precluding 
its use.  
 
The use of PHE has increased in the last 10 years, with figures from the US in 2007 stating it as 
the third most commonly used preservative (Lundov et al. 2011). As a preservative that is rarely 
associated with allergic contact dermatitis, PHE is a ‘milder’ preservation option, which appeals 
to increasing consumer demands for less harsh preservative systems in products (Varvaresou et 
al. 2009).  PHE, however, is not quite as efficacious as preservatives such as the parabens, 
formaldehyde releasing agents and isothiazolinones (Lundov et al. 2009), and its activity may 
be enhanced in combination with other preservatives or preservative enhancing agents. In this 
chapter the combination of PHE with three potential preservative boosters was evaluated.  The 
compounds CX3 and CX7 are cyclohexyloxyl derivatives with an unknown mechanism of action, 
and VSC (sorbitan caprylate) is a molecule with surfactant properties and is hypothesised to 
disrupt the cellular membrane (Pilz 2012). Only the combination of PHE with CX7 demonstrated 
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additive activity and would be potentially useful in products, but would require further 
evaluation. The combination of PHE with CX3 and VSC appeared to be antagonistic and would 
likely not enhance the preservative system within a product. This is in contrast to a previous 
study which found that the combination of PHE and VSC was synergistic (Pilz 2012), suggesting 
more work is needed to understand this particular preservative enhancer.  
6.3.4 Phenotypic characteristics of a diverse P. aeruginosa panel 
 
The growth curve dynamics and motility levels of the P. aeruginosa panel were very variable. By 
observing the 24 hour growth curve plots, the panel split largely into two groups; those that 
reached an OD over 0.20 after 15 hours, and those that did not reach 0.20 after 15 hours.  In 
relation to isolation source, the majority of the IND, CLIN and ENV strains were found in the 
group growing at a higher OD, whilst the CF strains grew at a range.  It is unknown if the OD was 
correlated to viable cell numbers or the biomass reached. The growth parameters lag phase, 
growth rate and maximum OD reached were analysed in more detail using statistical software, 
and no trends were observed between growth dynamics and isolation source.  This is not 
conclusive evidence, however, as 7 strains had to be excluded from the analysis, and overall the 
strain panel was relatively small. 
 
Motility was also very variable and there did not appear to be any link between motility levels 
and isolation source.  It was expected that the CF strains within the panel would be less motile, 
as this is a characteristic of P. aeruginosa isolates from chronic lung infections 
(Mahenthiralingam et al. 1994), however this was not the case.  As there were only 10 CF strains 
within a panel of only 40 strains, such differences may have been missed; the CF isolates were 
not representative of strains from chronic lung infection which are most likely to have adapted 
towards a non-motile phenotype. Furthermore, motility is dependent on growth media and 
conditions, illustrated by the fact that two of the panel strains, Pa#17 and Pa#18, have exhibited 
swarming motility in previous studies (Rashid and Kornberg 2000; Overhage et al. 2008; 
Tremblay and Deziel 2010), but were not observed to do so in this chapter.  One interesting 
observation from the panel was the unusual swimming phenotypes demonstrated by the three 
IND strains from the same isolation source (RW130, RW131 and RW146). The cause of this 
phenotype is unknown but could suggest adaptation to that particular industrial environment.   
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6.3.5 Modelling adaptive resistance to a preservative combination 
 
Adaptive resistance can be defined as the induction of often transient antimicrobial resistance 
in response to a certain stimulus (Fernández and Hancock 2012). The development of adaptive 
resistance to biocides has been observed for P. aeruginosa but the resistance mechanisms are 
poorly understood. Previous studies have examined adaptive resistance to the biocides CITMIT 
(Brozel and Cloete 1994), BIT (Al-Adham et al. 2012), PHE (Abdel Malek and Badran 2010), 
benzalkonium chloride (Joynson et al. 2002; Loughlin et al. 2002; Mc Cay et al. 2010), cetrimide 
(Al-Adham et al. 2012), didecyldimethylammonium bromide (Méchin et al. 1999), zinc 
pyrithione (Abdel Malek et al. 2009; Al-Adham et al. 2012), sodium pyrithione (Al-Adham et al. 
2012) and monochloramine (Sanderson and Stewart 1997).  Of these studies, which all 
investigated exposure to sub-inhibitory concentrations of a single biocidal agent, two used 
biofilm models (Sanderson and Stewart 1997; Al-Adham et al. 2012), whilst the others observed 
planktonic growth in broth containing increasing biocide concentrations.  
 
Using P. aeruginosa PA14, a well-characterised, genome sequenced strain (O'Toole and Kolter 
1998; Lee et al. 2006), and one of the most prevalent global clone types (Tümmler et al. 2014), 
this chapter examined the development of adaptive resistance using both planktonic growth 
and biofilm models. In addition, a combination of two preservatives (CITMIT and DMDMH) and 
one preservative enhancing agent (EDTA) was used, more reflective of preservative systems 
used in HPC products than a single preservative (Orth et al. 2006). In both models, adaptive 
resistance was developed to the CITMIT-DMDMH-EDTA combination; whilst growth of the 
ancestral PA14 was inhibited by 7.5-10% CITMIT-DMDMH-EDTA, end point PA14 derivatives of 
the planktonic growth and biofilm experiments could grow in 15% and 20% CITMIT-DMDMH-
EDTA respectively. The end point PA14 derivatives were also re-tested for susceptibility to 
CITMIT, DMDMH and the CITMIT-DMDMH-EDTA combination.  Isolates were found from both 
experiments with elevated MIC values for DMDMH and CITMIT-DMDMH-EDTA compared to the 
ancestral PA14 (Table 6.10). The long-term stability of the elevated resistance is unknown and 
would need to be investigated via progressive subculture in media without preservative, 
followed by further preservative susceptibility testing. No increases in MIC were observed for 
the isolates for CITMIT, however, which could be linked to the exposure level during the 
experiments being below the MIC of CITMIT for the ancestral PA14. 
 
Biofilms are thought to be the preferred mode of bacterial growth in natural and industrial 
settings, and are frequently encountered in infection (Donlan and Costerton 2002).  In industry, 
biofilm formation on industrial surfaces and machinery is very problematic, potentially leading 
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to product contamination and process inefficiency (Stickler 2004). Microorganisms adhered to 
industrial surfaces such as pipes are likely to be exposed a preservative concentration gradient, 
including potentially sub-lethal concentrations (Gilbert and McBain 2003).  A biofilm model of 
adaptive resistance may therefore better represent preservative exposure in industry and was 
investigated in this chapter, utilising a recently published experimental evolution method 
(Poltak and Cooper 2011). This method was straightforward to set up and sample, and allowed 
the isolation of colony morphotypes linked to different stages of biofilm formation and 
adaptation (Figure 6.8 and Table 6.9). Furthermore, the difficulty of preservative neutralisation 
(Orth et al. 2006) prior to performing viable counts was negated, as biofilms adhered to beads 
were removed from the preservative solution and washed before sampling.  Whilst these 
investigations were small scale, they have shown the applicability of the bead-biofilm model to 
examining adaptive resistance. Further work involving whole-genome resequencing of adapted 
isolates and transcriptomic analysis could be applied to the biofilm model to gain insight into 
genetic changes associated with adaptation to preservatives. 
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6.4 Conclusions 
 
The main conclusions from the work in this chapter were as follows: 
 
1) The preservative susceptibility of the P. aeruginosa panel was highly variable.  There is a 
possibility that strains of IND origin have a higher tolerance to the isothiazolinone 
preservatives and PHE than strains from other isolation sources, and strains of CF origin 
have a lower overall tolerance to preservatives.  Further investigation with a larger 
strain panel is required to confirm this.  
 
2) The growth dynamics and motility of strains within the P. aeruginosa strain panel were 
also very variable and motility did not appear to be linked to isolation source. These 
findings are in concordance with the theory that P. aeruginosa isolates from different 
environments are functionally indistinguishable from one another, but further work 
with a larger strain panel is required to obtain more conclusive results. 
 
3) The combination of CITMIT and the efflux pump inhibitor PAβN displayed the most 
efficacious anti-P. aeruginosa activity, having an additive or synergistic interaction for 9 
out of the 10 P. aeruginosa strains tested. It can also be hypothesised from these findings 
that efflux is involved in the resistance of P. aeruginosa to isothiazolinone preservatives. 
 
4) The development of adaptive resistance to a preservative combination was observed in 
both planktonic growth and biofilm models, although the stability of the resistance is 
unknown. The biofilm model of adaptive resistance has potential for further 
development to investigate adaptation to preservatives used in industry. 
 
 
The hypotheses proposed at the beginning of this chapter were accepted: 
 
Hypothesis 1: The phenotypic characteristics of P. aeruginosa strains are highly variable and 
unlinked to habitat 
Hypothesis 2: Adaptive resistance can be developed to a preservative combination in 
planktonic and biofilm growth models, where P. aeruginosa can grow in concentrations of the 
preservative combination above the MIC level for the ancestral strain. 
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7. General conclusions, discussion and future research 
 
7.1 Conclusions 
 
A novel and comprehensive study of P. aeruginosa as a bacterial contaminant of HPC products 
was conducted.  Both culture-dependent and culture-independent methods for the detection of 
the species from HPC products were investigated, and the applicability of the detection methods 
to industrial practices considered. The strain diversity of P. aeruginosa in industry was 
examined and related to the overall population biology of the species. Furthermore, the 
bacterial diversity encountered in HPC products was assessed to determine the species 
associated with HPC product contamination incidents.  In addition, a panel of P. aeruginosa 
strains from diverse isolation sources were characterised for their susceptibility to commonly 
used HPC preservatives, growth and motility characteristics, to determine any links between 
isolation source and phenotype. Finally, the evolution of resistance to a preservative 
combination was investigated using both planktonic growth and biofilm models. 
 
The main conclusions from the study are as follows: 
 
1. Culture-dependent detection of P. aeruginosa in industry can be complemented by 
culture-independent detection methods involving direct DNA extraction from HPC 
products and the application of species-specific PCRs (Chapter 3 and 4). 
 
Culture-dependent methods are used routinely in industry to detect bacterial contaminants but 
can lack selectivity, may introduce a culture bias and neglect the detection of VBNC 
microorganisms. Selective agars containing cetrimide as the selective agent are recommended 
for the detection of P. aeruginosa from HPC products. Whilst the comparative agar study 
conducted in Chapter 3 demonstrated that the cetrimide-based agar PCN performed the best 
overall, the selectivity of the agar was relatively low (34% after 24 hours incubation at 37°C).  
Few studies have extracted nucleic acids directly from HPC products without a prior culture 
enrichment step.  The work in Chapter 4, however, demonstrated that DNA may be extracted 
from a variety of contaminated HPC product types using a standardised and automated system: 
the Maxwell®16 instrument and tissue DNA extraction kits.  
 
A novel species-specific PCR for P. aeruginosa using phzS as the target gene was designed and 
evaluated using both a strain panel and contaminated HPC products. The phzS PCR showed 
potential as a new molecular diagnostic for P. aeruginosa, having 100% sensitivity and 
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specificity. The phzS PCR also matched the performance of the widely used oprL gene PCR  (De 
Vos et al. 1997). Application of species-specific PCRs could improve the identification of 
contaminants, particularly those which are difficult to cultivate or distinguish from mixtures of 
contaminants where colony morphologies are similar. Further work is needed to more 
accurately determine detection limits of the phzS PCR.  The use of HPC product samples 
artificially spiked with known numbers of cells and the development of a phzS qPCR could 
facilitate this. 
 
2. The bacterial diversity associated with HPC products is low and a combination of 
both culture-independent and culture-independent approaches gives the most 
comprehensive assessment of contaminating species (Chapter 4). 
 
This was the first study to use both culture-dependent and –independent techniques to assess 
the bacterial diversity associated with contaminated HPC products. Overall, bacterial diversity 
was low and contamination was largely due to one dominant genus, with no more than 3 genera 
being observed in total (Pseudomonas, Enterobacter and Herbaspirillum). This corroborated 
previous findings from studies of product recall data (Wong et al. 2000; Jimenez 2007; Lundov 
and Zachariae 2008; Sutton and Jimenez 2012), but was a much more thorough investigation, 
using a 16S rRNA gene metataxonomic sequencing approach.  Limitations with both culture-
dependent and culture-independent approaches, including issues with product neutralisation 
and the presence of potential PCR inhibitors, indicated that a combination of both approaches 
was necessary to fully catalogue the bacterial diversity present. 
 
3. P. aeruginosa has a non-clonal epidemic population structure and industrial P. 
aeruginosa strains are genotypically and phenotypically similar to strains from 
cystic fibrosis, clinical and environmental sources (Chapter 5 and 6).  
 
The strain diversity and population biology of P. aeruginosa in industry have not previously 
been investigated.  Using five genotyping techniques (RAPD, AT-typing, MLST, rMLST and 
wgMLST) the work in Chapter 5 determined that P. aeruginosa strains from industrial sources 
were diverse and that there was no association between strain type and HPC product type. In 
addition, industrial strains were a mixture of novel and previously found genotypes, and the 
previously found genotypes were linked to multiple habitats. AT-typing and eBURST analysis of 
a database containing 941 P. aeruginosa strains demonstrated that overall the P. aeruginosa 
population structure was non-clonal epidemic.  Only 1.7% of the database strains originated 
from industry, however, indicating the need for a strain panel which is more balanced with 
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regards to isolation source.  In general, no major phenotypic differences were identified 
between strains from cystic fibrosis, clinical, environmental or industrial sources (Chapter 6), 
further corroborating the lack of habitat selection displayed by P. aeruginosa. Whilst the 
preservative susceptibilities of the industrial strains appeared lower than the rest of the panel, 
this was not shown to be statistically significant. In addition, the growth dynamics and motility 
characteristics were highly variable across the whole panel of P. aeruginosa isolates. 
 
4. Bacterial genotyping methods may be of use to industry to identify persistent 
strains within the industrial environment (Chapter 5). 
 
Where bacterial strains have been cultivated from industrial products or from the industrial 
environment, genotyping techniques can be used to identify problematic or recurrent strain 
types. In this study three strains isolated from contaminated DWL in Italy were found to have 
the same genotype, despite being collected 6 years apart; RW130 and RW131 were isolated in 
2010, and RW146 in 2004. This indicates persistence of the strain type in the industrial 
environment which may be linked to recurrent contamination of products. Interestingly, 
although the same AT-genotype and ST, the three strains had varying preservative 
susceptibilities. The growth curve parameters for the strains could not be determined but all 
three strains reached a similar culture density by 15 hours (Figure 6.3), had similar swimming 
and swarming characteristics (Table 6.8), and did not display twitching motility. In addition, the 
strains had an atypical swimming motility morphology (Figure 6.6) not seen for other panel 
strains, suggesting potential adaptation to the industrial environment. 
 
5. Evolution of adaptive resistance to a preservative combination can be achieved 
using both planktonic growth and biofilm models. Further development of the 
biofilm model could prove useful in understanding the development of adaptive 
resistance in industrial settings (Chapter 6).   
 
The development of adaptive resistance to preservatives is poorly understood and the majority 
of previous studies have looked at planktonic growth in the presence of a single preservative. To 
more accurate model preservative adaptation, this study examined planktonic and biofilm 
growth and used a preservative combination, as would be found in HPC products. P. aeruginosa 
grew in elevated levels of preservatives in both models. Whether the increased tolerance was 
stable needs to be further investigated, but this preliminary work has suggested that the biofilm 
bead model (Traverse et al. 2013) is applicable to studying the evolution of preservative 
resistance. 
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7.2 Discussion and future research 
 
In the majority of scientific literature, P. aeruginosa is most commonly recognised as an 
opportunistic pathogen associated with the nosocomial environment.  As such, relatively little is 
known about P. aeruginosa in environmental niches or industrial settings. In addition, whilst the 
resistance of P. aeruginosa to antibiotics is well documented, the mechanisms of preservative 
resistance are poorly understood. This study has provided insight into P. aeruginosa in industry, 
focussing on the detection, diversity and genotypic and phenotypic characterisation of strains 
found as contaminants of HPC products. In this section, the results of the study will be discussed 
with reference to industrial practices and future directions will be suggested.  
 
7.2.1 P. aeruginosa in industry 
 
7.2.1.1 Can the detection of P. aeruginosa in HPC products be improved?  
 
The detection of P. aeruginosa and other microbial contaminants of HPC products is currently 
largely reliant on culture-dependent methods, the limitations of which have been previously 
discussed. The development of new selective media for the improved detection of P. aeruginosa 
is unlikely; the only novel media developed for this purpose in the last decade (chromID Pa) 
(Laine et al. 2009) was demonstrated in Chapter 3 to have inferior sensitivity to the widely used 
cetrimide-based agar PCN. Alternative and more recently developed, ‘rapid’ methods such as 
ATP-bioluminescence, impedance and flow cytometry are available (Jimenez 2001b), but 
estimate total bioburden rather than identifying specific species. The inclusion of culture-
independent methods in routine contaminant detection procedures would therefore benefit 
industry, affording increased detection sensitivity and specificity. With the optimisation of DNA 
extraction and PCR protocols, it is also likely that the detection limits could drop below 102 
cfu/g of product.  
 
The implementation of such procedures may be challenging, however, as the introduction of a 
new process into a company has many considerations. In the instance of contaminant detection 
in non-sterile products, the guidelines of professional organisations such as the PCPC, FDA, SCCS 
and Cosmetics Europe (see section 1.1.2), and any specified in-house standards, must be taken 
into account to ensure product quality and safety.  Furthermore, multi-national companies have 
to consider standardisation and harmonisation of new processes, which aims to achieve results 
that are comparable between different regions (Tate and Panteghini 2007). If culture-
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independent detection methods were deemed suitable for contaminant identification, their 
company-wide implementation would require a huge concerted effort.  Considerations would 
include, but not be limited to, overall costings, equipment and reagent purchases, equipment 
maintenance, theoretical and technical training for personnel, the development of standard 
operating procedures (SOPs) for personnel and risk assessment documentation. 
 
7.2.1.2 Sources of contamination in industrial settings 
 
The manufacture of HPC products is not conducted in a sterile environment, and this combined 
with the large scale of production provides numerous opportunities for product contamination 
to occur. Whilst good manufacturing practices (GMPs) are strictly followed to reduce microbial 
contamination (Perry 2001), it is not possible to eliminate the risk completely. Contamination 
may arise from raw materials or the manufacturing environment, where the design of the 
process equipment and plant cleanliness will contribute to the microbial bioburden found in 
finished products (Maukonen et al. 2003). Water is used extensively in manufacture, both as a 
raw material and to rinse and clean equipment, floors and walls (Jimenez 2007), and is a 
potentially major source of microbial contamination.  Gram-negative genera including 
Pseudomonas, Burkholderia, Alcaligenes, Stenotrophomonas, Ralstonia, Serratia and 
Flavobacterium are commonly found in water samples and may form biofilms in water storage 
and distribution systems (Jimenez 2007). Certain points within piping systems, such as dead-
ends, corners, cracks, and joints, are conducive to the formation of biofilms, which can be 
difficult to eradicate and may act as a reservoir for microorganisms (Maukonen et al. 2003).  It is 
therefore important that sampling valves are positioned throughout the system to monitor 
water quality, and effective decontamination measures are in place (Maukonen et al. 2003; 
Kawai et al. 2004).  
 
7.2.1.3 Is the industrial environment an important niche for P. aeruginosa? 
 
P. aeruginosa is postulated to be a predominantly aquatic microorganism in the natural 
environment (Selezska et al. 2012) and has minimal nutritional requirements which facilitate its 
survival in distilled water (Favero et al. 1971; Kayser et al. 1975). Together with a propensity to 
form biofilms, these characteristics make P. aeruginosa a likely contaminant of industrial water 
systems and raw materials with high water content. It is possible that P. aeruginosa is present 
throughout industrial manufacturing systems, but no studies have sampled this environment 
specifically for P. aeruginosa.  Whilst this study (Chapter 5) demonstrated that industrial strains 
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were diverse and there was no link between strain type and product type, only contaminants 
isolated from HPC product samples were surveyed.   
 
Further questions remain therefore, including: (i) what is the diversity of P. aeruginosa strains 
associated with industrial manufacturing sites, and how does this relate to global P. aeruginosa 
diversity? (ii) is the diversity equivalent to that found in industrial products, or is there a sub-
group of P. aeruginosa strains selected for in products? (iii) what are the main sources of 
bacterial contamination in industry? An approach such as that of Quick et al. (Quick et al. 2014) 
could be applied to industrial settings to investigate this. Quick et al. used WGS and 
metagenomics to trace the source of P. aeruginosa infections in burn victims at a recently 
opened hospital. Genomes of 144 P. aeruginosa isolates from patients, the hospital environment, 
water outlets and water samples were sequenced, in addition to the metagenome of a biofilm 
recovered from a thermostatic mixer valve. Phylogenetic analysis of study isolates and a global 
strain collection identified 8 distinct clades but found no overt association between genotype 
and ecological setting.  In addition, genotypes of isolates recovered from patients were linked to 
isolates from water outlets in their rooms, suggesting transmission from the hospital water 
system.   
 
In industry, this study design would translate to sampling different points within manufacturing 
environments, water distribution systems, raw materials and finished products. The genomes of 
recovered isolates could then be compared to each other and also combined with a data from a 
global collection of P. aeruginosa strains, as performed by Quick et al. (Quick et al. 2014).  Large-
scale sequencing projects such as this can provide unparalleled insight into the epidemiology 
and population biology of P. aeruginosa, but would benefit from balanced numbers of isolates 
from different sources (Spratt and Maiden 1999), including industry, to provide a more 
balanced view of population structure. 
 
7.2.2 P. aeruginosa resistance to preservatives 
 
7.2.2.1 Improving the understanding of preservative resistance 
 
P. aeruginosa is well documented to have resistance to multiple classes of antimicrobials (Poole 
2011), including preservatives (McDonnell and Russell 1999). In contrast to antibiotics, which 
have well defined targets within bacterial cells, preservative modes of action are poorly 
understood although believed to involve multiple cellular target sites (Maillard 2002). Similarly 
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the preservative resistance mechanisms employed by bacteria are not well characterised.  It is 
likely, however, that both intrinsic mechanisms, such as low overall outer membrane 
permeability and efflux systems (see section 1.3.2), and adaptive resistance mechanisms 
including biofilm formation (see section 1.3.4 and 1.3.5) are important in P. aeruginosa 
(McDonnell and Russell 1999).  
 
In industry, the exposure of microorganisms to sub-lethal concentrations of preservatives may 
trigger the development of adaptive resistance (Jimenez 2007). Adaptive resistance 
mechanisms for P. aeruginosa have been identified as generally nonspecific, involving changes 
in outer membrane proteins (Brozel and Cloete 1994; Abdel Malek et al. 2009; Abdel Malek and 
Badran 2010), fatty acid profiles of membranes (Jones et al. 1988; Méchin et al. 1999; Loughlin 
et al. 2002) and increased efflux (Abdel Malek et al. 2009). Adaptive resistance to a preservative 
combination was observed in this study (Chapter 6) using both planktonic and biofilm growth 
models. It is unknown whether this resistance was stable, whether adapted derivatives 
displayed cross-resistance to other antimicrobial agents, and what the underlying molecular 
mechanisms were, warranting further research in this area. 
 
To gain a greater understanding of the processes involved in the development of adaptive 
resistance, further work with the planktonic and biofilm models used in Chapter 6 could be 
performed. Experimental evolution models such as these are controlled and replicable, and 
allow changes in fitness can be tracked directly through sampling at different time points 
(Dettman et al. 2012).  When these experiments are combined with WGS, genome sequences of 
ancestral, intermediate and evolved strains can provide a record of the genetic changes which 
have occurred over the course of the experiment (Dettman et al. 2012). Whilst this has not been 
used for preservative adaptation yet, it has been used for P. aeruginosa adaptation to antibiotics 
(Wong et al. 2012), and for biofilm formation in Burkholderia (Poltak and Cooper 2011). 
Comparisons between genome sequences of an ancestral P. aeruginosa strain and derivatives 
grown in the presence of preservatives could reveal mutations underlying adaptation. 
 
It is also likely that changes in gene expression in response to preservative exposure are 
important in the development of adaptive resistance. Transcriptomic studies examine gene 
expression on a global scale, and can provide a ‘snapshot’ of a microorganisms’s response to 
variations in environmental conditions (Balasubramanian and Mathee 2009).  Detection and 
quantification of RNA transcripts has been performed for P. aeruginosa under numerous 
conditions including iron limitation, oxidative stress, osmotic stress, biofilm formation and 
interactions with human cells (Balasubramanian and Mathee 2009), although no studies have 
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yet looked at preservative exposure. Transcriptomic analysis using DNA microarray technology 
has been used to examine the molecular basis for adaptive resistance to CITMIT in B. lata, 
however, identifying altered expression of multiple genes involved in transport and highlighting 
efflux as an important resistance mechanism (Rushton et al. 2013). Interestingly, in this study 
the adaptation of Burkholderia to CITMIT was associated with a stably resistant phenotype and 
permanent changes in gene expression (Rushton et al. 2013).  A similar approach could be taken 
for P. aeruginosa exposure to the preservative combination used in this study, although taking 
advantage of RNA-seq as an improved method of transcriptional analysis (Croucher and 
Thomson 2010). 
 
7.2.2.2 The impact of understanding preservative resistance on industry 
 
Understanding how P. aeruginosa responds to stresses such as preservative exposure will lead 
to a better understanding of its success as an industrial contaminant, and inform preservation 
strategies. Experimental evolution models have the potential to highlight preservatives which 
bacteria can develop adaptive resistance to, and whether the adaptive resistance is stable. Much 
is currently unknown about the longevity of adaptive resistance (Fernández et al. 2011), with 
different studies reporting both transient (Brozel and Cloete 1994) and stable (Winder et al. 
2000; Rushton et al. 2013) increases in resistance in bacteria on exposure to sub-inhibitory 
preservative levels. Whilst the levels of preservatives in products are generally high enough to 
prevent growth or the development of adapted strains, exposure to sub-inhibitory levels of 
preservatives within the manufacturing environment is a possibility (Orus and Leranoz 2005). 
In addition, the persistence and recurrent contamination caused by a single P. aeruginosa strain 
type at an HPC manufacturing site (Chapter 5), is suggestive of the fact that strains can show an 
elevated fitness in the industrial environment, although in this instance the strain involved did 
not show specific preservative resistance adaptations. It may therefore be beneficial to include 
adapted bacterial strains in routine preservative efficacy testing (see section 1.1.2) strain panels 
for HPC products, as stably adapted strains may display higher levels of preservative resistance, 
increasing the stringency of the challenge testing procedure. 
 
Where different antimicrobials act upon the same cellular target or cellular pathways, there is 
the potential for cross-resistance to develop (Chapman 2003b). As preservative mechanisms of 
action are considered to be general and bacterial preservative resistance mechanisms thought 
to be non-specific, the development of cross-resistance between preservatives and other 
antimicrobial classes is of concern (Russell 2000). For P. aeruginosa, adaptive resistance to 
biocides has been linked with an increased tolerance to other classes of biocides and antibiotics 
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(Adair et al. 1969; Jones et al. 1988; Loughlin et al. 2002; Langsrud et al. 2003; Abdel Malek et al. 
2009; Abdel Malek and Badran 2010). In industry, this information could inform the 
development of preservative systems, which usually comprise two or more compounds with 
different modes of action (Orus and Leranoz 2005), to combat the emergence of resistant 
strains in products (Orth et al. 2006). Furthermore, the rotation of biocides used as 
disinfectants in industrial settings is supported (Langsrud et al. 2003), but if cross-resistance is 
occurring then the efficacy of the regimen will be compromised.  Determining which biocides 
are affected by this phenomenon would improve industrial practices. 
 
Identifying resistance mechanisms may also further help with product formulation through the 
selection of appropriate preservative enhancing agents.  For example, the inclusion of chelating 
agents such as EDTA in formulations increases the permeability of Gram-negative cell 
membranes, potentiating the activity of numerous classes of antimicrobial agents.  The study by 
Rushton et al. (Rushton et al. 2013) demonstrated an increase in the susceptibility of B. lata to 
the isothiazolinone preservative CITMIT in the presence of the efflux pump inhibitor PaβN.  This 
PhD (Chapter 6) also found that in 9 out of the 10 P. aeruginosa strains tested, there was an 
additive/synergistic relationship between CITMIT and PaβN. These results suggest that efflux 
may be involved in resistance to CITMIT.  The inhibition of microbial efflux may therefore be a 
valid strategy to improve the performance of certain antimicrobial agents (Tegos et al. 2011). 
The stability of efflux pump inhibitors in product formulations, however, would also have to be 
considered for use in the HPC industry. 
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7.3 Perspectives 
 
This study has re-enforced the fact that P. aeruginosa is a truly ubiquitous microorganism. The 
association of the species with water poses significant problems for the HPC industry where 
water is an important raw material and used in plant cleaning operations. Owing to its 
metabolic versatility, high levels of antimicrobial resistance and ability to form biofilms, P. 
aeruginosa would be extremely difficult to eliminate from the industrial environment. Improved 
methods for the detection of P. aeruginosa, both from water distribution systems and HPC 
products, would therefore be beneficial to manufacturers. As it is very difficult to implement 
new procedures within a multinational company, culture-independent detection methods could 
be trialled to complement, rather than replace, current culture-dependent practices. 
Furthermore, the application of WGS to bacterial isolates from industry, as has already been 
performed in the nosocomial environment, could highlight sources of contamination and further 
investigate P. aeruginosa population biology. Finally, continued research into the preservative 
resistance mechanisms of P. aeruginosa has the potential to inform the design of preservative 
systems and efficacious factory decontamination measures. 
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